FUNGICIDAL PYRIDINE COMPOUNDS

Abstract

The present invention relates to compounds of formula I

##STR00001##

wherein the variables are defined as given in the description and claims. The invention further relates to uses and composition for compounds of formula I.

Claims

1-21. (canceled)

22: A compound of formula I ##STR00749## wherein R.sup.1 is in each case independently selected from H, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with substituents R.sup.xt independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the acyclic moieties of R.sup.1 are unsubstituted or substituted with groups R.sup.1a which independently of one another are selected from: R.sup.1a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or substituted with substituents R.sup.11a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.1 are unsubstituted or substituted with groups R.sup.1b which independently of one another are selected from: R.sup.1b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio; R.sup.2 is in each case independently selected from H, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein R.sup.x is as defined above; wherein the acyclic moieties of R.sup.2 are unsubstituted or substituted with groups R.sup.2a which independently of one another are selected from: R.sup.2a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein phenyl group is unsubstituted or substituted with substituents R.sup.21a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.2 are unsubstituted or substituted with groups R.sup.2b which independently of one another are selected from: R.sup.2b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio; R.sup.3, R.sup.4 are independently selected from halogen, OH, CN, NO.sub.2, SH, C.sub.1-C.sub.6-alkylthio, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.2-C.sub.6-alkenyloxy, C.sub.2-C.sub.6-alkynyloxy, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl, aryl and phenoxy; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R and R are independently selected from H, C.sub.1-C.sub.4-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, saturated or partially unsaturated three-, four-, five, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein R and R are independently unsubstituted or substituted with R which is independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and phenyl; and wherein R.sup.x is as defined above; or wherein the acyclic moieties of R.sup.3 and R.sup.4 are independently not further substituted or carry 1, 2, 3 or up to the maximum possible number of identical or different groups R.sup.3a or R.sup.4a, respectively, which independently of one another are selected from: R.sup.3a, R.sup.4a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, aryl, phenoxy, a five-, six- or ten-membered heteroaryl; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S); wherein the heterocycle and the heteroaryl contain independently 1, 2, 3 or 4 heteroatoms selected from N, O and S; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S); wherein the carbocyclic, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl; and wherein R.sup.x, R, R and R are as defined above; n is 0, 1, 2; and wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R.sup.3 and R.sup.4 are independently not further substituted or carry 1, 2, 3, 4, 5 or up to the maximum number of identical or different groups R.sup.3b or R.sup.4b, respectively, which independently of one another are selected from: R.sup.3b, R.sup.4b halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or substituted with substituents selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; and wherein R.sup.x and n are as defined above; or R.sup.3, R.sup.4 together with the carbon atom to which they are bound form a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle; wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, wherein the heteroatom N may carry one substituent R.sup.N selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one, two or three substituents selected from CN, C.sub.1-C.sub.4-alkyl, halogen, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; and wherein the heteroatom S may be in the form of its oxide SO or SO.sub.2, and wherein the carbocycle or heterocycle is unsubstituted or carries one, two, three or four substituents R.sup.34 independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents R.sup.34a selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S); and R.sup.5 is halogene; R.sup.6 is halogene; R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl or five- or six-membered heteroaryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein the ring A is substituent by (R.sup.78).sub.o, wherein o is 0, 1, 2 or 3; and R.sup.78 are independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)NH(C.sub.1-C.sub.6-alkyl), CRNOR, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.2-C.sub.6-alkenyloxy, C.sub.2-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, three-, four-, five- or six-membered saturated or partially unsaturated heterocycle, five- or six-membered heteroaryl and phenyl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein n, R.sup.x, R and R is as defined above; and wherein the acyclic moieties of R.sup.78 are not further substituted or carry 1, 2, 3 or up to the maximum possible number of identical or different groups R.sup.78a which independently of one another are selected from: R.sup.78a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.3-C.sub.6-halogencycloalkenyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl and phenyl group is unsubstituted or unsubstituted or substituted with R.sup.78a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R.sup.78 are unsubstituted or substituted with identical or different groups R.sup.78b which independently of one another are selected from: R.sup.78b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, and C.sub.1-C.sub.6-alkylthio; R.sup.9 is in each case independently selected from H, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C.sub.2-C.sub.4-alkenyl), N(C.sub.2-C.sub.4-alkenyl).sub.2, NH(C.sub.2-C.sub.4-alkynyl), N(C.sub.2-C.sub.4-alkynyl).sub.2, NH(C.sub.3-C.sub.6-cycloalkyl), N(C.sub.3-C.sub.6-cycloalkyl).sub.2, N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkenyl), N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkynyl), N(C.sub.1-C.sub.4-alkyl)(C.sub.3-C.sub.6-cycloalkyl), N(C.sub.2-C.sub.4-alkenyl)(C.sub.2-C.sub.4-alkynyl), N(C.sub.2-C.sub.4-alkenyl)(C.sub.3-C.sub.6-cycloalkyl), N(C.sub.2-C.sub.4-alkynyl)(C.sub.3-C.sub.6-cycloalkyl), NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, C.sub.1-C.sub.6-cycloalkylthio, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)C.sub.2-C.sub.6-alkenyl, C(O)C.sub.2-C.sub.6-alkynyl, C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)NH(C.sub.1-C.sub.6-alkyl), CH(S), C(S)C.sub.1-C.sub.6-alkyl, C(S)C.sub.2-C.sub.6-alkenyl, C(S)C.sub.2-C.sub.6-alkynyl, C(S)C.sub.3-C.sub.6-cycloalkyl, C(S)NH(C.sub.1-C.sub.6-alkyl), C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, OR.sup.v, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein R.sup.x is as defined above; R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, phenyl and phenyl-C.sub.1-C.sub.6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the acyclic moieties of R.sup.9 are unsubstituted or substituted with groups R.sup.9a which independently of one another are selected from: R.sup.9a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substituents R.sup.91a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.9 are unsubstituted or substituted with groups R.sup.9b which independently of one another are selected from: R.sup.9b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio; R.sup.10 is in each case independently selected from the substituents as defined for R.sup.9, wherein the possible substituents for R.sup.10 are R.sup.10a and R.sup.10b, respectively, which correspond to R.sup.9a and R.sup.9b, respectively; R.sup.9, R.sup.10 together with the carbon atoms to which they are bound form a five-, six-, or seven-membered carbo-, heterocyclic or heteroaromatic ring; wherein the heterocyclic or heteroaromatic ring contains 1, 2, 3 or 4 heteroatoms selected from N, O and S, wherein N may carry one substituent R.sup.N and wherein S may be in the form of its oxide SO or SO.sub.2; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S); and wherein the carbo-, heterocyclic or heteroaromatic ring is substituent by (R.sup.11).sub.m, wherein m is 0, 1, 2, 3 or 4; R.sup.N is as defined above; R.sup.11 is in each case independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains 1, 2 or 3 heteroatoms selected from N, O and S; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S); and wherein R.sup.x is as defined above; wherein the acyclic moieties of R.sup.11 are unsubstituted or carry 1, 2, 3 or up to the maximum possible number of identical or different groups R.sup.11a which independently of one another are selected from: R.sup.11a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the phenyl group is unsubstituted or unsubstituted or substituted with R.sup.111a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-alkylthio; wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R.sup.11 are unsubstituted or substituted with identical or different groups R.sup.11b which independently of one another are selected from: R.sup.11b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, and C.sub.1-C.sub.6-alkylthio; R.sup.12 is in each case independently selected from hydrogen, OH, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)C.sub.2-C.sub.6-alkenyl, C(O)C.sub.2-C.sub.6-alkynyl, C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)O(C.sub.2-C.sub.6-alkenyl), C(O)O(C.sub.2-C.sub.6-alkynyl), C(O)O(C.sub.3-C.sub.6-cycloalkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.2-C.sub.6-alkenyl), C(O)NH(C.sub.2-C.sub.6-alkynyl), C(O)NH(C.sub.3-C.sub.6-cycloalkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, C(O)N(C.sub.2-C.sub.6-alkenyl).sub.2, C(O)N(C.sub.2-C.sub.6-alkynyl).sub.2, C(O)N(C.sub.3-C.sub.6-cycloalkyl).sub.2, CH(S), C(S)C.sub.1-C.sub.6-alkyl, C(S)C.sub.2-C.sub.6-alkenyl, C(S)C.sub.2-C.sub.6-alkynyl, C(S)C.sub.3-C.sub.6-cycloalkyl, C(S)O(C.sub.1-C.sub.6-alkyl), C(S)O(C.sub.2-C.sub.6-alkenyl), C(S)O(C.sub.2-C.sub.6-alkynyl), C(S)O(C.sub.3-C.sub.6-cycloalkyl), C(S)NH(C.sub.1-C.sub.6-alkyl), C(S)NH(C.sub.2-C.sub.6-alkenyl), C(S)NH(C.sub.2-C.sub.6-alkynyl), C(S)NH(C.sub.3-C.sub.6-cycloalkyl), C(S)N(C.sub.1-C.sub.6-alkyl).sub.2, C(S)N(C.sub.2-C.sub.6-alkenyl).sub.2, C(S)N(C.sub.2-C.sub.6-alkynyl).sub.2, C(S)N(C.sub.3-C.sub.6-cycloalkyl).sub.2, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, OR.sup.Y, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, S(O).sub.nC.sub.1-C.sub.6-alkoxy, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, S(O).sub.naryl, SO.sub.2NH(C.sub.1-C.sub.6-alkyl), SO.sub.2NH(C.sub.1-C.sub.6-halogenalkyl), SO.sub.2NH-aryl, tri-(C.sub.1-C.sub.6 alkyl)silyl and di(C.sub.1-C.sub.6 alkoxy)phosphoryl), five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; R.sup.Y is defined above; wherein the acyclic moieties of R.sup.12 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.12a which independently of one another are selected from: R.sup.12a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.3-C.sub.6-halogencycloalkenyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl, phenyl and phenoxy group is unsubstituted or carries one, two, three, four or five substituents R.sup.12a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.12 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.12b which independently of one another are selected from: R.sup.12b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio; and the N-oxides and the agriculturally acceptable salts thereof.

23: The compound of claim 22, wherein R.sup.1 and R.sup.2 are independently selected from H, halogen, and C.sub.1-C.sub.6-alkyl.

24: The compound of claim 22, wherein R.sup.3 and R.sup.4 are independently selected from C.sub.1-C.sub.4-alkyl and C.sub.1-C.sub.4-halogenalkyl.

25: The compound of claim 22 wherein R.sup.5 and R.sup.6 are fluor.

26: The compound of claim 22, wherein R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl, wherein the phenyl carries zero, one, two, three or four substituents (R.sup.78).sub.o.

27: The compound of claim 22, wherein R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein the heteroaryl carries zero, one, two, three or four substituents (R.sup.78).sub.o.

28: The compound of claim 22, wherein R.sup.78 is in each case halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, CN.

29: The compound of claim 22, wherein R.sup.9 and R.sup.10 are independently are selected from H, CN, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkynyl, OR.sup.Y, C.sub.3-C.sub.6-cycloalkyl. R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl or C.sub.2-C.sub.6-alkynyl.

30: The compound of claim 22, wherein R.sup.12 is hydrogen, C(O)C.sub.1-C.sub.6-alkyl, C(O)OC.sub.1-C.sub.6-alkyl, C(O)NHC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, SO.sub.2NH(C.sub.1-C.sub.6-alkyl), OH, OR.sup.Y or C.sub.1-C.sub.4-alkyl.

31: A composition comprising one compound of formula I, as defined in claim 22, an N-oxide or an agriculturally acceptable salt thereof.

32: The composition according to claim 31, comprising additionally a further active substance.

33: A method for combating phytopathogenic fungi, comprising treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of at least one compound of formula I, as defined in claim 22.

34: Seed, coated with at least one compound of the formula I, as defined in claim 22, in an amount of from 0.1 to 10 kg per 100 kg of seed.

35: A process for the synthesis of compound of the formula I of claim 22, comprising the a) step of reacting a compound B ##STR00750## wherein R.sup.3, R.sup.4, R.sup.7 and R.sup.8 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen; and Y is selected from the group consisting of H, S(O)yY.sup.1, wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 5-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy; and C(O)OY.sup.2, wherein Y.sup.2 is H, C.sub.1-C.sup.10-alkyl, C.sub.1-C.sub.10-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co, Cs, Fe, B, Al Ti, Zn or Pd; and S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup. wherein Y.sup.1 has the meanings mentioned above Y.sup.3 is C.sub.1-C.sub.4-alkyl Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3; b) directly to compound of the formula I or optionally via compound of the formula II ##STR00751## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 22 and R.sup.5, R.sup.6 are H or halogen.

36: An intermediate compound B of formula, ##STR00752## wherein R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.5 is H and halogen; R.sup.6 is H and halogen; R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; Y is selected from the group consisting of H, S(O)yY.sup.1, wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 6-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy; and C(O)OY.sup.2, wherein Y.sup.2 is H, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co; Cs, Fe, B, Al Ti, Zn or Pd and their Cl salts and hydrooxides; and S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup. wherein Y.sup.1 has the meanings mentioned above Y.sup.3 is C.sub.1-C.sub.4-alkyl; Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3; with the proviso that if YH, R.sup.5 and R.sup.6 can not be H; and if YC(O)OY.sup.2 and R.sup.5 and R.sup.6 are H, Y.sup.2 cannot be C.sub.1-C.sub.6-alkyl and C.sub.1-C.sub.6-haloalkyl.

37: A process for the synthesis of compound of the formula I of claim 22, comprising the step of a) reacting a compound C ##STR00753## wherein R.sup.3, R.sup.4, R.sup.7 and R.sup.8 are as defined in claim 22, R.sup.5 is halogen, and R.sup.6 is halogen, b) directly to compound of the formula I or optionally via compound of the formula II ##STR00754## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen.

38: An intermediate compound C as defined in claim 37, wherein R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.5 is halogen; R.sup.6 is halogen; R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen.

39: An intermediate compound II according to claim 35, wherein ##STR00755## wherein R.sup.1 is H; R.sup.2 is H; R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.5 is H; R.sup.6 is H; R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being F or Cl; R.sup.9 is C.sub.1-C.sub.4-haloalkyl; R.sup.10 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy, with the proviso that R.sup.9 is not CF.sub.3 and CF.sub.2CF.sub.3.

40: A process for the synthesis of compound of the formula I of claim 22, comprising the step of reacting a compound D ##STR00756## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 22 and R.sup.5, R.sup.6 are H or halogen and D is O or S.

41: An intermediate compound D according to claim 40, wherein R.sup.1 is H; R.sup.2 is H; R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; R.sup.5 is H, halogen; R.sup.6 is H; halogen, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being F or Cl; R.sup.9 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy; R.sup.10 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy.

Description

[0166] In the following, particular embodiments of the inventive compounds are described. Therein, specific meanings of the respective substituents are further detailed, wherein the meanings are in each case on their own but also in any combination with one another, particular embodiments of the present invention.

[0167] Furthermore, in respect of the variables, generally, the embodiments of the compounds I also apply to the intermediates. [0168] R.sup.1 according to the invention is in each case independently selected from hydrogen, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein [0169] R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x1 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0170] wherein the acyclic moieties of R.sup.1 are unsubstituted or substituted with identical or different groups R.sup.1a which independently of one another are selected from: [0171] R.sup.1a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or unsubstituted or substituted with R.sup.11a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0172] wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.1 are unsubstituted or substituted with identical or different groups R.sup.1b which independently of one another are selected from: [0173] R.sup.1b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0174] For every R.sup.1 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R.sup.1 that may be present in the ring.

[0175] According to one embodiment of formula I, R.sup.1 is H, halogen or C.sub.1-C.sub.6-alkyl, in particular H, CH.sub.3, Et, F, Cl, more specifically H, CH.sub.3, F or Cl most preferred H, F or Cl.

[0176] According to another embodiment of formula I, R.sup.1 is hydrogen.

[0177] According to still another embodiment of formula I, R.sup.1 is halogen, in particular Br, F or Cl, more specifically F or Cl.

[0178] According to another embodiment of formula I, R.sup.1 is F

[0179] According to another embodiment of formula I, R.sup.1 is Cl

[0180] According to another embodiment of formula I, R.sup.1 is Br.

[0181] According to still another embodiment of formula I, R.sup.1 is OH.

[0182] According to still another embodiment of formula I, R.sup.1 is CN.

[0183] According to still another embodiment of formula I, R.sup.1 is NO.sub.2.

[0184] According to still another embodiment of formula I, R.sup.1 is SH.

[0185] According to still another embodiment of formula I R.sup.1 is NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2 or NHSO.sub.2R.sup.x, wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x1 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, or C.sub.1-C.sub.4-halogenalkoxy. In particular C.sub.1-C.sub.4-alkyl, such as NHCH.sub.3 and N(CH.sub.3).sub.2. In particular R.sup.x is C.sub.1-C.sub.4-alkyl, and phenyl that is substituted with one CH.sub.3, more specifically SO.sub.2R.sup.x is CH3 and tosyl group (Ts).

[0186] According to still another embodiment of formula I, R.sup.1 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3 or CH.sub.2CH.sub.3.

[0187] According to still another embodiment of formula I, R.sup.1 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CHF.sub.2, CH.sub.2F, CCl.sub.3, CHCl.sub.2, CH.sub.2Cl, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0188] According to still another embodiment of formula I, R.sup.1 is C.sub.2-C.sub.6-alkenyl or C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-alkenyl or C.sub.2-C.sub.4-halogenalkenyl, such as CHCH.sub.2, C(CH.sub.3)CH.sub.2, CHCCl.sub.2, CHCF.sub.2, CClCCl.sub.2, CFCF.sub.2, CHCH.sub.2, CH.sub.2CHCCl.sub.2, CH.sub.2CHCF.sub.2, CH.sub.2CClCCl.sub.2, CH.sub.2CFCF.sub.2, CCl.sub.2CHCCl.sub.2, CF.sub.2CHCF.sub.2, CCl.sub.2CClCCl.sub.2, or CF.sub.2CFCF.sub.2.

[0189] According to still another embodiment of formula I, R.sup.1 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CCCl, CCF. CH.sub.2CCH, CH.sub.2CCCl, or CH.sub.2CCF.

[0190] According to still another embodiment of formula I, R.sup.1 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0191] According to still another embodiment of formula I, R.sup.1 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0192] According to still another embodiment of formula I R.sup.1 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0193] According to still another embodiment of formula I, R.sup.1 is C.sub.3-C.sub.6-cycloalkyl, for example cyclopropyl, substituted with one, two, three or up to the maximum possible number of identical or different groups R.sup.1b as defined and preferably herein.

[0194] According to still another embodiment of formula I, R.sup.1 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.1 is fully or partially halogenated cyclopropyl.

[0195] According to still another embodiment of formula I, R.sup.1 is unsubstituted aryl or aryl that is substituted with one, two, three or four R.sup.1b, as defined herein. In particular, R.sup.1 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R.sup.1b, as defined herein.

[0196] According to still another embodiment of formula I, R.sup.1 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R.sup.1 is 5- or 6-membered heteroaryl that is substituted with one, two or three R.sup.1b, as defined herein.

[0197] According to still another embodiment of formula I, R.sup.1 is in each case independently selected from hydrogen, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy and C.sub.3-C.sub.6-cycloalkyl; wherein the acyclic moieties of R.sup.1 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.1a as defined below and wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.1 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.1b as defined below.

[0198] According to still another embodiment of formula I, R.sup.1 is independently selected from hydrogen, halogen, OH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy and C.sub.1-C.sub.6-halogenalkoxy, in particular independently selected from H, F, Cl, Br, CN, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0199] R.sup.1a are the possible substituents for the acyclic moieties of R.sup.1.

[0200] R.sup.1a according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or unsubstituted or substituted with R.sup.11a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-alkoxy and C.sub.1-C.sub.2-halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

[0201] In to one embodiment R.sup.1a is independently selected from halogen, OH, CN, C.sub.1-C.sub.2-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.1a is independently selected from F, Cl, OH, CN, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0202] According to one embodiment R.sup.1a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

[0203] According to still another embodiment of formula I, R.sup.1a is independently selected from OH, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.1a is independently selected from OH, cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0204] According to still another embodiment of formula I, R.sup.1a is independently selected from aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with R.sup.11a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-alkoxy and C.sub.1-C.sub.2-halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

[0205] R.sup.1b are the possible substituents for the carbocyclic, heteroaryl and aryl moieties of R.sup.1. R.sup.1b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy.

[0206] According to one embodiment thereof R.sup.1b is independently selected from halogen, CN, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.1b is independently selected from F, Cl, Br, OH, CN, CH.sub.3, OCH.sub.3, CHF.sub.2, OCHF.sub.2, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl, OCF.sub.3, and OCHF.sub.2.

[0207] According to still another embodiment thereof R.sup.1b is independently selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.1b is independently selected from halogen, CN, OH, CH.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and halogenmethoxy, more specifically independently selected from F, Cl, OH, CH.sub.3, OCH.sub.3,CHF.sub.2, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl, OCHF.sub.2 and OCF.sub.3.

[0208] R.sup.x in the substituent NHSO.sub.2R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl and aryl that is substituted with one, two, three, four or five substituents R.sup.x1 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy. In particular, R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN and phenyl that is substituted with one, two or three R.sup.x1 independently selected from C.sub.1-C.sub.2-alkyl, more specifically R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl and phenyl that is substituted with one CH.sub.3, more specifically SO.sub.2R.sup.x is the tosyl group (Ts).

[0209] Particularly preferred embodiments of R.sup.1 according to the invention are in Table P1 below, wherein each line of lines P1-1 to P1-16 corresponds to one particular embodiment of the invention. Thereby, for every R.sup.1 that is present in the inventive compounds, these specific embodiments and preferences apply independently of the meaning of any other R.sup.1 that may be present in the ring:

TABLE-US-00001 TABLE P1 Ts in the table stands for the tosylgroup SO.sub.2-(p-CH.sub.3)phenyl. No. R.sup.1 P1-1 H P1-2 Cl P1-3 F P1-4 Br P1-5 OH P1-6 CN P1-7 NO.sub.2 P1-8 CH.sub.3 P1-9 CH.sub.2CH.sub.3 P1-10 CF.sub.3 P1-11 CHF.sub.2 P1-12 OCH.sub.3 P1-13 OCH.sub.2CH.sub.3 P1-14 OCF.sub.3 P1-15 OCHF.sub.2 P1-16 NH-Ts [0210] R.sup.2 according to the invention is in each case independently selected from hydrogen, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein [0211] R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x2 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0212] wherein the acyclic moieties of R.sup.2 are unsubstituted or substituted with identical or different groups R.sup.2a which independently of one another are selected from: [0213] R.sup.2a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with R.sup.21a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0214] wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.2 are unsubstituted or substituted with identical or different groups R.sup.2b which independently of one another are selected from: [0215] R.sup.2b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0216] For every R.sup.2 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of the other R.sup.2 that may be present in the ring.

[0217] According to one embodiment of formula I, R.sup.2 is H, halogen or C.sub.1-C.sub.6-alkyl, in particular H, CH.sub.3, Et, F, Cl, more specifically H, CH.sub.3, F or Cl most preferred H, F or Cl.

[0218] According to another of formula I, R.sup.2 is halogen, in particular Br, F or Cl, more specifically F or Cl.

[0219] According to another embodiment of formula I, R.sup.2 is F

[0220] According to another embodiment of formula I, R.sup.2 is Cl

[0221] According to another embodiment of formula I, R.sup.2 is Br.

[0222] According to still another embodiment of formula I, R.sup.2 is hydrogen.

[0223] According to still another embodiment of formula I, R.sup.2 is OH.

[0224] According to still another embodiment of formula I, R.sup.2 is CN.

[0225] According to still another embodiment of formula I, R.sup.2 is NO.sub.2.

[0226] According to still another embodiment of formula I, R.sup.2 is SH.

[0227] In a further specific embodiment R.sup.2 is NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2 or NHSO.sub.2R.sup.x, wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x2 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, or C.sub.1-C.sub.4-halogenalkoxy. In particular C.sub.1-C.sub.4-alkyl, such as NHCH.sub.3 and N(CH.sub.3).sub.2. In particular R.sup.x is C.sub.1-C.sub.4-alkyl, and phenyl that is substituted with one CH.sub.3, more specifically SO.sub.2R.sup.x is CH.sub.3 and tosyl group (Ts).

[0228] According to still another embodiment of formula I, R.sup.2 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3 or CH.sub.2CH.sub.3.

[0229] According to still another embodiment of formula I, R.sup.2 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CHF.sub.2, CH.sub.2F, CCl.sub.3, CHCl.sub.2, CH.sub.2Cl, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0230] According to still a further embodiment, R.sup.2 is C.sub.2-C.sub.6-alkenyl or C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-alkenyl or C.sub.2-C.sub.4-halogenalkenyl, such as CHCH.sub.2, CHCCl.sub.2, CHCF.sub.2, CClCCl.sub.2, CFCF.sub.2, CHCH.sub.2, CH.sub.2CHCCl.sub.2, CH.sub.2CHCF.sub.2, CH.sub.2CClCCl.sub.2, CH.sub.2CFCF.sub.2, CCl.sub.2CHCCl.sub.2, CF.sub.2CHCF.sub.2, CCl.sub.2CClCCl.sub.2, or CF.sub.2CFCF.sub.2.

[0231] According to still a further embodiment, R.sup.2 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CCCl, CCF. CH.sub.2CCH, CH.sub.2CCCl, or CH.sub.2CCF.

[0232] According to still another embodiment of formula I, R.sup.2 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0233] According to still another embodiment of formula I, R.sup.2 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0234] In a further specific embodiment R.sup.2 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0235] In a further specific embodiment, R.sup.2 is C.sub.3-C.sub.6-cycloalkyl, for example cyclopropyl, substituted with one, two, three or up to the maximum possible number of identical or different groups R.sup.2b as defined and preferably herein.

[0236] According to still another embodiment of formula I, R.sup.2 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.2 is fully or partially halogenated cyclopropyl.

[0237] According to still another embodiment of formula I, R.sup.2 is unsubstituted aryl or aryl that is substituted with one, two, three or four R.sup.2b, as defined herein. In particular, R.sup.2 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R.sup.2b, as defined herein.

[0238] According to still another embodiment of formula I, R.sup.2 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R.sup.2 is 5- or 6-membered heteroaryl that is substituted with one, two or three R.sup.2b, as defined herein.

[0239] According to still another embodiment of formula I, R.sup.2 is in each case independently selected from hydrogen, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy and C.sub.3-C.sub.6-cycloalkyl; wherein the acyclic moieties of R.sup.2 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.2a as defined below and wherein the cycloalkyl moieties of R.sup.2 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.2b as defined below.

[0240] According to still another embodiment of formula I, R.sup.2 is independently selected from hydrogen, halogen, OH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy and C.sub.1-C.sub.6-halogenalkoxy, in particular independently selected from H, F, Cl, Br, CN, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0241] R.sup.2a are the possible substituents for the acyclic moieties of R.sup.2.

[0242] R.sup.2a according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with R.sup.22a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-alkoxy and C.sub.1-C.sub.2-halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

[0243] According to one embodiment R.sup.2a is independently selected from halogen, OH, CN, C.sub.1-C.sub.2-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.2a is independently selected from F, Cl, OH, CN, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0244] According to one embodiment R.sup.2a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

[0245] According to still another embodiment of formula I, R.sup.2a is independently selected from OH, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.2a is independently selected from OH, cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0246] According to still another embodiment of formula I, R.sup.2a is independently selected from aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with R.sup.22a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-alkoxy and C.sub.1-C.sub.2-halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

[0247] R.sup.2b are the possible substituents for the carbocyclic, heteroaryl and aryl moieties of R.sup.2.

[0248] R.sup.2b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky and C.sub.1-C.sub.4-halogenalkoxy.

[0249] According to one embodiment thereof R.sup.2b is independently selected from halogen, CN, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.2b is independently selected from F, Cl, Br, OH, CN, CH.sub.3, OCH.sub.3, CHF.sub.2, OCHF.sub.2, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl, OCF.sub.3, and OCHF.sub.2.

[0250] According to still another embodiment thereof R.sup.2b is independently selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.2b is independently selected from halogen, OH, CH.sub.3, OCH.sub.3, CN, CHF.sub.2, OCHF.sub.2, OCF.sub.3, OCH.sub.3 cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl and halogenmethoxy, more specifically independently selected from F, Cl, OH, CH.sub.3, OCH.sub.3, CHF.sub.2, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl, OCHF.sub.2 and OCF.sub.3.

[0251] Particularly preferred embodiments of R.sup.2 according to the invention are in Table P2 below, wherein each line of lines P2-1 to P2-16 corresponds to one particular embodiment of the invention. Thereby, for every R.sup.2 that is present in the inventive compounds, these specific embodiments and preferences apply independently of the meaning of any other R.sup.2 that may be present in the ring:

TABLE-US-00002 TABLE P2 Ts in the table stands for the tosylgroup SO.sub.2-(p-CH.sub.3)phenyl. No. R.sup.2 P2-1 H P2-2 Cl P2-3 F P2-4 Br P2-5 OH P2-6 CN P2-7 NO.sub.2 P2-8 CH.sub.3 P2-9 CH.sub.2CH.sub.3 P2-10 CF.sub.3 P2-11 CHF.sub.2 P2-12 OCH.sub.3 P2-13 OCH.sub.2CH.sub.3 P2-14 OCF.sub.3 P2-15 OCHF.sub.2 P2-16 NH-Ts [0252] R.sup.3 is independently selected from halogen, OH, CN, NO.sub.2, SH, C.sub.1-C.sub.6-alkylthio, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.2-C.sub.6-alkenyloxy, C.sub.2-C.sub.6-alkynyloxy, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl, aryl and phenoxy; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and the heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R and R are independently selected from H, C.sub.1-C.sub.4-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; and wherein R and R are independently unsubstituted or substituted with R which is independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and phenyl; [0253] wherein R.sup.x is as defined above; [0254] wherein the acyclic moieties of R.sup.3 are independently not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.3a, which independently of one another are selected from: [0255] R.sup.3a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle, an aryl, phenoxy and a five-, six- or ten-membered heteroaryl, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and the heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo-, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl; and wherein R.sup.x, R and R are as defined above; n is 0, 1, 2; and [0256] wherein the carbocyclic, heterocyclic, heteroaryl and aryl moieties of R.sup.3 are independently unsubstituted or substituted with identical or different groups R.sup.3b, which independently of one another are selected from: [0257] R.sup.3b halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0258] and wherein R.sup.x and n are as defined above.

[0259] According to one embodiment of formula I, R.sup.3 is independently selected from CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkynyl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), CRNOR, C.sub.3-C.sub.6-halogencycloalkyl, a saturated three-, four-, five-, six-, membered carbo- or heterocycle, a five- or six-membered heteroaryl, aryl and C.sub.1-C.sub.6-alkyl substituted with CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, NHSO.sub.2R.sup.x, N(C.sub.1-C.sub.6-alkyl).sub.2, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl; wherein R.sup.x, R and R are defined below; and wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbo-, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.3b as defined below.

[0260] According to one embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkynyl, CH(O), C(O)C.sub.2-C.sub.6-alkyl, C(O)O(C.sub.2-C.sub.6-alkyl), CRNOR, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkyl-five- and six-membered heteroaryl or aryl; wherein the aryl is unsubstituted or substituted by halogen or C.sub.1-C.sub.6-halogenalkyl; wherein R and R are defined below; and wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.3b as defined below.

[0261] According to one embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl substituted with CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, NHSO.sub.2R.sup.x, N(C.sub.1-C.sub.6-alkyl).sub.2, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl; wherein R.sup.x is defined below; and wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.3b as defined below.

[0262] According to still another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, CN, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylaryl, C.sub.1-C.sub.6-alkylheteroaryl, phenyl, pyridine, pyrimidine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbocycle, heterocycle, heteroaryl and aryl moieties are unsubstituted or substituted by substituents R.sup.3b as defined below.

[0263] According to another embodiment of formula I, R.sup.3 is F

[0264] According to another embodiment of formula I, R.sup.3 is Cl

[0265] According to another embodiment of formula I, R.sup.3 is Br.

[0266] According to still another embodiment of formula I, R.sup.3 is OH.

[0267] According to still another embodiment of formula I, R.sup.3 is CN.

[0268] According to still another embodiment of formula I, R.sup.3 is NO.sub.2.

[0269] According to still another embodiment of formula I, R.sup.3 is SH.

[0270] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkylthio, such as SCH.sub.3, SC.sub.2H.sub.5, Sn-propyl, Si-propyl, Sn-butyl, Si-butyl, Stert-butyl, Sn-pentyl, Si-pentyl, CH.sub.2SCH.sub.3 or CH.sub.2SCH.sub.2CH.sub.3.

[0271] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-halogenalkylthio, such as SCF.sub.3, SCCl.sub.3, CH.sub.2SCF.sub.3 or CH.sub.2SCF.sub.3.

[0272] According to still another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted. In a particular embodiment, R.sup.3 is selected from C.sub.1-C.sub.6-halogenalkyl, phenyl-CH.sub.2, halogenphenyl-CH.sub.2, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R.sup.3b as defined below.

[0273] According to still another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted by substituents R.sup.3b as defined below. According to one embodiment thereof, the carbo- and heterocycle is unsubstituted. In a particular embodiment, R.sup.3 is selected from substituted C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted by substituents R.sup.3b as defined below.

[0274] According to another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylaryl, six-membered heteroaryl or aryl which is unsubstituted or substituted with halogen or C.sub.1-C.sub.6-halogenalkyl, and wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.3b as defined below.

[0275] According to still another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, CN, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylaryl, phenyl, pyridine, pyrimidine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.3a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.3b as defined below.

[0276] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0277] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0278] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl such as CH.sub.3.

[0279] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl such as C.sub.2H.sub.5.

[0280] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl which is substituted with at least one group R.sup.3a, which independently of one another are selected from: [0281] R.sup.3a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl, an aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH (C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0282] According to still another embodiment of formula I, R.sup.3 is CH.sub.3 is substituted with at least one group R.sup.3a, which independently of one another are selected from: [0283] R.sup.3a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl an aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH (C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0284] According to still another embodiment of formula I, R.sup.3 is O.sub.2H.sub.5 is substituted with at least one group R.sup.3a, which independently of one another are selected from: [0285] R.sup.3a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl an aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0286] According to still another embodiment of formula I, R.sup.3 is CH.sub.2CN.

[0287] According to still another embodiment of formula I, R.sup.3 is CH.sub.2OH.

[0288] According to still another embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0289] According to still another embodiment of formula I, R.sup.3 is CH.sub.2F.

[0290] According to still another embodiment of formula I, R.sup.3 is CHF.sub.2.

[0291] According to still another embodiment of formula I, R.sup.3 is CF.sub.3.

[0292] According to still a further embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2, CH.sub.2CHCH.sub.2 or C(CH.sub.3)CCH.sub.2.

[0293] According to a further specific embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CFCF.sub.2, CClCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CH.sub.2CFCF.sub.2, CH.sub.2CClCCl.sub.2, CF.sub.2CFCF.sub.2 or CCl.sub.2CClCCl.sub.2.

[0294] According to still a further embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-cycloalkenyl, in particular C.sub.2-C.sub.4-cycloalkenyl, such as CHCH.sub.2-cPr.

[0295] According to still a further embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CCCl, CCCH.sub.3, CH.sub.2CCH, CH.sub.2CCCl or CH.sub.2CCCH.sub.3.

[0296] According to still a further embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-cycloalkynyl in particular C.sub.2-C.sub.4-cycloalkynyl, such as CC-cPr.

[0297] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3, CH.sub.2CH.sub.3 or CH.sub.2OCH.sub.3.

[0298] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-alkoxy, such as CH.sub.2OCH.sub.3 or CH.sub.2OCH.sub.2CH.sub.3.

[0299] According to a further specific embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-alkenyloxy, in particular C.sub.2-C.sub.4-alkenyloxy, more specifically C.sub.1-C.sub.2-alkenyloxy such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2OC(CH.sub.3)CHCH.sub.2, CH.sub.2OCHCH.sub.2, or CH.sub.2OCH.sub.2CHCH.sub.2.

[0300] According to a further specific embodiment of formula I, R.sup.3 is C.sub.2-C.sub.6-alkynyloxy, in particular C.sub.2-C.sub.4-alkynyloxy, more specifically C.sub.1-C.sub.2-alkynyloxy such as OCCH, OCH.sub.2CCH or CH.sub.2OCCH

[0301] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0302] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-halogenalkoxy such as CH.sub.2OCF.sub.3, CH.sub.2OCHF.sub.2, CH.sub.2OCH.sub.2F, CH.sub.2OCCl.sub.3, CH.sub.2OCHCl.sub.2 or CH.sub.2OCH.sub.2Cl, in particular CH.sub.2OCF.sub.3, CH.sub.2OCHF.sub.2, CH.sub.2OCCl.sub.3 or CH.sub.2OCHCl.sub.2.

[0303] According to a further specific embodiment of formula I, R.sup.3 is CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl) or C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0304] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.4-alkyl-CH(O), C.sub.1-C.sub.4-alkyl-C(O)C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkyl-C(O)O(C.sub.1-C.sub.6-alkyl), C.sub.1-C.sub.4-alkyl-C(O)NH(C.sub.1-C.sub.6-alkyl) or C.sub.1-C.sub.4-alkyl-C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, especially CH.sub.2CH(O), CH.sub.2C(O)C.sub.1-C.sub.6-alkyl, CH.sub.2C(O)O(C.sub.1-C.sub.6-alkyl), CH.sub.2C(O)NH(C.sub.1-C.sub.6-alkyl) or CH.sub.2C(O)N(C.sub.1-C.sub.6-alkyl).sub.2 wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0305] According to a further specific embodiment of formula I, R.sup.3 is CRNOR such as C(CH.sub.3)NOCH.sub.3, C(CH.sub.3)NOCH.sub.2CH.sub.3 or C(CH.sub.3)NOCF.sub.3.

[0306] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-NH(C.sub.1-C.sub.4-alkyl) or C.sub.1-C.sub.6-alkyl-N(C.sub.1-C.sub.4-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0307] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-S(O).sub.nC.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1, 2 or 3.

[0308] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, wherein halogenalkyl is CF.sub.3 or CHF.sub.2 and n is 1, 2 or 3.

[0309] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-S(O).sub.n-aryl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.3b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3. According to one embodiment, R.sup.3 is unsubstituted phenyl. According to another embodiment, R.sup.3 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0310] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl-NHSO.sub.2R.sup.x wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x2 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, or C.sub.1-C.sub.4-halogenalkoxy, such as CH.sub.2NHSO.sub.2CF.sub.3 or CH.sub.2NHSO.sub.2CH.sub.3.

[0311] According to still another embodiment of formula I, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl which is substituted, a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0312] According to one embodiment, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0313] According to one embodiment, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0314] According to one embodiment, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, especially with CH.sub.2 optionally substituted CH.sub.2 which is substituted with a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0315] According to one embodiment, R.sup.3 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0316] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted with a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0317] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted with a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0318] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0319] According to a further specific embodiment of formula I, R.sup.3 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted with a 5-membered saturated heterocycle which contains one N as ring member and optionally one or two groups CH.sub.2 are replaced by C(O).

[0320] According to still another embodiment of formula I, R.sup.3 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0321] According to still another embodiment of formula I, R.sup.3 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

[0322] According to still a further embodiment, R.sup.3 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

[0323] According to still another embodiment of formula I, R.sup.3 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0324] According to one embodiment, R.sup.3 is a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0325] According to one embodiment, R.sup.3 is a 3-membered saturated carbocycle, which is unsubstituted such as cyclopropyl According to one embodiment, R.sup.3 is a 3-membered saturated carbocycle, which is substituted with halogen, more specifically by F, such as C.sub.3H.sub.3F.sub.2.

[0326] According to one embodiment, R.sup.3 is a 3-membered saturated carbocycle, which is substituted with halogen. More specifically by Cl, such as C.sub.3H.sub.3Cl.sub.2.

[0327] According to one embodiment, R.sup.3 is a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0328] According to one embodiment, R.sup.3 is a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0329] According to one embodiment, R.sup.3 is a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0330] According to still another embodiment of formula I, R.sup.3 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0331] According to still another embodiment of formula I, R.sup.3 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R.sup.3b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0332] According to still another embodiment of formula I, in the embodiments of R.sup.3 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one 0.

[0333] According to one embodiment, R.sup.3 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0334] According to still another embodiment of formula I, R.sup.3 is a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0335] According to still another embodiment of formula I, R.sup.3 is a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.3b. According to still another embodiment of formula I, it is substituted with R.sup.3b.

[0336] According to still another embodiment of formula I, R.sup.3 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted with one, two or three identical or different groups R.sup.3b which independently of one another are selected from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular from CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3 and S(O).sub.2CH.sub.3.

[0337] According to still another embodiment of formula I, R.sup.3 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.3b which independently of one another are selected from from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular from CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3. According to one embodiment, R.sup.3 is unsubstituted phenyl. According to another embodiment, R.sup.3 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0338] According to still another embodiment of formula I, R.sup.3 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0339] According to still another embodiment of formula I, R.sup.3 is a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0340] Particularly preferred embodiments of R.sup.3 according to the invention are in Table P3 below, wherein each line of lines P3-1 to P3-33 corresponds to one particular embodiment of the invention, wherein P3-1 to P3-33 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R.sup.3 is bound is marked with # in the drawings.

TABLE-US-00003 TABLE P3 (py = pyridyl): No. R.sup.3 P3-1 CH.sub.3 P3-2 C.sub.2H.sub.5 P3-3 iso-C.sub.3H.sub.7 P3-4 CH.sub.2CH.sub.2CH.sub.3 P3-5 CN P3-6 CH(CH.sub.3).sub.2 P3-7 CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P3-8 CH.sub.2CH(CH.sub.3).sub.2 P3-9 C(CH.sub.3).sub.3 P3-10 CH.sub.2CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P3-11 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 P3-12 CF.sub.3 P3-13 CHF.sub.2 P3-14 CHCl.sub.2 P3-15 CH.sub.2F P3-16 CH.sub.2Cl P3-17 CH.sub.2CF.sub.3 P3-18 CH.sub.2CCl.sub.3 P3-19 CF.sub.2CHF.sub.2 P3-20 C.sub.6H.sub.5 P3-21 4-ClC.sub.6H.sub.4 P3-22 4-FC.sub.6H.sub.4 P3-23 CH.sub.2C.sub.6H.sub.5 P3-24 3-pyridyl P3-25 4-pyridyl P3-26 [00055] P3-27 [00056] P3-28 [00057] P3-29 [00058] P3-30 [00059] P3-31 [00060] P3-32 [00061] P3-33 [00062] [0341] R.sup.4 is independently selected from halogen, OH, CN, NO.sub.2, SH, C.sub.1-C.sub.6-alkylthio, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.2-C.sub.6-alkenyloxy, C.sub.2-C.sub.6-alkynyloxy, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, a five- or six-membered heteroaryl, aryl and phenoxy; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; and wherein R and R are independently selected from H, C.sub.1-C.sub.4-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl or aryl; and wherein R and R are independently unsubstituted or substituted with R which is independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and phenyl; [0342] wherein R.sup.x is as defined above; [0343] wherein the acyclic moieties of R.sup.4 are independently not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.4a, which independently of one another are selected from: [0344] R.sup.4a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle, a five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbo-, heterocyclic, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl; and wherein R.sup.x, R and R are as defined above; n is 0, 1,2; and [0345] wherein the carbo-, heterocyclic, heteroaryl and phenyl moieties of R.sup.4 are independently unsubstituted or substituted with identical or different groups R.sup.4b, which independently of one another are selected from: [0346] R.sup.4b halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0347] and wherein R.sup.x and n are as defined above.

[0348] According to one embodiment of formula I, R.sup.4 is selected from CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.06-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkynyl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), CRNOR, C.sub.3-C.sub.6-halogencycloalkyl, a saturated three-, four-, five-, six-, membered carbo- or heterocycle, a five- or six-membered heteroaryl, aryl and phenoxy; and C.sub.1-C.sub.6-alkyl substituted with CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, NHSO.sub.2R.sup.x, N(C.sub.1-C.sub.6-alkyl).sub.2, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl; wherein R.sup.x, R and R are defined below; and wherein the acyclic moieties of R.sup.4 are unsubstituted or substituted with identical or different groups R.sup.4a as defined below and wherein wherein the carbo-, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.4b as defined below.

[0349] According to one embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.2-C.sub.06-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkynyl, CH(O), C(O)C.sub.2-C.sub.6-alkyl, C(O)O(C.sub.2-C.sub.6-alkyl), CRNOR, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkyl-five- and six-membered heteroaryl, a five- or six-membered heteroaryl, aryl aryl and phenoxy, which is unsubstituted or substituted by halogen or C.sub.1-C.sub.6-halogenalkyl; wherein R and R are defined below; and wherein the acyclic moieties of R.sup.3 are unsubstituted or substituted with identical or different groups R.sup.4a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.4b as defined below.

[0350] According to one embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl substituted with CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, NHSO.sub.2R.sup.x, N(C.sub.1-C.sub.6-alkyl).sub.2, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), a saturated three-, four-, five-, six-, membered carbo- or heterocycle, aryl; wherein R.sup.x is defined below; and wherein the acyclic moieties of R.sup.4 are unsubstituted or substituted with identical or different groups R.sup.4a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.4b as defined below.

[0351] According to another embodiment of formula I, R.sup.4 is F

[0352] According to another embodiment of formula I, R.sup.4 is Cl

[0353] According to another embodiment of formula I, R.sup.4 is Br.

[0354] According to still another embodiment of formula I, R.sup.4 is OH.

[0355] According to still another embodiment of formula I, R.sup.4 is CN.

[0356] According to still another embodiment of formula I, R.sup.4 is NO.sub.2.

[0357] According to still another embodiment of formula I, R.sup.4 is SH.

[0358] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylthio, such as SCH.sub.3, SC.sub.2H.sub.5, Sn-propyl, Si-propyl, Sn-butyl, Si-butyl, Stert-butyl, Sn-pentyl, Si-pentyl, CH.sub.2SCH.sub.3 or CH.sub.2SCH.sub.2CH.sub.3.

[0359] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-halogenalkylthio, such as SCF.sub.3, SCCl.sub.3, CH.sub.2SCF.sub.3 or CH.sub.2SCF.sub.3.

[0360] According to still another embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl or C.sub.1-C.sub.6-alkyl which is substituted, C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted. In a particular embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-halogenalkyl, phenyl-CH.sub.2, halogenphenyl-CH.sub.2, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or is substituted with substituents R.sup.4b as defined below.

[0361] According to still another embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl or C.sub.1-C.sub.6-alkyl which is substituted, C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted by substituents R.sup.4b as defined below. According to one embodiment thereof, the carbo- and heterocycle is unsubstituted.

[0362] In a particular embodiment, R.sup.4 is selected from substituted C.sub.1-C.sub.6-halogenalkyl, phenyl, halogenphenyl and three-, four-, five- or six-membered carbo- and heterocycle, wherein the carbo- and heterocycle is unsubstituted or substituted by substituents R.sup.4b as defined below.

[0363] According to another embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylaryl, six-membered heteroaryl or aryl which is unsubstituted or substituted with halogen or C.sub.1-C.sub.6-halogenalkyl, and wherein the acyclic moieties of R.sup.4 are unsubstituted or substituted with identical or different groups R.sup.4a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.4b as defined below.

[0364] According to still another embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, CN, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkylaryl, phenyl, pyridine, pyrimidine, thiophene, imidazole, triazol, oxadiazol wherein the acyclic moieties of R.sup.4 are unsubstituted or substituted with identical or different groups R.sup.4a as defined below and wherein wherein the carbocycle, heterocycle and heteroaryl and aryl moieties are unsubstituted or substituted with substituents R.sup.4b as defined below.

[0365] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0366] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl such as CH.sub.3.

[0367] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl such as C.sub.2H.sub.5.

[0368] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl which is substituted with at least one group R.sup.4a, which independently of one another are selected from: [0369] R.sup.4a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0370] According to still another embodiment of formula I, R.sup.4 is CH.sub.3 is substituted with at least one group R.sup.4a, which independently of one another are selected from: [0371] R.sup.4a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, an aryl or phenoxy, wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, heteroaryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0372] According to still another embodiment of formula I, R.sup.4 is O.sub.2H.sub.5 is substituted with at least one group R.sup.4a, which independently of one another are selected from: [0373] R.sup.4a halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, phenyl or phenoxy; wherein in each case one or two CH.sub.2 groups of the carbo- and heterocycle may be replaced by a group independently selected from C(O) and C(S), and wherein the heterocycle and heteroaryl contains independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, heteroaryl, aryl and phenyl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH (C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, and S(O).sub.nC.sub.1-C.sub.6-alkyl.

[0374] According to still another embodiment of formula I, R.sup.4 is CH.sub.2CN.

[0375] According to still another embodiment of formula I, R.sup.4 is CH.sub.2OH.

[0376] According to still another embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0377] According to still another embodiment of formula I, R.sup.4 is CH.sub.2F.

[0378] According to still another embodiment of formula I, R.sup.4 is CHF.sub.2.

[0379] According to still another embodiment of formula I, R.sup.4 is CF.sub.3.

[0380] According to still a further embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2, CH.sub.2CHCH.sub.2 or C(CH.sub.3)CCH.sub.2.

[0381] According to a further specific embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CFCF.sub.2, CClCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CH.sub.2CFCF.sub.2, CH.sub.2CClCCl.sub.2, CF.sub.2CFCF.sub.2 or CCl.sub.2CClCCl.sub.2.

[0382] According to still a further embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-cycloalkenyl, in particular C.sub.2-C.sub.4-cycloalkenyl, such as CHCH.sub.2-cPr.

[0383] According to still a further embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CCCl, CCCH.sub.3, CH.sub.2CCH, CH.sub.2CCCl or CH.sub.2CCCH.sub.3.

[0384] According to still a further embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-cycloalkynyl in particular C.sub.2-C.sub.4-cycloalkynyl, such as CC-cPr.

[0385] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3, CH.sub.2CH.sub.3 or CH.sub.2OCH.sub.3.

[0386] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-alkoxy, such as CH.sub.2OCH.sub.3 or CH.sub.2OCH.sub.2CH.sub.3.

[0387] According to a further specific embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-alkenyloxy, in particular C.sub.2-C.sub.4-alkenyloxy, more specifically C.sub.1-C.sub.2-alkenyloxy such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2OC(CH.sub.3)CHCH.sub.2, CH.sub.2OCHCH.sub.2, or CH.sub.2OCH.sub.2CHCH.sub.2.

[0388] According to a further specific embodiment of formula I, R.sup.4 is C.sub.2-C.sub.6-alkynyloxy, in particular C.sub.2-C.sub.4-alkynyloxy, more specifically C.sub.1-C.sub.2-alkynyloxy such as OCCH, OCH.sub.2CCH or CH.sub.2OCCH

[0389] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0390] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-halogenalkoxy such as CH.sub.2OCF.sub.3, CH.sub.2OCHF.sub.2, CH.sub.2OCH.sub.2F, CH.sub.2OCCl.sub.3, CH.sub.2OCHCl.sub.2 or CH.sub.2OCH.sub.2Cl, in particular CH.sub.2OCF.sub.3, CH.sub.2OCHF.sub.2, CH.sub.2OCCl.sub.3 or CH.sub.2OCHCl.sub.2.

[0391] According to a further specific embodiment of formula I, R.sup.4 is CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl) or C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0392] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.4-alkyl-CH(O), C.sub.1-C.sub.4-alkyl-C(O)C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkyl-C(O)O(C.sub.1-C.sub.6-alkyl), C.sub.1-C.sub.4-alkyl-C(O)NH(C.sub.1-C.sub.6-alkyl) or C.sub.1-C.sub.4-alkyl-C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, especially CH.sub.2CH(O), CH.sub.2C(O)C.sub.1-C.sub.6-alkyl, CH.sub.2C(O)O(C.sub.1-C.sub.6-alkyl), CH.sub.2C(O)NH(C.sub.1-C.sub.6-alkyl) or CH.sub.2C(O)N(C.sub.1-C.sub.6-alkyl).sub.2 wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0393] According to a further specific embodiment of formula I, R.sup.4 is CRNOR such as C(CH.sub.3)NOCH.sub.3, C(CH.sub.3)NOCH.sub.2CH.sub.3 or C(CH.sub.3)NOCF.sub.3.

[0394] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-NH(C.sub.1-C.sub.4-alkyl) or C.sub.1-C.sub.6-alkyl-N(C.sub.1-C.sub.4-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0395] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylthio, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.3-alkylthio such as CH.sub.2SCH.sub.3 or CH.sub.2SCH.sub.2CH.sub.3.

[0396] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-S(O).sub.nC.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1, 2 or 3.

[0397] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, wherein halogenalkyl is CF.sub.3 or CHF.sub.2 and n is 1, 2 or 3.

[0398] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-S(O).sub.n-aryl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.4b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3. According to one embodiment, R.sup.4 is unsubstituted phenyl. According to another embodiment, R.sup.4 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0399] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl-NHSO.sub.2R.sup.x wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x2 independently selected from C.sub.1-C.sub.4-alkyl, halogen, OH, CN, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, or C.sub.1-C.sub.4-halogenalkoxy, such as CH.sub.2NHSO.sub.2CF.sub.3 or CH.sub.2NHSO.sub.2CH.sub.3.

[0400] According to still another embodiment of formula I, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl which is substituted, a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0401] According to one embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0402] According to one embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0403] According to one embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0404] According to one embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, especially CH.sub.2 which is substituted with a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0405] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylheterocycle, especially CH.sub.2 substituted with a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0406] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylheterocycle, especially CH.sub.2 substituted with a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0407] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylheterocycle, especially CH.sub.2 substituted by a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0408] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkylheterocycle, especially CH.sub.2 substituted with a 5-membered saturated heterocycle which contains one N as ring member and optionally one or two groups CH.sub.2 are replaced by C(O).

[0409] According to still another embodiment of formula I, R.sup.4 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0410] According to still another embodiment of formula I, R.sup.4 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

[0411] According to still a further embodiment, R.sup.4 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the carbocycle and heterocycle are unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle or heterocycle is unsubstituted.

[0412] According to still another embodiment of formula I, R.sup.4 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered, wherein the carbocycle is unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle is unsubstituted.

[0413] According to one embodiment, R.sup.4 is a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0414] According to one embodiment, R.sup.4 is a 3-membered saturated carbocycle, which is unsubstituted such as cyclopropyl.

[0415] According to one embodiment, R.sup.4 is a 3-membered saturated carbocycle, which is substituted with halogen, more specifically by F, such as C.sub.3H.sub.3F.sub.2.

[0416] According to one embodiment, R.sup.4 is a 3-membered saturated carbocycle, which is substituted with halogen. More specifically by Cl, such as C.sub.3H.sub.3Cl.sub.2.

[0417] According to one embodiment, R.sup.4 is a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0418] According to one embodiment, R.sup.4 is a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0419] According to one embodiment, R.sup.4 is a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0420] According to still another embodiment of formula I, R.sup.4 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0421] According to still another embodiment of formula I, R.sup.4 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted with substituents R.sup.4b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0422] According to still another embodiment of formula I, in the embodiments of R.sup.4 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one O.

[0423] According to one embodiment, R.sup.4 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0424] According to still another embodiment of formula I, R.sup.4 is a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0425] According to still another embodiment of formula I, R.sup.4 is a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0426] According to still another embodiment of formula I, R.sup.4 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted with one, two or three identical or different groups R.sup.4b which independently of one another are selected from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular from CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3 and S(O).sub.2CH.sub.3.

[0427] According to still another embodiment of formula I, R.sup.4 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.4b which independently of one another are selected from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl, in particular from CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3, CHF.sub.2, OCHF.sub.2, OCF.sub.3. According to one embodiment, R.sup.4 is unsubstituted phenyl. According to another embodiment, R.sup.4 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0428] According to still another embodiment of formula I, R.sup.4 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0429] According to still another embodiment of formula I, R.sup.4 is a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0430] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0431] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one N as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0432] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0433] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains three N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b. According to one specific embodiment thereof, said 5-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) 0.

[0434] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one S as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0435] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one S and one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0436] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one S and two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0437] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one oxygen and one N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0438] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 5-membered saturated heteroaryl which contains one oxygen and two N as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0439] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 6-membered saturated heteroaryl which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0440] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 6-membered saturated heteroaryl which one N as ring member. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0441] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 6-membered saturated heteroaryl which two N as ring members.

[0442] According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0443] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 10-membered saturated heteroaryl which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0444] According to one specific embodiment thereof, said 10-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) N.

[0445] According to a further specific embodiment of formula I, R.sup.4 is C.sub.1-C.sub.6-alkyl, especially CH.sub.2 substituted by a 10-membered saturated heteroaryl which one N as ring members.

[0446] According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted by R.sup.4b.

[0447] According to still another embodiment of formula I, R.sup.4 is CH.sub.2 substituted by a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0448] According to still another embodiment of formula I, R.sup.4 is CH.sub.2 substituted by a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0449] According to a further particular embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, CN, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.06-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, aryl, heteroaryl, three-, four-, five- or six-membered carbocycle and heterocycle, phenoxy, and C.sub.1-C.sub.6-alkyl substituted by CN, three-, four-, five- or six-membered carbocycle and heterocycle, aryl and heteroaryl; wherein the carbocycle and heterocycle is unsubstituted or carries one, two, three or four substituents R.sup.4b as defined below. According to one embodiment thereof, the carbocycle, heterocycle, heteroaryl and aryl are unsubstituted. In a particular embodiment, R.sup.4 is selected from C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, aryl, heteroaryl, cypropropyl and C.sub.1-C.sub.6-alkyl substituted by aryl and heteroaryl; wherein the aryl and heteroaryl are unsubstituted or carries one, two, three or four substituents R.sup.4b as defined below. Particularly preferred embodiments of R.sup.4 according to the invention are in Table P4 below, wherein each line of lines P4-1 to P4-190 corresponds to one particular embodiment of the invention, wherein P4-1 to P4-190 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R.sup.4 is bound is marked with # in the drawings.

TABLE-US-00004 TABLE P4 (py = pyridyl): No. R.sup.4 P4-1 CF.sub.3 P4-2 CH.sub.2F P4-3 CH.sub.2Cl P4-4 CHF.sub.2 P4-5 CHCl.sub.2 P4-6 CH.sub.2CF.sub.3 P4-7 CH.sub.2CCl.sub.3 P4-8 CF.sub.2CHF.sub.2 P4-9 CH.sub.3 P4-10 C.sub.2H.sub.5 P4-11 iso-C.sub.3H.sub.7 P4-12 CH.sub.2CH.sub.2CH.sub.3 P4-13 CH(CH.sub.3).sub.2 P4-14 CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P4-15 CH.sub.2CH(CH.sub.3).sub.2 P4-16 C(CH.sub.3).sub.3 P4-17 CH.sub.2CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P4-18 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 P4-19 CH.sub.2OCH.sub.3 P4-20 CH.sub.2OCH.sub.2F P4-21 CH.sub.2OCHF.sub.2 P4-22 CH.sub.2OCF.sub.3 P4-23 CH.sub.2OCF.sub.2CHF.sub.2 P4-24 CH.sub.2NHMe P4-25 CH.sub.2SMe P4-26 CH.sub.2SOMe P4-27 CH.sub.2SO.sub.2Me P4-28 CH.sub.2NMe.sub.2 P4-29 CH.sub.2NSO.sub.2CF.sub.3 P4-30 CH.sub.2NSO.sub.2CH.sub.3 P4-31 CN P4-32 CH.sub.2CN P4-33 CHO P4-34 COMe P4-35 CO.sub.2Me P4-36 CH.sub.2CHO P4-37 CH.sub.2COMe P4-38 CH.sub.2CO.sub.2Me P4-39 [00063] P4-40 [00064] P4-41 [00065] P4-42 [00066] P4-43 [00067] P4-44 [00068] P4-45 [00069] P4-46 [00070] P4-47 [00071] P4-48 [00072] P4-49 [00073] P4-50 [00074] P4-51 [00075] P4-52 [00076] P4-53 [00077] P4-54 [00078] P4-55 [00079] P4-56 [00080] P4-57 [00081] P4-58 [00082] P4-59 [00083] P4-60 [00084] P4-61 [00085] P4-62 [00086] P4-63 [00087] P4-64 [00088] P4-65 [00089] P4-66 [00090] P4-67 [00091] P4-68 [00092] P4-69 [00093] P4-70 [00094] P4-71 C.sub.6H.sub.5 P4-72 4-ClC.sub.6H.sub.4 P4-73 3-ClC.sub.6H.sub.4 P4-74 2-ClC.sub.6H.sub.4 P4-75 2,4-Cl.sub.2C.sub.6H.sub.3 P4-76 4-FC.sub.6H.sub.4 P4-77 3-FC.sub.6H.sub.4 P4-78 2-FC.sub.6H.sub.4 P4-79 2,4-F.sub.2C.sub.6H.sub.3 P4-80 4-MeOC.sub.6H.sub.4 P4-81 3-MeOC.sub.6H.sub.4 P4-82 2-MeOC.sub.6H.sub.4 P4-83 4-MeO.sub.2SC.sub.6H.sub.4 P4-84 3-MeO.sub.2SC.sub.6H.sub.4 P4-85 2-MeO.sub.2SC.sub.6H.sub.4 P4-86 CH.sub.2C.sub.6H.sub.5 P4-87 CH.sub.2C.sub.6H.sub.4-4-F P4-88 CH.sub.2C.sub.6H.sub.4-4-Cl P4-89 CH.sub.2C.sub.6H.sub.3-2,4-Cl.sub.2 P4-90 CH.sub.2C.sub.6H.sub.4-4-SO.sub.2Me P4-91 3-py P4-92 2-py P4-93 4-py P4-94 [00095] P4-95 [00096] P4-96 [00097] P4-97 [00098] P4-98 [00099] P4-99 [00100] P4-100 [00101] P4-101 [00102] P4-102 [00103] P4-103 [00104] P4-104 [00105] P4-105 [00106] P4-106 [00107] P4-107 [00108] P4-108 [00109] P4-109 [00110] P4-110 [00111] P4-111 [00112] P4-112 [00113] P4-113 [00114] P4-114 [00115] P4-115 [00116] P4-116 [00117] P4-117 [00118] P4-118 [00119] P4-119 [00120] P4-120 [00121] P4-121 [00122] P4-122 [00123] P4-123 [00124] P4-124 [00125] P4-125 [00126] P4-126 [00127] P4-127 [00128] P4-128 [00129] P4-129 [00130] P4-130 [00131] P4-131 [00132] P4-132 [00133] P4-133 [00134] P4-134 [00135] P4-135 [00136] P4-136 [00137] P4-137 [00138] P4-138 [00139] P4-139 [00140] P4-140 [00141] P4-141 [00142] P4-142 [00143] P4-143 [00144] P4-144 [00145] P4-145 [00146] P4-146 [00147] P4-147 [00148] P4-148 [00149] P4-149 [00150] P4-150 [00151] P4-151 [00152] P4-152 [00153] P4-153 [00154] P4-154 [00155] P4-155 [00156] P4-156 [00157] P4-157 [00158] P4-158 [00159] P4-159 [00160] P4-160 [00161] P4-161 [00162] P4-162 [00163] P4-163 [00164] P4-164 [00165] P4-165 [00166] P4-166 [00167] P4-167 [00168] P4-168 [00169] P4-169 [00170] P4-170 [00171] P4-171 [00172] P4-172 [00173] P4-173 [00174] P4-174 [00175] P4-175 [00176] P4-176 [00177] P4-177 [00178] P4-178 [00179] P4-179 [00180] P4-180 [00181] P4-181 [00182] P4-182 [00183] P4-183 [00184] P4-184 [00185] P4-185 [00186] P4-186 [00187] P4-187 [00188] P4-188 [00189] P4-189 [00190] P4-190 [00191]

[0450] According to still another embodiment of formula I, R.sup.3, R.sup.4 together with the carbon atom to which they are bound form a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle; wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, wherein the heteroatom N may carry one substituent R.sup.N selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one, two or three substituents selected from CN, C.sub.1-C.sub.4-alkyl, halogen, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; and wherein the heteroatom S may be in the form of its oxide SO or SO.sub.2, and wherein the carbocycle or heterocycle is unsubstituted or carries one, two, three or four substituents R.sup.34 independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents R.sup.34a selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S).

[0451] According to one embodiment, R.sup.3 and R.sup.4 form a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0452] According to one embodiment, R.sup.3 and R.sup.4 form a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0453] According to one embodiment, R.sup.3 and R.sup.4 form a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0454] According to one embodiment, R.sup.3 and R.sup.4 form a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0455] According to one embodiment, R.sup.3 and R.sup.4 form a 7-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.4b. According to still another embodiment of formula I, it is substituted with R.sup.4b.

[0456] According to one embodiment, R.sup.3 and R.sup.4 together with the carbon atom to which they are bound form a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle that is unsubstituted or substituted. According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 is saturated.

[0457] According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 is a saturated unsubstituted or substituted heterocycle, wherein the heterocycle contains one, two or three, more particularly one or two, specifically one, heteroatom(s) selected from NH, NR.sup.N, O, S, S(O) and S(O).sub.2, wherein R.sup.N is defined and preferably defined above. According to one embodiment, this saturated heterocycle is unsubstituted. According to a further embodiment, the saturated heterocycle carries one, two, three or four substituents R.sup.34. In one further particular embodiment, said heterocycle is four- or six-membered.

[0458] According to a further embodiment, the unsubstituted or substituted and saturated or partially unsaturated heterocycle is three-, four-, five- or six-membered and contains one, two or three, more particularly one or two, heteroatoms selected from NH, NR.sup.N, O, S, S(O) and S(O).sub.2, wherein R.sup.N is as defined above or preferably selected from C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted by one C.sub.1-C.sub.2-alkyl. In one further particular embodiment, said heterocycle is four- or six-membered.

[0459] According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 contains one, two or three, more specifically one or two, heteroatoms selected from NH and NR.sup.N, wherein R.sup.N is as defined and preferably defined below, more particularly selected from C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted by one methyl. In one embodiment thereof, it contains one or two heteroatoms NH, in particular one NH. In another embodiment, it contains one or two heteroatoms NR.sup.N, in particular one NR.sup.N, wherein R.sup.N in each case is as defined and preferably defined above.

[0460] According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 contains one, two or three, more specifically one or two, in particular one, heteroatom(s) selected from S, S(O) and S(O).sub.2. In one embodiment thereof, it contains one or two heteroatoms S, in particular one S. In another embodiment, it contains one or two heteroatoms S(O), in particular one S(O). In still another embodiment, it contains one or two heteroatoms S(O).sub.2, in particular one S(O).sub.2.

[0461] According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 contains one or two heteroatoms O. In one embodiment thereof, it contains one heteroatom O. In another embodiment, it contains two heteroatoms O.

[0462] According to a further embodiment, the heterocycle formed by R.sup.3 and R.sup.4 is unsubstituted, i.e. it does not carry any substituent R.sup.34. According to a further embodiment, it carries one, two, three or four R.sup.34.

[0463] According to one particular embodiment, R.sup.3 and R.sup.4 together form a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of NH, NR.sup.N, O, S, S(O) and S(O).sub.2, as ring members, wherein R.sup.N is defined and preferably defined above. In one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.34. According to a further embodiment, it carries one, two, three or four R.sup.34.

[0464] According to a further particular embodiment, R.sup.3 and R.sup.4 together form a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of NH, NR.sup.N, O, S, S(O) and S(O).sub.2, as ring members, wherein R.sup.N is as defined and preferably defined above. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.34. According to a further embodiment, it carries one, two, three or four R.sup.34.

[0465] According to a further particular embodiment, R.sup.3 and R.sup.4 together form a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of NH, NR.sup.N, O, S, S(O) and S(O).sub.2, as ring members, wherein R.sup.N is as defined and preferably defined below. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.34. According to a further embodiment, it carries one, two, three or four R.sup.34. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2 heteroatoms selected from NH and NR.sup.N. According to a further specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2 heteroatoms O. According to a further specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2 heteroatoms selected from S, S(O) and S(O).sub.2. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.34. According to a further embodiment, it carries one, two, three or four R.sup.34.

[0466] According to one further embodiment R.sup.3 together with R.sup.4 and with the carbon atom to which they are bound form a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle, in particular three-, four-, five- or six-membered carbocycle, more specifically five- or six-membered carbocycle, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below. According to one embodiment thereof, R.sup.3 and R.sup.4 form a cyclopropyl, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below. According to a further embodiment thereof, R.sup.3 and R.sup.4 form a cyclobutyl, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below. According to still a further embodiment thereof, R.sup.3 and R.sup.4 form a cyclopentyl, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below. According to still a further embodiment thereof, R.sup.3 and R.sup.4 form a cyclohexyl, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below. According to still a further embodiment thereof, R.sup.3 and R.sup.4 form a cycloheptyl, that is unsubstituted or carries one, two, three or four substituents R.sup.34 as defined below.

[0467] R.sup.34 are the possible substituents for the carbo- or heterocycle formed by R.sup.3 and R.sup.4 and are independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents R.sup.34a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S).

[0468] In one preferred embodiment, R.sup.34 is in each case independently selected from halogen, OH, CN, SH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy and C.sub.1-C.sub.6-alkylthio. In one further preferred embodiment, R.sup.34 is in each case independently selected from halogen, C.sub.1-C.sub.6-alkyl and C.sub.1-C.sub.6-halogenalkyl. In one further particular embodiment, R.sup.34 is in each case independently selected from C.sub.1-C.sub.6-alkyl, such as methyl and ethyl.

[0469] R.sup.N is the substituent of the heteroatom NR.sup.N that is contained in the heterocycle formed by R.sup.3 and R.sup.4 in some of the inventive compounds. R.sup.N is selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalk and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted by one, two or three substituents selected from C.sub.1-C.sub.4-alkyl. In one preferred embodiment, R.sup.N is in each case independently selected from C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted by one methyl substituents. In one particular embodiment, R.sup.N is in each case independently selected from C.sub.1-C.sub.2-alkyl, more particularly methyl. In one particular embodiment, R.sup.N is in each case independently selected from SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted by one methyl.

[0470] According to still another embodiment of formula I, R.sup.3, R.sup.4 together with the carbon atom to which they are bound form a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- or heterocycle; wherein the carbocycle or heterocycle is unsubstituted or carries one, two, three or four substituents R.sup.34 independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents R.sup.34a selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy.

[0471] According to still another embodiment of formula I, R.sup.3, R.sup.4 together with the carbon atom to which they are bound form a saturated or partially unsaturated four-, five-, six-membered carbo- or heterocycle; wherein the carbocycle or heterocycle is unsubstituted or carries one, two, three or four substituents R.sup.34 independently selected from halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy.

[0472] Particularly preferred embodiments of combinations of R.sup.3 and R.sup.4 according to the invention are in Table P34 below, wherein each line of lines P34-1 to P34-171 corresponds to one particular embodiment of the invention, wherein P34-1 to P34-171 are also in any combination with one another a preferred embodiment of the present invention. The carbon atom, to which R.sup.3 and R.sup.4 are bound is marked with * in the drawings. Ts in the drawings stands for the tosylgroup SO.sub.2-(p-CH.sub.3)phenyl.

TABLE-US-00005 TABLE P34 No. R.sup.3 R.sup.4 P34-1 CH.sub.3 CH.sub.3 P34-2 CH.sub.3 CH.sub.2CH.sub.3 P34-3 CH.sub.3 CF.sub.3 P34-4 CH.sub.3 CHF.sub.2 P34-5 CH.sub.3 [00192] P34-6 CH.sub.3 [00193] P34-7 CH.sub.3 [00194] P34-8 CH.sub.3 [00195] P34-9 CH.sub.3 [00196] P34-10 CH.sub.3 [00197] P34-11 CH.sub.3 [00198] P34-12 CH.sub.3 [00199] P34-13 CH.sub.3 [00200] P34-14 CH.sub.3 C.sub.6H.sub.5 P34-15 CH.sub.3 4-FC.sub.6H.sub.4 P34-16 CH.sub.3 CH.sub.2C.sub.6H.sub.5 P34-17 CH.sub.3 CH.sub.2C.sub.6H.sub.4-4-F P34-18 CH.sub.3 3-py P34-19 CH.sub.3 2-py P34-20 CH.sub.3 4-py P34-21 CH.sub.3 [00201] P34-22 CH.sub.3 [00202] P34-23 CH.sub.3 [00203] P34-24 CH.sub.3 [00204] P34-25 CH.sub.3 [00205] P34-26 CH.sub.3 [00206] P34-27 CH.sub.3 [00207] P34-28 CH.sub.3 [00208] P34-29 CH.sub.3 [00209] P34-30 CH.sub.3 [00210] P34-31 CH.sub.3 [00211] P34-32 CH.sub.3 [00212] P34-33 CH.sub.3 [00213] P34-34 CH.sub.2F CH.sub.3 P34-35 CH.sub.2F CH.sub.2CH.sub.3 P34-36 CH.sub.2F CF.sub.3 P34-37 CH.sub.2F CHF.sub.2 P34-38 CH.sub.2F [00214] P34-39 CH.sub.2F [00215] P34-40 CH.sub.2F [00216] P34-41 CH.sub.2F [00217] P34-42 CH.sub.2F [00218] P34-43 CH.sub.2F [00219] P34-44 CH.sub.2F [00220] P34-45 CH.sub.2F [00221] P34-46 CH.sub.2F [00222] P34-47 CH.sub.2F C.sub.6H.sub.5 P34-48 CH.sub.2F 4-FC.sub.6H.sub.4 P34-49 CH.sub.2F CH.sub.2C.sub.6H.sub.5 P34-50 CH.sub.2F CH.sub.2C.sub.6H.sub.4-4-F P34-51 CH.sub.2F 3-py P34-52 CH.sub.2F 2-py P34-53 CH.sub.2F 4-py P34-54 CH.sub.2F [00223] P34-55 CH.sub.2F [00224] P34-56 CH.sub.2F [00225] P34-57 CH.sub.2F [00226] P34-58 CH.sub.2F [00227] P34-59 CH.sub.2F [00228] P34-60 CH.sub.2F [00229] P34-61 CH.sub.2F [00230] P34-62 CH.sub.2F [00231] P34-63 CH.sub.2F [00232] P34-64 CH.sub.2F [00233] P34-65 CH.sub.2F [00234] P34-66 CH.sub.2F [00235] P34-67 CHF.sub.2 CH.sub.3 P34-68 CHF.sub.2 CH.sub.2CH.sub.3 P34-69 CHF.sub.2 CF.sub.3 P34-70 CHF.sub.2 CHF.sub.2 P34-71 CHF.sub.2 [00236] P34-72 CHF.sub.2 [00237] P34-73 CHF.sub.2 [00238] P34-74 CHF.sub.2 [00239] P34-75 CHF.sub.2 [00240] P34-76 CHF.sub.2 [00241] P34-77 CHF.sub.2 [00242] P34-78 CHF.sub.2 [00243] P34-79 CHF.sub.2 [00244] P34-80 CHF.sub.2 C.sub.6H.sub.5 P34-81 CHF.sub.2 4-FC.sub.6H.sub.4 P34-82 CHF.sub.2 CH.sub.2C.sub.6H.sub.5 P34-83 CHF.sub.2 CH.sub.2C.sub.6H.sub.4-4-F P34-84 CHF.sub.2 3-py P34-85 CHF.sub.2 2-py P34-86 CHF.sub.2 4-py P34-87 CHF.sub.2 [00245] P34-88 CHF.sub.2 [00246] P34-89 CHF.sub.2 [00247] P34-90 CHF.sub.2 [00248] P34-91 CHF.sub.2 [00249] P34-92 CHF.sub.2 [00250] P34-93 CHF.sub.2 [00251] P34-94 CHF.sub.2 [00252] P34-95 CHF.sub.2 [00253] P34-96 CHF.sub.2 [00254] P34-97 CHF.sub.2 [00255] P34-98 CHF.sub.2 [00256] P34-99 CHF.sub.2 [00257] P34-100 CF.sub.3 CH.sub.3 P34-101 CF.sub.3 CH.sub.2CH.sub.3 P34-102 CF.sub.3 CF.sub.3 P34-103 CF.sub.3 CHF.sub.2 P34-104 CF.sub.3 [00258] P34-105 CF.sub.3 [00259] P34-106 CF.sub.3 [00260] P34-107 CF.sub.3 [00261] P34-108 CF.sub.3 [00262] P34-109 CF.sub.3 [00263] P34-110 CF.sub.3 [00264] P34-111 CF.sub.3 [00265] P34-112 CF.sub.3 [00266] P34-113 CF.sub.3 C.sub.6H.sub.5 P34-114 CF.sub.3 4-FC.sub.6H.sub.4 P34-115 CF.sub.3 CH.sub.2C.sub.6H.sub.5 P34-116 CF.sub.3 CH.sub.2C.sub.6H.sub.4-4-F P34-117 CF.sub.3 3-py P34-118 CF.sub.3 2-py P34-119 CF.sub.3 4-py P34-120 CF.sub.3 [00267] P34-121 CF.sub.3 [00268] P34-122 CF.sub.3 [00269] P34-123 CF.sub.3 [00270] P34-124 CF.sub.3 [00271] P34-125 CF.sub.3 [00272] P34-126 CF.sub.3 [00273] P34-127 CF.sub.3 [00274] P34-128 CF.sub.3 [00275] P34-129 CF.sub.3 [00276] P34-130 CF.sub.3 [00277] P34-131 CF.sub.3 [00278] P34-132 CF.sub.3 [00279] P34-133 [00280] P34-134 [00281] P34-135 [00282] P34-136 [00283] P34-137 [00284] P34-138 [00285] P34-139 [00286] P34-140 [00287] P34-141 [00288] P34-142 [00289] P34-143 [00290] P34-144 [00291] P34-145 [00292] P34-146 [00293] P34-147 [00294] P34-148 [00295] P34-149 [00296] P34-150 [00297] P34-151 [00298] P34-152 [00299] P34-153 [00300] P34-154 [00301] P34-155 [00302] P34-156 [00303] P34-157 [00304] P34-158 [00305] P34-159 [00306] P34-160 [00307] P34-161 [00308] P34-162 [00309] P34-163 [00310] P34-164 [00311] P34-165 [00312] P34-166 [00313] P34-167 [00314] P34-168 [00315] P34-169 [00316] P34-170 [00317] P34-171 [00318]

[0473] R.sup.x in the substituent NHSO.sub.2R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl and aryl that is substituted by one, two, three, four or five substituents R.sup.x1 independently selected from C.sub.1-C.sub.4-alkyl. In particular, R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl and phenyl that is substituted by one, two or three R.sup.x1 independently selected from C.sub.1-C.sub.2-alkyl, more specifically R.sup.x is in each case independently selected from C.sub.1-C.sub.4-alkyl and phenyl that is substituted by one CH.sub.3., more specifically SO.sub.2R.sup.x is the tosyl group (Ts).

[0474] R.sup.3a are the possible substituents for the the acyclic moieties of R.sup.3 and the R.sup.3a are in each case independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH (C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)OC.sub.1-C.sub.6-alkyl, C(O)NHC.sub.1-C.sub.6-alkyl, C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, CRNOR, a saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl and phenoxy; wherein in each case one or two CH.sub.2 groups of the carbocycle and heterocycle may be replaced by a group independently selected from C(O) and C(S); wherein the heterocycle and heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, phenyl and heteroaryl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl; wherein n is 0, 1 and 2;

[0475] In one preferred embodiment, R.sup.3a is in each case independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, heteroaryl, phenyl and halogenphenyl, wherein the halogenphenyl is substituted by halogen selected from the group consisting of F, Cl and Br. In one further preferred embodiment, R.sup.3a is in each case independently selected from halogen, heteroaryl, phenyl and halogenphenyl, wherein the halogenphenyl is substituted by halogen selected from the group consisting of F, Cl and Br, in particular selected from F and Cl.

[0476] In one further preferred embodiment, R.sup.3a is in each case independently selected from halogen, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, phenyl, and heteroaryl; wherein the heteroaryl and phenyl is substituted by halogen selected from the group consisting of F, Cl and Br or by C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy. In one further preferred embodiment, R.sup.3a is in each case independently selected from halogen heteroaryl and phenyl wherein the heteroaryl and phenyl is substituted by halogen selected from the group consisting of F, Cl and Br, in particular selected from F and Cl.

[0477] R.sup.3b are the possible substituents for the carbocycle, heterocycle, heteroaryl and aryl moieties are independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or substituted with substituents selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0478] In one preferred embodiment, R.sup.3b is in each case independently selected from halogen, OH, CN, SH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy and C.sub.1-C.sub.6-alkylthio. In one further preferred embodiment, R.sup.3b is in each case independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy and C.sub.1-C.sub.6-halogenalkyl. In one further particular embodiment, R.sup.3b is in each case independently selected from C.sub.1-C.sub.6-alkyl, such as methyl and ethyl. In one further particular embodiment, R.sup.3b is in each case independently selected from halogen, such as F, Cl and Br.

[0479] R.sup.4a are the possible substituents for the the acyclic moieties of R.sup.4 and the R.sup.4a are in each case independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), CRNOR, a saturated or partially unsaturated three-, four, five-, six-, seven-, eight-, nine-, or ten-membered carbocycle or heterocycle, five-, six- or ten-membered heteroaryl, aryl, phenoxy; wherein in each case one or two CH.sub.2 groups of the carbocycle and heterocycle may be replaced by a group independently selected from C(O) and C(S); wherein the heterocycle and heteroaryl contain independently one, two, three or four heteroatoms selected from N, O and S; wherein the carbocyclic, heterocyclic, phenyl and heteroaryl groups are independently unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl; wherein n is 0, 1 and 2; According to one preferred embodiment, R.sup.4a is in each case independently selected from halogen, OH, CN, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl) and CRNOR.

[0480] According to one preferred embodiment, R.sup.4a is in each case independently selected from OH, CN, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl) such as CN, CHO, C(O)O(CH.sub.3),CO.sub.2NH(CH.sub.3), CO.sub.2N(CH.sub.3).sub.2 or NHSO.sub.2CF.sub.3.

[0481] According to one preferred embodiment, R.sup.4a is in each case independently selected from C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, such as SCH.sub.3, SO.sub.2CH.sub.3, SO.sub.2Ph.

[0482] According to one preferred embodiment, R.sup.4a is in each case independently selected from NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, such as NH(CH.sub.3), N(CH.sub.3).sub.2 or NHSO.sub.2CH.sub.3, NHSO.sub.2CF.sub.3.

[0483] According to one preferred embodiment, R.sup.4a is in each case independently selected from C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, such as cyclopropyl or fully or partially halogenated cyclopropyl.

[0484] According to one preferred embodiment, R.sup.4a is in each case independently selected from C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0485] According to one preferred embodiment, R.sup.4a is in each case independently selected from heterocarbocycle, wherein the heretocyclocycle is a saturated, two CH.sub.2 groups are replaced by C(O) and contains one N as a ring member.

[0486] According to one preferred embodiment, R.sup.4a is in each case independently selected from aryl, wherein the aryl is substituted with halogen selected from the group consisting of F, Cl, Br, CH.sub.3, CHF.sub.2, OCH.sub.3, OCHF.sub.3, CN or SO.sub.2CH.sub.3.

[0487] According to one prefer embodiment, R.sup.4 is unsubstituted 5- or 6-membered heteroaryl.

[0488] According to still a further embodiment, R.sup.4 is 5- or 6-membered heteroaryl substituted by halogen selected from the group consisting of F, Cl, Br, CH.sub.3, CHF.sub.2, OCH.sub.3, OCHF.sub.3, CN or SO.sub.2CH.sub.3.

[0489] According to one preferred embodiment, R.sup.4a is in each case independently selected from halogen, OH, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and heterocycle, wherein the heretocyclocycle is a saturated and contains one N as a ring member.

[0490] According to one preferred embodiment, R.sup.4a is in each case independently selected from halogen, OH, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and heterocycle, wherein the heretocyclocycle is a saturated, one CH.sub.2 group is replaced by C(O) and contains one N as a ring member.

[0491] According to one preferred embodiment, R.sup.4a is in each case independently selected from halogen, OH, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and heterocycle, wherein the heretocyclocycle is a saturated, two CH.sub.2 groups are replaced by C(O) and contains one N as a ring member.

[0492] According to one preferred embodiment, R.sup.4a is in each case independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, phenyl, aryl, and heteroaryl, wherein the aryl and heteroaryl are substituted from the group consisting of F, Cl, Br, CH.sub.3, CHF.sub.2, OCH.sub.3, OCHF.sub.3, CN or SO.sub.2CH.sub.3. According to one further preferred embodiment, R.sup.4a is in each case independently selected from halogen, phenyl, halogenphenyl and heteroaryl, wherein the halogenphenyl is substituted with halogen selected from the group consisting of F, Cl and Br, in particular selected from F and Cl.

[0493] According to one further preferred embodiment, R.sup.4a is in each case independently selected from halogen, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, phenyl, wherein the phenyl is substituted with halogen selected from the group consisting of F, Cl and Br or by C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy. According to one further preferred embodiment, R.sup.4a is in each case independently selected from halogen and phenyl wherein the phenyl is substituted with halogen selected from the group consisting of F, Cl and Br, in particular selected from F and Cl.

[0494] R.sup.4b are the possible substituents for the carbocycle, heterocycle, heteroaryl and aryl moieties and are independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, S(O).sub.nC.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-alkoxy-C.sub.1-C.sub.4-alkyl, phenyl and phenoxy, wherein the phenyl groups are unsubstituted or substituted with substituents selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0495] According to one preferred embodiment, R.sup.4b is in each case independently selected from halogen, OH, CN, SH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.1-C.sub.6-alkylthio and S(O).sub.nC.sub.1-C.sub.6-alkyl. According to one further preferred embodiment, R.sup.4b is in each case independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-halogenalkoxy and S(O).sub.nC.sub.1-C.sub.6-alkyl. According to one further particular embodiment, R.sup.4b is in each case independently selected from C.sub.1-C.sub.6-alkyl, such as methyl and ethyl. According to one further particular embodiment, R.sup.4b is in each case independently selected from halogen, such as F, Cl and Br. According to one further particular embodiment, R.sup.4b is in each case independently selected from C.sub.1-C.sub.6-alkoxy, such as OCH.sub.3. According to one further particular embodiment, R.sup.4b is in each case independently selected from C.sub.1-C.sub.4-halogenalkoxy, such as OCHF.sub.2 and OCF.sub.3. According to one further particular embodiment, R.sup.4b is in each case independently selected from S(O).sub.nC.sub.1-C.sub.6-alkyl. such as SO.sub.2CH.sub.3.

[0496] R.sup.5 is halogen.

[0497] According to one preferred embodiment, R.sup.5 is F.

[0498] According to one preferred embodiment, R.sup.5 is Cl.

[0499] According to one preferred embodiment, R.sup.5 is Br.

[0500] According to one preferred embodiment, R.sup.5 is I.

[0501] R.sup.6 is halogen.

[0502] According to one preferred embodiment, R.sup.6 is F.

[0503] According to one preferred embodiment, R.sup.6 is Cl.

[0504] According to one preferred embodiment, R.sup.6 is Br.

[0505] According to one preferred embodiment, R.sup.6 is I. [0506] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound together form a phenyl or five- or six-membered heteroaryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein the heteroaryl carries zero, one, two, three or four substituents (R.sup.78).sub.o, wherein o is 0, 1, 2 or 3; and [0507] R.sup.78 are independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)NH(C.sub.1-C.sub.6-alkyl), CRNOR, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.2-C.sub.6-alkenyloxy, C.sub.2-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, three-, four-, five- or six-membered saturated or partially unsaturated heterocycle, five- or six-membered heteroaryl and phenyl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein n, R.sup.x, R and R are as defined above. [0508] and wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a which independently of one another are selected from: [0509] R.sup.78a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.3-C.sub.6-halogencycloalkenyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl and phenyl group is unsubstituted or carries one, two, three, four or five substituents R.sup.78a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0510] wherein the carbocyclic, phenyl, heterocyclic and heteroaryl moieties of R.sup.78 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.78b which independently of one another are selected from: [0511] R.sup.78b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio. According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form phenyl; wherein the phenyl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0512] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five- or six-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms selected from N, O and S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0513] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five- or six-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms N, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0514] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five- or six-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms selected from S and O, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0515] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five- or six-membered heteroaryl; wherein the heteroaryl contains one heteroatom S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0516] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five- or six-membered heteroaryl; wherein the heteroaryl contains one heteroatom O, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0517] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms selected from N, O and S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0518] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms N, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0519] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms selected from O and S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0520] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one heteroatom S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2.

[0521] According to one embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a five-membered heteroaryl; wherein the heteroaryl contains one heteroatom O, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0522] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a six-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms selected from N, O and S, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0523] According to a further embodiment, R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a six-membered heteroaryl; wherein the heteroaryl contains one or two heteroatoms N, and wherein the heteroaryl carries zero, one or two substituents (R.sup.78).sub.o, as defined and preferably defined herein, wherein o is 0, 1 or 2. According to one specific embodiment, o is 0. According to a further embodiment, o is 1 or 2. Particular embodiments thereof are listed in Table P78.

[0524] According to the invention, there can be zero, one, two or three R.sup.78 present, namely for o is 0, 1, 2 or 3.

[0525] According to one embodiment, o is 0.

[0526] According to a further embodiment, o is 1.

[0527] According to a further embodiment, o is 2 or 3. According to one specific embodiment thereof, o is 2, according to a further specific embodiment, o is 3.

[0528] For every R.sup.78 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R.sup.78 that may be present in the ring. Furthermore, the particular embodiments and preferences given herein for R.sup.78 apply independently for each of o=1, o=2 and o=3.

[0529] According to one specific embodiment, R.sup.78 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.

[0530] According to still another embodiment of formula I, R.sup.78 is F.

[0531] According to still another embodiment of formula I, R.sup.78 is Cl.

[0532] According to still another embodiment of formula I, R.sup.78 is Br.

[0533] According to a further specific embodiment, R.sup.78 is OH.

[0534] According to a further specific embodiment, R.sup.78 is CN.

[0535] According to a further specific embodiment, R.sup.78 is NO.sub.2.

[0536] According to still another embodiment of formula I, R.sup.78 is SH.

[0537] According to still another embodiment of formula I, R.sup.78 is NH.sub.2.

[0538] According to still another embodiment of formula I, R.sup.78 is, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C(O)(C.sub.1-C.sub.4-alkyl), N(C(O)(C.sub.1-C.sub.4-alkyl).sub.2, wherein C.sub.1-C.sub.4-alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0539] According to a further specific embodiment of formula I, R.sup.78 is NHSO.sub.2R.sup.x such as NHSO.sub.2CH.sub.3, NHSO.sub.2CH.sub.2CH.sub.3, NHSO.sub.2CF.sub.3 or NHSO.sub.2-Ts.

[0540] According to a further specific embodiment of formula I, R.sup.78 is CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl) or C(O)NH(C.sub.1-C.sub.6-alkyl), wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0541] According to a further specific embodiment of formula I, R.sup.78 is CRNOR such as C(CH.sub.3)NOCH.sub.3, C(CH.sub.3)NOCH.sub.2CH.sub.3 or C(CH.sub.3)NOCF.sub.3.

[0542] According to a further specific embodiment, R.sup.78 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl., in particular CH.sub.3.

[0543] According to a further specific embodiment, R.sup.78 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0544] According to still a further embodiment, R.sup.78 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2 or CH.sub.2CHCH.sub.2.

[0545] According to still another embodiment of formula I R.sup.78 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0546] According to still another embodiment of formula I, R.sup.78 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.1 is fully or partially halogenated cyclopropyl.

[0547] According to still a further embodiment, R.sup.78 is C.sub.3-C.sub.6-cycloalkyl-C.sub.2-C.sub.6-alkenyl, in particular C.sub.3-C.sub.6-cycloalkyl-C.sub.2-C.sub.4-alkenyl, more specifically C.sub.3-C.sub.6-cycloalkyl-C.sub.2-C.sub.3-alkenyl, such as C.sub.3H.sub.5CHCH.sub.2.

[0548] According to a further specific embodiment, R.sup.78 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2. CH.sub.2CFCF.sub.2, CH.sub.2CClCCl.sub.2. CF.sub.2CFCF.sub.2 or CCl.sub.2CClCCl.sub.2.

[0549] According to still a further embodiment, R.sup.78 is C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.4-alkynyl, more specifically C.sub.2-C.sub.3-alkynyl, such as CCH.

[0550] According to still a further embodiment, R.sup.78 is C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-halogenalkynyl, more specifically C.sub.2-C.sub.3-halogenalkynyl.

[0551] According to a further specific embodiment, R.sup.78 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0552] According to a further specific embodiment, R.sup.78 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2, OCH.sub.2Cl and OCF.sub.2CHF.sub.2, in particular OCF.sub.3, OCHF.sub.2 and OCF.sub.2CHF.sub.2.

[0553] According to a further specific embodiment of formula I, R.sup.78 is C.sub.2-C.sub.6-alkenyloxy, in particular C.sub.2-C.sub.4-alkenyloxy, more specifically C.sub.1-C.sub.2-alkenyloxy such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2.

[0554] According to a further specific embodiment of formula I, R.sup.78 is C.sub.2-C.sub.6-alkynyloxy, in particular C.sub.2-C.sub.4-alkynyloxy, more specifically C.sub.1-C.sub.2-alkynyloxy such as OCCH According to a further specific embodiment of formula I, R.sup.78 is S(O).sub.nC.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl and n is 1, 2 or 3.

[0555] According to a further specific embodiment of formula I, R.sup.78 is S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, wherein halogenalkyl is CF.sub.3 or CHF.sub.2 and n is 1, 2 or 3.

[0556] According to still another embodiment of formula I, R.sup.78 is a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted by substituents R.sup.78b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0557] According to still another embodiment of formula I, R.sup.78 is a saturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered heterocycle, in particular three-, four-, five- or six-membered, wherein the heterocycle contains one, two, three or four heteroatoms selected from N, O and S, and wherein the heterocycle is unsubstituted or substituted by substituents R.sup.78b as defined below. According to one embodiment thereof, the heterocycle is unsubstituted.

[0558] According to still another embodiment of formula I, in the embodiments of R.sup.78 described above, the heterocycle contains preferably one, two or three, more specifically one or two heteroatoms selected from N, O and S. More specifically, the hetereocycle contains one heteroatom selected from N, O and S. In particular, the heterocycle contains one or two, in particular one O.

[0559] According to one embodiment, R.sup.78 is a 4-membered saturated heterocycle which contains 1 or 2 heteroatoms, in particular 1 heteroatom, from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. For example, the formed heterocycle is oxetane. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.78b. According to still another embodiment of formula I, it is substituted by R.sup.78b.

[0560] According to still another embodiment of formula I, R.sup.78 is a 5-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S, as ring members. According to one embodiment, the heterocycle contains one O as heteroatom. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.78b. According to still another embodiment of formula I, it is substituted by R.sup.78b.

[0561] According to still another embodiment of formula I, R.sup.78 is a 6-membered saturated heterocycle which contains 1, 2 or 3, in particular 1 or 2, heteroatoms from the group consisting of N, O and S as ring members. According to one embodiment thereof, the heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.78b. According to still another embodiment of formula I, it is substituted by R.sup.78b. According to one specific embodiment thereof, said 6-membered saturated heterocycle contains 1 or 2, in particular 1, heteroatom(s) O. According to one embodiment thereof, the respective 6-membered heterocycle is unsubstituted, i.e. it does not carry any substituent R.sup.78b. According to still another embodiment of formula I, it is substituted by R.sup.78b.

[0562] According to still another embodiment of formula I, R.sup.78 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R.sup.78b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CHF.sub.2, CF.sub.3OCHF.sub.2, and OCF.sub.3.

[0563] According to still a further specific embodiment, R.sup.78 is unsubstituted phenyl or phenyl that is substituted by one, two, three or four R.sup.78b, as defined and preferably herein. In particular, R.sup.78 is unsubstituted phenyl or phenyl that is substituted by one, two, three or four R.sup.78b, as defined herein. In one embodiment R.sup.78 is unsubstituted phenyl.

[0564] According to still another embodiment of formula I, R.sup.78 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0565] According to still another embodiment of formula I, R.sup.78 is a 6-membered heteroaryl, such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0566] According to one further embodiment, R.sup.78 is in each case independently selected from halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, three-, four-, five- or six-membered saturated or partially unsaturated heterocycle, five- or six-membered heteroaryl and phenyl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a as defined and preferably defined herein, and wherein the heterocyclic, alicyclic, phenyl and heteroaryl moieties of R.sup.78 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.78b as defined and preferably defined herein.

[0567] According to one further embodiment, R.sup.78 is in each case independently selected from halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, three-, four-, five- or six-membered saturated or partially unsaturated heterocycle, five- or six-membered heteroaryl and phenyl; wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a as defined and preferably defined herein, and wherein the heterocyclic, alicyclic, phenyl and heteroaryl moieties of R.sup.78 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.78b as defined and preferably defined herein. According to one specific embodiment, the acyclic and cyclic moieties of R.sup.78 are not further substituted, according to another embodiment, the acyclic moieties of R.sup.78 carry one, two, three or four identical or different groups R.sup.78a as defined and preferably defined herein.

[0568] According to a further embodiment, R.sup.78 is in each case independently selected from halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.06-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and S(O).sub.nC.sub.1-C.sub.6-alkyl, wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.78 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.78b as defined and preferably defined herein.

[0569] According to a further embodiment, R.sup.78 is in each case independently selected from halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.06-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and S(O).sub.nC.sub.1-C.sub.6-alkyl, wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.78 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.78b as defined and preferably defined herein. According to one specific embodiment, the acyclic and cyclic moieties of R.sup.78 are not further substituted, according to another embodiment, the acyclic moieties of R.sup.78 carry one, two, three or four identical or different groups R.sup.78a as defined and preferably defined herein.

[0570] According to still a further embodiment, R.sup.78 is in each case independently selected from halogen, C.sub.1-C.sub.6-alkyl and C.sub.1-C.sub.6-alkoxy, wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a defined and preferably defined herein.

[0571] According to still a further embodiment, R.sup.78 is in each case independently selected from CN, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy and C.sub.1-C.sub.6-halogenalkoxy, wherein the acyclic moieties of R.sup.78 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.78a defined and preferably defined herein. According to one specific embodiment, the acyclic and cyclic moieties of R.sup.78 are not further substituted, according to another embodiment, the acyclic moieties of R.sup.78 carry one, two, three or four identical or different groups R.sup.78a as defined and preferably defined herein.

[0572] R.sup.78a are the possible substituents for the acyclic moieties of R.sup.78. R.sup.78a is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.3-C.sub.6-halogencycloalkenyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, five- or six-membered heteroaryl, phenyl and phenoxy, wherein the heteroaryl and phenyl group is unsubstituted or carries one, two, three, four or five substituents R.sup.78a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0573] According to one embodiment R.sup.78a is independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy. Specifically, R.sup.78a is independently selected from F, Cl, Br, I, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0574] According to a further embodiment, R.sup.78a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

[0575] R.sup.78b are the possible substituents for the cycloalkyl, heterocyclyl, heteroaryl and phenyl moieties of R.sup.78. R.sup.78b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0576] According to one embodiment thereof R.sup.78b is independently selected from halogen, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl and C.sub.1-C.sub.4-halogenalkoxy, in particular halogen, C.sub.1-C.sub.4-alkyl and C.sub.1-C.sub.4-alkoxy. Specifically, R.sup.78b is independently selected from F, Cl, CN, CH.sub.3, OCH.sub.3 and halogenmethoxy.

[0577] Particularly preferred embodiments of R.sup.7 and R.sup.8, optionally substituted by (R.sup.78).sub.o, according to the invention are in Table P78 below, wherein each line of lines P78-1 to P78-82 corresponds to one particular embodiment of the invention, wherein P78-1 to P78-82 are also in any combination with one another a preferred embodiment of the present invention. Thereby, the positions of the heteroaryls marked with # represents the connection points (carbon atoms 5 and 6 in formula I) with the remaining skeleton of the compounds of formula I:

TABLE-US-00006 TABLE P78 No. R.sup.7 + R.sup.8 P78-1 [00319] P78-2 [00320] P78-3 [00321] P78-4 [00322] P78-5 [00323] P78-6 [00324] P78-7 [00325] P78-8 [00326] P78-9 [00327] P78-10 [00328] P78-11 [00329] P78-12 [00330] P78-13 [00331] P78-14 [00332] P78-15 [00333] P78-16 [00334] P78-17 [00335] P78-18 [00336] P78-19 [00337] P78-20 [00338] P78-21 [00339] P78-22 [00340] P78-23 [00341] P78-24 [00342] P78-25 [00343] P78-26 [00344] P78-27 [00345] P78-28 [00346] P78-29 [00347] P78-30 [00348] P78-31 [00349] P78-32 [00350] P78-33 [00351] P78-34 [00352] P78-35 [00353] P78-36 [00354] P78-37 [00355] P78-38 [00356] P78-39 [00357] P78-40 [00358] P78-41 [00359] P78-42 [00360] P78-43 [00361] P78-44 [00362] P78-45 [00363] P78-46 [00364] P78-47 [00365] P78-48 [00366] P78-49 [00367] P78-50 [00368] P78-51 [00369] P78-52 [00370] P78-53 [00371] P78-54 [00372] P78-55 [00373] P78-56 [00374] P78-57 [00375] P78-58 [00376] P78-59 [00377] P78-60 [00378] P78-61 [00379] P78-62 [00380] P78-63 [00381] P78-64 [00382] P78-65 [00383] P78-66 [00384] P78-67 [00385] P78-68 [00386] P78-69 [00387] P78-70 [00388] P78-71 [00389] P78-72 [00390] P78-73 [00391] P78-74 [00392] P78-75 [00393] P78-76 [00394] P78-77 [00395] P78-78 [00396] P78-79 [00397] P78-80 [00398] P78-81 [00399] P78-82 [00400] [0578] R.sup.9 is in each case independently selected from H, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C.sub.2-C.sub.4-alkenyl), N(C.sub.2-C.sub.4-alkenyl).sub.2, NH(C.sub.2-C.sub.4-alkynyl), N (C.sub.2-C.sub.4-alkynyl).sub.2, NH (C.sub.3-C.sub.6-cycloalkyl), N (C.sub.3-C.sub.6-cycloalkyl).sub.2, N (C.sub.2-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkenyl), N(C.sub.2-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkynyl), N(C.sub.2-C.sub.4-alkyl)(C.sub.3-C.sub.6-cycloalkyl), N(C.sub.2-C.sub.4-alkenyl)(C.sub.2-C.sub.4-alkynyl), N (C.sub.2-C.sub.4-alkenyl)(C.sub.3-C.sub.6-cycloalkyl), N (C.sub.2-C.sub.4-alkynyl)(C.sub.3-C.sub.6-cycloalkyl), NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, C.sub.1-C.sub.6-cycloalkylthio, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)C.sub.2-C.sub.6-alkenyl, C(O)C.sub.2-C.sub.6-alkynyl, C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)NH(C.sub.1-C.sub.6-alkyl), CH(S), C(S)C.sub.1-C.sub.6-alkyl, C(S)C.sub.2-C.sub.6-alkenyl, C(S)C.sub.2-C.sub.6-alkynyl, C(S)C.sub.3-C.sub.6-cycloalkyl, C(S)NH(C.sub.1-C.sub.6-alkyl), C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.06-alkenyl, C.sub.2-C.sub.6-alkynyl, OR.sup.Y, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein [0579] R.sup.x is as defined above; [0580] R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl; phenyl and phenyl-C.sub.1-C.sub.6-alkyl; wherein the phenyl group is unsubstituted or substituted with substituents selected from the group consisting of halogen, CN, OH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy and C.sub.1-C.sub.6-halogenalkoxy; [0581] wherein the acyclic moieties of R.sup.9 are unsubstituted or substituted with groups R.sup.9a which independently of one another are selected from: [0582] R.sup.9a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenoxy group is unsubstituted or substituted with substituents R.sup.91a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0583] wherein the carbocycle, heteroaryl and aryl moieties of R.sup.9 are unsubstituted or substituted with groups R.sup.9b which independently of one another are selected from: [0584] R.sup.9b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0585] According to one embodiment of formula I, R.sup.9 is selected from the group consisting of H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, and OR.sup.Y.

[0586] According to one embodiment of formula I, R.sup.9 is H.

[0587] According to still another embodiment of formula I, R.sup.9 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.

[0588] According to still another embodiment of formula I, R.sup.9 is F.

[0589] According to still another embodiment of formula I, R.sup.9 is Cl.

[0590] According to still another embodiment of formula I, R.sup.9 is Br.

[0591] According to still another embodiment of formula I, R.sup.9 is OH.

[0592] According to still another embodiment of formula I, R.sup.9 is CN.

[0593] According to still another embodiment of formula I, R.sup.9 is NO.sub.2.

[0594] According to still another embodiment of formula I, R.sup.9 is SH.

[0595] According to still another embodiment of formula I, R.sup.9 is NH.sub.2.

[0596] According to still another embodiment of formula I, R.sup.9 is, NH(C.sub.1-C.sub.4-alkyl), in particular NH(CH.sub.3), NH(C.sub.2H.sub.5).

[0597] According to still another embodiment of formula I, R.sup.9 is, N(C.sub.1-C.sub.4-alkyl).sub.2, in particular NH(CH.sub.3).sub.2, NH(C.sub.2H.sub.5).sub.2.

[0598] According to still another embodiment of formula I, R.sup.9 is, NH(C.sub.2-C.sub.4-alkenyl), in particular NH(CHCH.sub.2), NH(CH.sub.2CHCH.sub.2).

[0599] According to still another embodiment of formula I, R.sup.9 is, N(C.sub.2-C.sub.4_-alkenyl).sub.2, in particular N(CHCH.sub.2).sub.2, N(CH.sub.2CHCH.sub.2).sub.2.

[0600] According to still another embodiment of formula I, R.sup.9 is, NH(C.sub.2-C.sub.4-alkynyl), in particular NH(CCH), NH(CH.sub.2CCH).

[0601] According to still another embodiment of formula I, R.sup.9 is, N(C.sub.2-C.sub.4-alkynyl).sub.2, in particular N(CCH).sub.2, N(CH.sub.2CCH).sub.2.

[0602] According to still another embodiment of formula I, R.sup.9 is, NH(C.sub.3-C.sub.6-cycloalkyl), in particular NH(C.sub.3H.sub.7), NH(C.sub.4H.sub.9).

[0603] According to still another embodiment of formula I, R.sup.9 is, N(C.sub.3-C.sub.6-cycloalkyl).sub.2, in particular N(C.sub.3H.sub.7).sub.2, N(C.sub.4H.sub.9).sub.2.

[0604] According to still another embodiment of formula I, R.sup.9 is N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkenyl), in particular N(CH.sub.3)(CHCH.sub.2), N(CH.sub.3)(CH.sub.2CHCH.sub.2), N(C.sub.2H.sub.5)(CHCH.sub.2), N(C.sub.2H.sub.5)(CH.sub.2CHCH.sub.2).

[0605] According to still another embodiment of formula I, R.sup.9 is N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkynyl), in particular N(CH.sub.3)(CCH), N(CH.sub.3)(CH.sub.2CCH), N(C.sub.2H.sub.5)(CCH), N(C.sub.2H.sub.5)(CH.sub.2CCH).

[0606] According to still another embodiment of formula I, R.sup.9 is N(C.sub.1-C.sub.4-alkyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CH.sub.3)(C.sub.3H.sub.7), N(CH.sub.3)(C.sub.4H.sub.9), N(C.sub.2H.sub.5)(C.sub.3H.sub.7), N(CH.sub.3)(C.sub.4H.sub.9).

[0607] According to still another embodiment of formula I, R.sup.9 is N(C.sub.2-C.sub.4-alkenyl)(C.sub.2-C.sub.4-alkynyl), in particular N(CHCH.sub.2)(CCH), N(CH.sub.2CHCH.sub.2)(CH.sub.2CCH), N(CHCH.sub.2)(CCH), N(CH.sub.2CHCH.sub.2)(CH.sub.2CCH).

[0608] According to still another embodiment of formula I, R.sup.9 is N(C.sub.2-C.sub.4-alkenyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CHCH.sub.2)(C.sub.3H.sub.7), N(CH.sub.2CHCH.sub.2)(C.sub.4H.sub.9), N(CHCH.sub.2)(C.sub.3H.sub.7), N(CH.sub.2CHCH.sub.2)(C.sub.4H.sub.9).

[0609] According to still another embodiment of formula I, R.sup.9 is N(C.sub.2-C.sub.4-alkynyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CCH)(C.sub.3H.sub.7), N(CH.sub.2CCH)(C.sub.4H.sub.9), N(CCH)(C.sub.3H.sub.7), N(CH.sub.2CCH)(C.sub.4H.sub.9).

[0610] According to still another embodiment of formula I, R.sup.9 is, NH(C(O)(C.sub.1-C.sub.4-alkyl), in particular NH(C(O)(CH.sub.3), NH(C(O)(C.sub.2H.sub.5).

[0611] According to still another embodiment of formula I, R.sup.9 is N(C(O)(C.sub.1-C.sub.4-alkyl).sub.2, in particular N(C(O)(CH.sub.3).sub.2, N(C(O)(C.sub.2H.sub.5).sub.2.

[0612] According to a further specific embodiment of formula I, R.sup.9 is NHSO.sub.2R.sup.x such as NHSO.sub.2CH.sub.3, NHSO.sub.2CH.sub.2CH.sub.3, NHSO.sub.2CF.sub.3, NHSO.sub.2-Ts.

[0613] According to still another embodiment of formula I, R.sup.9 is S(O).sub.nC.sub.1-C.sub.6-alkyl such as SCH.sub.3, S(O) CH.sub.3, S(O).sub.2CH.sub.3.

[0614] According to still another embodiment of formula I, R.sup.9 is S(O).sub.n-aryl such as S-phenyl, S(O) phenyl, S(O).sub.2phenyl.

[0615] According to still another embodiment of formula I, R.sup.9 is S(O).sub.nC.sub.2-C.sub.6-alkenyl such as SCHCH.sub.2, S(O)CHCH.sub.2, S(O).sub.2CHCH.sub.2, SCH.sub.2CHCH.sub.2, S(O)CH.sub.2CHCH.sub.2, S(O).sub.2CH.sub.2CHCH.sub.2.

[0616] According to still another embodiment of formula I, R.sup.9 is S(O).sub.nC.sub.2-C.sub.6-alkynyl such as SCCH, S(O)CCH, S(O).sub.2CCH, SCH.sub.2CCH, S(O)CH.sub.2CCH, S(O).sub.2CH.sub.2CCH.

[0617] According to a further specific embodiment of formula I, R.sup.9 is CH(O).

[0618] According to a further specific embodiment of formula I, R.sup.9 is C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl) or C(O)NH(C.sub.1-C.sub.6-alkyl), wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0619] According to a further specific embodiment of formula I, R.sup.9 is C(O)C.sub.2-C.sub.6-alkenyl, C(O)O(C.sub.2-C.sub.6-alkenyl) or C(O)NH(C.sub.2-C.sub.6-alkenyl), wherein alkenyl is CHCH.sub.2, CH.sub.2CHCH.sub.2.

[0620] According to a further specific embodiment of formula I, R.sup.9 is C(O)C.sub.2-C.sub.6-alkynyl, C(O)O(C.sub.2-C.sub.6-alkynyl) or C(O)NH(C.sub.2-C.sub.6-alkynyl), wherein alkynyl is CCH, CH.sub.2CCH.

[0621] According to a further specific embodiment of formula I, R.sup.9 is C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.3-C.sub.6-cycloalkyl) or C(O)NH(C.sub.3-C.sub.6-cycloalkyl), wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0622] According to a further specific embodiment of formula I, R.sup.9 is CH(S).

[0623] According to a further specific embodiment of formula I, R.sup.9 is C(S)C.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0624] According to a further specific embodiment of formula I, R.sup.9 is C(S)C.sub.2-C.sub.6-alkenyl, wherein alkenyl is CHCH.sub.2, CH.sub.2CHCH.sub.2.

[0625] According to a further specific embodiment of formula I, R.sup.9 is C(S)C.sub.2-C.sub.6-alkynyl, wherein alkynyl is CCH, CH.sub.2CCH.

[0626] According to a further specific embodiment of formula I, R.sup.9 is C(S)C.sub.3-C.sub.6-cycloalkyl, wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0627] According to a further specific embodiment of formula I, R.sup.9 is C(S)NHC.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0628] According to still another embodiment of formula I, R.sup.9 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3. or C.sub.2H.sub.5, in particular CH.sub.3 or CH.sub.2CH.sub.3.

[0629] According to still another embodiment of formula I, R.sup.9 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CH.sub.3CHF, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2, in particular FCH.sub.2 or F.sub.2CH.

[0630] According to still a further embodiment of formula I, R.sup.9 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2, C(CH.sub.3)CH.sub.2, CH.sub.2CHCH.sub.2.

[0631] According to a further specific embodiment of formula I, R.sup.9 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CF.sub.2CHCF.sub.2, CCl.sub.2CHCCl.sub.2, CF.sub.2CFCF.sub.2, CCl.sub.2CClCCl.sub.2.

[0632] According to still a further embodiment of formula I, R.sup.9 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CH.sub.2CCH, CCCl, CH.sub.2CCCl, or CCl.sub.2CCCl.

[0633] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl.

[0634] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, more specifically C.sub.1-C.sub.2-alkoxy. R.sup.9 is such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0635] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl. R.sup.9 is such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0636] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, more specifically C.sub.1-C.sub.2-alkenyl. R.sup.9 is such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2.

[0637] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.1-C.sub.2-halogenalkenyl.

[0638] According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.4-alkynyl, more specifically C.sub.1-C.sub.2-alkynyl. R.sup.9 is such as OCCH, According to a further specific embodiment of formula I, R.sup.9 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-halogenalkynyl, more specifically C.sub.1-C.sub.2-halogenalkynyl. R.sup.9 is such as OCCCl, OCH.sub.2CCCl, or OCCl.sub.2CCCl.

[0639] According to still another embodiment of formula I, R.sup.9 is is OR.sup.Y, wherein R.sup.Y C.sub.3-C.sub.6-cycloalkenyl, in particular cyclopropenyl.

[0640] According to still another embodiment of formula I, R.sup.9 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0641] According to still another embodiment of formula I, R.sup.9 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.9b is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl.

[0642] According to still another embodiment of formula I, R.sup.9 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R.sup.9b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3 and OCF.sub.3.

[0643] According to still another embodiment of formula I, R.sup.9 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.9b which independently of one another are selected from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CHF.sub.2, OCHF.sub.2, CF.sub.3 and OCF.sub.3. According to one embodiment, R.sup.9 is unsubstituted phenyl. According to another embodiment, R.sup.9 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0644] According to still another embodiment of formula I, R.sup.9 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0645] According to still another embodiment of formula I, R.sup.9 is a 6-membered heteroaryl such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0646] According to still another embodiment of formula I, R.sup.9 is in each case independently selected from H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.06-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and C.sub.3-C.sub.6-halogencycloalkyl, wherein the acyclic moieties of R.sup.9 are unsubstituted or substituted with identical or different groups R.sup.9a as defined and preferably defined herein, and wherein the carbocyclic, phenyl and heteroaryl moieties of R.sup.9 are unsubstituted or substituted with identical or different groups R.sup.9b as defined and preferably defined herein.

[0647] According to still another embodiment of formula I, R.sup.9 is in each case independently selected from H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.06-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and C.sub.3-C.sub.6-halogencycloalkyl, wherein the acyclic moieties of R.sup.9 are unsubstituted or substituted with identical or different groups R.sup.9a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.9 are unsubstituted or substituted with identical or different groups R.sup.9b as defined and preferably defined herein.

[0648] R.sup.9a are the possible substituents for the acyclic moieties of R.sup.9.

[0649] According to one embodiment R.sup.9a is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substituents R.sup.91a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0650] According to one embodiment R.sup.9a is independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy. Specifically, R.sup.9a is independently selected from F, Cl, Br, I, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0651] According to still another embodiment of formula I, R.sup.9a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

[0652] R.sup.9b are the possible substituents for the carbocyclic, heteroaryl and phenyl moieties of R.sup.9. R.sup.9b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0653] According to one embodiment thereof R.sup.9b is independently selected from halogen, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl and C.sub.1-C.sub.4-halogenalkoxy, in particular halogen, C.sub.1-C.sub.4-alkyl and C.sub.1-C.sub.4-alkoxy. Specifically, R.sup.9b is independently selected from F, Cl, CN, CH.sub.3, OCH.sub.3 and halogenmethoxy.

[0654] Particularly preferred embodiments of R.sup.9 according to the invention are in Table P9 below, wherein each line of lines P9-1 to P9-43 corresponds to one particular embodiment of the invention, wherein P9-1 to P9-43 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R.sup.9 is bound is marked with # in the drawings.

TABLE-US-00007 TABLE P9 No. R.sup.9 P9-1 H P9-2 CH.sub.3 P9-3 CH.sub.2F P9-4 CHF.sub.2 P9-5 CF.sub.3 P9-6 C.sub.2H.sub.5 P9-7 CH(CH.sub.3).sub.2 P9-8 CH.sub.2CH.sub.2CH.sub.3 P9-9 CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P9-10 CH.sub.2CH(CH.sub.3).sub.2 P9-11 C(CH.sub.3).sub.3 P9-12 CH.sub.2CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P9-13 CHCH.sub.2 P9-14 CH.sub.2CHCH.sub.2 P9-15 CCH P9-16 CH.sub.2CCH P9-17 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 P9-18 OH P9-19 OCH.sub.3 P9-20 OCHF.sub.2 P9-21 OC.sub.2H.sub.5 P9-22 CN P9-23 F P9-24 Cl P9-25 Br P9-26 NO.sub.2 P9-27 NH.sub.2 P9-28 CONH.sub.2 P9-29 CONH(CH.sub.3) P9-30 CON(CH.sub.3).sub.2 P9-31 HNCH.sub.3 P9-32 HNC.sub.2H.sub.5 P9-33 (CH.sub.3).sub.2N P9-34 SO.sub.2H P9-35 SO.sub.2CH.sub.3 P9-36 SOCH.sub.3 P9-37 SCH.sub.3 P9-38 [00401] P9-39 [00402] P9-40 [00403] P9-41 [00404] P9-42 [00405] P9-43 [00406] [0655] R.sup.10 is in each case independently selected from H, halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NH(C.sub.2-C.sub.4-alkenyl), N(C.sub.2-C.sub.4-alkenyl).sub.2, NH(C.sub.2-C.sub.4-alkynyl), N (C.sub.2-C.sub.4-alkynyl).sub.2, NH (C.sub.3-C.sub.6-cycloalkyl), N (C.sub.3-C.sub.6-cycloalkyl).sub.2, N (C.sub.2-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkenyl), N(C.sub.2-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkynyl), N(C.sub.2-C.sub.4-alkyl)(C.sub.3-C.sub.6-cycloalkyl), N(C.sub.2-C.sub.4-alkenyl)(C.sub.2-C.sub.4-alkynyl), N (C.sub.2-C.sub.4-alkenyl)(C.sub.3-C.sub.6-cycloalkyl), N (C.sub.2-C.sub.4-alkynyl)(C.sub.3-C.sub.6-cycloalkyl), NH(C(O)C.sub.1-C.sub.4-alkyl), N(C(O)C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.n-aryl, C.sub.1-C.sub.6-cycloalkylthio, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)C.sub.2-C.sub.6-alkenyl, C(O)C.sub.2-C.sub.6-alkynyl, C(O)C.sub.3-C.sub.6-cyclpalkyl, C(O)NH(C.sub.1-C.sub.6-alkyl), CH(S), C(S)C.sub.1-C.sub.6-alkyl, C(S)C.sub.2-C.sub.6-alkenyl, C(S)C.sub.2-C.sub.6-alkynyl, C(S)C.sub.3-C.sub.6-cyclpalkyl, C(S)NH(C.sub.1-C.sub.6-alkyl), C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.06-alkenyl, C.sub.2-C.sub.6-alkynyl, OR.sup.Y, C.sub.3-C.sub.6-cycloalkyl, five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein [0656] R.sup.x is as defined above; [0657] R.sup.Y is as defined above; [0658] wherein the acyclic moieties of R.sup.10 are unsubstituted or substituted with groups [0659] R.sup.10a which independently of one another are selected from: [0660] R.sup.10a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substituents R.sup.10a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0661] wherein the carbocyclic, heteroaryl and aryl moieties of R.sup.10 are unsubstituted or substituted with groups R.sup.10b which independently of one another are selected from: [0662] R.sup.10b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0663] According to one embodiment of formula I, R.sup.10 is selected from the group consisting of H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy and OR.sup.Y.

[0664] According to one embodiment of formula I, R.sup.10 is H.

[0665] R.sup.10 is selected from the group consisting of halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy and OR.sup.Y.

[0666] According to still another embodiment of formula I, R.sup.10 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.

[0667] According to still another embodiment of formula I, R.sup.10 is F.

[0668] According to still another embodiment of formula I, R.sup.10 is Cl.

[0669] According to still another embodiment of formula I, R.sup.10 is Br.

[0670] According to still another embodiment of formula I, R.sup.10 is OH.

[0671] According to still another embodiment of formula I, R.sup.10 is CN.

[0672] According to still another embodiment of formula I, R.sup.10 is NO.sub.2.

[0673] According to still another embodiment of formula I, R.sup.10 is SH.

[0674] According to still another embodiment of formula I, R.sup.10 is NH.sub.2.

[0675] According to still another embodiment of formula I, R.sup.10 is NH(C.sub.1-C.sub.4-alkyl), in particular NH(CH.sub.3), NH(C.sub.2H.sub.5).

[0676] According to still another embodiment of formula I, R.sup.10 is, N(C.sub.1-C.sub.4-alkyl).sub.2, in particular NH(CH.sub.3).sub.2, NH(C.sub.2H.sub.5).sub.2.

[0677] According to still another embodiment of formula I, R.sup.10 is NH(C.sub.2-C.sub.4-alkenyl), in particular NH(CHCH.sub.2), NH(CH.sub.2CHCH.sub.2).

[0678] According to still another embodiment of formula I, R.sup.10 is, N(C.sub.2-C.sub.4_-alkenyl).sub.2, in particular N(CHCH.sub.2).sub.2, N(CH.sub.2CHCH.sub.2).sub.2.

[0679] According to still another embodiment of formula I, R.sup.10 is NH(C.sub.2-C.sub.4-alkynyl), in particular NH(CCH), NH(CH.sub.2CCH).

[0680] According to still another embodiment of formula I, R.sup.10 is N(C.sub.2-C.sub.4-alkynyl).sub.2, in particular N(CCH).sub.2, N(CH.sub.2CCH).sub.2.

[0681] According to still another embodiment of formula I, R.sup.10 is NH(C.sub.3-C.sub.6-cycloalkyl), in particular NH(C.sub.3H.sub.7), NH(C.sub.4H.sub.9).

[0682] According to still another embodiment of formula I, R.sup.10 is N(C.sub.3-C.sub.6-cycloalkyl).sub.2, in particular N(C.sub.3H.sub.7).sub.2, N(C.sub.4H.sub.9).sub.2.

[0683] According to still another embodiment of formula I, R.sup.10 is N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkenyl), in particular N(CH.sub.3)(CHCH.sub.2), N(CH.sub.3)(CH.sub.2CHCH.sub.2), N(C.sub.2H.sub.5)(CHCH.sub.2), N(C.sub.2H.sub.5)(CH.sub.2CHCH.sub.2).

[0684] According to still another embodiment of formula I, R.sup.10 is N(C.sub.1-C.sub.4-alkyl)(C.sub.2-C.sub.4-alkynyl), in particular N(CH.sub.3)(CCH), N(CH.sub.3)(CH.sub.2CCH), N(C.sub.2H.sub.5)(CCH), N(C.sub.2H.sub.5)(CH.sub.2CCH).

[0685] According to still another embodiment of formula I, R.sup.10 is N(C.sub.1-C.sub.4-alkyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CH.sub.3)(C.sub.3H.sub.7), N(CH.sub.3)(C.sub.4H.sub.9), N(C.sub.2H.sub.5)(C.sub.3H.sub.7), N(CH.sub.3)(C.sub.4H.sub.9).

[0686] According to still another embodiment of formula I, R.sup.10 is N(C.sub.2-C.sub.4-alkenyl)(C.sub.2-C.sub.4-alkynyl), in particular N(CHCH.sub.2)(CCH), N(CH.sub.2CHCH.sub.2)(CH.sub.2CCH), N(CHCH.sub.2)(CCH), N(CH.sub.2CHCH.sub.2)(CH.sub.2CCH).

[0687] According to still another embodiment of formula I, R.sup.10 is N(C.sub.2-C.sub.4-alkenyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CHCH.sub.2)(C.sub.3H.sub.7), N(CH.sub.2CHCH.sub.2)(C.sub.4H.sub.9), N(CHCH.sub.2)(C.sub.3H.sub.7), N(CH.sub.2CHCH.sub.2)(C.sub.4H.sub.9).

[0688] According to still another embodiment of formula I, R.sup.10 is N(C.sub.2-C.sub.4-alkynyl)(C.sub.3-C.sub.6-cycloalkyl), in particular N(CCH)(C.sub.3H.sub.7), N(CH.sub.2CCH)(C.sub.4H.sub.9), N(CCH)(C.sub.3H.sub.7), N(CH.sub.2CCH)(C.sub.4H.sub.9).

[0689] According to still another embodiment of formula I, R.sup.10 is, NH(C(O)(C.sub.1-C.sub.4-alkyl), in particular NH(C(O)(CH.sub.3), NH(C(O)(C.sub.2H.sub.5).

[0690] According to still another embodiment of formula I, R.sup.10 is N(C(O)(C.sub.1-C.sub.4-alkyl).sub.2, in particular N(C(O)(CH.sub.3).sub.2, N(C(O)(C.sub.2H.sub.5).sub.2.

[0691] According to a further specific embodiment of formula I, R.sup.10 is NHSO.sub.2R.sup.x such as NHSO.sub.2CH.sub.3, NHSO.sub.2CH.sub.2CH.sub.3, NHSO.sub.2CF.sub.3, NHSO.sub.2-Ts.

[0692] According to still another embodiment of formula I, R.sup.10 is S(O).sub.nC.sub.1-C.sub.6-alkyl such as SCH.sub.3, S(O) CH.sub.3, S(O).sub.2CH.sub.3.

[0693] According to still another embodiment of formula I, R.sup.10 is S(O).sub.n-aryl such as S-phenyl, S(O) phenyl, S(O).sub.2phenyl.

[0694] According to still another embodiment of formula I, R.sup.10 is S(O).sub.nC.sub.2-C.sub.6-alkenyl such as SCHCH.sub.2, S(O)CHCH.sub.2, S(O).sub.2CHCH.sub.2, SCH.sub.2CHCH.sub.2, S(O)CH.sub.2CHCH.sub.2, S(O).sub.2CH.sub.2CHCH.sub.2.

[0695] According to still another embodiment of formula I, R.sup.10 is S(O).sub.nC.sub.2-C.sub.6-alkynyl such as SCCH, S(O)CCH, S(O).sub.2CCH, SCH.sub.2CCH, S(O)CH.sub.2CCH, S(O).sub.2CH.sub.2CCH.

[0696] According to a further specific embodiment of formula I, R.sup.10 is CH(O).

[0697] According to a further specific embodiment of formula I, R.sup.10 is C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl) or C(O)NH(C.sub.1-C.sub.6-alkyl), wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0698] According to a further specific embodiment of formula I, R.sup.10 is C(O)C.sub.2-C.sub.6-alkenyl, C(O)O(C.sub.2-C.sub.6-alkenyl) or C(O)NH(C.sub.2-C.sub.6-alkenyl), wherein alkenyl is CHCH.sub.2, C(CH.sub.3)CH.sub.2, CH.sub.2CHCH.sub.2.

[0699] According to a further specific embodiment of formula I, R.sup.10 is C(O)C.sub.2-C.sub.6-alkynyl, C(O)O(C.sub.2-C.sub.6-alkynyl) or C(O)NH(C.sub.2-C.sub.6-alkynyl), wherein alkynyl is CCH, CH.sub.2CCH, According to a further specific embodiment of formula I, R.sup.10 is C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.3-C.sub.6-cycloalkyl) or C(O)NH(C.sub.3-C.sub.6-cycloalkyl), wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0700] According to a further specific embodiment of formula I, R.sup.10 is CH(S).

[0701] According to a further specific embodiment of formula I, R.sup.10 is C(S)C.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0702] According to a further specific embodiment of formula I, R.sup.10 is C(S)C.sub.2-C.sub.6-alkenyl, wherein alkenyl is CHCH.sub.2, CH.sub.2CHCH.sub.2.

[0703] According to a further specific embodiment of formula I, R.sup.10 is C(S)C.sub.2-C.sub.6-alkynyl, wherein alkynyl is CCH, CH.sub.2CCH.

[0704] According to a further specific embodiment of formula I, R.sup.10 is C(S)C.sub.3-C.sub.6-cycloalkyl, wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0705] According to a further specific embodiment of formula I, R.sup.10 is C(S)NHC.sub.1-C.sub.6-alkyl, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0706] According to still another embodiment of formula I, R.sup.10 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3. or C.sub.2H.sub.5, in particular CH.sub.3 or CH.sub.2CH.sub.3.

[0707] According to still another embodiment of formula I, R.sup.10 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CH.sub.3CHF, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2, in particular FCH.sub.2 or F.sub.2CH.

[0708] According to still a further embodiment of formula I, R.sup.10 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2.

[0709] According to a further specific embodiment of formula I, R.sup.10 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CF.sub.2CHCF.sub.2, CCl.sub.2CHCCl.sub.2, CF.sub.2CFCF.sub.2, CCl.sub.2CClCCl.sub.2.

[0710] According to still a further embodiment of formula I, R.sup.10 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CH.sub.2CCH, CCCl, CH.sub.2CCCl, or CCl.sub.2CCCl.

[0711] According to a further specific embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl.

[0712] According to a further specific embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, more specifically C.sub.1-C.sub.2-alkoxy. R.sup.10 is such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0713] According to a further specific embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl. R.sup.10 is such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0714] According to a further specific embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, more specifically C.sub.1-C.sub.2-alkenyl. R.sup.10 is such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2.

[0715] According to a further specific embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.4-alkynyl, more specifically C.sub.1-C.sub.2-alkynyl. R.sup.10 is such as OCCH, OCCCl, OCH.sub.2CCCl, or OCCl.sub.2CCCl According to still another embodiment of formula I R.sup.10 is OR.sup.Y, wherein R.sup.Y is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0716] According to still another embodiment of formula I, R.sup.10 is OR.sup.Y, wherein R.sup.Y is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.1 is fully or partially halogenated cyclopropyl.

[0717] According to still another embodiment of formula I, R.sup.10 is is OR.sup.Y, wherein R.sup.Y C.sub.3-C.sub.6-cycloalkenyl, in particular cyclopropenyl.

[0718] According to still another embodiment of formula I, R.sup.10 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0719] According to still another embodiment of formula I, R.sup.10 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.10b is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl

[0720] According to still another embodiment of formula I, R.sup.10 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R.sup.10b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3 and OCF.sub.3.

[0721] According to still another embodiment of formula I, R.sup.10 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted with identical or different groups R.sup.10b which independently of one another are selected from CN, halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular CN, F, Cl, Br, CH.sub.3, OCH.sub.3, CHF.sub.2, OCHF.sub.2, CF.sub.3 and OCF.sub.3. According to one embodiment, R.sup.10 is unsubstituted phenyl. According to another embodiment, R.sup.10 is phenyl, that is substituted with one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0722] According to still another embodiment of formula I, R.sup.10 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0723] According to still another embodiment of formula I, R.sup.9 is a 6-membered heteroaryl such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0724] According to still another embodiment of formula I, R.sup.10 is in each case independently selected from H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.06-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and C.sub.3-C.sub.6-halogencycloalkyl, wherein the acyclic moieties of R.sup.10 are unsubstituted or substituted with identical or different groups R.sup.10a as defined and preferably defined herein, and wherein the carbocyclic, phenyl and heteroaryl moieties of R.sup.10 are unsubstituted or substituted with identical or different groups R.sup.10b as defined and preferably defined herein.

[0725] According to still another embodiment of formula I, R.sup.10 is in each case independently selected from H, halogen, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.06-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy, C.sub.3-C.sub.6-cycloalkyl and C.sub.3-C.sub.6-halogencycloalkyl, wherein the acyclic moieties of R.sup.10 are unsubstituted or substituted with identical or different groups R.sup.10a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.10 are unsubstituted or substituted with identical or different groups R.sup.10b as defined and preferably defined herein.

[0726] R.sup.10a are the possible substituents for the acyclic moieties of R.sup.9.

[0727] According to one embodiment R.sup.10a is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or substituted with substituents R.sup.10a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0728] According to one embodiment R.sup.10a is independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy. Specifically, R.sup.10a is independently selected from F, Cl, Br, I, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0729] According to still another embodiment of formula I, R.sup.10a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

[0730] R.sup.10b are the possible substituents for the carbocyclic, heteroaryl and phenyl moieties of R.sup.10. R.sup.10b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0731] According to one embodiment thereof R.sup.10b is independently selected from halogen, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl and C.sub.1-C.sub.4-halogenalkoxy, in particular halogen, C.sub.1-C.sub.4-alkyl and C.sub.1-C.sub.4-alkoxy. Specifically, R.sup.10b is independently selected from F, Cl, CN, CH.sub.3, OCH.sub.3 and halogenmethoxy.

[0732] Particularly preferred embodiments of R.sup.10 according to the invention are in Table P10 below, wherein each line of lines P10-1 to P10-43 corresponds to one particular embodiment of the invention, wherein P10-1 to P10-43 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R.sup.10 is bound is marked with # in the drawings.

TABLE-US-00008 TABLE P10 No. R.sup.10 P10-1 H P10-2 CH.sub.3 P10-3 CH.sub.2F P10-4 CHF.sub.2 P10-5 CF.sub.3 P10-6 C.sub.2H.sub.5 P10-7 CH(CH.sub.3).sub.2 P10-8 CH.sub.2CH.sub.2CH.sub.3 P10-9 CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P10-10 CH.sub.2CH(CH.sub.3).sub.2 P10-11 C(CH.sub.3).sub.3 P10-12 CH.sub.2CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P10-13 CHCH.sub.2 P10-14 CH.sub.2CHCH.sub.2 P10-15 CCH P10-16 CH.sub.2CCH P10-17 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 P10-18 OH P10-19 OCH.sub.3 P10-20 OCHF.sub.2 P10-21 OC.sub.2H.sub.5 P10-22 CN P10-23 F P10-24 Cl P10-25 Br P10-26 NO.sub.2 P10-27 NH.sub.2 P10-28 CONH.sub.2 P10-29 CONH(CH.sub.3) P10-30 CON(CH.sub.3).sub.2 P10-31 HNCH.sub.3 P10-32 HNC.sub.2H.sub.5 P10-33 (CH.sub.3).sub.2N P10-34 SO.sub.2H P10-35 SO.sub.2CH.sub.3 P10-36 SOCH.sub.3 P10-37 SCH.sub.3 P10-38 [00407] P10-39 [00408] P10-40 [00409] P10-41 [00410] P10-42 [00411] P10-43 [00412]

[0733] According to still another embodiment of formula I, R.sup.9, R.sup.10 together with the carbon atoms to which they are bound form a five-, six-, or seven-membered carbo-, heterocyclic or heteroaromatic ring; wherein the heterocyclic or heteroaromatic ring contains 1, 2, 3 or 4 heteroatoms selected from N, O and S, wherein N may carry one substituent R.sup.N selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted or substituted with substituents selected from C.sub.1-C.sub.4-alkyl, halogen, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, and CN; and wherein S may be in the form of its oxide SO or SO.sub.2; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S); and wherein the carbo-, heterocyclic or heteroaromatic ring is substituent by (R.sup.11).sub.m wherein m is 0, 1, 2, 3 or 4; [0734] R.sup.N is the substituent of the heteroatom N that is contained in the heterocycle formed by R.sup.9 and R.sup.10 in some of the inventive compounds. R.sup.N is selected from C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one, two or three substituents selected from C.sub.1-C.sub.4-alkyl. In one preferred embodiment, R.sup.N is in each case independently selected from C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl and SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one methyl substituents. In one particular embodiment, R.sup.N is in each case independently selected from C.sub.1-C.sub.2-alkyl, more particularly methyl. In one particular embodiment, R.sup.N is in each case independently selected from SO.sub.2Ph, wherein Ph is unsubstituted phenyl or phenyl that is substituted with one methyl.

[0735] According to still another embodiment of formula I, R.sup.9 and R.sup.10 together with the carbon atoms to which they are bound form a saturated or partially unsaturated five-, six- or seven-membered carbo- and heterocycle that is unsubstituted or substituted.

[0736] According to one embodiment, R.sup.9 and R.sup.10 form a 3-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0737] According to one embodiment, R.sup.9 and R.sup.10 form a 4-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0738] According to one embodiment, R.sup.9 and R.sup.10 form a 5-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0739] According to one embodiment, R.sup.9 and R.sup.10 form a 6-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0740] According to one embodiment, R.sup.9 and R.sup.10 form a 7-membered saturated carbocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0741] According to one embodiment, R.sup.9 and R.sup.10 form a 3-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0742] According to one embodiment, R.sup.9 and R.sup.10 form a 4-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0743] According to one embodiment, R.sup.9 and R.sup.10 form a 5-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0744] According to one embodiment, R.sup.9 and R.sup.10 form a 6-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0745] According to one embodiment, R.sup.9 and R.sup.10 form a 7-membered saturated heterocycle. According to one embodiment thereof, the carbocycle is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0746] According to one embodiment, R.sup.9 and R.sup.10 form a 5-membered saturated heteroaryl. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11.

[0747] According to one embodiment, R.sup.9 and R.sup.10 form a 6-membered heteroaryl. According to one embodiment thereof, the heteroaryl is unsubstituted, i.e. it does not carry any substituent R.sup.11. According to still another embodiment of formula I, it is substituted with R.sup.11. [0748] R.sup.11 according to the invention is in each case independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine-, or ten-membered carbo- and heterocycle, five- or six-membered heteroaryl and aryl; wherein the heterocycle and heteroaryl contains one, two or three heteroatoms selected from N, O and S; and wherein in each case one or two CH.sub.2 groups of the carbo- or heterocycle may be replaced by a group independently selected from C(O) and C(S); and wherein [0749] R.sup.x is as defined above; [0750] wherein the acyclic moieties of R.sup.11 are unsubstituted or substituted with identical or different groups R.sup.11a which independently of one another are selected from: [0751] R.sup.11a halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl group is unsubstituted or unsubstituted or substituted with R.sup.111a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-alkylthio; [0752] wherein the carbocyclic, heterocyclic, heteroaryl and aryl of R.sup.11 are unsubstituted or substituted with identical or different groups R.sup.11b which independently of one another are selected from: [0753] R.sup.11b halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0754] For every R.sup.11 that is present in the inventive compounds, the following embodiments and preferences apply independently of the meaning of any other R.sup.11 that may be present in the ring.

[0755] According to one embodiment of formula I, wherein m is 0, 1, 2, 3 or 4.

[0756] According to still another embodiment of formula I, m is 0.

[0757] According to still another embodiment of formula I, m is 1.

[0758] According to still another embodiment of formula I, m is 2 or 3. According to one specific embodiment thereof, m is 2. According to still another embodiment of formula I, m is 3.

[0759] According to one embodiment of formula I, R.sup.11 is halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy or, C.sub.1-C.sub.6-halogenalkoxy, in particular CH.sub.3, Et, CHF.sub.2, OCH.sub.3, OCHF.sub.2, OCF.sub.3, F, Cl, more specifically H, CH.sub.3, F or Cl most preferred F or Cl.

[0760] According to still another embodiment of formula I, R.sup.11 is halogen, in particular Br, F or Cl, more specifically F or Cl.

[0761] According to still another embodiment of formula I, R.sup.11 is OH.

[0762] According to still another embodiment of formula I, R.sup.11 is CN.

[0763] According to still another embodiment of formula I R.sup.11 is NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2 or NHSO.sub.2R.sup.x, wherein R.sup.x is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, unsubstituted aryl or aryl that is substituted with one, two, three, four or five substituents R.sup.x1 independently selected from C.sub.1-C.sub.4-alkyl.

[0764] According to still another embodiment of formula I, R.sup.11 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3.

[0765] According to still another embodiment of formula I, R.sup.11 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CHF.sub.2, CH.sub.2F, CCl.sub.3, CHCl.sub.2 or CH.sub.2Cl.

[0766] According to still another embodiment of formula I, R.sup.11 is C.sub.2-C.sub.6-alkenyl or C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-alkenyl or C.sub.2-C.sub.4-halogenalkenyl, such as CHCH.sub.2, C(CH.sub.3)CH.sub.2, CH.sub.2CHCH.sub.2, CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CFCF.sub.2, CClCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CH.sub.2CFCF.sub.2, CH.sub.2CClCCl.sub.2, CF.sub.2CFCF.sub.2 or CCl.sub.2CClCCl.sub.2.

[0767] According to still another embodiment of formula I, R.sup.11 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CH.sub.2CCH, CCCl, CCCH.sub.3, CH.sub.2CCH, CH.sub.2CCCl or CH.sub.2CCCH.sub.3.

[0768] According to still another embodiment of formula I, R.sup.11 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0769] According to still another embodiment of formula I, R.sup.11 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0770] According to still another embodiment of formula I R.sup.11 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0771] According to still another embodiment of formula I, R.sup.11 is C.sub.3-C.sub.6-cycloalkyl, for example cyclopropyl, substituted with one, two, three or up to the maximum possible number of identical or different groups R.sup.11b as defined and preferably herein.

[0772] According to still another embodiment of formula I, R.sup.11 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.11 is fully or partially halogenated cyclopropyl.

[0773] According to still another embodiment of formula I, R.sup.11 is unsubstituted aryl or aryl that is substituted with one, two, three or four R.sup.11b, as defined herein. In particular, R.sup.11 is unsubstituted phenyl or phenyl that is substituted with one, two, three or four R.sup.11b, as defined herein.

[0774] According to still another embodiment of formula I, R.sup.11 is unsubstituted 5- or 6-membered heteroaryl. According to still a further embodiment, R.sup.11 is 5- or 6-membered heteroaryl that is substituted with one, two or three R.sup.11b, as defined herein.

[0775] According to still another embodiment of formula I, R.sup.11 is in each case independently selected from halogen, OH, CN, NO.sub.2, SH, NH.sub.2, NH(C.sub.1-C.sub.4-alkyl), N(C.sub.1-C.sub.4-alkyl).sub.2, NHSO.sub.2R.sup.x, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy and C.sub.3-C.sub.6-cycloalkyl; wherein the acyclic moieties of R.sup.11 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.11a as defined below and wherein the carbocyclic, heterocyclic and heteroaryl moieties of R.sup.11 are not further substituted or carry one, two, three, four or five identical or different groups R.sup.11b as defined below.

[0776] According to still another embodiment of formula I, R.sup.11 is independently selected from halogen, OH, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy and C.sub.1-C.sub.6-halogenalkoxy, in particular independently selected from F, Cl, Br, CN, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0777] R.sup.11a are the possible substituents for the acyclic moieties of R.sup.1.

[0778] R.sup.11a according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or unsubstituted or substituted with R.sup.111a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, CN, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-alkylthio.

[0779] R.sup.11a according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, aryl and phenoxy, wherein the aryl and phenyl group is unsubstituted or unsubstituted or substituted with R.sup.111a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-halogenalkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkoxy, more specifically selected from halogen, such as F, Cl and Br.

[0780] In to one embodiment R.sup.11a is independently selected from halogen, OH, CN, C.sub.1-C.sub.2-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.11a is independently selected from F, Cl, OH, CN, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0781] According to one embodiment R.sup.11a is independently selected from halogen, such as F, Cl, Br and I, more specifically F, Cl and Br.

[0782] According to still another embodiment of formula I, R.sup.11a is independently selected from OH, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.11a is independently selected from OH, cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0783] R.sup.11b are the possible substituents for the carbocyclic, heterocyclic and heteroaryl moieties of R.sup.11.

[0784] R.sup.11b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy.

[0785] According to one embodiment thereof R.sup.11b is independently selected from halogen, CN, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalky and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.11b is independently selected from F, Cl, OH, CN, CH.sub.3, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and halogenmethoxy.

[0786] According to still another embodiment thereof R.sup.11b is independently selected from C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.2-halogenalkoxy. Specifically, R.sup.11b is independently selected from OH, CH.sub.3, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl and halogenmethoxy, more specifically independently selected from OH, CH.sub.3, OCH.sub.3, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl cyclopropyl and OCHF.sub.2.

[0787] Particularly preferred embodiments of combinations of R.sup.9 and R.sup.10 according to the invention are in Table P35 below, wherein each line of lines P35-1 to P35-305 corresponds to one particular embodiment of the invention, wherein P35-1 to P35-305 are also in any combination with one another a preferred embodiment of the present invention. The carbon atom, to which R.sup.9 bound is marked with * in the drawings and the carbon atom, to which R.sup.10 is bound is marked with # in the drawings. cPr stands for cyclopropyl.

TABLE-US-00009 TABLE P35 line R.sup.9 R.sup.10 P35-1 H H P35-2 H F P35-3 H Cl P35-4 H Br P35-5 H CH.sub.3 P35-6 H CH.sub.2CH.sub.3 P35-7 H CH.sub.2F P35-8 H CHF.sub.2 P35-9 H CF.sub.3 P35-10 H OCH.sub.3 P35-11 H OCH.sub.2F P35-12 H OCHF.sub.2 P35-13 H OCF.sub.3 P35-14 H cPr P35-15 H CCH P35-16 H CN P35-17 H SCH.sub.3 P35-18 F H P35-19 F F P35-20 F Cl P35-21 F Br P35-22 F CH.sub.3 P35-23 F CH.sub.2CH.sub.3 P35-24 F CH.sub.2F P35-25 F CHF.sub.2 P35-26 F CF.sub.3 P35-27 F OCH.sub.3 P35-28 F OCH.sub.2F P35-29 F OCHF.sub.2 P35-30 F OCF.sub.3 P35-31 F cPr P35-32 F CCH P35-33 F CN P35-34 F SCH.sub.3 P35-35 Cl H P35-36 Cl F P35-37 Cl Cl P35-38 Cl Br P35-39 Cl CH.sub.3 P35-40 Cl CH.sub.2CH.sub.3 P35-41 Cl CH.sub.2F P35-42 Cl CHF.sub.2 P35-43 Cl CF.sub.3 P35-44 Cl OCH.sub.3 P35-45 Cl OCH.sub.2F P35-46 Cl OCHF.sub.2 P35-47 Cl OCF.sub.3 P35-48 Cl cPr P35-49 Cl CCH P35-50 Cl CN P35-51 Cl SCH.sub.3 P35-52 Br H P35-53 Br F P35-54 Br Cl P35-55 Br Br P35-56 Br CH.sub.3 P35-57 Br CH.sub.2CH.sub.3 P35-58 Br CH.sub.2F P35-59 Br CHF.sub.2 P35-60 Br CF.sub.3 P35-61 Br OCH.sub.3 P35-62 Br OCH.sub.2F P35-63 Br OCHF.sub.2 P35-64 Br OCF.sub.3 P35-65 Br cPr P35-66 Br CCH P35-67 Br CN P35-68 Br SCH.sub.3 P35-69 CH.sub.3 H P35-70 CH.sub.3 F P35-71 CH.sub.3 Cl P35-72 CH.sub.3 Br P35-73 CH.sub.3 CH.sub.3 P35-74 CH.sub.3 CH.sub.2CH.sub.3 P35-75 CH.sub.3 CH.sub.2F P35-76 CH.sub.3 CHF.sub.2 P35-77 CH.sub.3 CF.sub.3 P35-78 CH.sub.3 OCH.sub.3 P35-79 CH.sub.3 OCH.sub.2F P35-80 CH.sub.3 OCHF.sub.2 P35-81 CH.sub.3 OCF.sub.3 P35-82 CH.sub.3 cPr P35-83 CH.sub.3 CCH P35-84 CH.sub.3 CN P35-85 CH.sub.3 SCH.sub.3 P35-86 CH.sub.2CH.sub.3 H P35-87 CH.sub.2CH.sub.3 F P35-88 CH.sub.2CH.sub.3 Cl P35-89 CH.sub.2CH.sub.3 Br P35-90 CH.sub.2CH.sub.3 CH.sub.3 P35-91 CH.sub.2CH.sub.3 CH.sub.2CH.sub.3 P35-92 CH.sub.2CH.sub.3 CH.sub.2F P35-93 CH.sub.2CH.sub.3 CHF.sub.2 P35-94 CH.sub.2CH.sub.3 CF.sub.3 P35-95 CH.sub.2CH.sub.3 OCH.sub.3 P35-96 CH.sub.2CH.sub.3 OCH.sub.2F P35-97 CH.sub.2CH.sub.3 OCHF.sub.2 P35-98 CH.sub.2CH.sub.3 OCF.sub.3 P35-99 CH.sub.2CH.sub.3 cPr P35-100 CH.sub.2CH.sub.3 CCH P35-101 CH.sub.2CH.sub.3 CN P35-102 CH.sub.2CH.sub.3 SCH.sub.3 P35-103 CH.sub.2F H P35-104 CH.sub.2F F P35-105 CH.sub.2F Cl P35-106 CH.sub.2F Br P35-107 CH.sub.2F CH.sub.3 P35-108 CH.sub.2F CH.sub.2CH.sub.3 P35-109 CH.sub.2F CH.sub.2F P35-110 CH.sub.2F CHF.sub.2 P35-111 CH.sub.2F CF.sub.3 P35-112 CH.sub.2F OCH.sub.3 P35-113 CH.sub.2F OCH.sub.2F P35-114 CH.sub.2F OCHF.sub.2 P35-115 CH.sub.2F OCF.sub.3 P35-116 CH.sub.2F cPr P35-117 CH.sub.2F CCH P35-118 CH.sub.2F CN P35-119 CH.sub.2F SCH.sub.3 P35-120 CHF.sub.2 H P35-121 CHF.sub.2 F P35-122 CHF.sub.2 Cl P35-123 CHF.sub.2 Br P35-124 CHF.sub.2 CH.sub.3 P35-125 CHF.sub.2 CH.sub.2CH.sub.3 P35-126 CHF.sub.2 CH.sub.2F P35-127 CHF.sub.2 CHF.sub.2 P35-128 CHF.sub.2 CF.sub.3 P35-129 CHF.sub.2 OCH.sub.3 P35-130 CHF.sub.2 OCH.sub.2F P35-131 CHF.sub.2 OCHF.sub.2 P35-132 CHF.sub.2 OCF.sub.3 P35-133 CHF.sub.2 cPr P35-134 CHF.sub.2 CCH P35-135 CHF.sub.2 CN P35-136 CHF.sub.2 SCH.sub.3 P35-137 CF.sub.3 H P35-138 CF.sub.3 F P35-139 CF.sub.3 Cl P35-140 CF.sub.3 Br P35-141 CF.sub.3 CH.sub.3 P35-142 CF.sub.3 CH.sub.2CH.sub.3 P35-143 CF.sub.3 CH.sub.2F P35-144 CF.sub.3 CHF.sub.2 P35-145 CF.sub.3 CF.sub.3 P35-146 CF.sub.3 OCH.sub.3 P35-147 CF.sub.3 OCH.sub.2F P35-148 CF.sub.3 OCHF.sub.2 P35-149 CF.sub.3 OCF.sub.3 P35-150 CF.sub.3 cPr P35-151 CF.sub.3 CCH P35-152 CF.sub.3 CN P35-153 CF.sub.3 SCH.sub.3 P35-154 OCH.sub.3 H P35-155 OCH.sub.3 F P35-156 OCH.sub.3 Cl P35-157 OCH.sub.3 Br P35-158 OCH.sub.3 CH.sub.3 P35-159 OCH.sub.3 CH.sub.2CH.sub.3 P35-160 OCH.sub.3 CH.sub.2F P35-161 OCH.sub.3 CHF.sub.2 P35-162 OCH.sub.3 CF.sub.3 P35-163 OCH.sub.3 OCH.sub.3 P35-164 OCH.sub.3 OCH.sub.2F P35-165 OCH.sub.3 OCHF.sub.2 P35-166 OCH.sub.3 OCF.sub.3 P35-167 OCH.sub.3 cPr P35-168 OCH.sub.3 CCH P35-169 OCH.sub.3 CN P35-170 OCH.sub.3 SCH.sub.3 P35-171 OCH.sub.2F H P35-172 OCH.sub.2F F P35-173 OCH.sub.2F Cl P35-174 OCH.sub.2F Br P35-175 OCH.sub.2F CH.sub.3 P35-176 OCH.sub.2F CH.sub.2CH.sub.3 P35-177 OCH.sub.2F CH.sub.2F P35-178 OCH.sub.2F CHF.sub.2 P35-179 OCH.sub.2F CF.sub.3 P35-180 OCH.sub.2F OCH.sub.3 P35-181 OCH.sub.2F OCH.sub.2F P35-182 OCH.sub.2F OCHF.sub.2 P35-183 OCH.sub.2F OCF.sub.3 P35-184 OCH.sub.2F cPr P35-185 OCH.sub.2F CCH P35-186 OCH.sub.2F CN P35-187 OCH.sub.2F SCH.sub.3 P35-188 OCHF.sub.2 H P35-189 OCHF.sub.2 F P35-190 OCHF.sub.2 Cl P35-191 OCHF.sub.2 Br P35-192 OCHF.sub.2 CH.sub.3 P35-193 OCHF.sub.2 CH.sub.2CH.sub.3 P35-194 OCHF.sub.2 CH.sub.2F P35-195 OCHF.sub.2 CHF.sub.2 P35-196 OCHF.sub.2 CF.sub.3 P35-197 OCHF.sub.2 OCH.sub.3 P35-198 OCHF.sub.2 OCH.sub.2F P35-199 OCHF.sub.2 OCHF.sub.2 P35-200 OCHF.sub.2 OCF.sub.3 P35-201 OCHF.sub.2 cPr P35-202 OCHF.sub.2 CCH P35-203 OCHF.sub.2 CN P35-204 OCHF.sub.2 SCH.sub.3 P35-205 OCF.sub.3 H P35-206 OCF.sub.3 F P35-207 OCF.sub.3 Cl P35-208 OCF.sub.3 Br P35-209 OCF.sub.3 CH.sub.3 P35-210 OCF.sub.3 CH.sub.2CH.sub.3 P35-211 OCF.sub.3 CH.sub.2F P35-212 OCF.sub.3 CHF.sub.2 P35-213 OCF.sub.3 CF.sub.3 P35-214 OCF.sub.3 OCH.sub.3 P35-215 OCF.sub.3 OCH.sub.2F P35-216 OCF.sub.3 OCHF.sub.2 P35-217 OCF.sub.3 OCF.sub.3 P35-218 OCF.sub.3 cPr P35-219 OCF.sub.3 CCH P35-220 OCF.sub.3 CN P35-221 OCF.sub.3 SCH.sub.3 P35-222 cPr H P35-223 cPr F P35-224 cPr Cl P35-225 cPr Br P35-226 cPr CH.sub.3 P35-227 cPr CH.sub.2CH.sub.3 P35-228 cPr CH.sub.2F P35-229 cPr CHF.sub.2 P35-230 cPr CF.sub.3 P35-231 cPr OCH.sub.3 P35-232 cPr OCH.sub.2F P35-233 cPr OCHF.sub.2 P35-234 cPr OCF.sub.3 P35-235 cPr cPr P35-236 cPr CCH P35-237 cPr CN P35-238 cPr SCH.sub.3 P35-239 CCH H P35-240 CCH F P35-241 CCH Cl P35-242 CCH Br P35-243 CCH CH.sub.3 P35-244 CCH CH.sub.2CH.sub.3 P35-245 CCH CH.sub.2F P35-246 CCH CHF.sub.2 P35-247 CCH CF.sub.3 P35-248 CCH OCH.sub.3 P35-249 CCH OCH.sub.2F P35-250 CCH OCHF.sub.2 P35-251 CCH OCF.sub.3 P35-252 CCH cPr P35-253 CCH CCH P35-254 CCH CN P35-255 CCH SCH.sub.3 P35-256 CN H P35-257 CN F P35-258 CN Cl P35-259 CN Br P35-260 CN CH.sub.3 P35-261 CN CH.sub.2CH.sub.3 P35-262 CN CH.sub.2F P35-263 CN CHF.sub.2 P35-264 CN CF.sub.3 P35-265 CN OCH.sub.3 P35-266 CN OCH.sub.2F P35-267 CN OCHF.sub.2 P35-268 CN OCF.sub.3 P35-269 CN cPr P35-270 CN CCH P35-271 CN CN P35-272 CN SCH.sub.3 P35-273 SCH.sub.3 H P35-274 SCH.sub.3 F P35-275 SCH.sub.3 Cl P35-276 SCH.sub.3 Br P35-277 SCH.sub.3 CH.sub.3 P35-278 SCH.sub.3 CH.sub.2CH.sub.3 P35-279 SCH.sub.3 CH.sub.2F P35-280 SCH.sub.3 CHF.sub.2 P35-281 SCH.sub.3 CF.sub.3 P35-282 SCH.sub.3 OCH.sub.3 P35-283 SCH.sub.3 OCH.sub.2F P35-284 SCH.sub.3 OCHF.sub.2 P35-285 SCH.sub.3 OCF.sub.3 P35-286 SCH.sub.3 cPr P35-287 SCH.sub.3 CCH P35-288 SCH.sub.3 CN P35-289 SCH.sub.3 SCH.sub.3 P35-290 [00413] P35-291 [00414] P35-292 [00415] P35-293 [00416] P35-294 [00417] P35-295 [00418] P35-296 [00419] P35-297 [00420] P35-298 [00421] P35-299 [00422] P35-300 [00423] P35-301 [00424] P35-302 [00425] P35-303 [00426] P35-304 [00427] P35-305 [00428] [0788] R.sup.12 is in each case independently selected from hydrogen, OH, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)C.sub.2-C.sub.6-alkenyl, C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)O(C.sub.2-C.sub.6-alkenyl), C(O)O(C.sub.2-C.sub.6-alkynyl), C(O)O(C.sub.3-C.sub.6-cycloalkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.2-C.sub.6-alkenyl), C(O)NH(C.sub.2-C.sub.6-alkynyl), C(O) NH(C.sub.3-C.sub.6-cycloalkyl), CH(S), C(S)C.sub.1-C.sub.6-alkyl, C(S)C.sub.2-C.sub.6-alkenyl, C(S)C.sub.2-C.sub.6-alkynyl, C(S)C.sub.3-C.sub.6-cycloalkyl, C(S)O(C.sub.1-C.sub.6-alkyl), C(S)O(C.sub.2-C.sub.6-alkenyl), C(S)O(C.sub.2-C.sub.6-alkynyl), C(S)O(C.sub.3-C.sub.6-cycloalkyl), C(S)NH (C.sub.1-C.sub.6-alkyl), C(S)NH (C.sub.2-C.sub.6-alkenyl), C(S)NH (C.sub.2-C.sub.6-alkynyl), C(S)NH(C.sub.3-C.sub.6-cycloalkyl), C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkoxy, OR.sup.Y, C.sub.1-C.sub.6-alkylthio, C.sub.1-C.sub.6-halogenalkylthio, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, S(O).sub.nC.sub.1-C.sub.6-alkoxy, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, S(O).sub.n-aryl, SO.sub.2NH(C.sub.1-C.sub.6-alkyl), SO.sub.2NH(C.sub.1-C.sub.6-halogenalkyl), SO.sub.2NH-aryl, tri-(C.sub.1-C.sub.6 alkyl)silyl and di-(C.sub.1-C.sub.6 alkoxy)phosphoryl), five- or six-membered heteroaryl and aryl; wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S; wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; wherein n and R.sup.Y are as defined above. [0789] R.sup.12a is the substituent of the acyclic moieties of R.sup.12. The acyclic moieties of R.sup.12 are not further substituted or carry one, two, three or up to the maximum possible number of identical or different groups R.sup.12a which independently of one another are selected from halogen, OH, CN, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-cycloalkenyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.3-C.sub.6-halogencycloalkenyl, C.sub.1-C.sub.4-halogenalkoxy, C.sub.1-C.sub.6-alkylthio, five- or six-membered heteroaryl, aryl and phenoxy, wherein the heteroaryl, aryl and phenoxy group is unsubstituted or carries one, two, three, four or five substituents R.sup.78a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; [0790] R.sup.12b is the substituent of carbocyclic, phenyl, heterocyclic and heteroaryl moieties of R.sup.12. The carbocyclic, phenyl, heterocyclic and heteroaryl moieties of R.sup.12 are not further substituted or carry one, two, three, four, five or up to the maximum number of identical or different groups R.sup.12b which independently of one another are selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0791] According to one embodiment of formula I, R.sup.12 is H.

[0792] According to still another embodiment of formula I, R.sup.12 is OH.

[0793] According to a further specific embodiment of formula I, R.sup.12 is CH(O).

[0794] According to a further specific embodiment of formula I, R.sup.12 is C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl) or C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0795] According to a further specific embodiment of formula I, R.sup.12 is C(O)C.sub.2-C.sub.6-alkenyl, C(O)O(C.sub.2-C.sub.6-alkenyl), C(O)NH (C.sub.2-C.sub.6-alkenyl) or C(O)N(C.sub.2-C.sub.6-alkenyl).sub.2), wherein alkenyl is CHCH.sub.2, CH.sub.2CHCH.sub.2.

[0796] According to a further specific embodiment of formula I, R.sup.12 is C(O)C.sub.2-C.sub.6-alkynyl, C(O)O(C.sub.2-C.sub.6-alkynyl), C(O)NH(C.sub.2-C.sub.6-alkynyl) or C(O)N(C.sub.2-C.sub.6-alkynyl).sub.2, wherein alkynyl is CCH, CH.sub.2CCH.

[0797] According to a further specific embodiment of formula I, R.sup.12 is C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.3-C.sub.6-cycloalkyl), C(O)NH (C.sub.3-C.sub.6-cycloalkyl) or C(O)N(C.sub.3-C.sub.6-cycloalkyl).sub.2, wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0798] According to a further specific embodiment of formula I, R.sup.12 is CH(S).

[0799] According to a further specific embodiment of formula I, R.sup.12 is C(S)C.sub.1-C.sub.6-alkyl, C(S)O(C.sub.1-C.sub.6-alkyl), C(S)NH(C.sub.1-C.sub.6-alkyl) or C(S)N(C.sub.1-C.sub.6-alkyl).sub.2, wherein alkyl is CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0800] According to a further specific embodiment of formula I, R.sup.12 is C(S)C.sub.2-C.sub.6-alkenyl, C(S)O(C.sub.2-C.sub.6-alkenyl), C(S)NH(C.sub.2-C.sub.6-alkenyl) or C(S)N(C.sub.2-C.sub.6-alkenyl).sub.2, wherein alkenyl is CHCH.sub.2, CH.sub.2CHCH.sub.2.

[0801] According to a further specific embodiment of formula I, R.sup.12 is C(S)O(C.sub.2-C.sub.6-alkynyl), C(S)NH(C.sub.2-C.sub.6-alkynyl) or C(S)N(C.sub.2-C.sub.6-alkynyl).sub.2, wherein alkynyl is CCH, CH.sub.2CCH.

[0802] According to a further specific embodiment of formula I, R.sup.12 is C(S)C.sub.3-C.sub.6-cycloalkyl, C(S)O(C.sub.3-C.sub.6-cycloalkyl) or C(S)N(C.sub.3-C.sub.6-cycloalkyl).sub.2, wherein cycloalkyl is cyclopropyl (C.sub.3H.sub.7) or cyclobutyl (C.sub.4H.sub.9).

[0803] According to still another embodiment of formula I, R.sup.12 is C.sub.1-C.sub.6-alkyl, such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl, tert-butyl, n-pentyl or i-pentyl.

[0804] According to still another embodiment of formula I, R.sup.12 is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl.

[0805] According to still another embodiment of formula I, R.sup.12 is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0806] According to still another embodiment of formula I R.sup.12 is C.sub.3-C.sub.6-cycloalkyl, in particular cyclopropyl.

[0807] According to still another embodiment of formula I, R.sup.12 is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.12b is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-C.sub.2-cyclopropyl.

[0808] According to still another embodiment of formula I, R.sup.12 is C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy, in particular C.sub.1-C.sub.3-alkoxy, C.sub.1-C.sub.3-halogenalkoxy, such as CH.sub.2OCH.sub.3, CH.sub.2OCF.sub.3 or CH.sub.2OCHF.sub.2.

[0809] According to a further specific embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, phenyl and phenyl-C.sub.1-C.sub.6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy;

[0810] According to a further specific embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, more specifically C.sub.1-C.sub.2-alkyl. R.sup.12 is such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[0811] According to a further specific embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y is C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl. R.sup.12 is such as OCF.sub.3, OCHF.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[0812] According to a further specific embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, more specifically C.sub.1-C.sub.2-alkenyl. R.sup.12 is such as OCHCH.sub.2, OCH.sub.2CHCH.sub.2.

[0813] According to a further specific embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.6-alkynyl, in particular C.sub.2-C.sub.4-alkynyl, more specifically C.sub.1-C.sub.2-alkynyl. R.sup.12 is such as OCCH

[0814] According to still another embodiment of formula I, R.sup.12 is OR.sup.Y, wherein R.sup.Y is C.sub.3-C.sub.6-halogencycloalkyl. In a special embodiment R.sup.1 is fully or partially halogenated cyclopropyl.

[0815] According to still another embodiment of formula I, R.sup.12 is is OR.sup.Y, wherein R.sup.Y and phenyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0816] According to still another embodiment of formula I, R.sup.12 is is OR.sup.Y, wherein R.sup.Y phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, herein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy. R.sup.12 is such as OCH.sub.2Ph.

[0817] According to still a further embodiment of formula I, R.sup.12 is C.sub.2-C.sub.6-alkenyl, in particular C.sub.2-C.sub.4-alkenyl, such as CHCH.sub.2, C(CH.sub.3)CH.sub.2, CH.sub.2CHCH.sub.2.

[0818] According to a further specific embodiment of formula I, R.sup.12 is C.sub.2-C.sub.6-halogenalkenyl, in particular C.sub.2-C.sub.4-halogenalkenyl, more specifically C.sub.2-C.sub.3-halogenalkenyl such as CHCHF, CHCHCl, CHCF.sub.2, CHCCl.sub.2, CH.sub.2CHCHF, CH.sub.2CHCHCl, CH.sub.2CHCF.sub.2, CH.sub.2CHCCl.sub.2, CF.sub.2CHCF.sub.2, CCl.sub.2CHCCl.sub.2, CF.sub.2CFCF.sub.2, CCl.sub.2CClCCl.sub.2.

[0819] According to still a further embodiment of formula I, R.sup.12 is C.sub.2-C.sub.6-alkynyl or C.sub.2-C.sub.6-halogenalkynyl, in particular C.sub.2-C.sub.4-alkynyl or C.sub.2-C.sub.4-halogenalkynyl, such as CCH, CH.sub.2CCH.

[0820] According to still another embodiment of formula I, R.sup.12 is S(O).sub.nC.sub.1-C.sub.6-alkyl such as SCH.sub.3, S(O) CH.sub.3, S(O).sub.2CH.sub.3.

[0821] According to still another embodiment of formula I, R.sup.12 is S(O).sub.nC.sub.1-C.sub.6-halogenalkyl such as SCF.sub.3, S(O)CF.sub.3, S(O).sub.2CF.sub.3, SCHF.sub.2, S(O)CHF.sub.2, S(O).sub.2CHF.sub.2.

[0822] According to still another embodiment of formula I, R.sup.12 is S(O).sub.n-aryl such as S-phenyl, S(O) phenyl, S(O).sub.2phenyl, wherein the phenyl group is unsubstituted or carries one, two, three, four or five substituents R.sup.78a selected from the group consisting of halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy; According to still another embodiment of formula I, R.sup.12 is S(O).sub.nC.sub.2-C.sub.6-alkenyl such as SCHCH.sub.2, S(O)CHCH.sub.2, S(O).sub.2CHCH.sub.2, SCH.sub.2CHCH.sub.2, S(O)CH.sub.2CHCH.sub.2, S(O).sub.2CH.sub.2CHCH.sub.2.

[0823] According to still another embodiment of formula I, R.sup.12 is S(O).sub.nC.sub.2-C.sub.6-alkynyl such as SCCH, S(O)CCH, S(O).sub.2CCH, SCH.sub.2CCH, S(O)CH.sub.2CCH, S(O).sub.2CH.sub.2CCH.

[0824] According to still another embodiment of formula I, R.sup.12 is SO.sub.2NH(C.sub.1-C.sub.6-alkyl), is C.sub.1-C.sub.6-alkyl, in particular C.sub.1-C.sub.4-alkyl, more specifically C.sub.1-C.sub.2-alkyl. R.sup.12 is such as SO.sub.2NHCH.sub.3 or SO.sub.2NHCH.sub.2CH.sub.3.

[0825] According to still another embodiment of formula I, R.sup.12 is SO.sub.2NH(C.sub.1-C.sub.6-halogenalkyl), wherein C.sub.1-C.sub.6-halogenalkyl, in particular C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl. R.sup.12 is such as SO.sub.2NHCF.sub.3, SO.sub.2NHCHF.sub.2, SO.sub.2NHCH.sub.2F, SO.sub.2NHCCl.sub.3, SO.sub.2NHCHCl.sub.2 or SO.sub.2NHCH.sub.2Cl, in particular SO.sub.2NHCF.sub.3, SO.sub.2NHCHF.sub.2, SO.sub.2NHCCl.sub.3 or SO.sub.2NHCHCl.sub.2.

[0826] According to still another embodiment of formula I, R.sup.12 is SO.sub.2NHaryl, wherein the aryl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy. R.sup.12 is such as SO.sub.2NHPh.

[0827] According to still another embodiment of formula I, R.sup.12 is tri-(C.sub.1-C.sub.6 alkyl)silyl, in particular C.sub.1-C.sub.4-alkyl, such as CH.sub.3. or C.sub.2H.sub.5. R.sup.12 is such as OSi(CH.sub.3).sub.3

[0828] According to still another embodiment of formula I, R.sup.12 is di-(C.sub.1-C.sub.6 alkoxy)phosphoryl), in particular C.sub.1-C.sub.4-alkoxy, such as OCH.sub.3. or OC.sub.2H.sub.5. R.sup.12 is such as OPO(OCH.sub.3).sub.2.

[0829] According to still another embodiment of formula I, R.sup.12 is phenyl-C.sub.1-C.sub.6-alkyl, such as phenyl-CH.sub.2, wherein the phenyl moiety in each case is unsubstituted or substituted by one, two or three identical or different groups R.sup.12b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3 and OCF.sub.3.

[0830] According to still another embodiment of formula I, R.sup.12 is aryl, in particular phenyl, wherein the aryl or phenyl moiety in each case is unsubstituted or substituted by identical or different groups R.sup.12b which independently of one another are selected from halogen, C.sub.1-C.sub.2-alkyl, C.sub.1-C.sub.2-alkoxy, C.sub.1-C.sub.2-halogenalkyl and C.sub.1-C.sub.2-halogenalkoxy, in particular F, Cl, Br, CH.sub.3, OCH.sub.3, CF.sub.3 and OCF.sub.3. According to one embodiment, R.sup.12 is unsubstituted phenyl. According to another embodiment, R.sup.12 is phenyl, that is substituted by one, two or three, in particular one, halogen, in particular selected from F, Cl and Br, more specifically selected from F and Cl.

[0831] According to still another embodiment of formula I, R.sup.12 is a 5-membered heteroaryl such as pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl and 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl.

[0832] According to still another embodiment of formula I, R.sup.12 is a 6-membered heteroaryl such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.

[0833] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, halogen, OH, CN, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.1-C.sub.6-halogenalkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy and C.sub.3-C.sub.6-cycloalkyl wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the carbocyclic, phenyl and heteroaryl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0834] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, halogen, OH, CN, C.sub.1-C.sub.6-alkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-alkenyloxy, C.sub.3-C.sub.6-alkynyloxy and C.sub.3-C.sub.6-cycloalkyl, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0835] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H and OR.sup.Y, wherein R.sup.Y is most preferably C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-halogenalkenyl, C.sub.2-C.sub.6-alkynyl, C.sub.2-C.sub.6-halogenalkynyl, phenyl and phenyl-C.sub.1-C.sub.6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, OH, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0836] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H and OR.sup.Y, wherein R.sup.Y is most preferably C.sub.2-C.sub.6-alkenyl, C.sub.2-C.sub.6-alkynyl, phenyl and phenyl-C.sub.1-C.sub.6-alkyl; wherein the phenyl groups are unsubstituted or carry one, two, three, four or five substituents selected from the group consisting of CN, halogen, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-halogenalkyl, C.sub.1-C.sub.4-alkoxy and C.sub.1-C.sub.4-halogenalkoxy.

[0837] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, CH(O), C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl) and C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, C(O)C.sub.2-C.sub.6-alkenyl, C(O)O(C.sub.2-C.sub.6-alkenyl), C(O)NH(C.sub.2-C.sub.6-alkenyl), C(O)N(C.sub.2-C.sub.6-alkenyl).sub.2, C(O)C.sub.2-C.sub.6-alkynyl, C(O)O(C.sub.2-C.sub.6-alkynyl), C(O)NH(C.sub.2-C.sub.6-alkynyl), C(O)N(C.sub.2-C.sub.6-alkynyl).sub.2C(O)C.sub.3-C.sub.6-cycloalkyl, C(O)O(C.sub.3-C.sub.6-cycloalkyl), C(O)NH(C.sub.3-C.sub.6-cycloalkyl) and C(O)N(C.sub.3-C.sub.6-cycloalkyl).sub.2, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0838] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), C(O)NH(C.sub.1-C.sub.6-alkyl), C(O)N(C.sub.1-C.sub.6-alkyl).sub.2, C(O)C.sub.2-C.sub.6-alkenyl, C(O)O(C.sub.2-C.sub.6-alkenyl), C(O)NH(C.sub.2-C.sub.6-alkenyl), C(O)N(C.sub.2-C.sub.6-alkenyl).sub.2, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the cycloalkyl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0839] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.nC.sub.1-C.sub.6-halogenalkyl, S(O).sub.nC.sub.1-C.sub.6-alkoxy, S(O).sub.nC.sub.2-C.sub.6-alkenyl, S(O).sub.nC.sub.2-C.sub.6-alkynyl, S(O).sub.naryl, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the aryl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0840] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, SO.sub.2NH(C.sub.1-C.sub.6-alkyl), SO.sub.2NH(C.sub.1-C.sub.6-halogenalkyl), SO.sub.2NH-phenyl, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the aryl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0841] According to still another embodiment of formula I, R.sup.12 is in each case independently selected from H, C.sub.1-C.sub.6-alkyl, C(O)C.sub.1-C.sub.6-alkyl, C(O)O(C.sub.1-C.sub.6-alkyl), S(O).sub.nC.sub.1-C.sub.6-alkyl, S(O).sub.naryl, wherein the acyclic moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12a as defined and preferably defined herein, and wherein the aryl moieties of R.sup.12 are unsubstituted or substituted with identical or different groups R.sup.12b as defined and preferably defined herein.

[0842] According to one embodiment R.sup.12a is independently selected from halogen, C.sub.1-C.sub.6-alkoxy, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl and C.sub.1-C.sub.4-halogenalkoxy. Specifically, R.sup.12a is independently selected from F, Cl, Br, I, C.sub.1-C.sub.2-alkoxy, cyclopropyl, 1-F-cyclopropyl, 1-Cl-cyclopropyl, 1,1-F.sub.2-cyclopropyl, 1,1-Cl.sub.2-cyclopropyl and C.sub.1-C.sub.2-halogenalkoxy.

[0843] According to still another embodiment of formula I, R.sup.12a is independently halogen, in particular selected from F, Cl, Br and I, more specifically F, Cl and Br.

[0844] R.sup.12b are the possible substituents for the cycloalkyl, heteroaryl and phenyl moieties of R.sup.12. R.sup.12b according to the invention is independently selected from halogen, OH, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl, C.sub.3-C.sub.6-cycloalkyl, C.sub.3-C.sub.6-halogencycloalkyl, C.sub.1-C.sub.4-halogenalkoxy and C.sub.1-C.sub.6-alkylthio.

[0845] According to one embodiment thereof R.sup.12b is independently selected from halogen, CN, C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-halogenalkyl and C.sub.1-C.sub.4-halogenalkoxy, in particular halogen, C.sub.1-C.sub.4-alkyl and C.sub.1-C.sub.4-alkoxy. Specifically, R.sup.12b is independently selected from F, Cl, CN, CH.sub.3, CHF.sub.2, CF.sub.3OCH.sub.3 and halogenmethoxy.

[0846] Particularly preferred embodiments of R.sup.12 according to the invention are in Table P12 below, wherein each line of lines P12-1 to P12-50 corresponds to one particular embodiment of the invention, wherein P12-1 to P12-50 are also in any combination with one another a preferred embodiment of the present invention. The connection point to the carbon atom, to which R.sup.12 is bound is marked with # in the drawings.

TABLE-US-00010 TABLE P12 No. R.sup.12 P12-1 H P12-2 CH.sub.3 P12-3 CH.sub.2F P12-4 CHF.sub.2 P12-5 CF.sub.3 P12-6 C.sub.2H.sub.5 P12-7 C.sub.3H.sub.7 P12-8 CH(CH.sub.3).sub.2 P12-9 CH.sub.2CH.sub.2CH.sub.3 P12-10 CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P12-11 CH.sub.2CH(CH.sub.3).sub.2 P12-12 C(CH.sub.3).sub.3 P12-13 CH.sub.2CH.sub.2CH.sub.2CH.sub.2CH.sub.3 P12-14 CHCH.sub.2 P12-15 CH.sub.2CHCH.sub.2 P12-16 CCH P12-17 CH.sub.2CCH P12-18 CH.sub.2CH.sub.2CH(CH.sub.3).sub.2 P12-19 OH P12-20 OCH.sub.3 P12-21 OCHF.sub.2 P12-22 OC.sub.2H.sub.5 P12-23 OCH.sub.2OCH.sub.3 P12-24 OCH.sub.2Ph P12-25 OCH.sub.2CHCH.sub.2 P12-26 C(O)CH.sub.3 P12-27 C(O)OCH.sub.3 P12-28 C(O)OCH.sub.2CH.sub.3 P12-29 C(O)OCH(CH.sub.3).sub.2 P12-30 C(O)OC(CH.sub.3).sub.3 P12-31 CONH.sub.2 P12-32 CONH(CH.sub.3) P12-33 CON(CH.sub.3).sub.2 P12-34 SO.sub.2H P12-35 SO.sub.2CH.sub.3 P12-36 SOCH.sub.3 P12-37 SCH.sub.3 P12-38 SO.sub.2NHCH.sub.3 P12-39 SO.sub.2NHCF.sub.3 P12-40 SO.sub.2NHPh P12-41 SO.sub.2Ph P12-42 SO.sub.2C.sub.6H.sub.4-4-CH.sub.3 P12-43 Si(CH.sub.3).sub.3 P12-44 PO(OCH.sub.3).sub.2 P12-45 [00429] P12-46 [00430] P12-47 [00431] P12-48 [00432] P12-49 [00433] P12-50 [00434]

[0847] Particular embodiments of the compounds I are the following compounds: I-A, I-B, I-C, I-D, I-E, I-F, I-G. In these formulae, the substituents R.sup.4, R.sup.9, R.sup.10 and R.sup.12 are independently as defined in claim 1 or preferably defined below:

##STR00435##

[0848] Table 1-1 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is H and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-1.A-1 to I-A.1-1.A-540, I-B.1-1.A-1 to I-B.1-1.A-540, I-C.1-1.A-1 to I-C.1-1.A-540, I-D.1-1.A-1 to I-D.1-1.A-540, I-E.1-1.A-1 to I-E.1-1.A-540, I-F.1-1.A-1 to I-F.1-1.A-540, I-G.1-1.A-1 to I-G.1-1.A-540).

[0849] Table 1-2 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is CH.sub.3 and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-2.A-1 to I-A.1-2.A-540, I-B.1-2.A-1 to I-B.1-2.A-540, I-C.1-2.A-1 to I-C.1-2.A-540, I-D.1-2.A-1 to I-D.1-2.A-540, I-E.1-2.A-1 to I-E.1-2.A-540, I-F.1-2.A-1 to I-F.1-2.A-540, I-G.1-2.A-1 to I-G.1-2.A-540).

[0850] Table 1-3 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is CH.sub.2CHCH.sub.2 and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-3.A-1 to I-A.1-3.A-540, I-B.1-3.A-1 to I-B.1-3.A-540, I-C.1-3.A-1 to I-C.1-3.A-540, I-D.1-3.A-1 to I-D.1-3.A-540, I-E.1-3.A-1 to I-E.1-3.A-540, I-F.1-3.A-1 to I-F.1-3.A-540, I-G.1-3.A-1 to I-G.1-3.A-540).

[0851] Table 1-4 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is C(O)OCH.sub.3 and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-4.A-1 to I-A.1-4.A-540, I-B.1-4.A-1 to I-B.1-4.A-540, I-C.1-4.A-1 to I-C.1-4.A-540, I-D.1-4.A-1 to I-D.1-4.A-540, I-E.1-4.A-1 to I-E.1-4.A-540, I-F.1-4.A-1 to I-F.1-4.A-540, I-G.1-4.A-1 to I-G.1-4.A-540).

[0852] Table 1-5 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is SO.sub.2NHCH.sub.3 and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-5.A-1 to I-A.1-5.A-540, I-B.1-5.A-1 to I-B.1-5.A-540, I-C.1-5.A-1 to I-C.1-5.A-540, I-D.1-5.A-1 to I-D.1-5.A-540, I-E.1-5.A-1 to I-E.1-5.A-540, I-F.1-5.A-1 to I-F.1-5.A-540, I-G.1-5.A-1 to I-G.1-5.A-540).

[0853] Table 1-6 Compounds of the formula I-A, I-B, I-C, I-D, I-E, I-F, I-G in which R.sup.12 is OH and the meaning for the combination of R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table A (compounds I-A.1-6.A-1 to I-A.1-6.A-540, I-B.1-6.A-1 to I-B.1-6.A-540, I-C.1-6.A-1 to I-C.1-6.A-540, I-D.1-6.A-1 to I-D.1-6.A-540, I-E.1-6.A-1 to I-E.1-6.A-540, I-F.1-6.A-1 to I-F.1-6.A-540, I-G.1-6.A-1 to I-G.1-6.A-540).

TABLE-US-00011 TABLE A No. R.sup.4 R.sup.9 R.sup.10 A-1 CH.sub.3 CH.sub.3 CH.sub.3 A-2 CH.sub.2F CH.sub.3 CH.sub.3 A-3 CHF.sub.2 CH.sub.3 CH.sub.3 A-4 CH.sub.2CH.sub.3 CH.sub.3 CH.sub.3 A-5 CF.sub.3 CH.sub.3 CH.sub.3 A-6 [00436] CH.sub.3 CH.sub.3 A-7 [00437] CH.sub.3 CH.sub.3 A-8 C.sub.6H.sub.5 CH.sub.3 CH.sub.3 A-9 CH.sub.2C.sub.6H.sub.5 CH.sub.3 CH.sub.3 A-10 2-py CH.sub.3 CH.sub.3 A-11 [00438] CH.sub.3 CH.sub.3 A-12 [00439] CH.sub.3 CH.sub.3 A-13 [00440] CH.sub.3 CH.sub.3 A-14 [00441] CH.sub.3 CH.sub.3 A-15 [00442] CH.sub.3 CH.sub.3 A-16 CH.sub.3 CH.sub.2F CH.sub.3 A-17 CH.sub.2F CH.sub.2F CH.sub.3 A-18 CHF.sub.2 CH.sub.2F CH.sub.3 A-19 CH.sub.2CH.sub.3 CH.sub.2F CH.sub.3 A-20 CF.sub.3 CH.sub.2F CH.sub.3 A-21 [00443] CH.sub.2F CH.sub.3 A-22 [00444] CH.sub.2F CH.sub.3 A-23 C.sub.6H.sub.5 CH.sub.2F CH.sub.3 A-24 CH.sub.2C.sub.6H.sub.5 CH.sub.2F CH.sub.3 A-25 2-py CH.sub.2F CH.sub.3 A-26 [00445] CH.sub.2F CH.sub.3 A-27 [00446] CH.sub.2F CH.sub.3 A-28 [00447] CH.sub.2F CH.sub.3 A-29 [00448] CH.sub.2F CH.sub.3 A-30 [00449] CH.sub.2F CH.sub.3 A-31 CH.sub.3 CHF.sub.2 CH.sub.3 A-32 CH.sub.2F CHF.sub.2 CH.sub.3 A-33 CHF.sub.2 CHF.sub.2 CH.sub.3 A-34 CH.sub.2CH.sub.3 CHF.sub.2 CH.sub.3 A-35 CF.sub.3 CHF.sub.2 CH.sub.3 A-36 [00450] CHF.sub.2 CH.sub.3 A-37 [00451] CHF.sub.2 CH.sub.3 A-38 C.sub.6H.sub.5 CHF.sub.2 CH.sub.3 A-39 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 CH.sub.3 A-40 2-py CHF.sub.2 CH.sub.3 A-41 [00452] CHF.sub.2 CH.sub.3 A-42 [00453] CHF.sub.2 CH.sub.3 A-43 [00454] CHF.sub.2 CH.sub.3 A-44 [00455] CHF.sub.2 CH.sub.3 A-45 [00456] CHF.sub.2 CH.sub.3 A-46 CH.sub.3 CF.sub.3 CH.sub.3 A-47 CH.sub.2F CF.sub.3 CH.sub.3 A-48 CHF.sub.2 CF.sub.3 CH.sub.3 A-49 CH.sub.2CH.sub.3 CF.sub.3 CH.sub.3 A-50 CF.sub.3 CF.sub.3 CH.sub.3 A-51 [00457] CF.sub.3 CH.sub.3 A-52 [00458] CF.sub.3 CH.sub.3 A-53 C.sub.6H.sub.5 CF.sub.3 CH.sub.3 A-54 CH.sub.2C.sub.6H.sub.5 CF.sub.3 CH.sub.3 A-55 2-py CF.sub.3 CH.sub.3 A-56 [00459] CF.sub.3 CH.sub.3 A-57 [00460] CF.sub.3 CH.sub.3 A-58 [00461] CF.sub.3 CH.sub.3 A-59 [00462] CF.sub.3 CH.sub.3 A-60 [00463] CF.sub.3 CH.sub.3 A-61 CH.sub.3 Cl CH.sub.3 A-62 CH.sub.2F Cl CH.sub.3 A-63 CHF.sub.2 Cl CH.sub.3 A-64 CH.sub.2CH.sub.3 Cl CH.sub.3 A-65 CF.sub.3 Cl CH.sub.3 A-66 [00464] Cl CH.sub.3 A-67 [00465] Cl CH.sub.3 A-68 C.sub.6H.sub.5 Cl CH.sub.3 A-69 CH.sub.2C.sub.6H.sub.5 Cl CH.sub.3 A-70 2-py Cl CH.sub.3 A-71 [00466] Cl CH.sub.3 A-72 [00467] Cl CH.sub.3 A-73 [00468] Cl CH.sub.3 A-74 [00469] Cl CH.sub.3 A-75 [00470] Cl CH.sub.3 A-76 CH.sub.3 OCH.sub.3 CH.sub.3 A-77 CH.sub.2F OCH.sub.3 CH.sub.3 A-78 CHF.sub.2 OCH.sub.3 CH.sub.3 A-79 CH.sub.2CH.sub.3 OCH.sub.3 CH.sub.3 A-80 CF.sub.3 OCH.sub.3 CH.sub.3 A-81 [00471] OCH.sub.3 CH.sub.3 A-82 [00472] OCH.sub.3 CH.sub.3 A-83 C.sub.6H.sub.5 OCH.sub.3 CH.sub.3 A-84 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 CH.sub.3 A-85 2-py OCH.sub.3 CH.sub.3 A-86 [00473] OCH.sub.3 CH.sub.3 A-87 [00474] OCH.sub.3 CH.sub.3 A-88 [00475] OCH.sub.3 CH.sub.3 A-89 [00476] OCH.sub.3 CH.sub.3 A-90 [00477] OCH.sub.3 CH.sub.3 A-91 CH.sub.3 CH.sub.3 CH.sub.2F A-92 CH.sub.2F CH.sub.3 CH.sub.2F A-93 CHF.sub.2 CH.sub.3 CH.sub.2F A-94 CH.sub.2CH.sub.3 CH.sub.3 CH.sub.2F A-95 CF.sub.3 CH.sub.3 CH.sub.2F A-96 [00478] CH.sub.3 CH.sub.2F A-97 [00479] CH.sub.3 CH.sub.2F A-98 C.sub.6H.sub.5 CH.sub.3 CH.sub.2F A-99 CH.sub.2C.sub.6H.sub.5 CH.sub.3 CH.sub.2F A-100 2-py CH.sub.3 CH.sub.2F A-101 [00480] CH.sub.3 CH.sub.2F A-102 [00481] CH.sub.3 CH.sub.2F A-103 [00482] CH.sub.3 CH.sub.2F A-104 [00483] CH.sub.3 CH.sub.2F A-105 [00484] CH.sub.3 CH.sub.2F A-106 CH.sub.3 CH.sub.2F CH.sub.2F A-107 CH.sub.2F CH.sub.2F CH.sub.2F A-108 CHF.sub.2 CH.sub.2F CH.sub.2F A-109 CH.sub.2CH.sub.3 CH.sub.2F CH.sub.2F A-110 CF.sub.3 CH.sub.2F CH.sub.2F A-111 [00485] CH.sub.2F CH.sub.2F A-112 [00486] CH.sub.2F CH.sub.2F A-113 C.sub.6H.sub.5 CH.sub.2F CH.sub.2F A-114 CH.sub.2C.sub.6H.sub.5 CH.sub.2F CH.sub.2F A-115 2-py CH.sub.2F CH.sub.2F A-116 [00487] CH.sub.2F CH.sub.2F A-117 [00488] CH.sub.2F CH.sub.2F A-118 [00489] CH.sub.2F CH.sub.2F A-119 [00490] CH.sub.2F CH.sub.2F A-120 [00491] CH.sub.2F CH.sub.2F A-121 CH.sub.3 CHF.sub.2 CH.sub.2F A-122 CH.sub.2F CHF.sub.2 CH.sub.2F A-123 CHF.sub.2 CHF.sub.2 CH.sub.2F A-124 CH.sub.2CH.sub.3 CHF.sub.2 CH.sub.2F A-125 CF.sub.3 CHF.sub.2 CH.sub.2F A-126 [00492] CHF.sub.2 CH.sub.2F A-127 [00493] CHF.sub.2 CH.sub.2F A-128 C.sub.6H.sub.5 CHF.sub.2 CH.sub.2F A-129 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 CH.sub.2F A-130 2-py CHF.sub.2 CH.sub.2F A-131 [00494] CHF.sub.2 CH.sub.2F A-132 [00495] CHF.sub.2 CH.sub.2F A-133 [00496] CHF.sub.2 CH.sub.2F A-134 [00497] CHF.sub.2 CH.sub.2F A-135 [00498] CHF.sub.2 CH.sub.2F A-136 CH.sub.3 CF.sub.3 CH.sub.2F A-137 CH.sub.2F CF.sub.3 CH.sub.2F A-138 CHF.sub.2 CF.sub.3 CH.sub.2F A-139 CH.sub.2CH.sub.3 CF.sub.3 CH.sub.2F A-140 CF.sub.3 CF.sub.3 CH.sub.2F A-141 [00499] CF.sub.3 CH.sub.2F A-142 [00500] CF.sub.3 CH.sub.2F A-143 C.sub.6H.sub.5 CF.sub.3 CH.sub.2F A-144 CH.sub.2C.sub.6H.sub.5 CF.sub.3 CH.sub.2F A-145 2-py CF.sub.3 CH.sub.2F A-146 [00501] CF.sub.3 CH.sub.2F A-147 [00502] CF.sub.3 CH.sub.2F A-148 [00503] CF.sub.3 CH.sub.2F A-149 [00504] CF.sub.3 CH.sub.2F A-150 [00505] CF.sub.3 CH.sub.2F A-151 CH.sub.3 Cl CH.sub.2F A-152 CH.sub.2F Cl CH.sub.2F A-153 CHF.sub.2 Cl CH.sub.2F A-154 CH.sub.2CH.sub.3 Cl CH.sub.2F A-155 CF.sub.3 Cl CH.sub.2F A-156 [00506] Cl CH.sub.2F A-157 [00507] Cl CH.sub.2F A-158 C.sub.6H.sub.5 Cl CH.sub.2F A-159 CH.sub.2C.sub.6H.sub.5 Cl CH.sub.2F A-160 2-py Cl CH.sub.2F A-161 [00508] Cl CH.sub.2F A-162 [00509] Cl CH.sub.2F A-163 [00510] Cl CH.sub.2F A-164 [00511] Cl CH.sub.2F A-165 [00512] Cl CH.sub.2F A-166 CH.sub.3 OCH.sub.3 CH.sub.2F A-167 CH.sub.2F OCH.sub.3 CH.sub.2F A-168 CHF.sub.2 OCH.sub.3 CH.sub.2F A-169 CH.sub.2CH.sub.3 OCH.sub.3 CH.sub.2F A-170 CF.sub.3 OCH.sub.3 CH.sub.2F A-171 [00513] OCH.sub.3 CH.sub.2F A-172 [00514] OCH.sub.3 CH.sub.2F A-173 C.sub.6H.sub.5 OCH.sub.3 CH.sub.2F A-174 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 CH.sub.2F A-175 2-py OCH.sub.3 CH.sub.2F A-176 [00515] OCH.sub.3 CH.sub.2F A-177 [00516] OCH.sub.3 CH.sub.2F A-178 [00517] OCH.sub.3 CH.sub.2F A-179 [00518] OCH.sub.3 CH.sub.2F A-180 [00519] OCH.sub.3 CH.sub.2F A-181 CH.sub.3 CH.sub.3 CHF.sub.2 A-182 CH.sub.2F CH.sub.3 CHF.sub.2 A-183 CHF.sub.2 CH.sub.3 CHF.sub.2 A-184 CH.sub.2CH.sub.3 CH.sub.3 CHF.sub.2 A-185 CF.sub.3 CH.sub.3 CHF.sub.2 A-186 [00520] CH.sub.3 CHF.sub.2 A-187 [00521] CH.sub.3 CHF.sub.2 A-188 C.sub.6H.sub.5 CH.sub.3 CHF.sub.2 A-189 CH.sub.2C.sub.6H.sub.5 CH.sub.3 CHF.sub.2 A-190 2-py CH.sub.3 CHF.sub.2 A-191 [00522] CH.sub.3 CHF.sub.2 A-192 [00523] CH.sub.3 CHF.sub.2 A-193 [00524] CH.sub.3 CHF.sub.2 A-194 [00525] CH.sub.3 CHF.sub.2 A-195 [00526] CH.sub.3 CHF.sub.2 A-196 CH.sub.3 CH.sub.2F CHF.sub.2 A-197 CH.sub.2F CH.sub.2F CHF.sub.2 A-198 CHF.sub.2 CH.sub.2F CHF.sub.2 A-199 CH.sub.2CH.sub.3 CH.sub.2F CHF.sub.2 A-200 CF.sub.3 CH.sub.2F CHF.sub.2 A-201 [00527] CH.sub.2F CHF.sub.2 A-202 [00528] CH.sub.2F CHF.sub.2 A-203 C.sub.6H.sub.5 CH.sub.2F CHF.sub.2 A-204 CH.sub.2C.sub.6H.sub.5 CH.sub.2F CHF.sub.2 A-205 2-py CH.sub.2F CHF.sub.2 A-206 [00529] CH.sub.2F CHF.sub.2 A-207 [00530] CH.sub.2F CHF.sub.2 A-208 [00531] CH.sub.2F CHF.sub.2 A-209 [00532] CH.sub.2F CHF.sub.2 A-210 [00533] CH.sub.2F CHF.sub.2 A-211 CH.sub.3 CHF.sub.2 CHF.sub.2 A-212 CH.sub.2F CHF.sub.2 CHF.sub.2 A-213 CHF.sub.2 CHF.sub.2 CHF.sub.2 A-214 CH.sub.2CH.sub.3 CHF.sub.2 CHF.sub.2 A-215 CF.sub.3 CHF.sub.2 CHF.sub.2 A-216 [00534] CHF.sub.2 CHF.sub.2 A-217 [00535] CHF.sub.2 CHF.sub.2 A-218 C.sub.6H.sub.5 CHF.sub.2 CHF.sub.2 A-219 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 CHF.sub.2 A-220 2-py CHF.sub.2 CHF.sub.2 A-221 [00536] CHF.sub.2 CHF.sub.2 A-222 [00537] CHF.sub.2 CHF.sub.2 A-223 [00538] CHF.sub.2 CHF.sub.2 A-224 [00539] CHF.sub.2 CHF.sub.2 A-225 [00540] CHF.sub.2 CHF.sub.2 A-226 CH.sub.3 CF.sub.3 CHF.sub.2 A-227 CH.sub.2F CF.sub.3 CHF.sub.2 A-228 CHF.sub.2 CF.sub.3 CHF.sub.2 A-229 CH.sub.2CH.sub.3 CF.sub.3 CHF.sub.2 A-230 CF.sub.3 CF.sub.3 CHF.sub.2 A-231 [00541] CF.sub.3 CHF.sub.2 A-232 [00542] CF.sub.3 CHF.sub.2 A-233 C.sub.6H.sub.5 CF.sub.3 CHF.sub.2 A-234 CH.sub.2C.sub.6H.sub.5 CF.sub.3 CHF.sub.2 A-235 2-py CF.sub.3 CHF.sub.2 A-236 [00543] CF.sub.3 CHF.sub.2 A-237 [00544] CF.sub.3 CHF.sub.2 A-238 [00545] CF.sub.3 CHF.sub.2 A-239 [00546] CF.sub.3 CHF.sub.2 A-240 [00547] CF.sub.3 CHF.sub.2 A-241 CH.sub.3 Cl CHF.sub.2 A-242 CH.sub.2F Cl CHF.sub.2 A-243 CHF.sub.2 Cl CHF.sub.2 A-244 CH.sub.2CH.sub.3 Cl CHF.sub.2 A-245 CF.sub.3 Cl CHF.sub.2 A-246 [00548] Cl CHF.sub.2 A-247 [00549] Cl CHF.sub.2 A-248 C.sub.6H.sub.5 Cl CHF.sub.2 A-249 CH.sub.2C.sub.6H.sub.5 Cl CHF.sub.2 A-250 2-py Cl CHF.sub.2 A-251 [00550] Cl CHF.sub.2 A-252 [00551] Cl CHF.sub.2 A-253 [00552] Cl CHF.sub.2 A-254 [00553] Cl CHF.sub.2 A-255 [00554] Cl CHF.sub.2 A-256 CH.sub.3 OCH.sub.3 CHF.sub.2 A-257 CH.sub.2F OCH.sub.3 CHF.sub.2 A-258 CHF.sub.2 OCH.sub.3 CHF.sub.2 A-259 CH.sub.2CH.sub.3 OCH.sub.3 CHF.sub.2 A-260 CF.sub.3 OCH.sub.3 CHF.sub.2 A-261 [00555] OCH.sub.3 CHF.sub.2 A-262 [00556] OCH.sub.3 CHF.sub.2 A-263 C.sub.6H.sub.5 OCH.sub.3 CHF.sub.2 A-264 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 CHF.sub.2 A-265 2-py OCH.sub.3 CHF.sub.2 A-266 [00557] OCH.sub.3 CHF.sub.2 A-267 [00558] OCH.sub.3 CHF.sub.2 A-268 [00559] OCH.sub.3 CHF.sub.2 A-269 [00560] OCH.sub.3 CHF.sub.2 A-270 [00561] OCH.sub.3 CHF.sub.2 A-271 CH.sub.3 CH.sub.3 CF.sub.3 A-272 CH.sub.2F CH.sub.3 CF.sub.3 A-273 CHF.sub.2 CH.sub.3 CF.sub.3 A-274 CH.sub.2CH.sub.3 CH.sub.3 CF.sub.3 A-275 CF.sub.3 CH.sub.3 CF.sub.3 A-276 [00562] CH.sub.3 CF.sub.3 A-277 [00563] CH.sub.3 CF.sub.3 A-278 C.sub.6H.sub.5 CH.sub.3 CF.sub.3 A-279 CH.sub.2C.sub.6H.sub.5 CH.sub.3 CF.sub.3 A-280 2-py CH.sub.3 CF.sub.3 A-281 [00564] CH.sub.3 CF.sub.3 A-282 [00565] CH.sub.3 CF.sub.3 A-283 [00566] CH.sub.3 CF.sub.3 A-284 [00567] CH.sub.3 CF.sub.3 A-285 [00568] CH.sub.3 CF.sub.3 A-286 CH.sub.3 CH.sub.2F CF.sub.3 A-287 CH.sub.2F CH.sub.2F CF.sub.3 A-288 CHF.sub.2 CH.sub.2F CF.sub.3 A-289 CH.sub.2CH.sub.3 CH.sub.2F CF.sub.3 A-290 CF.sub.3 CH.sub.2F CF.sub.3 A-291 [00569] CH.sub.2F CF.sub.3 A-292 [00570] CH.sub.2F CF.sub.3 A-293 C.sub.6H.sub.5 CH.sub.2F CF.sub.3 A-294 CH.sub.2C.sub.6H.sub.5 CH.sub.2F CF.sub.3 A-295 2-py CH.sub.2F CF.sub.3 A-296 [00571] CH.sub.2F CF.sub.3 A-297 [00572] CH.sub.2F CF.sub.3 A-298 [00573] CH.sub.2F CF.sub.3 A-299 [00574] CH.sub.2F CF.sub.3 A-300 [00575] CH.sub.2F CF.sub.3 A-301 CH.sub.3 CHF.sub.2 CF.sub.3 A-302 CH.sub.2F CHF.sub.2 CF.sub.3 A-303 CHF.sub.2 CHF.sub.2 CF.sub.3 A-304 CH.sub.2CH.sub.3 CHF.sub.2 CF.sub.3 A-305 CF.sub.3 CHF.sub.2 CF.sub.3 A-306 [00576] CHF.sub.2 CF.sub.3 A-307 [00577] CHF.sub.2 CF.sub.3 A-308 C.sub.6H.sub.5 CHF.sub.2 CF.sub.3 A-309 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 CF.sub.3 A-310 2-py CHF.sub.2 CF.sub.3 A-311 [00578] CHF.sub.2 CF.sub.3 A-312 [00579] CHF.sub.2 CF.sub.3 A-313 [00580] CHF.sub.2 CF.sub.3 A-314 [00581] CHF.sub.2 CF.sub.3 A-315 [00582] CHF.sub.2 CF.sub.3 A-316 CH.sub.3 CF.sub.3 CF.sub.3 A-317 CH.sub.2F CF.sub.3 CF.sub.3 A-318 CHF.sub.2 CF.sub.3 CF.sub.3 A-319 CH.sub.2CH.sub.3 CF.sub.3 CF.sub.3 A-320 CF.sub.3 CF.sub.3 CF.sub.3 A-321 [00583] CF.sub.3 CF.sub.3 A-322 [00584] CF.sub.3 CF.sub.3 A-323 C.sub.6H.sub.5 CF.sub.3 CF.sub.3 A-324 CH.sub.2C.sub.6H.sub.5 CF.sub.3 CF.sub.3 A-325 2-py CF.sub.3 CF.sub.3 A-326 [00585] CF.sub.3 CF.sub.3 A-327 [00586] CF.sub.3 CF.sub.3 A-328 [00587] CF.sub.3 CF.sub.3 A-329 [00588] CF.sub.3 CF.sub.3 A-330 [00589] CF.sub.3 CF.sub.3 A-331 CH.sub.3 Cl CF.sub.3 A-332 CH.sub.2F Cl CF.sub.3 A-333 CHF.sub.2 Cl CF.sub.3 A-334 CH.sub.2CH.sub.3 Cl CF.sub.3 A-335 CF.sub.3 Cl CF.sub.3 A-336 [00590] Cl CF.sub.3 A-337 [00591] Cl CF.sub.3 A-338 C.sub.6H.sub.5 Cl CF.sub.3 A-339 CH.sub.2C.sub.6H.sub.5 Cl CF.sub.3 A-340 2-py Cl CF.sub.3 A-341 [00592] Cl CF.sub.3 A-342 [00593] Cl CF.sub.3 A-343 [00594] Cl CF.sub.3 A-344 [00595] Cl CF.sub.3 A-345 [00596] Cl CF.sub.3 A-346 CH.sub.3 OCH.sub.3 CF.sub.3 A-347 CH.sub.2F OCH.sub.3 CF.sub.3 A-348 CHF.sub.2 OCH.sub.3 CF.sub.3 A-349 CH.sub.2CH.sub.3 OCH.sub.3 CF.sub.3 A-350 CF.sub.3 OCH.sub.3 CF.sub.3 A-351 [00597] OCH.sub.3 CF.sub.3 A-352 [00598] OCH.sub.3 CF.sub.3 A-353 C.sub.6H.sub.5 OCH.sub.3 CF.sub.3 A-354 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 CF.sub.3 A-355 2-py OCH.sub.3 CF.sub.3 A-356 [00599] OCH.sub.3 CF.sub.3 A-357 [00600] OCH.sub.3 CF.sub.3 A-358 [00601] OCH.sub.3 CF.sub.3 A-359 [00602] OCH.sub.3 CF.sub.3 A-360 [00603] OCH.sub.3 CF.sub.3 A-361 CH.sub.3 CH.sub.3 Cl A-362 CH.sub.2F CH.sub.3 Cl A-363 CHF.sub.2 CH.sub.3 Cl A-364 CH.sub.2CH.sub.3 CH.sub.3 Cl A-365 CF.sub.3 CH.sub.3 Cl A-366 [00604] CH.sub.3 Cl A-367 [00605] CH.sub.3 Cl A-368 C.sub.6H.sub.5 CH.sub.3 Cl A-369 CH.sub.2C.sub.6H.sub.5 CH.sub.3 Cl A-370 2-py CH.sub.3 Cl A-371 [00606] CH.sub.3 Cl A-372 [00607] CH.sub.3 Cl A-373 [00608] CH.sub.3 Cl A-374 [00609] CH.sub.3 Cl A-375 [00610] CH.sub.3 Cl A-376 CH.sub.3 CH.sub.2F Cl A-377 CH.sub.2F CH.sub.2F Cl A-378 CHF.sub.2 CH.sub.2F Cl A-379 CH.sub.2CH.sub.3 CH.sub.2F Cl A-380 CF.sub.3 CH.sub.2F Cl A-381 [00611] CH.sub.2F Cl A-382 [00612] CH.sub.2F Cl A-383 C.sub.6H.sub.5 CH.sub.2F Cl A-384 CH.sub.2C.sub.6H.sub.5 CH.sub.2F Cl A-385 2-py CH.sub.2F Cl A-386 [00613] CH.sub.2F Cl A-387 [00614] CH.sub.2F Cl A-388 [00615] CH.sub.2F Cl A-389 [00616] CH.sub.2F Cl A-390 [00617] CH.sub.2F Cl A-391 CH.sub.3 CHF.sub.2 Cl A-392 CH.sub.2F CHF.sub.2 Cl A-393 CHF.sub.2 CHF.sub.2 Cl A-394 CH.sub.2CH.sub.3 CHF.sub.2 Cl A-395 CF.sub.3 CHF.sub.2 Cl A-396 [00618] CHF.sub.2 Cl A-397 [00619] CHF.sub.2 Cl A-398 C.sub.6H.sub.5 CHF.sub.2 Cl A-399 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 Cl A-400 2-py CHF.sub.2 Cl A-401 [00620] CHF.sub.2 Cl A-402 [00621] CHF.sub.2 Cl A-403 [00622] CHF.sub.2 Cl A-404 [00623] CHF.sub.2 Cl A-405 [00624] CHF.sub.2 Cl A-406 CH.sub.3 CF.sub.3 Cl A-407 CH.sub.2F CF.sub.3 Cl A-408 CHF.sub.2 CF.sub.3 Cl A-409 CH.sub.2CH.sub.3 CF.sub.3 Cl A-410 CF.sub.3 CF.sub.3 Cl A-411 [00625] CF.sub.3 Cl A-412 [00626] CF.sub.3 Cl A-413 C.sub.6H.sub.5 CF.sub.3 Cl A-414 CH.sub.2C.sub.6H.sub.5 CF.sub.3 Cl A-415 2-py CF.sub.3 Cl A-416 [00627] CF.sub.3 Cl A-417 [00628] CF.sub.3 Cl A-418 [00629] CF.sub.3 Cl A-419 [00630] CF.sub.3 Cl A-420 [00631] CF Cl A-421 CH.sub.3 Cl Cl A-422 CH.sub.2F Cl Cl A-423 CHF.sub.2 Cl Cl A-424 CH.sub.2CH.sub.3 Cl Cl A-425 CF.sub.3 Cl Cl A-426 [00632] Cl Cl A-427 [00633] Cl Cl A-428 C.sub.6H.sub.5 Cl Cl A-429 CH.sub.2C.sub.6H.sub.5 Cl Cl A-430 2-py Cl Cl A-431 [00634] Cl Cl A-432 [00635] Cl Cl A-433 [00636] Cl Cl A-434 [00637] Cl Cl A-435 [00638] Cl Cl A-436 CH.sub.3 OCH.sub.3 Cl A-437 CH.sub.2F OCH.sub.3 Cl A-438 CHF.sub.2 OCH.sub.3 Cl A-439 CH.sub.2CH.sub.3 OCH.sub.3 Cl A-440 CF.sub.3 OCH.sub.3 Cl A-441 [00639] OCH.sub.3 Cl A-442 [00640] OCH.sub.3 Cl A-443 C.sub.6H.sub.5 OCH.sub.3 Cl A-444 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 Cl A-445 2-py OCH.sub.3 Cl A-446 [00641] OCH.sub.3 Cl A-447 [00642] OCH.sub.3 Cl A-448 [00643] OCH.sub.3 Cl A-449 [00644] OCH.sub.3 Cl A-450 [00645] OCH.sub.3 Cl A-451 CH.sub.3 CH.sub.3 OCH.sub.3 A-452 CH.sub.2F CH.sub.3 OCH.sub.3 A-453 CHF.sub.2 CH.sub.3 OCH.sub.3 A-454 CH.sub.2CH.sub.3 CH.sub.3 OCH.sub.3 A-455 CF.sub.3 CH.sub.3 OCH.sub.3 A-456 [00646] CH.sub.3 OCH.sub.3 A-457 [00647] CH.sub.3 OCH.sub.3 A-458 C.sub.6H.sub.5 CH.sub.3 OCH.sub.3 A-459 CH.sub.2C.sub.6H.sub.5 CH.sub.3 OCH.sub.3 A-460 2-py CH.sub.3 OCH A-461 [00648] CH.sub.3 OCH.sub.3 A-462 [00649] CH.sub.3 OCH.sub.3 A-463 [00650] CH.sub.3 OCH.sub.3 A-464 [00651] CH.sub.3 OCH.sub.3 A-465 [00652] CH.sub.3 OCH.sub.3 A-466 CH.sub.3 CH.sub.2F OCH.sub.3 A-467 CH.sub.2F CH.sub.2F OCH.sub.3 A-468 CHF.sub.2 CH.sub.2F OCH.sub.3 A-469 CH.sub.2CH.sub.3 CH.sub.2F OCH.sub.3 A-470 CF.sub.3 CH.sub.2F OCH.sub.3 A-471 [00653] CH.sub.2F OCH.sub.3 A-472 [00654] CH.sub.2F OCH.sub.3 A-473 C.sub.6H.sub.5 CH.sub.2F OCH.sub.3 A-474 CH.sub.2C.sub.6H.sub.5 CH.sub.2F OCH.sub.3 A-475 2-py CH.sub.2F OCH.sub.3 A-476 [00655] CH.sub.2F OCH.sub.3 A-477 [00656] CH.sub.2F OCH.sub.3 A-478 [00657] CH.sub.2F OCH.sub.3 A-479 [00658] CH.sub.2F OCH.sub.3 A-480 [00659] CH.sub.2F OCH.sub.3 A-481 CH.sub.3 CHF.sub.2 OCH.sub.3 A-482 CH.sub.2F CHF.sub.2 OCH.sub.3 A-483 CHF.sub.2 CHF.sub.2 OCH.sub.3 A-484 CH.sub.2CH.sub.3 CHF.sub.2 OCH.sub.3 A-485 CF.sub.3 CHF.sub.2 OCH.sub.3 A-486 [00660] CHF.sub.2 OCH.sub.3 A-487 [00661] CHF.sub.2 OCH.sub.3 A-488 C.sub.6H.sub.5 CHF.sub.2 OCH.sub.3 A-489 CH.sub.2C.sub.6H.sub.5 CHF.sub.2 OCH.sub.3 A-490 2-py CHF.sub.2 OCH.sub.3 A-491 [00662] CHF.sub.2 OCH.sub.3 A-492 [00663] CHF.sub.2 OCH.sub.3 A-493 [00664] CHF.sub.2 OCH.sub.3 A-494 [00665] CHF.sub.2 OCH.sub.3 A-495 [00666] CHF.sub.2 OCH.sub.3 A-496 CH.sub.3 CF.sub.3 OCH.sub.3 A-497 CH.sub.2F CF.sub.3 OCH.sub.3 A-498 CHF.sub.2 CF.sub.3 OCH.sub.3 A-499 CH.sub.2CH.sub.3 CF.sub.3 OCH.sub.3 A-500 CF.sub.3 CF.sub.3 OCH.sub.3 A-501 [00667] CF.sub.3 OCH.sub.3 A-502 [00668] CF.sub.3 OCH.sub.3 A-503 C.sub.6H.sub.5 CF.sub.3 OCH.sub.3 A-504 CH.sub.2C.sub.6H.sub.5 CF.sub.3 OCH.sub.3 A-505 2-py CF.sub.3 OCH.sub.3 A-506 [00669] CF.sub.3 OCH.sub.3 A-507 [00670] CF.sub.3 OCH.sub.3 A-508 [00671] CF.sub.3 OCH.sub.3 A-509 [00672] CF.sub.3 OCH.sub.3 A-510 [00673] CF.sub.3 OCH.sub.3 A-511 CH.sub.3 Cl OCH.sub.3 A-512 CH.sub.2F Cl OCH.sub.3 A-513 CHF.sub.2 Cl OCH.sub.3 A-514 CH.sub.2CH.sub.3 Cl OCH.sub.3 A-515 CF.sub.3 Cl OCH.sub.3 A-516 [00674] Cl OCH.sub.3 A-517 [00675] Cl OCH.sub.3 A-518 C.sub.6H.sub.5 Cl OCH.sub.3 A-519 CH.sub.2C.sub.6H.sub.5 Cl OCH.sub.3 A-520 2-py Cl OCH.sub.3 A-521 [00676] Cl OCH.sub.3 A-522 [00677] Cl OCH.sub.3 A-523 [00678] Cl OCH.sub.3 A-524 [00679] Cl OCH.sub.3 A-525 [00680] Cl OCH.sub.3 A-526 CH.sub.3 OCH.sub.3 OCH.sub.3 A-527 CH.sub.2F OCH.sub.3 OCH.sub.3 A-528 CHF.sub.2 OCH.sub.3 OCH.sub.3 A-529 CH.sub.2CH.sub.3 OCH.sub.3 OCH.sub.3 A-530 CF.sub.3 OCH.sub.3 OCH.sub.3 A-531 [00681] OCH.sub.3 OCH.sub.3 A-532 [00682] OCH.sub.3 OCH.sub.3 A-533 C.sub.6H.sub.5 OCH.sub.3 OCH.sub.3 A-534 CH.sub.2C.sub.6H.sub.5 OCH.sub.3 OCH.sub.3 A-535 2-py OCH.sub.3 OCH.sub.3 A-536 [00683] OCH.sub.3 OCH.sub.3 A-537 [00684] OCH.sub.3 OCH.sub.3 A-538 [00685] OCH.sub.3 OCH.sub.3 A-539 [00686] OCH.sub.3 OCH.sub.3 A-540 [00687] OCH.sub.3 OCH.sub.3

[0854] Accordingly, the present invention relates further to the process for the synthesis of compounds of the formula I of claim 1, comprising the a) step of reacting a compound B

##STR00688## [0855] wherein R.sup.3, R.sup.4, R.sup.7 and R.sup.8 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen; and [0856] Y is selected from the group consisting of [0857] H, [0858] S(O)yY.sup.1, [0859] wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 5-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy; and [0860] C(O)OY.sup.2, [0861] wherein Y.sup.2 is H, C.sub.1-C.sub.10-alkyl, C.sub.1-C.sub.10-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co, Cs, Fe, B, Al Ti, Zn or Pd; and [0862] S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup. [0863] wherein Y.sup.1 has the meanings mentioned above [0864] Y.sup.3 is C.sub.1-C.sub.4-alkyl [0865] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3; [0866] b) directly to compound of the formula I or optionally via compound of the formula II

##STR00689##

wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen.

[0867] Accordingly, the present invention relates further to the the intermediate compounds B

##STR00690## [0868] wherein [0869] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0870] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0871] R.sup.5 is halogen; [0872] R.sup.6 is halogen; [0873] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0874] Y is selected from the group consisting of H, [0875] S(O)yY.sup.1, [0876] wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 6-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy; and C(O)OY.sup.2, [0877] wherein Y.sup.2 is H, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co; Cs, Fe, B, Al Ti, Zn or Pd and their Cl salts and hydrooxides; and [0878] S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup. [0879] wherein Y.sup.1 has the meanings mentioned above [0880] Y.sup.3 is C.sub.1-C.sub.4-alkyl; [0881] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3; [0882] with the proviso that [0883] if YH, R.sup.5 and R.sup.6 can not be H; and [0884] if YC(O)OY.sup.2 and R.sup.5 and R.sup.6 are H, Y.sup.2 can not be C.sub.1-C.sub.6-alkyl and C.sub.1-C.sub.6-haloalkyl.

[0885] According to one embodiment the invention relates to the intermediate compounds B, wherein [0886] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0887] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0888] R.sup.5 is halogen; [0889] R.sup.6 is halogen; [0890] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0891] Y is H.

[0892] According to one further embodiment the invention relates to the intermediate compounds B, wherein [0893] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0894] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0895] R.sup.5 is hydrogen, [0896] R.sup.6 is hydrogen, [0897] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0898] Y is S(O)yY.sup.1, [0899] wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 5-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[0900] According to one embodiment the invention relates to the intermediate compounds B, wherein [0901] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0902] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0903] R.sup.5 is halogen, [0904] R.sup.6 is halogen, [0905] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0906] Y is S(O)yY.sup.1, [0907] wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 5-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 5-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[0908] According to one embodiment the invention relates to the intermediate compounds B, wherein [0909] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0910] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0911] R.sup.5 is hydrogen, [0912] R.sup.6 is hydrogen, [0913] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0914] Y is C(O)OY.sup.2, [0915] wherein Y.sup.2 is H, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co, Cs, Fe, B, Al Ti, Zn or Pd.

[0916] According to one embodiment the invention relates to the intermediate compounds B, wherein [0917] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0918] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0919] R.sup.5 is halogen, [0920] R.sup.6 is halogen, [0921] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0922] Y is C(O)OY.sup.2, [0923] wherein Y.sup.2 is H, C.sub.1-C.sub.6_alkyl, C.sub.1-C.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co, Cs, Fe, B, Al Ti, Zn or Pd.

[0924] According to one embodiment the invention relates to the intermediate compounds B, wherein [0925] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0926] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0927] R.sup.5 is hydrogen, [0928] R.sup.6 is hydrogen, [0929] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0930] Y is S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup. [0931] wherein Y.sup.1 has the meanings mentioned above [0932] Y.sup.3 is C.sub.1-C.sub.4-alkyl [0933] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3.

[0934] According to one embodiment the invention relates to the intermediate compounds B, wherein [0935] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0936] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [0937] R.sup.5 is hydrogen, [0938] R.sup.6 is hydrogen, [0939] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen; [0940] Y is S.sup.+(Y.sup.1)(Y.sup.3)(Y.sup.4).sup. [0941] wherein Y.sup.1 has the meanings mentioned above [0942] Y.sup.3 is C.sub.1-C.sub.4-alkyl [0943] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3.

[0944] According to one embodiment of formula B, R.sup.3 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[0945] According to still another embodiment of formula B, R.sup.3 is CH.sub.3.

[0946] According to still another embodiment of formula B, R.sup.3 is C.sub.2H.sub.5.

[0947] According to still another embodiment of formula B, R.sup.3 is C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0948] According to still another embodiment of formula B, R.sup.3 is CH.sub.2F.

[0949] According to still another embodiment of formula B, R.sup.3 is CHF.sub.2.

[0950] According to still another embodiment of formula B, R.sup.3 is CF.sub.3.

[0951] According to still another embodiment of formula B, R.sup.3 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[0952] According to one embodiment of formula B, R.sup.4 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[0953] According to still another embodiment of formula B, R.sup.4 is CH.sub.3.

[0954] According to still another embodiment of formula B, R.sup.4 is C.sub.2H.sub.5.

[0955] According to still another embodiment of formula B, R.sup.4 is C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[0956] According to still another embodiment of formula B, R.sup.4 is CH.sub.2F.

[0957] According to still another embodiment of formula B, R.sup.4 is CHF.sub.2.

[0958] According to still another embodiment of formula B, R.sup.4 is CF.sub.3.

[0959] According to still another embodiment of formula B, R.sup.4 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[0960] According to one embodiment of formula I B, R.sup.5 is Cl.

[0961] According to still another embodiment of formula B, R.sup.5 is Br.

[0962] According to still another embodiment of formula B, R.sup.5 is F.

[0963] According to still another embodiment of formula B, R.sup.5 is H.

[0964] According to one embodiment of formula B, R.sup.6 is Cl.

[0965] According to still another embodiment of formula B, R.sup.6 is Br.

[0966] According to still another embodiment of formula B, R.sup.6 is F.

[0967] According to still another embodiment of formula B, R.sup.6 is H.

[0968] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound together form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen.

[0969] According to one embodiment of formula B, R.sup.7 and R.sup.8 form phenyl.

[0970] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form phenyl substituted by F.

[0971] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 1-F-phenyl.

[0972] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 2-F-phenyl.

[0973] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 3-F-phenyl.

[0974] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 4-F-phenyl.

[0975] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form phenyl substituted by Br.

[0976] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 1-Br-phenyl.

[0977] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 2-Br-phenyl.

[0978] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 3-Br-phenyl.

[0979] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 4-Br-phenyl.

[0980] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form phenyl substituted by Cl.

[0981] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 1-Cl-phenyl.

[0982] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 2-Cl-phenyl.

[0983] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 3-Cl-phenyl.

[0984] According to still another embodiment of formula B, R.sup.7 and R.sup.8 form 4-Cl-phenyl. [0985] Y is selected from the group consisting of H, [0986] S(O)yY.sup.1, [0987] wherein y is 0, 1 or 2 and Y.sup.1 is phenyl, benzyl and 5- and 6-membered heteroaryl, wherein the heteroaryl contains one, two or three heteroatoms selected from N, O and S, and wherein phenyl, benzyl and 5- and 6-membered heteroaryl is unsubstituted or substituted by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy; and [0988] C(O)OY.sup.2, [0989] wherein Y.sup.2 is H, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Mg, Ca, Cu, Ni Co; Cs, Fe, B, Al Ti, Zn or Pd and their Cl salts and hydrooxides; and [0990] S.sup.+(Y.sup.1)(Y.sup.3)(Y.sup.4).sup. [0991] wherein Y.sup.1 has the meanings mentioned above [0992] Y.sup.3 is C.sub.1-C.sub.4-alkyl; [0993] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3.

[0994] According to one embodiment of formula B, Y is H.

[0995] Y can be S(O)yY.sup.1, where Y.sup.1 is C.sub.1-C.sub.4-alkyl such as SC.sub.2H.sub.5, S-n-C.sub.3H.sub.7, S-i-C.sub.3H.sub.7, S-n C.sub.4H.sub.9, S-i-C.sub.4H.sub.9, S-sec-C.sub.4H.sub.9, S-t-C.sub.4H.sub.9, SOCH.sub.3, SOC.sub.2H.sub.5, SO-n-C.sub.3H.sub.7, SO-i-C.sub.3H.sub.7, SO-n-C.sub.4H.sub.9, SO-i-C.sub.4H.sub.9, SO-sec-C.sub.4H.sub.9, SO-t-C.sub.4H.sub.9, SO.sub.2CH.sub.3, SO.sub.2C.sub.2H.sub.5, SO.sub.2-n-C.sub.3H.sub.7, SO.sub.2-i-C.sub.3H.sub.7, SO.sub.2-n-C.sub.4H.sub.9, SO.sub.2-i-C.sub.4H.sub.9, SO.sub.2-sec-C.sub.4H.sub.9, SO.sub.2-t-C.sub.4H.sub.9 According to still another embodiment of formula B, Y is SY.sup.1, wherein Y.sup.1 is phenyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[0996] According to still another embodiment of formula B, Y is selected from the group consisting of SC.sub.6H.sub.5, S-(o-FC.sub.6H.sub.4), S-(m-FC.sub.6H.sub.4), S-(p-FC.sub.6H.sub.4), S-(o-C.sub.1-C.sub.6H.sub.4), S-(m-C.sub.1-C.sub.6H.sub.4), S-(p-C.sub.1-C.sub.6H.sub.4), S(o-CH.sub.3C.sub.6H.sub.4), S-(m-CH.sub.3C.sub.6H.sub.4), S-(p-CH.sub.3C.sub.6H.sub.4), S-(o-OCH.sub.3C.sub.6H.sub.4), S-(m-OCH.sub.3C.sub.6H.sub.4), S-(p-OCH.sub.3C.sub.6H.sub.4), S-(o-NO.sub.2C.sub.6H.sub.4), S-(m-NO.sub.2C.sub.6H.sub.4), S-(p-NO.sub.2C.sub.6H.sub.4), preferably of SC.sub.6H.sub.5.

[0997] According to still another embodiment of formula B, Y is SOY.sup.1, wherein Y.sup.1 is phenyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[0998] According to still another embodiment of formula B, Y is selected from the group consisting of SOC.sub.6H.sub.5, SO-(o-FC.sub.6H.sub.4), SO-(m-FC.sub.6H.sub.4), SO-(p-FC.sub.6H.sub.4), SO-(o-C.sub.1-C.sub.6H.sub.4), SO-(m-C.sub.1-C.sub.6H.sub.4), SO(p-C.sub.1-C.sub.6H.sub.4), SO-(o-CH.sub.3C.sub.6H.sub.4), SO-(m-CH.sub.3C.sub.6H.sub.4), SO-(p-CH.sub.3C.sub.6H.sub.4), SO-(o-OCH.sub.3C.sub.6H.sub.4), SO(m-OCH.sub.3C.sub.6H.sub.4), SO-(p-OCH.sub.3C.sub.6H.sub.4), SO-(o-NO.sub.2C.sub.6H.sub.4), SO-(m-NO.sub.2C.sub.6H.sub.4), SO-(p-NO.sub.2C.sub.6H.sub.4), preferably of SOC.sub.6H.sub.5.

[0999] According to still another embodiment of formula B, Y is SO.sub.2Y.sup.1, wherein Y.sup.1 is phenyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[1000] According to still another embodiment of formula B, Y is selected from the group consisting of SO.sub.2C.sub.6H.sub.5, SO.sub.2-(o-FC.sub.6H.sub.4), SO.sub.2-(m-FC.sub.6H.sub.4), SO.sub.2-(p-FC.sub.6H.sub.4), SO.sub.2-(o-ClC.sub.6H.sub.4), SO.sub.2-(m-ClC.sub.6H.sub.4), SO.sub.2-(p-C.sub.1-C.sub.6H.sub.4), SO.sub.2-(o-CH.sub.3C.sub.6H.sub.4), SO.sub.2-(m-CH.sub.3C.sub.6H.sub.4), SO.sub.2-(p-CH.sub.3C.sub.6H.sub.4), SO.sub.2-(o- OCH.sub.3C.sub.6H.sub.4), SO.sub.2-(m-OCH.sub.3C.sub.6H.sub.4), SO.sub.2-(p-OCH.sub.3C.sub.6H.sub.4), SO.sub.2-(o-NO.sub.2C.sub.6H.sub.4), SO.sub.2-(m-NO.sub.2C.sub.6H.sub.4), SO.sub.2-(p-NO.sub.2C.sub.6H.sub.4), preferably of SO.sub.2C.sub.6H.sub.5.

[1001] According to still another embodiment of formula B, Y is SY.sup.1, wherein Y.sup.1 is benzyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[1002] According to still another embodiment of formula B, Y is selected from the group consisting of SC.sub.6H.sub.5, S-(o-F-benzyl), S-(m-F-benzyl), S-(p-F-benzyl), S-(o-Cl-benzyl), S-(m-Cl-benzyl), S-(p-Cl-benzyl), S-(o-CH.sub.3-benzyl), S-(m-CH.sub.3-benzyl), S-(p-CH.sub.3-benzyl), S-(o-OCH.sub.3-benzyl), S-(m-OCH.sub.3-benzyl), S-(p-OCH.sub.3-benzyl), S-(o-NO.sub.2-benzyl), S-(m-NO.sub.2-benzyl), S-(p-NO.sub.2-benzyl), preferably of S-benzyl.

[1003] According to still another embodiment of formula B; Y is SOY.sup.1, wherein Y.sup.1 is benzyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[1004] According to still another embodiment of formula B, Y is selected from the group consisting of SO-benzyl, SO-(o-F-benzyl), SO-(m-F-benzyl), SO-(p-F-benzyl), SO-(o-Cl-benzyl), SO-(m-Cl-benzyl), SO-(p-Cl-benzyl), SO-(o-CH.sub.3-benzyl), SO-(m-CH.sub.3-benzyl), SO-(p-CH.sub.3-benzyl), SO-(o-OCH.sub.3-benzyl), SO-(m-OCH.sub.3-benzyl), SO-(p-OCH.sub.3-benzyl), SO-(o-NO.sub.2-benzyl), SO-(m-NO.sub.2-benzyl), SO-(p-NO.sub.2-benzyl), preferably of SO-benzyl.

[1005] According to still another embodiment of formula B, Y is SO.sub.2Y.sup.1, wherein Y.sup.1 is benzyl which is unsubstituted or substituted by by CN, NO.sub.2, halogen, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-halogenalkyl, C.sub.1-C.sub.6-alkoxy.

[1006] According to still another embodiment of formula B, Y is selected from the group consisting of SO.sub.2-benzyl, SO.sub.2-(o-F-benzyl), SO.sub.2-(m-F-benzyl), SO.sub.2-(p-F-benzyl), SO.sub.2-(o-Cl-benzyl), SO.sub.2-(m-Cl-benzyl), SO.sub.2-(p-Cl-benzyl), SO.sub.2-(o-CH.sub.3-benzyl), SO.sub.2-(m-CH.sub.3-benzyl), SO.sub.2-(p-CH.sub.3-benzyl), SO.sub.2-(o-OCH.sub.3-benzyl), SO.sub.2-(m-OCH.sub.3-benzyl), SO.sub.2-(p-OCH.sub.3-benzyl), SO.sub.2-(o-NO.sub.2-benzyl), SO.sub.2-(m-NO.sub.2-benzyl), SO.sub.2-(p-NO.sub.2-benzyl), preferably of SO.sub.2-benzyl.

[1007] According to another embodiment of formula B, Y is C(O)OY.sup.2, [1008] wherein Y.sup.2 is H, C.sub.1-C.sub.6-alkyl, C.sub.1-C.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co; Cs, Fe, B, Al Ti, Zn or Pd. wherein Y.sup.2 is H, C.sub.1-C10.sub.6-alkyl, C.sub.1-C10.sub.6-haloalkyl, phenyl, benzyl, Na, K, Li, Mg, Ca, Cu, Ni Co; Cs, Fe, B, Al Ti, Zn or Pd and their Cl salts and hydrooxides.

[1009] According to one embodiment of formula B, Y.sup.2 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1010] According to still another embodiment of formula B, Y.sup.2 is CH.sub.3.

[1011] According to still another embodiment of formula B, Y.sup.2 is C.sub.2H.sub.5.

[1012] According to still another embodiment of formula B, Y.sup.2 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1013] According to still another embodiment of formula B, Y.sup.2 is CH.sub.2F.

[1014] According to still another embodiment of formula B, Y.sup.2 is CHF.sub.2.

[1015] According to still another embodiment of formula B, Y.sup.2 is CF.sub.3.

[1016] According to still another embodiment of formula B, Y.sup.2 is phenyl.

[1017] According to still another embodiment of formula B, Y.sup.2 is benzyl.

[1018] According to still another embodiment of formula B, Y.sup.2 is Mg and their Cl salts and hydrooxides.

[1019] According to still another embodiment of formula B, Y.sup.2 is Ca and their Cl salts and hydrooxides.

[1020] According to still another embodiment of formula B, Y.sup.2 is Cu and their Cl salts and hydrooxides.

[1021] According to still another embodiment of formula B, Y.sup.2 is Ni and their Cl salts and hydrooxides.

[1022] According to still another embodiment of formula B, Y.sup.2 is Co and their Cl salts and hydrooxides.

[1023] According to still another embodiment of formula B; Y.sup.2 is Cs and their Cl salts and hydrooxides.

[1024] According to still another embodiment of formula B, Y.sup.2 is Fe and their Cl salts and hydrooxides.

[1025] According to still another embodiment of formula B, Y.sup.2 is B and their Cl salts and hydrooxides.

[1026] According to still another embodiment of formula B, Y.sup.2 is Al and their Cl salts and hydrooxides.

[1027] According to still another embodiment of formula B, Y.sup.2 is Ti and their Cl salts and hydrooxides.

[1028] According to still another embodiment of formula B, Y.sup.2 is Zn and their Cl salts and hydrooxides.

[1029] According to still another embodiment of formula B, Y.sup.2 is Pd and their Cl salts and hydrooxides.

[1030] According to still another embodiment of formula B, C(O)OY.sup.1 is selected from the group consisting of CO.sub.2CH.sub.3, CO.sub.2C.sub.2H.sub.5, CO.sub.2-(n-C.sub.3H.sub.7), CO.sub.2-(i-C.sub.3H.sub.7), CO.sub.2-(n-C.sub.4H.sub.9), CO.sub.2-(i-C.sub.4H.sub.9), CO.sub.2-(sec-C.sub.4H.sub.9), COO.sub.2-(t-C.sub.4H.sub.9), COO.sub.2-phenyl, COO.sub.2-benzyl, COOH, COOLi, COONa, COOK, (COO).sub.2Mg, COOMgCl, COOMgOH, (COO).sub.2Ca, COOCaCl, COOCaOH, (COO).sub.3B, (COO).sub.2BCl, (COO).sub.2BOH, COOBCl.sub.2, COOB(OH).sub.2, (COO).sub.3Al, (COO).sub.2AlCl, (COO).sub.2AlOH, COOAlCl.sub.2, COOAl(OH).sub.2, (COO).sub.4Ti, (COO).sub.3TiCl, (COO).sub.3TiOH, (COO).sub.2TiCl.sub.2, (COO).sub.2Ti(OH).sub.2, COOTiCl.sub.3, COOTi(OH).sub.3, (COO).sub.2Fe, COOFeCl, COOFeOH, (COO).sub.3Fe, (COO).sub.2FeCl, (COO).sub.2FeOH, COOFeCl.sub.2, COOFe(OH).sub.2, (COO).sub.2Co, COOCoCl, COOCo(OH), (COO).sub.3COO, (COO).sub.2CoCl, (COO).sub.2Co(OH), COOCoCl.sub.2, COOCo(OH).sub.2, (COO).sub.2Ni, COONiCl, COONi(OH), COOCu, (COO).sub.2Cu, COOCuCl, COOCu(OH), (COO).sub.2Zn, COOZnCl, COOZn(OH), (COO).sub.2Pd, COOPdCl, COOPd(OH); preferably selected from the group consisting of CO.sub.2CH.sub.3, CO.sub.2C.sub.2H.sub.5, CO.sub.2-(n-C.sub.3H.sub.7), CO.sub.2-(i-C.sub.3H.sub.7), CO.sub.2-(n-C.sub.4H.sub.9), CO.sub.2-(i-C.sub.4H.sub.9), CO.sub.2-(sec-C.sub.4H.sub.9), CO.sub.2-(t-C.sub.4H.sub.9), COOH, COOLi, COONa, COOK, COOCu, (COO).sub.2Cu, COOCuCl, COOCu(OH).

[1031] According to still another embodiment of formula B, Y is S.sup.+(Y.sup.1)(Y.sup.3) (Y.sup.4).sup., wherein [1032] Y.sup.1 has the meanings mentioned above [1033] Y.sup.3 is C.sub.1-C.sub.4-alkyl; [1034] Y.sup.4 is halogen, CH.sub.3SO.sub.3, CF.sub.3SO.sub.3, Y.sup.3OSO.sub.2O 4-CH.sub.3C.sub.6H.sub.4SO.sub.3.

[1035] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(CH.sub.3).sub.2, S.sup.+(CH.sub.3)C.sub.2H.sub.5, S.sup.+(CH.sub.3)-n-C.sub.3H.sub.7, S.sup.+(CH.sub.3)-i-C.sub.3H.sub.7, S.sup.+(CH.sub.3)-n C.sub.4H.sub.9, S.sup.+(CH.sub.3)-i-C.sub.4H.sub.9, S.sup.+(CH.sub.3)-sec-C.sub.4H.sub.9, S.sup.+(CH.sub.3)-t-C.sub.4H.sub.9.

[1036] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(C.sub.2H.sub.5).sub.2, S.sup.+(C.sub.2H.sub.5)-n-C.sub.3H.sub.7, S.sup.+(C.sub.2H.sub.5)-i-C.sub.3H.sub.7, S.sup.+(C.sub.2H.sub.5)-n C.sub.4H.sub.9, S.sup.+(C.sub.2H.sub.5)-i-C.sub.4H.sub.9, S.sup.+(C.sub.2H.sub.5)-sec-C.sub.4H.sub.9, S.sup.+(C.sub.2H.sub.5)-t-C.sub.4H.sub.9.

[1037] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(CH.sub.3)C.sub.6H.sub.5, S.sup.+(CH.sub.3)-(o-FC.sub.6H.sub.4), S.sup.+(CH.sub.3)-(m-FC.sub.6H.sub.4), S.sup.+(CH.sub.3)-(p-FC.sub.6H.sub.4), S.sup.+(CH.sub.3)-(o-ClC.sub.6H.sub.4), S.sup.+(CH.sub.3)-(m-C.sub.1-C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(p-C.sub.1-C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(o-CH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)- (m-CH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(p-CH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)(OOCH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(m-OCH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(p-OCH.sub.3C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(o-NO.sub.2C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(m-NO.sub.2C.sub.6H.sub.4), S.sup.+(CH.sub.3)-(p-NO.sub.2C.sub.6H.sub.4).

[1038] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5, S.sup.+(C.sub.2H.sub.5)-(o-FC.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(m-FC.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(p-FC.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(o-C.sub.1-C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(m-C.sub.1-C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(p-ClC.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(o-CH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(m-CH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(p-CH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(o-OCH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(m-OCH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(p-OCH.sub.3C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(o-NO.sub.2C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(m-NO.sub.2C.sub.6H.sub.4), S.sup.+(C.sub.2H.sub.5)-(p-NO.sub.2C.sub.6H.sub.4).

[1039] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(CH.sub.3)-benzyl, S.sup.+(CH.sub.3)-(o-F-benzyl), S.sup.+(CH.sub.3)-(m-F-benzyl), S.sup.+(CH.sub.3)-(p-F-benzyl), S.sup.+(CH.sub.3)-(o-Cl-benzyl), S.sup.+(CH.sub.3)-(m-Cl-benzyl), S.sup.+(CH.sub.3)-(p-Cl-benzyl), S.sup.+(CH.sub.3)-(o-CH.sub.3-benzyl), S.sup.+(CH.sub.3)-(m-CH.sub.3-benzyl), S.sup.+(CH.sub.3)-(p-CH.sub.3-benzyl), S.sup.+(CH.sub.3)-(o-OCH.sub.3-benzyl), S.sup.+(CH.sub.3)-(m-OCH.sub.3-benzyl), S.sup.+(CH.sub.3)-(p-OCH.sub.3-benzyl), S.sup.+(CH.sub.3)-(o-NO.sub.2-benzyl), S.sup.+(CH.sub.3)-(m-NO.sub.2-benzyl), S.sup.+(CH.sub.3)-(p-NO.sub.2-benzyl).

[1040] According to still another embodiment of formula B, Y is selected from the group consisting of S.sup.+(C.sub.2H.sub.5)-benzyl, S.sup.+(C.sub.2H.sub.5)-(o-F-benzyl), S.sup.+(C.sub.2H.sub.5)-(m-F-benzyl), S.sup.+(C.sub.2H.sub.5)-(p-F-benzyl), S.sup.+(C.sub.2H.sub.5)(o-Cl-benzyl), S(C.sub.2H.sub.5)-(m-Cl-benzyl), S.sup.+(C.sub.2H)-(p-Cl-benzyl), S.sup.+(C.sub.2H.sub.5)-(o-CH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(m-CH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(p-CH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(o-OCH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(m-OCH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(p-OCH.sub.3-benzyl), S.sup.+(C.sub.2H.sub.5)-(o-NO.sub.2-benzyl), S.sup.+(C.sub.2H.sub.5)-(m-NO.sub.2-benzyl), S.sup.+(C.sub.2H.sub.5)-(p-NO.sub.2-benzyl).

[1041] Particular embodiments of the compounds B are the following compounds: B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8 and B-9. In these formulae, the substituents Y, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently as defined in claim 1 or preferably defined below:

##STR00691##

[1042] Table 2-1 Compounds of the formula B-1, B-2, B-3, B-4, B-5, B-6, B-7, B-8 and B-9 the meaning for the combination of Y, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 for each individual compound corresponds in each case to one line of Table B (compounds B-1.2-1.B-1 to B-1.2-1.B-540, compounds B-2.2-1.B-1 to B-2.2-1.B-540, compounds B-3.2-1.B-1 to B-3.2-1.B-540, compounds B-4.2-1.B-1 to B-4.2-1.B-540, compounds B-5.2-1.B-1 to B-5.2-1.B-540, compounds B-6.2-1.B-1 to B-6.2-1.B-540, compounds B-7.2-1.B-1 to B-7.2-1.B-540, compounds B-8.2-1.B-1 to B-8.2-1.B-540, compounds B-9.2-1.B-1 to B-9.2-1.B-540).

TABLE-US-00012 TABLE B No. R.sup.3 R.sup.4 R.sup.5 R.sup.6 Y B-1 CH.sub.3 CH.sub.3 F F H B-2 CH.sub.3 C.sub.2H.sub.5 F F H B-3 C.sub.2H.sub.5 C.sub.2H.sub.5 F F H B-4 CH.sub.3 CH.sub.3 Cl F H B-5 C.sub.2H.sub.5 CH.sub.3 Cl F H B-6 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F H B-7 CH.sub.3 CH.sub.3 Cl Cl H B-8 C.sub.2H.sub.5 CH.sub.3 Cl Cl H B-9 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl H B-10 CH.sub.3 CH.sub.3 H H H B-11 CH.sub.3 C.sub.2H.sub.5 H H H B-12 C.sub.2H.sub.5 C.sub.2H.sub.5 H H H B-13 CH.sub.3 CH.sub.3 Br Br H B-14 CH.sub.3 C.sub.2H.sub.5 Br Br H B-15 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br H B-16 CH.sub.3 CH.sub.3 F F SCH.sub.3 B-17 CH.sub.3 C.sub.2H.sub.5 F F SCH.sub.3 B-18 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SCH.sub.3 B-19 CH.sub.3 CH.sub.3 Cl F SCH.sub.3 B-20 C.sub.2H.sub.5 CH.sub.3 Cl F SCH.sub.3 B-21 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SCH.sub.3 B-22 CH.sub.3 CH.sub.3 Cl Cl SCH.sub.3 B-23 C.sub.2H.sub.5 CH.sub.3 Cl Cl SCH.sub.3 B-24 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SCH.sub.3 B-25 CH.sub.3 CH.sub.3 H H SCH.sub.3 B-26 CH.sub.3 C.sub.2H.sub.5 H H SCH.sub.3 B-27 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SCH.sub.3 B-28 CH.sub.3 CH.sub.3 Br Br SCH.sub.3 B-29 CH.sub.3 C.sub.2H.sub.5 Br Br SCH.sub.3 B-30 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SCH.sub.3 B-31 CH.sub.3 CH.sub.3 F F SC.sub.2H.sub.5 B-32 CH.sub.3 C.sub.2H.sub.5 F F SC.sub.2H.sub.5 B-33 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SC.sub.2H.sub.5 B-34 CH.sub.3 CH.sub.3 Cl F SC.sub.2H.sub.5 B-35 C.sub.2H.sub.5 CH.sub.3 Cl F SC.sub.2H.sub.5 B-36 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SC.sub.2H.sub.5 B-37 CH.sub.3 CH.sub.3 Cl Cl SC.sub.2H.sub.5 B-38 C.sub.2H.sub.5 CH.sub.3 Cl Cl SC.sub.2H.sub.5 B-39 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SC.sub.2H.sub.5 B-40 CH.sub.3 CH.sub.3 H H SC.sub.2H.sub.5 B-41 CH.sub.3 C.sub.2H.sub.5 H H SC.sub.2H.sub.5 B-42 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SC.sub.2H.sub.5 B-43 CH.sub.3 CH.sub.3 Br Br SC.sub.2H.sub.5 B-44 CH.sub.3 C.sub.2H.sub.5 Br Br SC.sub.2H.sub.5 B-45 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SC.sub.2H.sub.5 B-46 CH.sub.3 CH.sub.3 F F SOCH.sub.3 B-47 CH.sub.3 C.sub.2H.sub.5 F F SOCH.sub.3 B-48 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SOCH.sub.3 B-49 CH.sub.3 CH.sub.3 Cl F SOCH.sub.3 B-50 C.sub.2H.sub.5 CH.sub.3 Cl F SOCH.sub.3 B-51 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SOCH.sub.3 B-52 CH.sub.3 CH.sub.3 Cl Cl SOCH.sub.3 B-53 C.sub.2H.sub.5 CH.sub.3 Cl Cl SOCH.sub.3 B-54 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SOCH.sub.3 B-55 CH.sub.3 CH.sub.3 H H SOCH.sub.3 B-56 CH.sub.3 C.sub.2H.sub.5 H H SOCH.sub.3 B-57 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SOCH.sub.3 B-58 CH.sub.3 CH.sub.3 Br Br SOCH.sub.3 B-59 CH.sub.3 C.sub.2H.sub.5 Br Br SOCH.sub.3 B-60 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SOCH.sub.3 B-61 CH.sub.3 CH.sub.3 F F SOC.sub.2H.sub.5 B-62 CH.sub.3 C.sub.2H.sub.5 F F SOC.sub.2H.sub.5 B-63 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SOC.sub.2H.sub.5 B-64 CH.sub.3 CH.sub.3 Cl F SOC.sub.2H.sub.5 B-65 C.sub.2H.sub.5 CH.sub.3 Cl F SOC.sub.2H.sub.5 B-66 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SOC.sub.2H.sub.5 B-67 CH.sub.3 CH.sub.3 Cl Cl SOC.sub.2H.sub.5 B-68 C.sub.2H.sub.5 CH.sub.3 Cl Cl SOC.sub.2H.sub.5 B-69 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SOC.sub.2H.sub.5 B-70 CH.sub.3 CH.sub.3 H H SOC.sub.2H.sub.5 B-71 CH.sub.3 C.sub.2H.sub.5 H H SOC.sub.2H.sub.5 B-72 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SOC.sub.2H.sub.5 B-73 CH.sub.3 CH.sub.3 Br Br SOC.sub.2H.sub.5 B-74 CH.sub.3 C.sub.2H.sub.5 Br Br SOC.sub.2H.sub.5 B-75 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SOC.sub.2H.sub.5 B-76 CH.sub.3 CH.sub.3 F F SO.sub.2CH.sub.3 B-77 CH.sub.3 C.sub.2H.sub.5 F F SO.sub.2CH.sub.3 B-78 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SO.sub.2CH.sub.3 B-79 CH.sub.3 CH.sub.3 Cl F SO.sub.2CH.sub.3 B-80 C.sub.2H.sub.5 CH.sub.3 Cl F SO.sub.2CH.sub.3 B-81 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SO.sub.2CH.sub.3 B-82 CH.sub.3 CH.sub.3 Cl Cl SO.sub.2CH.sub.3 B-83 C.sub.2H.sub.5 CH.sub.3 Cl Cl SO.sub.2CH.sub.3 B-84 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SO.sub.2CH.sub.3 B-85 CH.sub.3 CH.sub.3 H H SO.sub.2CH.sub.3 B-86 CH.sub.3 C.sub.2H.sub.5 H H SO.sub.2CH.sub.3 B-87 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SO.sub.2CH.sub.3 B-88 CH.sub.3 CH.sub.3 F F SO.sub.2C.sub.2H.sub.5 B-89 CH.sub.3 CH.sub.3 Br Br SO.sub.2CH.sub.3 B-90 CH.sub.3 C.sub.2H.sub.5 Br Br SO.sub.2CH.sub.3 B-91 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SO.sub.2CH.sub.3 B-92 CH.sub.3 C.sub.2H.sub.5 F F SO.sub.2C.sub.2H.sub.5 B-93 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SO.sub.2C.sub.2H.sub.5 B-94 CH.sub.3 CH.sub.3 Cl F SO.sub.2C.sub.2H.sub.5 B-95 C.sub.2H.sub.5 CH.sub.3 Cl F SO.sub.2C.sub.2H.sub.5 B-96 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SO.sub.2C.sub.2H.sub.5 B-97 CH.sub.3 CH.sub.3 Cl Cl SO.sub.2C.sub.2H.sub.5 B-98 C.sub.2H.sub.5 CH.sub.3 Cl Cl SO.sub.2C.sub.2H.sub.5 B-99 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SO.sub.2C.sub.2H.sub.5 B-100 CH.sub.3 CH.sub.3 H H SO.sub.2C.sub.2H.sub.5 B-101 CH.sub.3 C.sub.2H.sub.5 H H SO.sub.2C.sub.2H.sub.5 B-102 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SO.sub.2C.sub.2H.sub.5 B-103 CH.sub.3 CH.sub.3 Br Br SO.sub.2C.sub.2H.sub.5 B-104 CH.sub.3 C.sub.2H.sub.5 Br Br SO.sub.2C.sub.2H.sub.5 B-105 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SO.sub.2C.sub.2H.sub.5 B-106 CH.sub.3 CH.sub.3 F F SC.sub.6H.sub.5 B-107 CH.sub.3 C.sub.2H.sub.5 F F SC.sub.6H.sub.5 B-108 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SC.sub.6H.sub.5 B-109 CH.sub.3 CH.sub.3 Cl F SC.sub.6H.sub.5 B-110 C.sub.2H.sub.5 CH.sub.3 Cl F SC.sub.6H.sub.5 B-111 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SC.sub.6H.sub.5 B-112 CH.sub.3 CH.sub.3 Cl Cl SC.sub.6H.sub.5 B-113 C.sub.2H.sub.5 CH.sub.3 Cl Cl SC.sub.6H.sub.5 B-114 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SC.sub.6H.sub.5 B-115 CH.sub.3 CH.sub.3 H H SC.sub.6H.sub.5 B-116 CH.sub.3 C.sub.2H.sub.5 H H SC.sub.6H.sub.5 B-117 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SC.sub.6H.sub.5 B-118 CH.sub.3 CH.sub.3 Br Br SC.sub.6H.sub.5 B-119 CH.sub.3 C.sub.2H.sub.5 Br Br SC.sub.6H.sub.5 B-120 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SC.sub.6H.sub.5 B-121 CH.sub.3 CH.sub.3 F F SOC.sub.6H.sub.5 B-122 CH.sub.3 C.sub.2H.sub.5 F F SOC.sub.6H.sub.5 B-123 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SOC.sub.6H.sub.5 B-124 CH.sub.3 CH.sub.3 Cl F SOC.sub.6H.sub.5 B-125 C.sub.2H.sub.5 CH.sub.3 Cl F SOC.sub.6H.sub.5 B-126 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SOC.sub.6H.sub.5 B-127 CH.sub.3 CH.sub.3 Cl Cl SOC.sub.6H.sub.5 B-128 C.sub.2H.sub.5 CH.sub.3 Cl Cl SOC.sub.6H.sub.5 B-129 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SOC.sub.6H.sub.5 B-130 CH.sub.3 CH.sub.3 H H SOC.sub.6H.sub.5 B-131 CH.sub.3 C.sub.2H.sub.5 H H SOC.sub.6H.sub.5 B-132 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SOC.sub.6H.sub.5 B-133 CH.sub.3 CH.sub.3 Br Br SOC.sub.6H.sub.5 B-134 CH.sub.3 C.sub.2H.sub.5 Br Br SOC.sub.6H.sub.5 B-135 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SOC.sub.6H.sub.5 B-136 CH.sub.3 CH.sub.3 F F SO.sub.2C.sub.6H.sub.5 B-137 CH.sub.3 C.sub.2H.sub.5 F F SO.sub.2C.sub.6H.sub.5 B-138 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SO.sub.2C.sub.6H.sub.5 B-139 CH.sub.3 CH.sub.3 Cl F SO.sub.2C.sub.6H.sub.5 B-140 C.sub.2H.sub.5 CH.sub.3 Cl F SO.sub.2C.sub.6H.sub.5 B-141 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SO.sub.2C.sub.6H.sub.5 B-142 CH.sub.3 CH.sub.3 Cl Cl SO.sub.2C.sub.6H.sub.5 B-143 C.sub.2H.sub.5 CH.sub.3 Cl Cl SO.sub.2C.sub.6H.sub.5 B-144 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SO.sub.2C.sub.6H.sub.5 B-145 CH.sub.3 CH.sub.3 H H SO.sub.2C.sub.6H.sub.5 B-146 CH.sub.3 C.sub.2H.sub.5 H H SO.sub.2C.sub.6H.sub.5 B-147 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SO.sub.2C.sub.6H.sub.5 B-148 CH.sub.3 CH.sub.3 Br Br SO.sub.2C.sub.6H.sub.5 B-149 CH.sub.3 C.sub.2H.sub.5 Br Br SO.sub.2C.sub.6H.sub.5 B-150 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br B-151 CH.sub.3 CH.sub.3 F F S-benzyl B-152 CH.sub.3 C.sub.2H.sub.5 F F S-benzyl B-153 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S-benzyl B-154 CH.sub.3 CH.sub.3 Cl F S-benzyl B-155 C.sub.2H.sub.5 CH.sub.3 Cl F S-benzyl B-156 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S-benzyl B-157 CH.sub.3 CH.sub.3 Cl Cl S-benzyl B-158 C.sub.2H.sub.5 CH.sub.3 Cl Cl S-benzyl B-159 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S-benzyl B-160 CH.sub.3 CH.sub.3 H H S-benzyl B-161 CH.sub.3 C.sub.2H.sub.5 H H S-benzyl B-162 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S-benzyl B-163 CH.sub.3 CH.sub.3 Br Br S-benzyl B-164 CH.sub.3 C.sub.2H.sub.5 Br Br S-benzyl B-165 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S-benzyl B-166 CH.sub.3 CH.sub.3 F F SO-benzyl B-167 CH.sub.3 C.sub.2H.sub.5 F F SO-benzyl B-168 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SO-benzyl B-169 CH.sub.3 CH.sub.3 Cl F SO-benzyl B-170 C.sub.2H.sub.5 CH.sub.3 Cl F SO-benzyl B-171 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SO-benzyl B-172 CH.sub.3 CH.sub.3 Cl Cl SO-benzyl B-173 C.sub.2H.sub.5 CH.sub.3 Cl Cl SO-benzyl B-174 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SO-benzyl B-175 CH.sub.3 CH.sub.3 H H SO-benzyl B-176 CH.sub.3 C.sub.2H.sub.5 H H SO-benzyl B-177 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SO-benzyl B-178 CH.sub.3 CH.sub.3 Br Br SO-benzyl B-179 CH.sub.3 C.sub.2H.sub.5 Br Br SO-benzyl B-180 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SO-benzyl B-181 CH.sub.3 CH.sub.3 F F SO.sub.2-benzyl B-182 CH.sub.3 C.sub.2H.sub.5 F F SO.sub.2-benzyl B-183 C.sub.2H.sub.5 C.sub.2H.sub.5 F F SO.sub.2-benzyl B-184 CH.sub.3 CH.sub.3 Cl F SO.sub.2-benzyl B-185 C.sub.2H.sub.5 CH.sub.3 Cl F SO.sub.2-benzyl B-186 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F SO.sub.2-benzyl B-187 CH.sub.3 CH.sub.3 Cl Cl SO.sub.2-benzyl B-188 C.sub.2H.sub.5 CH.sub.3 Cl Cl SO.sub.2-benzyl B-189 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl SO.sub.2-benzyl B-190 CH.sub.3 CH.sub.3 H H SO.sub.2-benzyl B-191 CH.sub.3 C.sub.2H.sub.5 H H SO.sub.2-benzyl B-192 C.sub.2H.sub.5 C.sub.2H.sub.5 H H SO.sub.2-benzyl B-193 CH.sub.3 CH.sub.3 Br Br SO.sub.2-benzyl B-194 CH.sub.3 C.sub.2H.sub.5 Br Br SO.sub.2-benzyl B-195 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br SO.sub.2-benzyl B-196 CH.sub.3 CH.sub.3 F F S.sup.+(CH.sub.3).sub.2 B-197 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3).sub.2 B-198 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3).sub.2 B-199 CH.sub.3 CH.sub.3 Cl F S.sup.+(CH.sub.3).sub.2 B-200 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(CH.sub.3).sub.2 B-201 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(CH.sub.3).sub.2 B-202 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(CH.sub.3).sub.2 B-203 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(CH.sub.3).sub.2 B-204 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(CH.sub.3).sub.2 B-205 CH.sub.3 CH.sub.3 H H S.sup.+(CH.sub.3).sub.2 B-206 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3).sub.2 B-207 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3).sub.2 B-208 CH.sub.3 CH.sub.3 Br Br S.sup.+(CH.sub.3).sub.2 B-209 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3).sub.2 B-210 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3).sub.2 B-211 CH.sub.3 CH.sub.3 F F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-212 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-213 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-214 CH.sub.3 CH.sub.3 Cl F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-215 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-216 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-217 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-218 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-219 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-220 CH.sub.3 CH.sub.3 H H S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-221 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-222 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-223 CH.sub.3 CH.sub.3 Br Br S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-224 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-225 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)C.sub.2H.sub.5 B-226 CH.sub.3 CH.sub.3 F F S.sup.+(C.sub.2H.sub.5).sub.2 B-227 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5).sub.2 B-228 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5).sub.2 B-229 CH.sub.3 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5).sub.2 B-230 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5).sub.2 B-231 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(C.sub.2H.sub.5).sub.2 B-232 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5).sub.2 B-233 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5).sub.2 B-234 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(C.sub.2H.sub.5).sub.2 B-235 CH.sub.3 CH.sub.3 H H S.sup.+(C.sub.2H.sub.5).sub.2 B-236 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5).sub.2 B-237 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5).sub.2 B-238 CH.sub.3 CH.sub.3 Br Br S.sup.+(C.sub.2H.sub.5).sub.2 B-239 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5).sub.2 B-240 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5).sub.2 B-241 CH.sub.3 CH.sub.3 F F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-242 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-243 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-244 CH.sub.3 CH.sub.3 Cl F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-245 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-246 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-247 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-248 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-249 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-250 CH.sub.3 CH.sub.3 H H S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-251 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-252 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-253 CH.sub.3 CH.sub.3 Br Br S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-254 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-255 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)C.sub.6H.sub.5 B-256 CH.sub.3 CH.sub.3 F F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-257 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-258 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-259 CH.sub.3 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-260 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-261 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-262 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-263 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-264 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-265 CH.sub.3 CH.sub.3 H H S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-266 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-267 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-268 CH.sub.3 CH.sub.3 Br Br S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-269 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-270 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5)C.sub.6H.sub.5 B-271 CH.sub.3 CH.sub.3 F F S.sup.+(CH.sub.3)-benzyl B-272 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)-benzyl B-273 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(CH.sub.3)-benzyl B-274 CH.sub.3 CH.sub.3 Cl F S.sup.+(CH.sub.3)-benzyl B-275 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(CH.sub.3)-benzyl B-276 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(CH.sub.3)-benzyl B-277 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)-benzyl B-278 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(CH.sub.3)-benzyl B-279 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(CH.sub.3)-benzyl B-280 CH.sub.3 CH.sub.3 H H S.sup.+(CH.sub.3)-benzyl B-281 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)-benzyl B-282 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(CH.sub.3)-benzyl B-283 CH.sub.3 CH.sub.3 Br Br S.sup.+(CH.sub.3)-benzyl B-284 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)-benzyl B-285 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(CH.sub.3)-benzyl B-286 CH.sub.3 CH.sub.3 F F S.sup.+(C.sub.2H.sub.5)-benzyl B-287 CH.sub.3 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5)-benzyl B-288 C.sub.2H.sub.5 C.sub.2H.sub.5 F F S.sup.+(C.sub.2H.sub.5)-benzyl B-289 CH.sub.3 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5)-benzyl B-290 C.sub.2H.sub.5 CH.sub.3 Cl F S.sup.+(C.sub.2H.sub.5)-benzyl B-291 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F S.sup.+(C.sub.2H.sub.5)-benzyl B-292 CH.sub.3 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5)-benzyl B-293 C.sub.2H.sub.5 CH.sub.3 Cl Cl S.sup.+(C.sub.2H.sub.5)-benzyl B-294 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl S.sup.+(C.sub.2H.sub.5)-benzyl B-295 CH.sub.3 CH.sub.3 H H S.sup.+(C.sub.2H.sub.5)-benzyl B-296 CH.sub.3 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5)-benzyl B-297 C.sub.2H.sub.5 C.sub.2H.sub.5 H H S.sup.+(C.sub.2H.sub.5)-benzyl B-298 CH.sub.3 CH.sub.3 Br Br S.sup.+(C.sub.2H.sub.5)-benzyl B-299 CH.sub.3 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5)-benzyl B-300 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br S.sup.+(C.sub.2H.sub.5)-benzyl B-301 CH.sub.3 CH.sub.3 F F CO.sub.2CH.sub.3 B-302 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2CH.sub.3 B-303 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2CH.sub.3 B-304 CH.sub.3 CH.sub.3 Cl F CO.sub.2CH.sub.3 B-305 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2CH.sub.3 B-306 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2CH.sub.3 B-307 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2CH.sub.3 B-308 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2CH.sub.3 B-309 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2CH.sub.3 B-310 CH.sub.3 CH.sub.3 H H CO.sub.2CH.sub.3 B-311 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2CH.sub.3 B-312 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2CH.sub.3 B-313 CH.sub.3 CH.sub.3 Br Br CO.sub.2CH.sub.3 B-314 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2CH.sub.3 B-315 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2CH.sub.3 B-316 CH.sub.3 CH.sub.3 F F CO.sub.2C.sub.2H.sub.5 B-317 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2C.sub.2H.sub.5 B-318 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2C.sub.2H.sub.5 B-319 CH.sub.3 CH.sub.3 Cl F CO.sub.2C.sub.2H.sub.5 B-320 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2C.sub.2H.sub.5 B-321 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2C.sub.2H.sub.5 B-322 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2C.sub.2H.sub.5 B-323 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2C.sub.2H.sub.5 B-324 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2C.sub.2H.sub.5 B-325 CH.sub.3 CH.sub.3 H H CO.sub.2C.sub.2H.sub.5 B-326 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2C.sub.2H.sub.5 B-327 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2C.sub.2H.sub.5 B-328 CH.sub.3 CH.sub.3 Br Br CO.sub.2C.sub.2H.sub.5 B-329 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2C.sub.2H.sub.5 B-330 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2C.sub.2H.sub.5 B-331 CH.sub.3 CH.sub.3 F F CO.sub.2(n-C.sub.3H.sub.7 B-332 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(n-C.sub.3H.sub.7 B-333 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(n-C.sub.3H.sub.7 B-334 CH.sub.3 CH.sub.3 Cl F CO.sub.2(n-C.sub.3H.sub.7 B-335 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(n-C.sub.3H.sub.7 B-336 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(n-C.sub.3H.sub.7 B-337 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(n-C.sub.3H.sub.7 B-338 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(n-C.sub.3H.sub.7 B-339 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(n-C.sub.3H.sub.7 B-340 CH.sub.3 CH.sub.3 H H CO.sub.2(n-C.sub.3H.sub.7 B-341 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(n-C.sub.3H.sub.7 B-342 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(n-C.sub.3H.sub.7 B-343 CH.sub.3 CH.sub.3 F F CO.sub.2(i-C.sub.3H.sub.7) B-344 CH.sub.3 CH.sub.3 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-345 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-346 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-347 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(i-C.sub.3H.sub.7) B-348 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(i-C.sub.3H.sub.7) B-349 CH.sub.3 CH.sub.3 Cl F CO.sub.2(i-C.sub.3H.sub.7) B-350 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(i-C.sub.3H.sub.7) B-351 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(i-C.sub.3H.sub.7) B-352 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(i-C.sub.3H.sub.7) B-353 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(i-C.sub.3H.sub.7) B-354 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(i-C.sub.3H.sub.7) B-355 CH.sub.3 CH.sub.3 H H CO.sub.2(i-C.sub.3H.sub.7) B-356 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(i-C.sub.3H.sub.7) B-357 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(i-C.sub.3H.sub.7) B-358 CH.sub.3 CH.sub.3 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-359 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-360 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.3H.sub.7) B-361 CH.sub.3 CH.sub.3 F F CO.sub.2(n-C.sub.4H.sub.9) B-362 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(n-C.sub.4H.sub.9) B-363 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(n-C.sub.4H.sub.9) B-364 CH.sub.3 CH.sub.3 Cl F CO.sub.2(n-C.sub.4H.sub.9) B-365 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(n-C.sub.4H.sub.9) B-366 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(n-C.sub.4H.sub.9) B-367 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(n-C.sub.4H.sub.9) B-368 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(n-C.sub.4H.sub.9) B-369 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(n-C.sub.4H.sub.9) B-370 CH.sub.3 CH.sub.3 H H CO.sub.2(n-C.sub.4H.sub.9) B-371 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(n-C.sub.4H.sub.9) B-372 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(n-C.sub.4H.sub.9) B-373 CH.sub.3 CH.sub.3 Br Br CO.sub.2(n-C.sub.4H.sub.9) B-374 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(n-C.sub.4H.sub.9) B-375 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(n-C.sub.4H.sub.9) B-376 CH.sub.3 CH.sub.3 F F CO.sub.2(i-C.sub.4H.sub.9) B-377 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(i-C.sub.4H.sub.9) B-378 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(i-C.sub.4H.sub.9) B-379 CH.sub.3 CH.sub.3 Cl F CO.sub.2(i-C.sub.4H.sub.9) B-380 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(i-C.sub.4H.sub.9) B-381 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(i-C.sub.4H.sub.9) B-382 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(i-C.sub.4H.sub.9) B-383 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(i-C.sub.4H.sub.9) B-384 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(i-C.sub.4H.sub.9) B-385 CH.sub.3 CH.sub.3 H H CO.sub.2(i-C.sub.4H.sub.9) B-386 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(i-C.sub.4H.sub.9) B-387 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(i-C.sub.4H.sub.9) B-388 CH.sub.3 CH.sub.3 Br Br CO.sub.2(i-C.sub.4H.sub.9) B-389 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.4H.sub.9) B-390 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(i-C.sub.4H.sub.9) B-391 CH.sub.3 CH.sub.3 F F CO.sub.2(sec-C.sub.4H.sub.9) B-392 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(sec-C.sub.4H.sub.9) B-393 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(sec-C.sub.4H.sub.9) B-394 CH.sub.3 CH.sub.3 Cl F CO.sub.2(sec-C.sub.4H.sub.9) B-395 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(sec-C.sub.4H.sub.9) B-396 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(sec-C.sub.4H.sub.9) B-397 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(sec-C.sub.4H.sub.9) B-398 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(sec-C.sub.4H.sub.9) B-399 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(sec-C.sub.4H.sub.9) B-400 CH.sub.3 CH.sub.3 H H CO.sub.2(sec-C.sub.4H.sub.9) B-401 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(sec-C.sub.4H.sub.9) B-402 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(sec-C.sub.4H.sub.9) B-403 CH.sub.3 CH.sub.3 Br Br CO.sub.2(sec-C.sub.4H.sub.9) B-404 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(sec-C.sub.4H.sub.9) B-405 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(sec-C.sub.4H.sub.9) B-406 CH.sub.3 CH.sub.3 F F CO.sub.2(t-C.sub.4H.sub.9) B-407 CH.sub.3 C.sub.2H.sub.5 F F CO.sub.2(t-C.sub.4H.sub.9) B-408 C.sub.2H.sub.5 C.sub.2H.sub.5 F F CO.sub.2(t-C.sub.4H.sub.9) B-409 CH.sub.3 CH.sub.3 Cl F CO.sub.2(t-C.sub.4H.sub.9) B-410 C.sub.2H.sub.5 CH.sub.3 Cl F CO.sub.2(t-C.sub.4H.sub.9) B-411 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F CO.sub.2(t-C.sub.4H.sub.9) B-412 CH.sub.3 CH.sub.3 Cl Cl CO.sub.2(t-C.sub.4H.sub.9) B-413 C.sub.2H.sub.5 CH.sub.3 Cl Cl CO.sub.2(t-C.sub.4H.sub.9) B-414 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl CO.sub.2(t-C.sub.4H.sub.9) B-415 CH.sub.3 CH.sub.3 H H CO.sub.2(t-C.sub.4H.sub.9) B-416 CH.sub.3 C.sub.2H.sub.5 H H CO.sub.2(t-C.sub.4H.sub.9) B-417 C.sub.2H.sub.5 C.sub.2H.sub.5 H H CO.sub.2(t-C.sub.4H.sub.9)) B-418 CH.sub.3 CH.sub.3 Br Br CO.sub.2(t-C.sub.4H.sub.9) B-419 CH.sub.3 C.sub.2H.sub.5 Br Br CO.sub.2(t-C.sub.4H.sub.9) B-420 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br CO.sub.2(t-C.sub.4H.sub.9) B-421 CH.sub.3 CH.sub.3 F F COOH B-422 CH.sub.3 C.sub.2H.sub.5 F F COOH B-423 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOH B-424 CH.sub.3 CH.sub.3 Cl F COOH B-425 C.sub.2H.sub.5 CH.sub.3 Cl F COOH B-426 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOH B-427 CH.sub.3 CH.sub.3 Cl Cl COOH B-428 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOH B-429 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOH B-430 CH.sub.3 CH.sub.3 H H COOH B-431 CH.sub.3 C.sub.2H.sub.5 H H COOH B-432 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOH B-433 CH.sub.3 CH.sub.3 Br Br COOH B-434 CH.sub.3 C.sub.2H.sub.5 Br Br COOH B-435 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOH B-436 CH.sub.3 CH.sub.3 F F COOLi B-437 CH.sub.3 C.sub.2H.sub.5 F F COOLi B-438 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOLi B-439 CH.sub.3 CH.sub.3 Cl F COOLi B-440 C.sub.2H.sub.5 CH.sub.3 Cl F COOLi B-441 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOLi B-442 CH.sub.3 CH.sub.3 Cl Cl COOLi B-443 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOLi B-444 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOLi B-445 CH.sub.3 CH.sub.3 H H COOLi B-446 CH.sub.3 C.sub.2H.sub.5 H H COOLi B-447 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOLi B-448 CH.sub.3 CH.sub.3 Br Br COOLi B-449 CH.sub.3 C.sub.2H.sub.5 Br Br COOLi B-450 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOLi B-451 CH.sub.3 CH.sub.3 F F COONa B-452 CH.sub.3 C.sub.2H.sub.5 F F COONa B-453 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COONa B-454 CH.sub.3 CH.sub.3 Cl F COONa B-455 C.sub.2H.sub.5 CH.sub.3 Cl F COONa B-456 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COONa B-457 CH.sub.3 CH.sub.3 Cl Cl COONa B-458 C.sub.2H.sub.5 CH.sub.3 Cl Cl COONa B-459 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COONa B-460 CH.sub.3 CH.sub.3 H H COONa B-461 CH.sub.3 C.sub.2H.sub.5 H H COONa B-462 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COONa B-463 CH.sub.3 CH.sub.3 Br Br COONa B-464 CH.sub.3 C.sub.2H.sub.5 Br Br COONa B-465 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COONa B-466 CH.sub.3 CH.sub.3 F F COOK B-467 CH.sub.3 C.sub.2H.sub.5 F F COOK B-468 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOK B-469 CH.sub.3 CH.sub.3 Cl F COOK B-470 C.sub.2H.sub.5 CH.sub.3 Cl F COOK B-471 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOK B-472 CH.sub.3 CH.sub.3 Cl Cl COOK B-473 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOK B-474 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOK B-475 CH.sub.3 CH.sub.3 H H COOK B-476 CH.sub.3 C.sub.2H.sub.5 H H COOK B-477 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOK B-478 CH.sub.3 CH.sub.3 Br Br COOK B-479 CH.sub.3 C.sub.2H.sub.5 Br Br COOK B-480 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOK B-481 CH.sub.3 CH.sub.3 F F COOCu B-482 CH.sub.3 C.sub.2H.sub.5 F F COOCu B-483 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOCu B-484 CH.sub.3 CH.sub.3 Cl F COOCu B-485 C.sub.2H.sub.5 CH.sub.3 Cl F COOCu B-486 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOCu B-487 CH.sub.3 CH.sub.3 Cl Cl COOCu B-488 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOCu B-489 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOCu B-490 CH.sub.3 CH.sub.3 H H COOCu B-491 CH.sub.3 C.sub.2H.sub.5 H H COOCu B-492 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOCu B-493 CH.sub.3 CH.sub.3 Br Br COOCu B-494 CH.sub.3 C.sub.2H.sub.5 Br Br COOCu B-495 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOCu B-496 CH.sub.3 CH.sub.3 F F (COO).sub.2Cu B-497 CH.sub.3 C.sub.2H.sub.5 F F (COO).sub.2Cu B-498 C.sub.2H.sub.5 C.sub.2H.sub.5 F F (COO).sub.2Cu B-499 CH.sub.3 CH.sub.3 Cl F (COO).sub.2Cu B-500 C.sub.2H.sub.5 CH.sub.3 Cl F (COO).sub.2Cu B-501 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F (COO).sub.2Cu B-502 CH.sub.3 CH.sub.3 Cl Cl (COO).sub.2Cu B-503 C.sub.2H.sub.5 CH.sub.3 Cl Cl (COO).sub.2Cu B-504 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl (COO).sub.2Cu B-505 CH.sub.3 CH.sub.3 H H (COO).sub.2Cu B-506 CH.sub.3 C.sub.2H.sub.5 H H (COO).sub.2Cu B-507 C.sub.2H.sub.5 C.sub.2H.sub.5 H H (COO).sub.2Cu B-508 CH.sub.3 CH.sub.3 Br Br (COO).sub.2Cu B-509 CH.sub.3 C.sub.2H.sub.5 Br Br (COO).sub.2Cu B-510 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br (COO).sub.2Cu B-511 CH.sub.3 CH.sub.3 F F COOCuCl B-512 CH.sub.3 C.sub.2H.sub.5 F F COOCuCl B-513 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOCuCl B-514 CH.sub.3 CH.sub.3 Cl F COOCuCl B-515 C.sub.2H.sub.5 CH.sub.3 Cl F COOCuCl B-516 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOCuCl B-517 CH.sub.3 CH.sub.3 Cl Cl COOCuCl B-518 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOCuCl B-519 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOCuCl B-520 CH.sub.3 CH.sub.3 H H COOCuCl B-521 CH.sub.3 C.sub.2H.sub.5 H H COOCuCl B-522 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOCuCl B-523 CH.sub.3 CH.sub.3 Br Br COOCuCl B-524 CH.sub.3 C.sub.2H.sub.5 Br Br COOCuCl B-525 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOCuCl B-526 CH.sub.3 CH.sub.3 F F COOCu(OH) B-527 CH.sub.3 C.sub.2H.sub.5 F F COOCu(OH) B-528 C.sub.2H.sub.5 C.sub.2H.sub.5 F F COOCu(OH) B-529 CH.sub.3 CH.sub.3 Cl F COOCu(OH) B-530 C.sub.2H.sub.5 CH.sub.3 Cl F COOCu(OH) B-531 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F COOCu(OH) B-532 CH.sub.3 CH.sub.3 Cl Cl COOCu(OH) B-533 C.sub.2H.sub.5 CH.sub.3 Cl Cl COOCu(OH) B-534 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl COOCu(OH) B-535 CH.sub.3 CH.sub.3 H H COOCu(OH B-536 CH.sub.3 C.sub.2H.sub.5 H H COOCu(OH B-537 C.sub.2H.sub.5 C.sub.2H.sub.5 H H COOCu(OH B-538 CH.sub.3 CH.sub.3 Br Br COOCu(OH B-539 CH.sub.3 C.sub.2H.sub.5 Br Br COOCu(OH B-540 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br COOCu(OH

[1043] Accordingly, the present invention relates further to the process for the synthesis of compounds of the formula I, comprising the step of [1044] a) reacting a compound C

##STR00692## [1045] wherein R.sup.3, R.sup.4, R.sup.7 and R.sup.8 are as defined in claim 1, [1046] R.sup.5 is halogen, and [1047] R.sup.6 is halogen, [1048] b) directly to compound of the formula I or optionally via compound of the formula II

##STR00693## [1049] wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen.

[1050] Accordingly, the present invention relates further to the intermediate compounds C

##STR00694## [1051] wherein [1052] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1053] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1054] R.sup.5 is halogen; [1055] R.sup.6 is halogen; [1056] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen.

[1057] According to one embodiment of formula C, R.sup.3 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1058] According to still another embodiment of formula C, R.sup.3 is CH.sub.3.

[1059] According to still another embodiment of formula C; R.sup.3 is C.sub.2H.sub.5.

[1060] According to still another embodiment of formula C; R.sup.3 is C.sub.1-C.sub.4-halogenalkylmore specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1061] According to still another embodiment of formula C, R.sup.3 is CH.sub.2F.

[1062] According to still another embodiment of formula C, R.sup.3 is CHF.sub.2.

[1063] According to still another embodiment of formula C, R.sup.3 is CF.sub.3.

[1064] According to still another embodiment of formula C, R.sup.3 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1065] According to one embodiment of formula C, R.sup.4 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1066] According to still another embodiment of formula C, R.sup.4 is CH.sub.3.

[1067] According to still another embodiment of formula C, R.sup.4 is C.sub.2H.sub.5.

[1068] According to still another embodiment of formula C, R.sup.4 is C.sub.1-C.sub.4-halogenalkylmore specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1069] According to still another embodiment of formula C, R.sup.4 is CH.sub.2F.

[1070] According to still another embodiment of formula C, R.sup.4 is CHF.sub.2.

[1071] According to still another embodiment of formula C, R.sup.4 is CF.sub.3.

[1072] According to still another embodiment of formula C, R.sup.4 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1073] According to one embodiment of formula C, R.sup.5 is Cl.

[1074] According to still another embodiment of formula C, R.sup.5 is Br.

[1075] According to still another embodiment of formula C, R.sup.5 is F.

[1076] According to one embodiment of formula C, R.sup.6 is Cl.

[1077] According to still another embodiment of formula C, R.sup.6 is Br.

[1078] According to still another embodiment of formula C, R.sup.6 is F.

[1079] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound together form a phenyl which is unsubstituted or substituted by R.sup.78 being halogen.

[1080] According to one embodiment of formula I, R.sup.7 and R.sup.8 form phenyl.

[1081] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form phenyl substituted by F.

[1082] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 1-F-phenyl.

[1083] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 2-F-phenyl.

[1084] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 3-F-phenyl.

[1085] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 4-F-phenyl.

[1086] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form phenyl substituted by Br.

[1087] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 1-Br-phenyl.

[1088] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 2-Br-phenyl.

[1089] According to still another embodiment of formula C; R.sup.7 and R.sup.8 form 3-Br-phenyl.

[1090] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 4-Br-phenyl.

[1091] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form phenyl substituted by Cl.

[1092] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 1-Cl-phenyl.

[1093] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 2-Cl-phenyl.

[1094] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 3-Cl-phenyl.

[1095] According to still another embodiment of formula C, R.sup.7 and R.sup.8 form 4-Cl-phenyl.

[1096] Particular embodiments of the compounds C are the following compounds: C-1,C-2, C-3, C-4, C-5, C-6, C-7,C-8 and C-9. In these formulae, the substituents R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently as defined in claim 1 or preferably defined below:

##STR00695## ##STR00696##

[1097] Table 3-1 Compounds of the formula C-1, C-2, C-3, C-4, C-5, C-6, C-7, C-8 and C-9 the meaning for the combination of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 for each individual compound corresponds in each case to one line of Table C (compounds C-1.3-1.C-1 to C-1.3-1.C-12, compounds C-2.3-1.C-1 to C-2.3-1.C-12, compounds C-3.3-1.C-1 to C-3.3-1.C-12, compounds C-4.3-1.C-1 to C-4.3-1.C-12, compounds C-5.3-1.C-1 to C-5.3-1.C-12, compounds C-6.3-1.C-1 to C-6.3-1.C-12, compounds C-7.3-1.-1 to C-7.3-1.C-12, compounds C-8.3-1.C-1 to C-8.3-1.C-12, compounds C-9.3-1.C-1 to C-9.3-1.C-12).

TABLE-US-00013 TABLE C No. R.sup.3 R.sup.4 R.sup.5 R.sup.6 C-1 CH.sub.3 CH.sub.3 F F C-2 CH.sub.3 C.sub.2H.sub.5 F F C-3 C.sub.2H.sub.5 C.sub.2H.sub.5 F F C-4 CH.sub.3 CH.sub.3 Cl F C-5 C.sub.2H.sub.5 CH.sub.3 Cl F C-6 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl F C-7 CH.sub.3 CH.sub.3 Cl Cl C-8 C.sub.2H.sub.5 CH.sub.3 Cl Cl C-9 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl C-10 CH.sub.3 CH.sub.3 H H C-11 CH.sub.3 C.sub.2H.sub.5 H H C-12 C.sub.2H.sub.5 C.sub.2H.sub.5 H H

[1098] Accordingly, the present invention relates further to the compounds II

##STR00697## [1099] wherein [1100] R.sup.1 is H; [1101] R.sup.2 is H; [1102] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1103] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1104] R.sup.5 is H; [1105] R.sup.6 is H; [1106] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being F or Cl; [1107] R.sup.9 is C.sub.1-C.sub.4-haloalkyl; [1108] R.sup.10 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy, [1109] with the proviso that R.sup.9 is not CF.sub.3 and CF.sub.2CF.sub.3.

[1110] According to one embodiment of formula II, R.sup.3 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1111] According to still another embodiment of formula II, R.sup.3 is CH.sub.3.

[1112] According to still another embodiment of formula II, R.sup.3 is C.sub.2H.sub.5.

[1113] According to still another embodiment of formula II, R.sup.3 is C.sub.1-C.sub.4-halogenalkylmore specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1114] According to still another embodiment of formula II, R.sup.3 is CH.sub.2F.

[1115] According to still another embodiment of formula II, R.sup.3 is CHF.sub.2.

[1116] According to still another embodiment of formula II, R.sup.3 is CF.sub.3.

[1117] According to still another embodiment of formula II, R.sup.3 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1118] According to one embodiment of formula II, R.sup.4 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1119] According to still another embodiment of formula II, R.sup.4 is CH.sub.3.

[1120] According to still another embodiment of formula II, R.sup.4 is C.sub.2H.sub.5.

[1121] According to still another embodiment of formula II, R.sup.4 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1122] According to still another embodiment of formula II, R.sup.4 is CH.sub.2F.

[1123] According to still another embodiment of formula II, R.sup.4 is CH F.sub.2.

[1124] According to still another embodiment of formula II, R.sup.4 is CF.sub.3.

[1125] According to still another embodiment of formula II, R.sup.4 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1126] According to still another embodiment of formula II, R.sup.9 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2, CH.sub.3CHF, CH.sub.3CF.sub.2 or CF.sub.2CHF.sub.2.

[1127] According to still another embodiment of formula II, R.sup.9 is CH.sub.2F.

[1128] According to still another embodiment of formula II, R.sup.9 is CHF.sub.2.

[1129] According to still another embodiment of formula II, R.sup.9 is CHCl.sub.2.

[1130] According to still another embodiment of formula II, R.sup.9 is CH.sub.2F, CHF.sub.2, CH.sub.2Cl, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl, CH.sub.3CHF, CH.sub.3CF.sub.2, CHCl.sub.2.

[1131] According to still another embodiment of formula II, R.sup.10 is CH.sub.3.

[1132] According to still another embodiment of formula II, R.sup.10 is C.sub.2H.sub.5.

[1133] According to still another embodiment of formula II, R.sup.10 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2, CH.sub.3CHF, CH.sub.3CF.sub.2 or CF.sub.2CHF.sub.2.

[1134] According to still another embodiment of formula II, R.sup.10 is CH.sub.2F.

[1135] According to still another embodiment of formula II, R.sup.10 is CHF.sub.2.

[1136] According to still another embodiment of formula II, R.sup.10 is CF.sub.3.

[1137] According to still another embodiment of formula II, R.sup.10 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl, CH.sub.3CHF, CH.sub.3CF.sub.2

[1138] According to a further specific embodiment of formula II, R.sup.10 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3, CH.sub.2CH.sub.3 or CH.sub.2OCH.sub.3.

[1139] According to a further specific embodiment of formula II, R.sup.10 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-alkoxy, such as CH.sub.2OCH.sub.3 or CH.sub.2OCH.sub.2CH.sub.3.

[1140] According to a further specific embodiment of formula II, R.sup.10 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCH F.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[1141] Particular embodiments of the compounds II are the following compounds: II-1, II-2, II-3, II-4, II-5, II-6, II-7, II-8 and II-9. In these formulae, the substituents R.sup.3, R.sup.4, R.sup.9 and R.sup.10 are independently as defined in claim 1 or preferably defined below:

##STR00698## ##STR00699##

[1142] Table 4-1 Compounds of the formula II-1, II-2, II-3, II-4, II-5, II-6, II-7, II-8 and II-9 in which the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds II-1.4-1.D-1 to II-1.4-1.D-216, compounds II-2.4-1.D-1 to II-2.4-1.D-216, compounds II-3.4-1.D-1 to II-3.4-1.D-216, compounds II-4.4-1.D-1 to II-4.4-1.D-216, compounds II-5.4-1.D-1 to II-5.4-1.D-216, compounds II-6.4-1.D-1 to II-6.4-1.D-216, compounds II-7.4-1.D-1 to II-7.4-1.D-216, compounds II-8.4-1.D-1 to II-8.4-1.D-216 compounds II-9.4-1.D-1 to II-9.4-1.D-216).

TABLE-US-00014 TABLE D No. R.sup.3 R.sup.4 R.sup.9 R.sup.10 D-1 CH.sub.3 CH.sub.3 Cl Cl D-2 C.sub.2H.sub.5 CH.sub.3 Cl Cl D-3 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Cl D-4 CH.sub.3 CH.sub.3 Br Cl D-5 C.sub.2H.sub.5 CH.sub.3 Br Cl D-6 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Cl D-7 CH.sub.3 CH.sub.3 CH.sub.3 Cl D-8 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 Cl D-9 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 Cl D-10 CH.sub.3 CH.sub.3 CH.sub.2F Cl D-11 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F Cl D-12 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F Cl D-13 CH.sub.3 CH.sub.3 CHF.sub.2 Cl D-14 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 Cl D-15 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 Cl D-16 CH.sub.3 CH.sub.3 OCH.sub.3 Cl D-17 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 Cl D-18 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 Cl D-19 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 Cl D-20 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl D-21 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl D-22 CH.sub.3 CH.sub.3 CHFCH.sub.3 Cl D-23 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 Cl D-24 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 Cl D-25 CH.sub.3 CH.sub.3 CHCl.sub.2 Cl D-26 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 Cl D-27 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 Cl D-28 CH.sub.3 CH.sub.3 Cl Br D-29 C.sub.2H.sub.5 CH.sub.3 Cl Br D-30 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl Br D-31 CH.sub.3 CH.sub.3 Br Br D-32 C.sub.2H.sub.5 CH.sub.3 Br Br D-33 C.sub.2H.sub.5 C.sub.2H.sub.5 Br Br D-34 CH.sub.3 CH.sub.3 CH.sub.3 Br D-35 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 Br D-36 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 Br D-37 CH.sub.3 CH.sub.3 CH.sub.2F Br D-38 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F Br D-39 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F Br D-40 CH.sub.3 CH.sub.3 CHF.sub.2 Br D-41 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 Br D-42 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 Br D-43 CH.sub.3 CH.sub.3 OCH.sub.3 Br D-44 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 Br D-45 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 Br D-46 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 Br D-47 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 Br D-48 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 Br D-49 CH.sub.3 CH.sub.3 CHFCH.sub.3 Br D-50 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 Br D-51 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 Br D-52 CH.sub.3 CH.sub.3 CHCl.sub.2 Br D-53 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 Br D-54 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 Br D-55 CH.sub.3 CH.sub.3 Cl CH.sub.3 D-56 C.sub.2H.sub.5 CH.sub.3 Cl CH.sub.3 D-57 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl CH.sub.3 D-58 CH.sub.3 CH.sub.3 Br CH.sub.3 D-59 C.sub.2H.sub.5 CH.sub.3 Br CH.sub.3 D-60 C.sub.2H.sub.5 C.sub.2H.sub.5 Br CH.sub.3 D-61 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.3 D-62 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 CH.sub.3 D-63 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 D-64 CH.sub.3 CH.sub.3 CH.sub.2F CH.sub.3 D-65 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F CH.sub.3 D-66 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F CH.sub.3 D-67 CH.sub.3 CH.sub.3 CHF.sub.2 CH.sub.3 D-68 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 CH.sub.3 D-69 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 CH.sub.3 D-70 CH.sub.3 CH.sub.3 OCH.sub.3 CH.sub.3 D-71 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 CH.sub.3 D-72 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 CH.sub.3 D-73 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 CH.sub.3 D-74 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 D-75 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 D-76 CH.sub.3 CH.sub.3 CHFCH.sub.3 CH.sub.3 D-77 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 CH.sub.3 D-78 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 CH.sub.3 D-79 CH.sub.3 CH.sub.3 CHCl.sub.2 CH.sub.3 D-80 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 CH.sub.3 D-81 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 CH.sub.3 D-82 CH.sub.3 CH.sub.3 Cl CH.sub.2F D-83 C.sub.2H.sub.5 CH.sub.3 Cl CH.sub.2F D-84 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl CH.sub.2F D-85 CH.sub.3 CH.sub.3 Br CH.sub.2F D-86 C.sub.2H.sub.5 CH.sub.3 Br CH.sub.2F D-87 C.sub.2H.sub.5 C.sub.2H.sub.5 Br CH.sub.2F D-88 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.2F D-89 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 CH.sub.2F D-90 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 CH.sub.2F D-91 CH.sub.3 CH.sub.3 CH.sub.2F CH.sub.2F D-92 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F CH.sub.2F D-93 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F CH.sub.2F D-94 CH.sub.3 CH.sub.3 CHF.sub.2 CH.sub.2F D-95 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 CH.sub.2F D-96 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 CH.sub.2F D-97 CH.sub.3 CH.sub.3 OCH.sub.3 CH.sub.2F D-98 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 CH.sub.2F D-99 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 CH.sub.2F D-100 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F D-101 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F D-102 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F D-103 CH.sub.3 CH.sub.3 CHFCH.sub.3 CH.sub.2F D-104 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 CH.sub.2F D-105 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 CH.sub.2F D-106 CH.sub.3 CH.sub.3 CHCl.sub.2 CH.sub.2F D-107 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 CH.sub.2F D-108 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 CH.sub.2F D-109 CH.sub.3 CH.sub.3 Cl CHF.sub.2 D-110 C.sub.2H.sub.5 CH.sub.3 Cl CHF.sub.2 D-111 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl CHF.sub.2 D-112 CH.sub.3 CH.sub.3 Br CHF.sub.2 D-113 C.sub.2H.sub.5 CH.sub.3 Br CHF.sub.2 D-114 C.sub.2H.sub.5 C.sub.2H.sub.5 Br CHF.sub.2 D-115 CH.sub.3 CH.sub.3 CH.sub.3 CHF.sub.2 D-116 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 CHF.sub.2 D-117 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 CHF.sub.2 D-118 CH.sub.3 CH.sub.3 CH.sub.2F CHF.sub.2 D-119 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F CHF.sub.2 D-120 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F CHF.sub.2 D-121 CH.sub.3 CH.sub.3 CHF.sub.2 CHF.sub.2 D-122 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 CHF.sub.2 D-123 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 CHF.sub.2 D-124 CH.sub.3 CH.sub.3 OCH.sub.3 CHF.sub.2 D-125 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 CHF.sub.2 D-126 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 CHF.sub.2 D-127 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 D-128 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 D-129 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 D-130 CH.sub.3 CH.sub.3 CHFCH.sub.3 CHF.sub.2 D-131 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 CHF.sub.2 D-132 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 CHF.sub.2 D-133 CH.sub.3 CH.sub.3 CHCl.sub.2 CHF.sub.2 D-134 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 CHF.sub.2 D-135 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 CHF.sub.2 D-136 CH.sub.3 CH.sub.3 Cl OCH.sub.3 D-137 C.sub.2H.sub.5 CH.sub.3 Cl OCH.sub.3 D-138 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl OCH.sub.3 D-139 CH.sub.3 CH.sub.3 Br OCH.sub.3 D-140 C.sub.2H.sub.5 CH.sub.3 Br OCH.sub.3 D-141 C.sub.2H.sub.5 C.sub.2H.sub.5 Br OCH.sub.3 D-142 CH.sub.3 CH.sub.3 CH.sub.3 OCH.sub.3 D-143 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 OCH.sub.3 D-144 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 OCH.sub.3 D-145 CH.sub.3 CH.sub.3 CH.sub.2F OCH.sub.3 D-146 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F OCH.sub.3 D-147 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F OCH.sub.3 D-148 CH.sub.3 CH.sub.3 CHF.sub.2 OCH.sub.3 D-149 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 OCH.sub.3 D-150 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 OCH.sub.3 D-151 CH.sub.3 CH.sub.3 OCH.sub.3 OCH.sub.3 D-152 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 OCH.sub.3 D-153 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 OCH.sub.3 D-154 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 D-155 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 D-156 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 D-157 CH.sub.3 CH.sub.3 CHFCH.sub.3 OCH.sub.3 D-158 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 OCH.sub.3 D-159 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 OCH.sub.3 D-160 CH.sub.3 CH.sub.3 CHCl.sub.2 OCH.sub.3 D-161 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 OCH.sub.3 D-162 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 OCH.sub.3 D-163 CH.sub.3 CH.sub.3 Cl C.sub.2H.sub.5 D-164 C.sub.2H.sub.5 CH.sub.3 Cl C.sub.2H.sub.5 D-165 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl C.sub.2H.sub.5 D-166 CH.sub.3 CH.sub.3 Br C.sub.2H.sub.5 D-167 C.sub.2H.sub.5 CH.sub.3 Br C.sub.2H.sub.5 D-168 C.sub.2H.sub.5 C.sub.2H.sub.5 Br C.sub.2H.sub.5 D-169 CH.sub.3 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 D-170 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 D-171 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 C.sub.2H.sub.5 D-172 CH.sub.3 CH.sub.3 CH.sub.2F C.sub.2H.sub.5 D-173 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F C.sub.2H.sub.5 D-174 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F C.sub.2H.sub.5 D-175 CH.sub.3 CH.sub.3 CHF.sub.2 C.sub.2H.sub.5 D-176 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 C.sub.2H.sub.5 D-177 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 C.sub.2H.sub.5 D-178 CH.sub.3 CH.sub.3 OCH.sub.3 C.sub.2H.sub.5 D-179 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 C.sub.2H.sub.5 D-180 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 C.sub.2H.sub.5 D-181 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 D-182 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 D-183 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 D-184 CH.sub.3 CH.sub.3 CHFCH.sub.3 C.sub.2H.sub.5 D-185 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 C.sub.2H.sub.5 D-186 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 C.sub.2H.sub.5 D-187 CH.sub.3 CH.sub.3 CHCl.sub.2 C.sub.2H.sub.5 D-188 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 C.sub.2H.sub.5 D-189 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 C.sub.2H.sub.5 D-190 CH.sub.3 CH.sub.3 Cl CHFCH.sub.3 D-191 C.sub.2H.sub.5 CH.sub.3 Cl CHFCH.sub.3 D-192 C.sub.2H.sub.5 C.sub.2H.sub.5 Cl CHFCH.sub.3 D-193 CH.sub.3 CH.sub.3 Br CHFCH.sub.3 D-194 C.sub.2H.sub.5 CH.sub.3 Br CHFCH.sub.3 D-195 C.sub.2H.sub.5 C.sub.2H.sub.5 Br CHFCH.sub.3 D-196 CH.sub.3 CH.sub.3 CH.sub.3 CHFCH.sub.3 D-197 C.sub.2H.sub.5 CH.sub.3 CH.sub.3 CHFCH.sub.3 D-198 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.3 CHFCH.sub.3 D-199 CH.sub.3 CH.sub.3 CH.sub.2F CHFCH.sub.3 D-200 CH.sub.3 C.sub.2H.sub.5 CH.sub.2F CHFCH.sub.3 D-201 C.sub.2H.sub.5 C.sub.2H.sub.5 CH.sub.2F CHFCH.sub.3 D-202 CH.sub.3 CH.sub.3 CHF.sub.2 CHFCH.sub.3 D-203 CH.sub.3 C.sub.2H.sub.5 CHF.sub.2 CHFCH.sub.3 D-204 C.sub.2H.sub.5 C.sub.2H.sub.5 CHF.sub.2 CHFCH.sub.3 D-205 CH.sub.3 CH.sub.3 OCH.sub.3 CHFCH.sub.3 D-206 CH.sub.3 C.sub.2H.sub.5 OCH.sub.3 CHFCH.sub.3 D-207 C.sub.2H.sub.5 C.sub.2H.sub.5 OCH.sub.3 CHFCH.sub.3 D-208 CH.sub.3 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 D-209 CH.sub.3 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 D-210 C.sub.2H.sub.5 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 D-211 CH.sub.3 CH.sub.3 CHFCH.sub.3 CHFCH.sub.3 D-212 CH.sub.3 C.sub.2H.sub.5 CHFCH.sub.3 CHFCH.sub.3 D-213 C.sub.2H.sub.5 C.sub.2H.sub.5 CHFCH.sub.3 CHFCH.sub.3 D-214 CH.sub.3 CH.sub.3 CHCl.sub.2 CHFCH.sub.3 D-215 C.sub.2H.sub.5 CH.sub.3 CHCl.sub.2 CHFCH.sub.3 D-216 C.sub.2H.sub.5 C.sub.2H.sub.5 CHCl.sub.2 CHFCH.sub.3

[1143] Accordingly, the present invention relates further to the process for the synthesis of compounds of the formula I of claim 1, comprising the step of reacting a compound D

##STR00700## [1144] wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.7, R.sup.8, R.sup.9 and R.sup.10 are as defined in claim 1 and R.sup.5, R.sup.6 are H or halogen.

[1145] Accordingly, the present invention relates further to the intermediate compounds D, wherein [1146] R.sup.1 is H; [1147] R.sup.2 is H; [1148] R.sup.3 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1149] R.sup.4 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl; [1150] R.sup.5 is H, halogen; [1151] R.sup.6 is H; halogen, [1152] R.sup.7 and R.sup.8 together with the carbon atoms to which they are bound form a phenyl which is unsubstituted or substituted by R.sup.78 being F or Cl; [1153] R.sup.9 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy; [1154] R.sup.10 is C.sub.1-C.sub.4-alkyl, C.sub.1-C.sub.4-haloalkyl, C.sub.1-C.sub.4-alkoxy, C.sub.1-C.sub.4-haloalkoxy.

[1155] According to one embodiment of formula D, R.sup.3 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1156] According to still another embodiment of formula D, R.sup.3 is CH.sub.3.

[1157] According to still another embodiment of formula D, R.sup.3 is C.sub.2H.sub.5.

[1158] According to still another embodiment of formula D, R.sup.3 is C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1159] According to still another embodiment of formula D, R.sup.3 is CH.sub.2F.

[1160] According to still another embodiment of formula D, R.sup.3 is CHF.sub.2.

[1161] According to still another embodiment of formula D, R.sup.3 is CF.sub.3.

[1162] According to still another embodiment of formula D, R.sup.3 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1163] According to one embodiment of formula D, R.sup.4 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1164] According to still another embodiment of formula D, R.sup.4 is CH.sub.3.

[1165] According to still another embodiment of formula D, R.sup.4 is C.sub.2H.sub.5.

[1166] According to still another embodiment of formula D, R.sup.4 is C.sub.1-C.sub.4-halogenalkyl, more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1167] According to still another embodiment of formula D; R.sup.4 is CH.sub.2F.

[1168] According to still another embodiment of formula D, R.sup.4 is CHF.sub.2.

[1169] According to still another embodiment of formula D, R.sup.4 is CF.sub.3.

[1170] According to still another embodiment of formula D, R.sup.4 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1171] According to still another embodiment of formula D, R.sup.5 is H.

[1172] According to still another embodiment of formula D, R.sup.5 is halogen.

[1173] According to still another embodiment of formula D, R.sup.6 is H.

[1174] According to still another embodiment of formula D, R.sup.6 is halogen.

[1175] According to one embodiment of formula D R.sup.9 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1176] According to still another embodiment of formula D, R.sup.9 is CH.sub.3.

[1177] According to still another embodiment of formula D, R.sup.9 is C.sub.2H.sub.5.

[1178] According to still another embodiment of formula D, R.sup.9 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1179] According to still another embodiment of formula D, R.sup.9 is CH.sub.2F.

[1180] According to still another embodiment of formula D, R.sup.9 is CHF.sub.2.

[1181] According to still another embodiment of formula D, R.sup.9 is CF.sub.3.

[1182] According to still another embodiment of formula D, R.sup.9 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl, CHCl.sub.2

[1183] According to a further specific embodiment of formula D, R.sup.9 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3, CH.sub.2CH.sub.3 or CH.sub.2OCH.sub.3.

[1184] According to a further specific embodiment of formula D, R.sup.9 is C.sub.1-C.sub.6-alkyl-C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkyl-C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkyl-C.sub.1-C.sub.2-alkoxy, such as CH.sub.2OCH.sub.3 or CH.sub.2OCH.sub.2CH.sub.3.

[1185] According to a further specific embodiment of formula D, R.sup.9 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCH F.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[1186] According to one embodiment of formula D, R.sup.9 is C.sub.1-C.sub.4-alkyl such as CH.sub.3, C.sub.2H.sub.5, n-propyl, i-propyl, n-butyl, i-butyl or tert-butyl.

[1187] According to still another embodiment of formula D, R.sup.10 is CH.sub.3.

[1188] According to still another embodiment of formula D, R.sup.10 is C.sub.2H.sub.5.

[1189] According to still another embodiment of formula D, R.sup.10 is C.sub.1-C.sub.4-halogenalkyl more specifically C.sub.1-C.sub.2-halogenalkyl, such as CF.sub.3, CCl.sub.3, FCH.sub.2, ClCH.sub.2, F.sub.2CH, Cl.sub.2CH, CF.sub.3CH.sub.2, CCl.sub.3CH.sub.2 or CF.sub.2CHF.sub.2.

[1190] According to still another embodiment of formula D, R.sup.10 is CH.sub.2F.

[1191] According to still another embodiment of formula D, R.sup.10 is CHF.sub.2.

[1192] According to still another embodiment of formula D, R.sup.10 is CF.sub.3.

[1193] According to still another embodiment of formula D, R.sup.10 is CH.sub.3, CH.sub.2F, CHF.sub.2, CF.sub.3, CH.sub.2Cl, C.sub.2H.sub.5, CH.sub.2CH.sub.2F, CH.sub.2CHF.sub.2, CH.sub.2CF.sub.3, CH.sub.2CH.sub.2Cl, n-C.sub.3H.sub.7, (CH.sub.2).sub.2CH.sub.2F, (CH.sub.2).sub.2CHF.sub.2, (CH.sub.2).sub.2CF.sub.3, (CH.sub.2).sub.2CH.sub.2Cl, i-C.sub.3H.sub.7, n-C.sub.4H.sub.9, (CH.sub.2).sub.3CH.sub.2F, (CH.sub.2).sub.3CHF.sub.2 (CH.sub.2).sub.3CF.sub.3, (CH.sub.2).sub.3CH.sub.2Cl.

[1194] According to a further specific embodiment of formula D, R.sup.10 is C.sub.1-C.sub.6-alkoxy, in particular C.sub.1-C.sub.4-alkoxy, more specifically C.sub.1-C.sub.2-alkoxy such as OCH.sub.3 or OCH.sub.2CH.sub.3.

[1195] According to a further specific embodiment of formula D, R.sup.10 is C.sub.1-C.sub.6-halogenalkoxy, in particular C.sub.1-C.sub.4-halogenalkoxy, more specifically C.sub.1-C.sub.2-halogenalkoxy such as OCF.sub.3, OCH F.sub.2, OCH.sub.2F, OCCl.sub.3, OCHCl.sub.2 or OCH.sub.2Cl, in particular OCF.sub.3, OCHF.sub.2, OCCl.sub.3 or OCHCl.sub.2.

[1196] Particular embodiments of the compounds D are the following compounds: D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8, D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18. In these formulae, the substituents R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.9 and R.sup.10 are independently as defined in claim 1 or preferably defined below:

##STR00701## ##STR00702## ##STR00703##

[1197] Table 5-1 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8,D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is H, R.sup.6 is H and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-1.D-1 to D-1.5-1.D-216, compounds D-2.5-1.D-1 to D-2.5-1.D-216, compounds D-3.5-1.D-1 to D-3.5-1.D-216, compounds D-4.5-1.D-1 to D-4.5-1.D-216, compounds D-5.5-1.D-1 to D-5.5-1.D-216, compounds D-6.5-1.D-1 to D-6.5-1.D-216, compounds D-7.5-1.D-1 to D-7.5-1.D-216, compounds D-8.5-1.D-1 to D-8.5-1.D-216, compounds D-9.5-1.D-1 to D-9.5-1.D-216, compounds D-10.5-1.D-1 to D-10.5-1.D-216, compounds D-11.5-1.D-1 to D-11.5-1.D-216, compounds D-12.5-1.D-1 to D-12.5-1.D-216, compounds D-13.5-1.D-1 to D-13.5-1.D-216, compounds D-14.5-1.D-1 to D-14.5-1.D-216, compounds D-15.5-1.D-1 to D-15.5-1.D-216, compounds D-16.5-1.D-1 to D-16.5-1.D-216, compounds D-17.5-1.D-1 to D-17.5-1.D-216, compounds D-18.5-1.D-1 to D-18.5-1.D-216.

[1198] Table 5-2 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8,D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is H, R.sup.6 is F and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-2.D-1 to D-1.5-2.D-216, compounds D-2.5-2.D-1 to D-2.5-2.D-216, compounds D-3.5-2.D-1 to D-3.5-2.D-216, compounds D-4.5-2.D-1 to D-4.5-2.D-216, compounds D-5.5-2.D-1 to D-5.5-2.D-216, compounds D-6.5-2.D-1 to D-6.5-2.D-216, compounds D-7.5-2.D-1 to D-7.5-2.D-216, compounds D-8.5-2.D-1 to D-8.5-2.D-216, compounds D-9.5-2.D-1 to D-9.5-2.D-216, compounds D-10.5-2.D-1 to D-10.5-2.D-216, compounds D-11.5-2.D-1 to D-11.5-2.D-216, compounds D-12.5-2.D-1 to D-12.5-2.D-216, compounds D-13.5-2.D-1 to D-13.5-2.D-216, compounds D-14.5-2.D-1 to D-14.5-2.D-216, compounds D-15.5-2.D-1 to D-15.5-2.D-216, compounds D-16.5-2.D-1 to D-16.5-2.D-216, compounds D-17.5-2.D-1 to D-17.5-2.D-216, compounds D-18.5-2.D-1 to D-18.5-2.D-216).

[1199] Table 5-3 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8,D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is H, R.sup.6 is Cl and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-3.D-1 to D-1.5-3.D-216, compounds D-2.5-3.D-1 to D-2.5-3.D-216, compounds D-3.5-3.D-1 to D-3.5-3.D-216, compounds D-4.5-3.D-1 to D-4.5-3.D-216, compounds D-5.5-3.D-1 to D-5.5-3.D-216, compounds D-6.5-3.D-1 to D-6.5-3.D-216, compounds D-7.5-3.D-1 to D-7.5-3.D-216, compounds D-8.5-3.D-1 to D-8.5-3.D-216, compounds D-9.5-3.D-1 to D-9.5-3.D-216, compounds D-10.5-3.D-1 to D-10.5-3.D-216, compounds D-11.5-3.D-1 to D-11.5-3.D-216, compounds D-12.5-3.D-1 to D-12.5-3.D-216, compounds D-13.5-3.D-1 to D-13.5-3.D-216, compounds D-14.5-3.D-1 to D-14.5-3.D-216, compounds D-15.5-3.D-1 to D-15.5-3.D-216, compounds D-16.5-3.D-1 to D-16.5-3.D-216, compounds D-17.5-3.D-1 to D-17.5-3.D-216, compounds D-18.5-3.D-1 to D-18.5-3.D-216).

[1200] Table 5-4 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8,D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is F, R.sup.6 is F and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-4.D-1 to D-1.5-4.D-216, compounds D-2.5-4.D-1 to D-2.5-4.D-216, compounds D-3.5-4.D-1 to D-3.5-4.D-216, compounds D-4.5-4.D-1 to D-4.5-4.D-216, compounds D-5.5-4.D-1 to D-5.5-4.D-216, compounds D-6.5-4.D-1 to D-6.5-4.D-216, compounds D-7.5-4.D-1 to D-7.5-4.D-216, compounds D-8.5-4.D-1 to D-8.5-4.D-216, compounds D-9.5-4.D-1 to E9.5-4.D-216, compounds D-10.5-4.D-1 to D-10.5-4.D-216, compounds D-11.5-4.D-1 to D-11.5-4.D-216, compounds D-12.5-4.D-1 to D-12.5-4.D-216, compounds D-13.5-4.D-1 to D-13.5-4.D-216, compounds D-14.5-4.D-1 to D-14.5-4.D-216, compounds D-15.5-4.D-1 to D-15.5-4.D-216, compounds D-16.5-4.D-1 to D-16.5-4.D-216, compounds D-17.5-4.D-1 to D-17.5-4.D-216, compounds D-18.5-4.D-1 to D-18.5-4.D-216).

[1201] Table 5-5 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8,D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is F, R.sup.6 is Cl and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-5.D-1 to D-1.5-5.D-216 compounds D-2.5-5.D-1 to D-2.5-5.D-216, compounds D-3.5-5.D-1 to D-3.5-5.D-216, compounds D-4.5-5.D-1 to D-4.5-5.D-216, compounds D-5.5-5.D-1 to D-5.5-5.D-216, compounds D-6.5-5.D-1 to D-6.5-5.D-192, compounds D-7.5-5.D-1 to D-7.5-5.D-192, compounds D-8.5-5.D-1 to D-8.5-5.D-216, compounds D-9.5-5.D-1 to D-9.5-5.D-216, compounds D-10.5-5.D-1 to D-10.5-5.D-216, compounds D-11.5-5.D-1 to D-11.5-5.D-216, compounds D-12.5-5.D-1 to D-12.5-5.D-216, compounds D-13.5-5.D-1 to D-13.5-5.D-216, compounds D-14.5-5.D-1 to D-14.5-5.D-216, compounds D-15.5-5.D-1 to D-15.5-5.D-216, compounds D-16.5-5.D-1 to D-16.5-5.D-216, compounds D-17.5-5.D-1 to D-17.5-5.D-216, compounds D-18.5-5.D-1 to D-18.5-5.D-216).

[1202] Table 5-6 Compounds of the formula D-1, D-2, D-3, D-4, D-5, D-6, D-7, D-8, D-9, D-10, D-11, D-12, D-13, D-14, D-15, D-16, D-17 and D-18 in which R.sup.5 is Cl, R.sup.6 is Cl and the meaning for the combination of R.sup.3, R.sup.4, R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table D (compounds D-1.5-6.D-1 to D-1.5-6.D-216, compounds D-2.5-6.D-1 to D-2.5-6.D-216, compounds D-3.5-6.D-1 to D-3.5-6.D-216, compounds D-4.5-6.D-1 to D-4.5-6.D-216, compounds D-5.5-6.D-1 to D-5.5-6.D-216, compounds D-6.5-6.D-1 to D-6.5-6.D-216, compounds D-7.5-6.D-1 to D-7.5-6.D-216, compounds D-8.5-6.D-1 to D-8.5-6.D-216, compounds D-9.5-6.D-1 to D-9.5-6.D-216, compounds D-10.5-6.D-1 to D-10.5-6.D-216, compounds D-11.5-6.D-1 to D-11.5-6.D-216, compounds D-12.5-6.D-1 to D-12.5-6.D-216, compounds D-13.5-6.D-1 to D-13.5-6.D-216, compounds D-14.5-6.D-1 to D-14.5-6.D-216, compounds D-15.5-6.D-1 to D-15.5-6.D-216, compounds D-16.5-6.D-1 to D-16.5-6.D-216, compounds D-17.5-6.D-1 to D-17.5-6.D-216, compounds D-18.5-6.D-1 to D-18.5-6.D-216).

[1203] Accordingly, the present invention relates further to the compounds E

##STR00704##

[1204] Particular embodiments of the compounds E are the following compounds: E-1, E-2, E-3, E-4, E-5, E-6, E-7, E-8, E-9 and E-10. In these formulae, the substituents X, R.sup.9 and R.sup.10 are independently as defined in claim 1 or preferably defined below:

##STR00705##

[1205] Table 6-1 Compounds of the formula E-1, E-2, E-3, E-4, E-5, E-6, E-7, E-8, E-9 and E-10 in the meaning for the combination of R.sup.9 and R.sup.10 for each individual compound corresponds in each case to one line of Table E (compounds E-1.6-1.E-1 to E-1.6-1.E-50, compounds E-2.6-1.E-1 to E-2.6-1.E-50, compounds E-3.6-1.E-1 to E-3.6-1.E-50, compounds E-4.6-1.E-1 to E-4.6-1.E-50, compounds E-5.6-1.E-1 to E-5.6-1.E-50, compounds E-6.6-1.E-1 to E-6.6-1.E-50, compounds E-7.6-1.E-1 to E-7.6-1.E-50, compounds E-8.6-1.E-1 to E-8.6-1.E-50, compounds E-9.6-1.E-1 to E-9.6-1.E-50, compounds E-10.6-1.E-1 to E-10.6-1.E-50).

TABLE-US-00015 TABLE E No. R.sup.9 R.sup.10 E-1 CH.sub.3 CH.sub.3 E-2 CH.sub.2F CH.sub.3 E-3 CHF.sub.2 CH.sub.3 E-4 CF.sub.3 CH.sub.3 E-5 CH.sub.2Cl CH.sub.3 E-6 CHCl.sub.2 CH.sub.3 E-7 CCl.sub.3 CH.sub.3 E-8 CH.sub.2Br CH.sub.3 E-9 CHBr.sub.2 CH.sub.3 E-10 CBr.sub.3 CH.sub.3 E-11 CH.sub.3 CH.sub.2F E-12 CH.sub.2F CH.sub.2F E-13 CHF.sub.2 CH.sub.2F E-14 CF.sub.3 CH.sub.2F E-15 CH.sub.2Cl CH.sub.2F E-16 CHCl.sub.2 CH.sub.2F E-17 CCl.sub.3 CH.sub.2F E-18 CH.sub.2Br CH.sub.2F E-19 CHBr.sub.2 CH.sub.2F E-20 CBr.sub.3 CH.sub.2F E-21 CH.sub.3 CHF.sub.2 E-22 CH.sub.2F CHF.sub.2 E-23 CHF.sub.2 CHF.sub.2 E-24 CF.sub.3 CHF.sub.2 E-25 CH.sub.2Cl CHF.sub.2 E-26 CHCl.sub.2 CHF.sub.2 E-27 CCl.sub.3 CHF.sub.2 E-28 CH.sub.2Br CHF.sub.2 E-29 CHBr.sub.2 CHF.sub.2 E-30 CBr.sub.3 CHF.sub.2 E-31 CH.sub.3 CF.sub.3 E-32 CH.sub.2F CF.sub.3 E-33 CHF.sub.2 CF.sub.3 E-34 CF.sub.3 CF.sub.3 E-35 CH.sub.2Cl CF.sub.3 E-36 CHCl.sub.2 CF.sub.3 E-37 CCl.sub.3 CF.sub.3 E-38 CH.sub.2Br CF.sub.3 E-39 CHBr.sub.2 CF.sub.3 E-40 CBr.sub.3 CF.sub.3 E-41 CH.sub.3 OCH.sub.3 E-42 CH.sub.2F OCH.sub.3 E-43 CHF.sub.2 OCH.sub.3 E-44 CF.sub.3 OCH.sub.3 E-45 CH.sub.2Cl OCH.sub.3 E-46 CHCl.sub.2 OCH.sub.3 E-47 CCl.sub.3 OCH.sub.3 E-48 CH.sub.2Br OCH.sub.3 E-49 CHBr.sub.2 OCH.sub.3 E-50 CBr.sub.3 OCH.sub.3

[1206] The compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants.

[1207] The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e. g. wheat, rye, barley, triticale, oats or rice; beet, e. g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e. g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e. g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants.

[1208] Preferably, compounds I and compositions thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.

[1209] The term plant propagation material is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.

[1210] Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans.

[1211] The term cultivated plants is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://cera-gmc.org/, see GM crop database therein). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties.

[1212] Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxylphenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase (PDS) inhibitors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or ACCase inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61, 2005, 246; 61, 2005, 258; 61, 2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1185; and references quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady (glyphosate-tolerant, Monsanto, U.S.A.), Cultivance (imidazolinone tolerant, BASF SE, Germany) and LibertyLink (glufosinate-tolerant, Bayer CropScience, Germany).

[1213] Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as 6-endotoxins, e. g. CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b), CryIIIA, CryIIIB(b1) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhabdus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilbene synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO 02/015701). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of arthropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard (corn cultivars producing the Cry1Ab toxin), YieldGard Plus (corn cultivars producing Cry1Ab and Cry3Bb1 toxins), Starlink (corn cultivars producing the Cry9c toxin), Herculex RW (corn cultivars producing Cry34Ab1, Cry35Ab1 and the enzyme phosphinothricin-N-acetyltransferase [PAT]); NuCOTN 33B (cotton cultivars producing the Cry1Ac toxin), Bollgard I (cotton cultivars producing the Cry1Ac toxin), Bollgard II (cotton cultivars producing Cry1Ac and Cry2Ab2 toxins); VIPCOT (cotton cultivars producing a VIP-toxin); NewLeaf (potato cultivars producing the Cry3A toxin); Bt-Xtra, NatureGard, KnockOut, BiteGard, Pro-tecta, Bt11 (e. g. Agrisure CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the Cry1Ab toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the Cry1Ac toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1F toxin and PAT enzyme).

[1214] Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the SOX-called pathogenesis-related proteins (PR proteins, see, e. g. EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the Mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.

[1215] Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.

[1216] Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera rape, DOW Agro Sciences, Canada).

[1217] Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora potato, BASF SE, Germany).

[1218] The compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases:

[1219] Albugo spp. (white rust) on ornamentals, vegetables (e. g. A. candida) and sunflowers (e. g. A. tragopogonis); Alternaria spp. (Alternaria leaf spot) on vegetables, rape (A. brassicola or brassicae), sugar beets (A. tenuis), fruits, rice, soybeans, potatoes (e. g. A. solani or A. alternata), tomatoes (e. g. A. solani or A. alternata) and wheat; Aphanomyces spp. on sugar beets and vegetables; Ascochyta spp. on cereals and vegetables, e. g. A. tritici(anthracnose) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), e. g. Southern leaf blight (D. maydis) or Northern leaf blight (B. zeicola) on corn, e. g. spot blotch (B. sorokiniana) on cereals and e. g. B. oryzae on rice and turfs; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (e. g. on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: grey mold) on fruits and berries (e. g. strawberries), vegetables (e. g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat; Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broad-leaved trees and evergreens, e. g. C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spots) on corn (e. g. Gray leaf spot: C. zeae-maydis), rice, sugar beets (e. g. C. beticola), sugar cane, vegetables, coffee, soybeans (e. g. C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (e. g. C. fulvum: leaf mold) and cereals, e. g. C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium of Bipolaris) spp. (leaf spots) on corn (C. carbonum), cereals (e. g. C. sativus, anamorph: B. sorokiniana) and rice (e. g. C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnose) on cotton (e. g. C. gossypi), corn (e. g. C. graminicola: Anthracnose stalk rot), soft fruits, potatoes (e. g. C. coccodes: black dot), beans (e. g. C. lindemuthianum) and soybeans (e. g. C. truncatum or C. gloeosporioides); Corticium spp., e. g. C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamentals; Cycloconium spp., e. g. C. oleaginum on olive trees; Cylindrocarpon spp. (e. g. fruit tree canker or young vine decline, teleomorph: Nectria or Neonectria spp.) on fruit trees, vines (e. g. C. liriodendri, teleomorph: Neonectria liriodendri: Black Foot Disease) and ornamentals; Dematophora (teleomorph: Rosellinia) necatrix (root and stem rot) on soybeans; Diaporthe spp., e. g. D. phaseolorum (damping off) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (e. g. D. teres, net blotch) and wheat (e. g. D. tritici-repentis: tan spot), rice and turf; Esca (dieback, apoplexy) on vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (earlier Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruits (E. pyri), soft fruits (E. veneta: anthracnose) and vines (E. ampelina: anthracnose); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets (E. betae), vegetables (e. g. E. pisi), such as cucurbits (e. g. E. cichoracearum), cabbages, rape (e. g. E. cruciferarum); Eutypa lata (Eutypa canker or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental woods; Exserohilum (syn. Helminthosporium) spp. on corn (e. g. E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (e. g. wheat or barley), F. oxysporum on tomatoes, F. solani (f. sp. glycines now syn. F. virguliforme) and F. tucumaniae and F. brasiliense each causing sudden death syndrome on soybeans, and F. verticilloides on corn; Gaeumannomyces graminis (take-all) on cereals (e. g. wheat or barley) and corn; Gibberella spp. on cereals (e. g. G. zeae) and rice (e. g. G. fujikuror Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants and G. gossypii on cotton; Grainstaining complex on rice; Guignardia bidwellii (black rot) on vines; Gymnosporangium spp. on rosaceous plants and junipers, e. g. G. sabinae (rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochliobolus) on corn, cereals and rice; Hemilela spp., e. g. H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. phaseol) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (e. g. wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., e. g. M. laxa, M. fructicola and M. fructigena (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants; Mycosphaerella spp. on cereals, bananas, soft fruits and ground nuts, such as e. g. M. graminicola (anamorph: Septoria tritici Septoria blotch) on wheat or M. fijiensis (black Sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (e. g. P. brassicae), rape (e. g. P. parasitica), onions (e. g. P. destructor), tobacco (P. tabacina) and soybeans (e. g. P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. e. g. on vines (e. g. P. tracheiphila and P. tetraspora) and soybeans (e. g. P. gregata: stem rot); Phoma lingam (root and stem rot) on rape and cabbage and P. betae (root rot, leaf spot and damping-off) on sugar beets; Phomopsis spp. on sunflowers, vines (e. g. P. viticola: can and leaf spot) and soybeans (e. g. stem rot: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e. g. P. capsici), soybeans (e. g. P. megasperma, syn. P. sojae), potatoes and tomatoes (e. g. P. infestans: late blight) and broadleaved trees (e. g. P. ramorum: sudden oak death); Plasmodiophora brassicae (club root) on cabbage, rape, radish and other plants; Plasmopara spp., e. g. P. viticola (grapevine downy mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on rosaceous plants, hop, pome and soft fruits, e. g. P. leucotricha on apples; Polymyxa spp., e. g. on cereals, such as barley and wheat (P. graminis) and sugar beets (P. betae) and thereby transmitted viral diseases; Pseudocercosporella herpotrichoides (eyespot, teleomorph: Tapesia yallundae) on cereals, e. g. wheat or barley; Pseudoperonospora (downy mildew) on various plants, e. g. P. cubensis on cucurbits or P. humili on hop; Pseudopezicula tracheiphilla (red fire disease or rotbrenner, anamorph: Phialophora) on vines; Puccinia spp. (rusts) on various plants, e. g. P. triticina (brown or leaf rust), P. striiformis (stripe or yellow rust), P. hordei (dwarf rust), P. graminis (stem or black rust) or P. recondita (brown or leaf rust) on cereals, such as e. g. wheat, barley or rye, P. kuehnii (orange rust) on sugar cane and P. asparagi on asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis (tan spot) on wheat or P. teres (net blotch) on barley; Pyricularia spp., e. g. P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on turf and cereals; Pythium spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e. g. P. ultimum or P. aphanidermatum); Ramularia spp., e. g. R. collo-cygni (Ramularia leaf spots, Physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e. g. R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer(black mold, soft rot) on strawberries, carrots, cabbage, vines and tomatoes; Rhynchosporium secalis (scald) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem rot or white mold) on vegetables and field crops, such as rape, sunflowers (e. g. S. sclerotiorum) and soybeans (e. g. S. rolfsii or S. sclerotiorum); Septoria spp. on various plants, e. g. S. glycines (brown spot) on soybeans, S. tritici(Septoria blotch) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckei) on vines; Setospaeria spp. (leaf blight) on corn (e. g. S. turcicum, syn. Helminthosporium turcicum) and turf; Sphaceotheca spp. (smut) on corn, (e. g. S. reiliana: head smut), sorghum und sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (powdery scab) on potatoes and thereby transmitted viral diseases; Stagonospora spp. on cereals, e. g. S. nodorum (Stagonospora blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., e. g. T. deformans (leaf curl disease) on peaches and T. pruni (plum pocket) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruits, vegetables, soybeans and cotton, e. g. T. basicola (syn. Chalara elegans); Tiletia spp. (common bunt or stinking smut) on cereals, such as e. g. T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (grey snow mold) on barley or wheat; Urocystis spp., e. g. U. occulta (stem smut) on rye; Uromyces spp. (rust) on vegetables, such as beans (e. g. U. appendiculatus, syn. U. phaseoli) and sugar beets (e. g. U. betae); Ustilago spp. (loose smut) on cereals (e. g. U. nuda and U. avaenae), corn (e. g. U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (e. g. V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamentals, vines, soft fruits, vegetables and field crops, e. g. V. dahliae on strawberries, rape, potatoes and tomatoes.

[1220] The compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials.

[1221] The term protection of materials is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. As to the protection of wood and other materials, the particular attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichoderma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of stored products and harvest the following yeast fungi are worthy of note: Candida spp. and Saccharomyces cerevisae.

[1222] The method of treatment according to the invention can also be used in the field of protecting stored products or harvest against attack of fungi and microorganisms. According to the present invention, the term stored products is understood to denote natural substances of plant or animal origin and their processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of crop plant origin, such as plants or parts thereof, for example stalks, leafs, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, comminuted, ground, pressed or roasted, which process is also known as post-harvest treatment. Also falling under the definition of stored products is timber, whether in the form of crude timber, such as construction timber, electricity pylons and barriers, or in the form of finished articles, such as furniture or objects made from wood. Stored products of animal origin are hides, leather, furs, hairs and the like. The combinations according the present invention can prevent disadvantageous effects such as decay, discoloration or mold. Preferably stored products is understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pomes, stone fruits, soft fruits and citrus fruits and their processed forms.

[1223] The compounds I and compositions thereof, respectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively.

[1224] The term plant health is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e. g. increased biomass and/or increased content of valuable ingredients), plant vigor (e. g. improved plant growth and/or greener leaves (greening effect)), quality (e. g. improved content or composition of certain ingredients) and tolerance to abiotic and/or biotic stress. The above identified indicators for the health condition of a plant may be interdependent or may result from each other.

[1225] The compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention.

[1226] The compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi.

[1227] Plant propagation materials may be treated with compounds I as such or a composition comprising at least one compound I prophylactically either at or before planting or transplanting.

[1228] The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I according to the invention.

[1229] An agrochemical composition comprises a fungicidally effective amount of a compound I. The term effective amount denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.

[1230] The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e. g. SC, OD, FS), emulsifiable concentrates (e. g. EC), emulsions (e. g. EW, EO, ES, ME), capsules (e. g. CS, ZC), pastes, pastilles, wettable powders or dusts (e. g. WP, SP, WS, DP, DS), pressings (e. g. BR, TB, DT), granules (e. g. WG, SG, GR, FG, GG, MG), insecticidal articles (e. g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e. g. GF). These and further compositions types are defined in the Catalogue of pesticide formulation types and international coding system, Technical Monograph No. 2, 6.sup.th Ed. May 2008, CropLife International.

[1231] The compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

[1232] Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.

[1233] Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e. g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e. g. ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, e. g. cyclohexanone; esters, e. g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e. g. N-methyl pyrrolidone, fatty acid dimethyl amides; and mixtures thereof.

[1234] Suitable solid carriers or fillers are mineral earths, e. g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e. g. cellulose, starch; fertilizers, e. g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e. g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.

[1235] Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

[1236] Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylaryl sulfonates, diphenyl sulfonates, alpha-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkyl naphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.

[1237] Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinyl pyrrolidone, vinyl alcohols, or vinyl acetate.

[1238] Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-BC type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinyl amines or polyethylene amines.

[1239] Suitable adjuvants are compounds, which have a negligible or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

[1240] Suitable thickeners are polysaccharides (e. g. xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.

[1241] Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.

[1242] Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.

[1243] Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.

[1244] Suitable colorants (e. g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e. g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e. g. alizarin-, azo- and phthalocyanine colorants).

[1245] Suitable tackifiers or binders are polyvinyl pyrrolidones, polyvinyl acetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.

[1246] Examples for composition types and their preparation are: [1247] i) Water-soluble concentrates (SL, LS)

[1248] 10-60 wt % of a compound I and 5-15 wt % wetting agent (e. g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e. g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water. [1249] ii) Dispersible concentrates (DC)

[1250] 5-25 wt % of a compound I and 1-10 wt % dispersant (e. g. polyvinyl pyrrolidone) are dissolved in organic solvent (e. g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion. [1251] iii) Emulsifiable concentrates (EC)

[1252] 15-70 wt % of a compound I and 5-10 wt % emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e. g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion. [1253] iv) Emulsions (EW, EO, ES)

[1254] 5-40 wt % of a compound I and 1-10 wt % emulsifiers (e. g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e. g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion. [1255] v) Suspensions (SC, OD, FS)

[1256] In an agitated ball mill, 20-60 wt % of a compound I are comminuted with addition of 2-10 wt % dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate), 0.1-2 wt % thickener (e. g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt % binder (e. g. polyvinyl alcohol) is added. [1257] vi) Water-dispersible granules and water-soluble granules (WG, SG)

[1258] 50-80 wt % of a compound I are ground finely with addition of dispersants and wetting agents (e. g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as water-dispersible or water-soluble granules by means of technical appliances (e. g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance. [1259] vii) Water-dispersible powders and water-soluble powders (WP, SP, WS)

[1260] 50-80 wt % of a compound I are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e. g. sodium lignosulfonate), 1-3 wt % wetting agents (e. g. alcohol ethoxylate) and solid carrier (e. g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance. [1261] viii) Gel (GW, GF)

[1262] In an agitated ball mill, 5-25 wt % of a compound I are comminuted with addition of 3-10 wt % dispersants (e. g. sodium lignosulfonate), 1-5 wt % thickener (e. g. carboxymethyl cellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance. [1263] ix) Microemulsion (ME)

[1264] 5-20 wt % of a compound I are added to 5-30 wt % organic solvent blend (e. g. fatty acid dimethyl amide and cyclohexanone), 10-25 wt % surfactant blend (e. g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion. [1265] x) Microcapsules (CS)

[1266] An oil phase comprising 5-50 wt % of a compound I, 0-40 wt % water insoluble organic solvent (e. g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e. g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). Radical polymerization results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound I according to the invention, 0-40 wt % water insoluble organic solvent (e. g. aromatic hydrocarbon), and an isocyanate monomer (e. g. diphenylmethene-4,4-diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e. g. polyvinyl alcohol). The addition of a polyamine (e. g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS composition. [1267] xi) Dustable Powders (DP, DS)

[1268] 1-10 wt % of a compound I are ground finely and mixed intimately with solid carrier (e. g. finely divided kaolin) ad 100 wt %. [1269] xii) Granules (GR, FG)

[1270] 0.3-30 wt % of a compound I is ground finely and associated with solid carrier (e. g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or fluidized bed. [1271] xiii) Ultra-low volume liquids (UL)

[1272] 1-50 wt % of a compound I are dissolved in organic solvent (e. g. aromatic hydrocarbon) ad 100 wt %.

[1273] The compositions types i) to xiii) may optionally comprise further auxiliaries, such as 0.1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0.1-1 wt % anti-foaming agents, and 0.1-1 wt % colorants.

[1274] The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, more preferably between 1 and 70%, and in particular between 10 and 60%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).

[1275] For the purposes of treatment of plant propagation materials, particularly seeds, solutions for seed treatment (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC), and gels (GF) are usually employed. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40%, in the ready-to-use preparations. Application can be carried out before or during sowing. Methods for applying compound I and compositions thereof, respectively, onto plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, and soaking as well as in-furrow application methods. Preferably, compound I or the compositions thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e. g. by seed dressing, pelleting, coating and dusting.

[1276] When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.

[1277] In treatment of plant propagation materials such as seeds, e. g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.

[1278] When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.

[1279] Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e. g. herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides) may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.

[1280] A pesticide is generally a chemical or biological agent (such as pestidal active ingredient, compound, composition, virus, bacterium, antimicrobial or disinfectant) that through its effect deters, incapacitates, kills or otherwise discourages pests. Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms), and microbes that destroy property, cause nuisance, spread disease or are vectors for disease. The term pesticide includes also plant growth regulators that alter the expected growth, flowering, or reproduction rate of plants; defoliants that cause leaves or other foliage to drop from a plant, usually to facilitate harvest; desiccants that promote drying of living tissues, such as unwanted plant tops; plant activators that activate plant physiology for defense of against certain pests; safeners that reduce unwanted herbicidal action of pesticides on crop plants; and plant growth promoters that affect plant physiology e.g. to increase plant growth, biomass, yield or any other quality parameter of the harvestable goods of a crop plant.

[1281] The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.

[1282] According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank or any other kind of vessel used for applications (e. g. seed treater drums, seed pelleting machinery, knapsack sprayer) and further auxiliaries may be added, if appropriate.

[1283] Consequently, one embodiment of the invention is a kit for preparing a usable pesticidal composition, the kit comprising a) a composition comprising component 1) as defined herein and at least one auxiliary; and b) a composition comprising component 2) as defined herein and at least one auxiliary; and optionally c) a composition comprising at least one auxiliary and optionally a further active component 3) as defined herein.

[1284] Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained.

[1285] The following list of pesticides II (e. g. pesticidally-active substances and biopesticides), in conjunction with which the compounds I can be used, is intended to illustrate the possible combinations but does not limit them: [1286] A) Respiration inhibitors [1287] Inhibitors of complex III at Q.sub.o site: azoxystrobin (A.1.1), coumethoxystrobin (A.1.2), coumoxystrobin (A.1.3), dimoxystrobin (A.1.4), enestroburin (A.1.5), fenaminstrobin (A.1.6), fenoxystrobin/flufenoxystrobin (A.1.7), fluoxastrobin (A.1.8), kresoxim-methyl (A.1.9), mandestrobin (A.1.10), metominostrobin (A.1.11), orysastrobin (A.1.12), picoxystrobin (A.1.13), pyraclostrobin (A.1.14), pyrametostrobin (A.1.15), pyraoxystrobin (A.1.16), trifloxystrobin (A.1.17), 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide (A.1.18), pyribencarb (A.1.19), triclopyricarb/chlorodincarb (A.1.20), famoxadone (A.1.21), fenamidone (A.1.21), methyl-N-[2-[(1,4-dimethyl-5-phenylpyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate (A.1.22), 1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one (A.1.23), 1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one (A.1.24), 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one (A.1.25), 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.26), 1-[2-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one (A.1.27), 1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one (A.1.30), 1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one (A.1.31). 1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methy]phenyl]tetrazol-5-one (A.1.32), (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxyimino-N,3-dimethylpent-3-enamide (A.1.34), (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-1-pent-3-enamide (A.1.35), pyriminostrobin (A.1.36), bifujunzhi (A.1.37), 2-(ortho((2,5-dimethylphenyl-oxymethylen)phenyl)-3-methoxy-acrylic acid methylester (A.1.38); [1288] inhibitors of complex III at Q.sub.i site: cyazofamid (A.2.1), amisulbrom (A.2.2), [(6S,7R,8R)-8-benzyl-3-[(3-hydroxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methy-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate (A.2.3), fenpicoxamid (A.2.4); [1289] inhibitors of complex II: benodanil (A.3.1), benzovindiflupyr (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A.3.6), fluopyram (A.3.7), flutolanil (A.3.8), fluxapyroxad (A.3.9), furametpyr (A.3.10), isofetamid (A.3.11), isopyrazam (A.3.12), mepronil (A.3.13), oxycarboxin (A.3.14), penflufen (A.3.15), penthiopyrad (A.3.16), pydiflumetofen (A.3.17), pyraziflumid (A.3.18), sedaxane (A.3.19), tecloftalam (A.3.20), thifluzamide (A.3.21), 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.22), 3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.23), 1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.24), 3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.25), 1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.26), 3-(difluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.27), 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide (A.3.28), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-5-fluoro-1,3-dimethyl-pyrazole-4-carboxamide (A.3.29), methyl (E)-2-[2-[(5-cyano-2-methyl-phenoxy)methyl]phenyl]-3-methoxy-prop-2-enoate (A.3.30), N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide (A.3.31), 2-(difluoromethyl)-N-(1,1,3-trimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.32), 2-(difluoromethyl)-N-[(3R)-1,1,3-trimethylindan-4-yl]pyridine-3-carboxamide (A.3.33), 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.34), 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (A.3.35), 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine-3-carboxamide (A.3.36), 2-(difluoromethyl)-N-[(3R)-1,1-dimethyl-3-propyl-indan-4-yl]pyridine-3-carboxamide (A.3.37), 2-(difluoromethyl)-N-(3-isobutyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide (A.3.38), 2-(difluoromethyl)-N-[(3R)-3-isobutyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (A.3.39); [1290] other respiration inhibitors: diflumetorim (A.4.1); nitrophenyl derivates: binapacryl (A.4.2), dinobuton (A.4.3), dinocap (A.4.4), fluazinam (A.4.5), meptyldinocap (A.4.6), ferimzone (A.4.7); organometal compounds: fentin salts, e. g. fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide (A.4.10); ametoctradin (A.4.11); silthiofam (A.4.12); [1291] B) Sterol biosynthesis inhibitors (SBI fungicides) [1292] C14 demethylase inhibitors: triazoles: azaconazole (B.1.1), bitertanol (B.1.2), bromuconazole (B.1.3), cyproconazole (B.1.4), difenoconazole (B.1.5), diniconazole (B.1.6), diniconazole-M (B.1.7), epoxiconazole (B.1.8), fenbuconazole (B.1.9), fluquinconazole (B.1.10), flusilazole (B.1.11), flutriafol (B.1.12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipconazole (B.1.15), metconazole (B.1.17), myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobutrazole (B.1.20), penconazole (B.1.21), propiconazole (B.1.22), prothioconazole (B.1.23), simeconazole (B.1.24), tebuconazole (B.1.25), tetraconazole (B.1.26), triadimefon (B.1.27), triadimenol (B.1.28), triticonazole (B.1.29), uniconazole (B.1.30), ipfentrifluconazole, (B.1.37), mefentrifluconazole (B.1.38), 2-(chloromethyl)-2-methyl-5-(p-tolylmethyl)-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol (B.1.43); imidazoles: imazalil (B.1.44), pefurazoate (B.1.45), prochloraz (B.1.46), triflumizol (B.1.47); pyrimidines, pyridines and piperazines: fenarimol (B.1.49), pyrifenox (B. 1.50), triforine (B.1.51), [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol (B.1.52); [1293] Delta14-reductase inhibitors: aldimorph (B.2.1), dodemorph (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8); [1294] Inhibitors of 3-keto reductase: fenhexamid (B.3.1); [1295] Other Sterol biosynthesis inhibitors: chlorphenomizole (B.4.1); [1296] C) Nucleic acid synthesis inhibitors [1297] phenylamides or acyl amino acid fungicides: benalaxyl (C.1.1), benalaxyl-M (C.1.2), kiralaxyl (C.1.3), metalaxyl (C.1.4), metalaxyl-M (C.1.5), ofurace (C.1.6), oxadixyl (C.1.7); [1298] other nucleic acid synthesis inhibitors: hymexazole (C.2.1), octhilinone (C.2.2), oxolinic acid (C.2.3), bupirimate (C.2.4), 5-fluorocytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine (C.2.6), 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine (C.2.7), 5-fluoro-2-(4-chlorophenylmethoxy)pyrimidin-4 amine (C.2.8); [1299] D) Inhibitors of cell division and cytoskeleton [1300] tubulin inhibitors: benomyl (D.1.1), carbendazim (D.1.2), fuberidazole (D1.3), thiabendazole (D.1.4), thiophanate-methyl (D.1.5), 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine (D.1.6), 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine (D.1.7), N-ethyl-2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]butanamide (D.1.8), N-ethyl-2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-2-methylsulfanyl-acetamide (D.1.9), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)butanamide (D.1.10), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2-methoxy-acetamide (D.1.11), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-propyl-butanamide (D.1.12), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-2-methoxy-N-propyl-acetamide (D.1.13), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-2-methylsulfanyl-N-propyl-acetamide (D.1.14), 2-[(3-ethynyl-8-methyl-6-quinolyl)oxy]-N-(2-fluoroethyl)-2-methylsulfanyl-acetamide (D.1.15), 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine (D.1.16); [1301] other cell division inhibitors: diethofencarb (D.2.1), ethaboxam (D.2.2), pencycuron (D.2.3), fluopicolide (D.2.4), zoxamide (D.2.5), metrafenone (D.2.6), pyriofenone (D.2.7); [1302] E) Inhibitors of amino acid and protein synthesis [1303] methionine synthesis inhibitors: cyprodinil (E.1.1), mepanipyrim (E.1.2), pyrimethanil (E.1.3); [1304] protein synthesis inhibitors: blasticidin-S(E.2.1), kasugamycin (E.2.2), kasugamycin hydrochloride-hydrate (E.2.3), mildiomycin (E.2.4), streptomycin (E.2.5), oxytetracyclin (E.2.6); [1305] F) Signal transduction inhibitors [1306] MAP/histidine kinase inhibitors: fluoroimid (F.1.1), iprodione (F.1.2), procymidone (F.1.3), vinclozolin (F.1.4), fludioxonil (F.1.5); [1307] G protein inhibitors: quinoxyfen (F.2.1); [1308] G) Lipid and membrane synthesis inhibitors [1309] Phospholipid biosynthesis inhibitors: edifenphos (G.1.1), iprobenfos (G.1.2), pyrazophos (G.1.3), isoprothiolane (G.1.4); [1310] lipid peroxidation: dicloran (G.2.1), quintozene (G.2.2), tecnazene (G.2.3), tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7); [1311] phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1), flumorph (G.3.2), mandipropamid (G.3.3), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7); [1312] compounds affecting cell membrane permeability and fatty acides: propamocarb (G.4.1); [1313] inhibitors of oxysterol binding protein: oxathiapiprolin (G.5.1), 2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate (G.5.2), 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl) 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate (G.5.3), 4-[1-[2-[3-(difluoromethyl)-5-methyl-pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-ylpyridine-2-carboxamide (G.5.4), 4-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.5), 4-[1-[2-[3-(difluoromethyl)-5-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.6), 4-[1-[2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.7), 4-[1-[2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.8), 4-[1-[2-[5-(difluoromethyl)-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.9), 4-[1-[2-[3,5-bis(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.10), (4-[1-[2-[5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]-N-tetralin-1-yl-pyridine-2-carboxamide (G.5.11); [1314] H) Inhibitors with Multi Site Action [1315] inorganic active substances: Bordeaux mixture (H.1.1), copper (H.1.2), copper acetate (H.1.3), copper hydroxide (H.1.4), copper oxychloride (H.1.5), basic copper sulfate (H.1.6), sulfur (H.1.7); [1316] thio- and dithiocarbamates: ferbam (H.2.1), mancozeb (H.2.2), maneb (H.2.3), metam (H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H.2.7), zineb (H.2.8), ziram (H.2.9); [1317] organochlorine compounds: anilazine (H.3.1), chlorothalonil (H.3.2), captafol (H.3.3), captan (H.3.4), folpet (H.3.5), dichlofluanid (H.3.6), dichlorophen (H.3.7), hexachlorobenzene (H.3.8), pentachlorphenole (H.3.9) and its salts, phthalide (H.3.10), tolylfluanid (H.3.11); [1318] guanidines and others: guanidine (H.4.1), dodine (H.4.2), dodine free base (H.4.3), guazatine (H.4.4), guazatine-acetate (H.4.5), iminoctadine (H.4.6), iminoctadine-triacetate (H.4.7), iminoctadine-tris(albesilate) (H.4.8), dithianon (H.4.9), 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c]dipyrrole-1,3,5,7(2H,6H)-tetraone (H.4.10); [1319] I) Cell wall synthesis inhibitors [1320] inhibitors of glucan synthesis: validamycin (I.1.1), polyoxin B (I.1.2); [1321] melanin synthesis inhibitors: pyroquilon (I.2.1), tricyclazole (I.2.2), carpropamid (I.2.3), dicyclomet (I.2.4), fenoxanil (I.2.5); [1322] J) Plant defence inducers [1323] acibenzolar-S-methyl (J.1.1), probenazole (J.1.2), isotianil (J.1.3), tiadinil (J.1.4), prohexadione-calcium (J.1.5); phosphonates: fosetyl (J.1.6), fosetyl-aluminum (J.1.7), phosphorous acid and its salts (J.1.8), calcium phosphonate (J.1.11), potassium phosphonate (J.1.12), potassium or sodium bicarbonate (J.1.9), 4-cyclopropyl-N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide (J.1.10); [1324] K) Unknown mode of action [1325] bronopol (K.1.1), chinomethionat (K.1.2), cyflufenamid (K.1.3), cymoxanil (K.1.4), dazomet (K.1.5), debacarb (K.1.6), diclocymet (K.1.7), diclomezine (K.1.8), difenzoquat (K.1.9), difenzoquat-methylsulfate (K.1.10), diphenylamin (K.1.11), fenitropan (K.1.12), fenpyrazamine (K.1.13), flumetover (K.1.14), flusulfamide (K.1.15), flutianil (K.1.16), harpin (K.1.17), methasulfocarb (K.1.18), nitrapyrin (K.1.19), nitrothal-isopropyl (K.1.20), tolprocarb (K.1.21), oxincopper (K.1.22), proquinazid (K.1.23), tebufloquin (K.1.24), tecloftalam (K.1.25), triazoxide (K.1.26), N-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine (K.1.27), N-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine (K.1.28), N-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]-oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine (K.1.29), N-(5-bromo-6-indan-2-yloxy-2-methyl-3-pyridyl)-N-ethyl-N-methyl-formamidine (K.1.30), N-[5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.31), N-[5-bromo-6-(4-isopropylcyclohexoxy)-2-methyl-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.32), N-[5-bromo-2-methyl-6-(1-phenylethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (K.1.33), N-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine (K.1.34), N-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethylN-methyl formamidine (K. 1.35), 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide (K.1.36), 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole) (K.1.37), 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3 yl]-pyridine (K.1.38), 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole (K.1.39), ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate (K.1.40), picarbutrazox (K.1.41), pentyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate (K.1.42), but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate (K.1.43), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol (K.1.44), 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol (K.1.45), quinofumelin (K.1.47), 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine (K.1.49), 2-(6-benzyl-2-pyridyl)quinazoline (K.1.50), 2-[6-(3-fluoro-4-methoxy-phenyl)-5-methyl-2-pyridyl]quinazoline (K.1.51), dichlobentiazox (K.1.52), N-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyl-formamidine (K.1.53); [1326] M) Growth regulators [1327] abscisic acid (M.1.1), amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat, chlormequat chloride, choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat, mepiquat chloride, naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione, prohexadione-calcium, prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-tri-iodobenzoic acid, trinexapac-ethyl and uniconazole; [1328] N) Herbicides from classes N.1 to N.15 [1329] N.1 Lipid biosynthesis inhibitors: alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, diclofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifopbutyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, haloxyfop-P, haloxyfop-Pmethyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, 4-(4-chloro-4-cyclo-propyl-2-fluoro[, 1-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-72-6); 4-(2,4-dichloro-4-cyclopropyl[1,1-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1312337-45-3); 4-(4-chloro-4-ethyl-2-fluoro[1,1-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3(6H)-one (CAS 1033757-93-5); 4-(2,4-Dichloro-4-ethyl[, 1-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2H-pyran-3,5(4H,6H)-dione (CAS 1312340-84-3); 5-(acetyloxy)-4-(4-chloro-4-cyclopropyl-2-fluoro[1,1-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312337-48-6); 5-(acetyloxy)-4-(2,4-dichloro-4-cyclopropyl-[1,1-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one; 5-(acetyloxy)-4-(4-chloro-4-ethyl-2-fluoro[1,1-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312340-82-1); 5-(acetyloxy)-4-(2,4-dichloro-4-ethyl[, 1-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1033760-55-2); 4-(4-chloro-4-cyclopropyl-2-fluoro[1,1-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312337-51-1); 4-(2,4-dichloro-4-cyclopropyl-[1,1-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester; 4-(4-chloro-4-ethyl-2-fluoro[1,1-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312340-83-2); 4-(2,4-dichloro-4-ethy h[1,1-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1033760-58-5); benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, esprocarb, ethofumesate, flupropanate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thiobencarb, tiocarbazil, triallate and vernolate; [1330] N.2 ALS inhibitors: amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuronmethyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methyl-sodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl, tritosulfuron, imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin, imazethapyr; cloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan and pyroxsulam; bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid-1-methyl-ethyl ester (CAS 420138-41-6), 4-[[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]-methyl]amino]-benzoic acid propyl ester (CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzenemethanamine (CAS 420138-01-8); flucarbazone, flucarbazone-sodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone, thiencarbazone-methyl; triafamone; [1331] N.3 Photosynthesis inhibitors: amicarbazone; chlorotriazine; ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn, hexazinone, metribuzin, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn, trietazin; chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron, thiadiazuron, desmedipham, karbutilat, phenmedipham, phenmediphamethyl, bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, bromacil, lenacil, terbacil, bentazon, bentazon-sodium, pyridate, pyridafol, pentanochlor, propanil; diquat, diquat-dibromide, paraquat, paraquat-dichloride, paraquat-dimetilsulfate; [1332] N.4 protoporphyrinogen-IX oxidase inhibitors: acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlormethoxyfen, cinidon-ethyl, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6), N-ethyl-3-(2,6-dichloro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452098-92-9), N tetrahydrofurfuryl-3-(2,6-dichloro-4-trifluoromethyl phenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 915396-43-9), N-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethyl phenoxy)-5-methyl-1 Hpyrazole-1-carboxamide (CAS 452099-05-7), N tetrahydro-furfuryl-3-(2-chloro-6-fluoro-4-trifluoro-methylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452100-03-7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thioxo-[1,3,5]triazinan-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoro methyl-3-(2,2,7-tri-fluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidine-2,4-dione (CAS 1304113-05-0), methyl (E)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1H-methyl-pyrazol-3-yl]-4-fluoro-phenoxy]-3-methoxy-but-2-enoate (CAS 948893-00-3), 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione (CAS 212754-02-4); [1333] N.5 Bleacher herbicides: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, 4-(3-trifluoromethyl-phenoxy)-2-(4-trifluoromethylphenyl)-pyrimidine (CAS 180608-33-7); benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquintrione, isoxaflutole, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone; aclonifen, amitrole, flumeturon; [1334] N.6 EPSP synthase inhibitors: glyphosate, glyphosate-isopropylammonium, glyposate-potassium, glyphosate-trimesium (sulfosate); [1335] N.7 Glutamine synthase inhibitors: bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P, glufosinate-ammonium; [1336] N.8 DHP synthase inhibitors: asulam; [1337] N.9 Mitosis inhibitors: benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine, trifluralin; amiprophos, amiprophos-methyl, butamiphos; chlorthal, chlorthal-dimethyl, dithiopyr, thiazopyr, propyzamide, tebutam; carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flamprop-M-isopropyl, flamprop-M-methyl, propham; [1338] N.10 VLCFA inhibitors: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor, thenylchlor, flufenacet, mefenacet, diphenamid, naproanilide, napropamide, napropamide-M, fentrazamide, anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone, isoxazoline compounds of the formulae II.1, II.2, II.3, II.4, II.5, II.6, II.7, II.8 and II.9

##STR00706##

[1339] N.11 Cellulose biosynthesis inhibitors: chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam, 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899-01-1); [1340] N.12 Decoupler herbicides: dinoseb, dinoterb, DNOC and its salts; [1341] N.13 Auxinic herbicides: 2,4-D and its salts and esters, clacyfos, 2,4-DB and its salts and esters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as aminopyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl)ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (CAS 943832-60-8); MCPA and its salts and esters, MCPA-thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxylic acid, benzyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxylate (CAS 1390661-72-9); [1342] N.14 Auxin transport inhibitors: diflufenzopyr, diflufenzopyr-sodium, naptalam and naptalam-sodium; [1343] N.15 Other herbicides: bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin (CAS 403640-27-7), methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine, tridiphane; [1344] O) Insecticides from classes O.1 to O.29 [1345] O.1 Acetylcholine esterase (AChE) inhibitors: aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion; [1346] O.2 GABA-gated chloride channel antagonists: endosulfan, chlordane; ethiprole, fipronil, flufiprole, pyrafluprole, pyriprole; [1347] O.3 Sodium channel modulators: acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alphacypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, meperfluthrin, metofluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethylfluthrin, tetramethrin, tralomethrin and transfluthrin; DDT, methoxychlor; [1348] O.4 Nicotinic acetylcholine receptor agonists (nAChR): acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam; (2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitro-2-pentylidenehydrazinecarboximidamide; 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; nicotine; [1349] O.5 Nicotinic acetylcholine receptor allosteric activators: spinosad, spinetoram; [1350] O.6 Chloride channel activators: abamectin, emamectin benzoate, ivermectin, lepimectin, milbemectin; [1351] O.7 Juvenile hormone mimics: hydroprene, kinoprene, methoprene; fenoxycarb, pyriproxyfen; [1352] O.8 miscellaneous non-specific (multi-site) inhibitors: methyl bromide and other alkyl halides; chloropicrin, sulfuryl fluoride, borax, tartar emetic; [1353] O.9 Selective homopteran feeding blockers: pymetrozine, flonicamid; [1354] O.10 Mite growth inhibitors: clofentezine, hexythiazox, diflovidazin; etoxazole; [1355] O.11 Microbial disruptors of insect midgut membranes: Bacillus thuringiensis, Bacillus sphaericus and the insecticdal proteins they produce: Bacillus thuringiensis subsp. israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, the Bt crop proteins: Cry1Ab, Cry1Ac, Cry1 Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1; [1356] O.12 Inhibitors of mitochondrial ATP synthase: diafenthiuron; azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradifon; [1357] O.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient: chlorfenapyr, DNOC, sulfluramid; [1358] O.14 Nicotinic acetylcholine receptor (nAChR) channel blockers: bensultap, cartap hydrochloride, thiocyclam, thiosultap sodium; [1359] O.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron; [1360] O.16 Inhibitors of the chitin biosynthesis type 1: buprofezin; [1361] O.17 Moulting disruptors: cyromazine; [1362] O.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide, halofenozide, fufenozide, chromafenozide; [1363] O.19 Octopamin receptor agonists: amitraz; [1364] O.20 Mitochondrial complex III electron transport inhibitors: hydramethylnon, acequinocyl, fluacrypyrim; [1365] O.21 Mitochondrial complex I electron transport inhibitors: fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad; rotenone; [1366] O.22 Voltage-dependent sodium channel blockers: indoxacarb, metaflumizone, 2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide, N-(3-chloro-2-methylphenyl)-2-[(4-chlorophenyl)-[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide; [1367] O.23 Inhibitors of the of acetyl CoA carboxylase: spirodiclofen, spiromesifen, spirotetramat; [1368] O.24 Mitochondrial complex IV electron transport inhibitors: aluminium phosphide, calcium phosphide, phosphine, zinc phosphide, cyanide; [1369] O.25 Mitochondrial complex II electron transport inhibitors: cyenopyrafen, cyflumetofen; [1370] O.26 Ryanodine receptor-modulators: flubendiamide, chlorantraniliprole, cyantraniliprole, cyclaniliprole, tetraniliprole; (R)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide, (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamide, methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate; N-[4,6-dichloro-2-[(diethyllambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyllambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanyl idene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide; 3-chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide; 3-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide; N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide; cyhalodiamide; [1371] O.27. insecticidal active compounds of unknown or uncertain mode of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone, fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, triflumezopyrim, 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one, 3-(4-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one, 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine, Bacillus firmus; (E/Z)N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide; (E/Z)N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide; (E/Z)N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide.); N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide; N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N-isopropyl-acetamidine; fluazaindolizine; 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide; fluxametamide; 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole; 3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; 3-(benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide; N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methylbenzamide; N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide; 4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; 3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; 2-chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide; 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; 4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide; N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; 2-(1,3-dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; 2-[6-[2-(5-fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; 2-[6-[2-(3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; N-ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; N-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthiopropanamide; N,2-dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; N-ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide; 1-[(6-chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine; 1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol; 1-isopropyl-N,5-dimethyl-N-pyridazin-4-ylpyrazole-4-carboxamide; 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; N,5-dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; 1-[1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; 1-(1,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; 1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; N-methyl-1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; 1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; 1-(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide, N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide; N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide; 2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide; 2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide; methyl 2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate; N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide; N(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide; 2-(3-pyridinyl)-N-(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide; N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide, N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)propanamide; N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)propanamide; N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfanyl]-N-ethyl-propanamide; N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl-propanamide; sarolaner, lotilaner.

[1372] The active substances referred to as component 2, their preparation and their activity e. g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their pesticidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; U.S. Pat. Nos. 3,296,272; 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 10/139271, WO 11/028657, WO 12/168188, WO 07/006670, WO 11/77514; WO 13/047749, WO 10/069882, WO 13/047441, WO 03/16303, WO 09/90181, WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/24010, WO 13/047441, WO 13/162072, WO 13/092224, WO 11/135833, CN 1907024, CN 1456054, CN 103387541, CN 1309897, WO 12/84812, CN 1907024, WO 09094442, WO 14/60177, WO 13/116251, WO 08/013622, WO 15/65922, WO 94/01546, EP 2865265, WO 07/129454, WO 12/165511, WO 11/081174, WO 13/47441).

[1373] The present invention furthermore relates to agrochemical compositions comprising a mixture of at least one compound I (component 1) and at least one further active substance useful for plant protection, e. g. selected from the groups A) to O) (component 2), in particular one further fungicide, e. g. one or more fungicide from the groups A) to K), as described above, and if desired one suitable solvent or solid carrier. Those mixtures are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi. Furthermore, combating harmful fungi with a mixture of compounds I and at least one fungicide from groups A) to K), as described above, is more efficient than combating those fungi with individual compounds I or individual fungicides from groups A) to K).

[1374] By applying compounds I together with at least one active substance from groups A) to O) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is obtained (synergistic mixtures).

[1375] This can be obtained by applying the compounds I and at least one further active substance simultaneously, either jointly (e. g. as tank-mix) or seperately, or in succession, wherein the time interval between the individual applications is selected to ensure that the active substance applied first still occurs at the site of action in a sufficient amount at the time of application of the further active substance(s). The order of application is not essential for working of the present invention.

[1376] When applying compound I and a pesticide II sequentially the time between both applications may vary e. g. between 2 hours to 7 days. Also a broader range is possible ranging from 0.25 hour to 30 days, preferably from 0.5 hour to 14 days, particularly from 1 hour to 7 days or from 1.5 hours to 5 days, even more preferred from 2 hours to 1 day.

[1377] In the binary mixtures and compositions according to the invention the weight ratio of the component 1) and the component 2) generally depends from the properties of the active components used, usually it is in the range of from 1:10,000 to 10,000:1, often it is in the range of from 1:100 to 100:1, regularly in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, more preferably in the range of from 1:10 to 10:1, even more preferably in the range of from 1:4 to 4:1 and in particular in the range of from 1:2 to 2:1.

[1378] According to further embodiments of the binary mixtures and compositions, the weight ratio of the component 1) and the component 2) usually is in the range of from 1000:1 to 1:1, often in the range of from 100:1 to 1:1, regularly in the range of from 50:1 to 1:1, preferably in the range of from 20:1 to 1:1, more preferably in the range of from 10:1 to 1:1, even more preferably in the range of from 4:1 to 1:1 and in particular in the range of from 2:1 to 1:1.

[1379] According to further embodiments of the mixtures and compositions, the weight ratio of the component 1) and the component 2) usually is in the range of from 20,000:1 to 1:10, often in the range of from 10,000:1 to 1:1, regularly in the range of from 5,000:1 to 5:1, preferably in the range of from 5,000:1 to 10:1, more preferably in the range of from 2,000:1 to 30:1, even more preferably in the range of from 2,000:1 to 100:1 and in particular in the range of from 1,000:1 to 100:1.

[1380] According to a further embodiments of the binary mixtures and compositions, the weight ratio of the component 1) and the component 2) usually is in the range of from 1:1 to 1:1000, often in the range of from 1:1 to 1:100, regularly in the range of from 1:1 to 1:50, preferably in the range of from 1:1 to 1:20, more preferably in the range of from 1:1 to 1:10, even more preferably in the range of from 1:1 to 1:4 and in particular in the range of from 1:1 to 1:2.

[1381] According to further embodiments of the mixtures and compositions, the weight ratio of the component 1) and the component 2) usually is in the range of from 10:1 to 1:20,000, often in the range of from 1:1 to 1:10,000, regularly in the range of from 1:5 to 1:5,000, preferably in the range of from 1:10 to 1:5,000, more preferably in the range of from 1:30 to 1:2,000, even more preferably in the range of from 1:100 to 1:2,000 to and in particular in the range of from 1:100 to 1:1,000.

[1382] In the ternary mixtures, i.e. compositions according to the invention comprising the component 1) and component 2) and a compound III (component 3), the weight ratio of component 1) and component 2) depends from the properties of the active substances used, usually it is in the range of from 1:100 to 100:1, regularly in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, more preferably in the range of from 1:10 to 10:1 and in particular in the range of from 1:4 to 4:1, and the weight ratio of component 1) and component 3) usually it is in the range of from 1:100 to 100:1, regularly in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, more preferably in the range of from 1:10 to 10:1 and in particular in the range of from 1:4 to 4:1.

[1383] Any further active components are, if desired, added in a ratio of from 20:1 to 1:20 to the component 1).

[1384] These ratios are also suitable for inventive mixtures applied by seed treatment.

[1385] Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex III at Q.sub.o site in group A), more preferably selected from compounds (A.1.1), (A.1.4), (A.1.8), (A.1.9), (A.1.10), (A.1.12), (A.1.13), (A.1.14), (A.1.17), (A.1.21), (A.1.24), (A.1.25), (A.1.26), (A.1.27), (A.1.30), (A.1.31), (A.1.32), (A.1.34) and (A.1.35); particularly selected from (A.1.1), (A.1.4), (A.1.8), (A.1.9), (A.1.13), (A.1.14), (A.1.17), (A.1.24), (A.1.25), (A.1.26), (A.1.27), (A.1.30), (A.1.31), (A.1.32), (A.1.34) and (A.1.35).

[1386] Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex III at Q.sub.i site in group A), more preferably selected from compounds (A.2.1), (A.2.3) and (A.2.4); particularly selected from (A.2.3) and (A.2.4).

[1387] Preference is also given to mixtures comprising as component 2) at least one active substance selected from inhibitors of complex II in group A), more preferably selected from compounds (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.11), (A.3.12), (A.3.15), (A.3.16), (A.3.17), (A.3.18), (A.3.19), (A.3.20), (A.3.21), (A.3.22), (A.3.23), (A.3.24), (A.3.25), (A.3.27), (A.3.28), (A.3.29), (A.3.31), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39); particularly selected from (A.3.2), (A.3.3), (A.3.4), (A.3.7), (A.3.9), (A.3.12), (A.3.15), (A.3.17), (A.3.19), (A.3.22), (A.3.23), (A.3.24), (A.3.25), (A.3.27), (A.3.29), (A.3.31), (A.3.32), (A.3.33), (A.3.34), (A.3.35), (A.3.36), (A.3.37), (A.3.38) and (A.3.39).

[1388] Preference is also given to mixtures comprising as component 2) at least one active substance selected from other respiration inhibitors in group A), more preferably selected from compounds (A.4.5) and (A.4.11); in particular (A.4.11).

[1389] Preference is also given to mixtures comprising as component 2) at least one active substance selected from C14 demethylase inhibitors in group B), more preferably selected from compounds (B.1.4), (B.1.5), (B.1.8), (B.1.10), (B.1.11), (B.1.12), (B.1.13), (B.1.17), (B.1.18), (B.1.21), (B.1.22), (B.1.23), (B.1.25), (B.1.26), (B.1.29), (B.1.34), (B.1.37), (B.1.38), (B.1.43) and (B.1.46); particularly selected from (B.1.5), (B.1.8), (B.1.10), (B.1.17), (B.1.22), (B.1.23), (B.1.25), (B.1.33), (B.1.34), (B.1.37), (B.138), (B.1.43) and (B.1.46).

[1390] Preference is also given to mixtures comprising as component 2) at least one active substance selected from Delta14-reductase inhibitors in group B), more preferably selected from compounds (B.2.4), (B.2.5), (B.2.6) and (B.2.8); in particular (B.2.4).

[1391] Preference is also given to mixtures comprising as component 2) at least one active substance selected from phenylamides and acyl amino acid fungicides in group C), more preferably selected from compounds (C.1.1), (C.1.2), (C.1.4) and (C.1.5); particularly selected from (C.1.1) and (C.1.4).

[1392] Preference is also given to mixtures comprising as component 2) at least one active substance selected from other nucleic acid synthesis inhibitors in group C), more preferably selected from compounds (C.2.6), (C.2.7) and (C.2.8).

[1393] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group D), more preferably selected from compounds (D.1.1), (D.1.2), (D.1.5), (D.2.4) and (D.2.6); particularly selected from (D.1.2), (D.1.5) and (D.2.6).

[1394] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group E), more preferably selected from compounds (E.1.1), (E.1.3), (E.2.2) and (E.2.3); in particular (E.1.3).

[1395] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group F), more preferably selected from compounds (F.1.2), (F.1.4) and (F.1.5).

[1396] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group G), more preferably selected from compounds (G.3.1), (G.3.3), (G.3.6), (G.5.1), (G.5.2), (G.5.3), (G.5.4), (G.5.5), G.5.6), G.5.7), (G.5.8), (G.5.9), (G.5.10) and (G.5.11); particularly selected from (G.3.1), (G.5.1), (G.5.2) and (G.5.3).

[1397] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group H), more preferably selected from compounds (H.2.2), (H.2.3), (H.2.5), (H.2.7), (H.2.8), (H.3.2), (H.3.4), (H.3.5), (H.4.9) and (H.4.10); particularly selected from (H.2.2), (H.2.5), (H.3.2), (H.4.9) and (H.4.10).

[1398] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group I), more preferably selected from compounds (I.2.2) and (I.2.5).

[1399] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group J), more preferably selected from compounds (J.1.2), (J.1.5), (J.1.8), (J.1.11) and (J.1.12); in particular (J.1.5).

[1400] Preference is also given to mixtures comprising as component 2) at least one active substance selected from group K), more preferably selected from compounds (K.1.41), (K.1.42), (K.1.44), (K.1.45), (K.1.47) and (K.1.49); particularly selected from (K.1.41), (K.1.44), (K.1.45), (K.1.47) and (K.1.49).

SYNTHESIS EXAMPLE

[1401] With due modification of the starting compounds, the procedures shown in the synthesis examples below were used to obtain further compounds I. The resulting compounds, together with physical data, are listed in Table I below.

[1402] HPLC-MS: HPLC-column Kinetex XB C18 1.7 (502.1 mm); eluent: acetonitrile/water+0.1% TFA (5 gradient from 5:95 to 100:0 in 1.5 min at 60 C., flow gradient from 0.8 to 1.0 ml/min in 1.5 min). MS: Quadrupol Electrospray lonisation, 80 V (positive mode).

1. Synthesis of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-1)

Route A

1.1 1-(5,6-dibromo-3-pyridyl)-3,3-dimethyl-4H-isoquinoline

[1403] To a solution of 1.3 g 2,3-dibromo-5-cyanopyridine (5 mmol) and 1 g of 2-methyl-1-phenyl-propan-2-ol (7 mmol) in 20 ml of DCE at 0 C., 3 mL trifluoromethyl acid (33 mmol) were added. The reaction mixture was allowed to warm to rt overnight. Then, it was diluted with ethyl acetate and extracted with Na.sub.2CO.sub.3. The organic phase is washed with water, dried with Na.sub.2SO.sub.4 and concentrated. The crude was purified via HPLC (water/acetonitrile) to yield 1.33 g (26%) of the title compound as a colorless oil.

[1404] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.5 (s, 1H); 8.2 (s, 1H); 7.5 (t, 1H); 7.3 (m, 2H); 7.1 (d, 1H); 2.8 (2, 2H); 1.3 (s, 6H).

1.2 1-(5,6-dibromo-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline

[1405] To a solution of 1.73 g of 1-(5,6-dibromo-3-pyridyl)-3,3-dimethyl-4H-isoquinoline (3 mmol) in 20 mL of acetonitrile at rt, 1.53 ml of NEt.sub.3*3HF (9 mmol). After 1 h at 90 C., the reaction mixture was diluted with ethyl acetate and extracted with Na.sub.2CO.sub.3. The organic phase is washed with water, dried with Na.sub.2SO.sub.4 and concentrated. The crude was purified via HPLC (water/acetonitrile) to yield 990 mg (74%) of the title compound as a yellow oil

[1406] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.5 (s, 1H); 8.2 (s, 1H); 7.8 (d, 1H); 7.7 (t, 1H); 7.5 (t, 1H); 7.3 (s, 1H); 1.4 (s, 6H).

1.3 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline (I-1)

[1407] To a solution of 2 g 1-(5,6-dibromo-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline (5 mmol) in 22 mL dioxane, 1.75 g of trimetylboroxin (14 mmol), 2.2 g of potassium carbonate (16 mmol) and 200 mg of palladium triphenylphosphine (0.2 mmol). The reaction was allowed to stir for 7 days at rt, after it was diluted with MTBE. The non-organic phase was extracted 2 times with MTBE. The combined organic phase were washed with water, dried with Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (heptane/EtOAc) to yield 1 g (72%) of the title compound as a white solid (m.p.: 103 C.)

[1408] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.5 (s, 1H); 7.8 (d, 1H); 7.7-7.6 (m, 1H); 7.5 (t, 1H); 7.3 (d, 1H); 2.5 (s, 3H); 2.3 (s, 3H); 1.4 (s, 6H).

1.4 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-1)

[1409] To a solution of 560 mg of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline in 25 mL of MeOH at 0 C., 212 mg of NaBH.sub.4 (6 mmol) were added. The reaction mixture was allowed to warm to rt overnight. Then, it was diluted with ethyl acetate and extracted with Na.sub.2CO.sub.3. The organic phase is washed with water, dried with Na.sub.2SO.sub.4 and concentrated. The crude was purified via HPLC (water/acetonitrile) to yield 150 mg (26%) of the title compound as a yellow oil

[1410] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.3 (s, 1H); 7.75 (d, 1H); 7.35 (t, 1H); 7.3 (t, 1H); 7.2 (s, 1H); 6.8 (d, 1H); 5.15 (d, 1H); 2.5 (s, 3H); 2.2 (s, 3H); 1.4 (s, 3H); 1.35 (s, 3H).

Route B

[1411] Alternatively, 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline can be also obtained from 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethylisoquinoline

1.5 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline

[1412] To a solution of 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline (5 g, 13.5 mmol) in 170 mL NH.sub.4Cl sat. solution, carbonyl iron (0.09 g, 1.6 mmol) were added.

[1413] The reaction mixture was stirred overnight at 80 C., then water and MTBE were added. The mixture was filtered through celite, after separation the aq. phase was extracted 2 times with MTBE. The combined org. phases were washed with water, dried over MgSO4 and concentrated. The residue was purified via silica gel column chromatography (EtOAc, heptane) giving 1.2 g of the tittle compound (30%) as an orange oil.

[1414] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.7 (s, 1H); 7.9 (d, 1H); 7.8 (s, 1H); 7.6 (t, 1H); 7.5 (t, 1H); 7.3 (d, 1H); 7.0 (s, 1H); 2.5 (s, 3H); 1.4 (s, 6H).

Route C

[1415] Alternatively, compound of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline using intermediate B.

1.6 4,4-dibromo-3,3-dimethyl-1-phenylsulfanyl-isoquinoline

[1416] To a solution of 3,3-dimethyl-1-phenylsulfanyl-4H-isoquinoline (2.7 g. 10.06 mmol) and AlBN (0.17 g, 0,001 mmol) in 100 mL cyclohexan, NBS (4.1 g, 22.6 mmol) were added under nitrogen atmosphere. The reaction mixture was allowed to react at 65 C. for 2 h, then filtered and concentrated giving 4.3 g of the tittle compound (71%) as a yellow oil, which was used at the next step without further purification.

1.7 4,4-difluoro-3,3-dimethyl-1-phenylsulfanyl-isoquinoline

[1417] To a solution of 4,4-dibromo-3,3-dimethyl-1-phenylsulfanyl-isoquinoline (4.3 g, 0.007 mol) in 50 mL acetonitrile, Et.sub.3N*3HCl (3.5 mL, 0.021 mol) was added at rt. The reaction mixture was stirred overnight, before being quenched with a 20% NaOH sol. The aq. phase was extracted 3 times with MTBE, the combined org. phases were washed with brine, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified by silica gel column chromatography (EtOAc/heptane) giving 1.1 g of the tittle compound (49%) as a yellow oil.

[1418] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.8 (d, 1H), 7.7 (d, 1H), 7.6 (m, 2H), 7.5 (m, 2H), 7.3 (m, 2H), 1.3 (s, 6H)

1.8 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline

[1419] To a solution of magnesium (71.9 mg, 0.003 mol) and LiCl (125.3 mg, 0.003 mol) under Ar atmosphere in 0.5 mL THF, 0.7 mL of 1M DIBALH solution were added at 0 C. The reaction mixture was stirred for 10 min, 5-bromo-2,3-dimethylpyridine (500 mg, 2.7 mmol) was slowly added (exothermic reaction). After 2 h at rt, this mixture was added to a solution of 4,4-difluoro-3,3-dimethyl-1-phenylsulfanyl-isoquinoline (103.0 mg, 0.34 mmol) and 11 mg from NiCl.sub.2(PPh.sub.3).sub.2 in 0.5 mL THF under Ar atmosphere at 0 C. The final mixture was allowed to react overnight at rt. Cold water and MTBE were added, the aq. phase was extracted 3 times with MTBE. The combined org. phase were dried over Na.sub.2SO.sub.4 and concentrated. The residue was purified by MPLC (water/acetonitrile) giving 26.3 mg of the titled compound (26%, 85% purity) as brown oil.

Route E

[1420] Synthesis of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline using intermediate D

1.9 1,1-difluoro-2-methyl-1-phenyl-propan-2-amine

[1421] To a solution of 2,2-difluoro-2-phenyl-acetonitrile (0.1 g, 0.001 mol) in 2 mL THF at 0 C., methyl magnesium bromide (0.65 mL, 0.001 mol) was slowly added. After 10 min, titanium isopropoxide (0.19 g, 0.001 mol) was added. The reaction was allowed to react overnight at rt, then water was added. The aq. Phase was extracted 3 times with MTBE, the combined org. phases were washed with water, a NaCl solution, dried over Na.sub.2SO.sub.4 and concentrated. 0,093 g of the tittle compound were isolated (100%) and used at the next step without further purification.

[1422] 1H-NMR (CDCl.sub.3, in ppm): 7.5-7.3 (m, 5H); 1.2 (s, 6H).

1.10 5,6-dimethylpyridine-3-carbonyl chloride

[1423] To a solution of 5,6-dimethylpyridine-3-carboxylic acid (0.6 g, 4.0 mmol) in 10 mL CH.sub.2Cl.sub.2, oxalyl chloride (1.5 mL, 0.006 mol) were added at 0 C. Slowly DMF was added, after a few minutes the reaction was finished. The reaction mixture was direct concentrated giving the tittle compound, which was used as the next step without further purification.

1.11 N-(2,2-difluoro-1,1-dimethyl-2-phenyl-ethyl)-5,6-dimethyl-pyridine-3-carboxamide

[1424] To a solution of 1,1-difluoro-2-methyl-1-phenyl-propan-2-amine (0,740 g, 0.004 mol) in 7 mL CH.sub.2Cl.sub.2, Et.sub.3N (2.5 mL, 0.01 mol) was added a 0 C. Then, a solution of 5,6-dimethylpyridine-3-carbonyl chloride (0.74 g, 0.004 mol) in 3 mL CH.sub.2Cl.sub.2 was added slowly. The reaction mixture was allowed to react overnight at rt, then water was added. The aq. phase was extracted 3 times with CH.sub.2Cl.sub.2. The combinaded org. phases were washed with water, a NaCl solution, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (MTBE/heptane) giving 0.67 g of the tittle compound (52%) as a brown oil.

[1425] 1H-NMR (CDCl.sub.3, in ppm): 8.6 (s, 1H), 7.7 (s, 1H); 7.6-7.4 (m, 5H); 6.2 (br s, 1H); 2.6 (s, 3H); 2.3 (s, 3H); 1.6 (s, 6H).

1.12 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline

[1426] To a solution of compound N-(2,2-difluoro-1,1-dimethyl-2-phenyl-ethyl)-5,6-dimethyl-pyridine-3-carboxamide (300 mg, 0.94 mmol) in 5 mL CH.sub.2Cl.sub.2, pyridine (1.2 mL, 1.13 mmol) was added. At 75 C., Tf2O (1.1 mL, 1.04 mmol) was added. The reaction mixture was allowed to warm to rt, after 5 h water was added and the aq. phase was extracted 3 times with CH.sub.2Cl.sub.2. The combinaded org. phases were washed with water, a NaCl solution, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (MTBE/heptane) giving 60 mg of the tittle compound (21%) as a solid.

Route D

[1427] Alternatively, compound 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline can also be synthesized (I-1)

1.13 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-1)

2. Synthesis of 1-(6-bromo-5-methyl-)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-10)

2.1 1-(6-bromo-5-methyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline

[1428] To a solution of 1 g of 1-(5,6-dibromo-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline (2 mmol) in 10 mL of THF at 78 C., 1.6 mL of BuLi (1.6 M; 3 mmol) was added dropwise. After 30 min, the reaction mixture was diluted with a sat. solution NH.sub.4Cl and extracted with MTBE. The organic phase was dried over MgSO.sub.4 and concentrated. The crude was purified via HPLC (water/acetonitrile) to yield 0.8 g (24%) of the title compound as a solid (m.p: 103 C.) and 0.8 g (18%) of 1-(6-bromo-3-pyridyl)-3,3-dimethyl-4H-isoquinoline as an oil.

[1429] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.4 (s, 1H); 7.9 (d, 1H); 7.8 (d, 1H); 7.7 (t, 1H); 7.5 (t, 1H); 7.3 (d, 1H); 2.5 (s, 3H); 1.4 (s, 6H).

2.2 1-(6-bromo-5-methyl-)-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline

[1430] To a solution of 0.3 g of 1-(6-bromo-5-methyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline (1 mmol) in 25 mL MeoH at 0 C., 350 mg of NaBH.sub.4 (10 mmol) were added. The reaction mixture was allowed to warm to rt overnight. Then, it was diluted with ethyl acetate and extracted with Na.sub.2CO.sub.3. The organic phase is washed with water, dried with Na.sub.2SO.sub.4 and concentrated. The crude was purified via HPLC (water/acetonitrile) to yield 302 mg (100%) of the title compound as a yellow oil

[1431] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.2 (s, 1H); 7.8 (d, 1H); 7.5-7.2 (m, 3H); 6.8 (d, 1H); 7.3 (d, 1H); 5.2 (brs, 1); 2.3 (s, 3H); 1.3 (s, 3H); 1.2 (s, 3H).

3. Synthesis of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-2-hydroxy-3,3-dimethyl-1H-isoquinoline (I-15)

Route A

Synthesis 1-15 Using Int. B

3.1 4,4-difluoro-3,3-dimethyl-isoquinoline

[1432] To a 1.2 L solution of 3,3-dimethyl-4H-isoquinoline (30 g, 0.1888 mol) in cyclohexan, NBS (73.8, 0.4 mol) and AlBN (3.1 g, 0.019 mol) was added under nitrogen atmosphere. After 30 min at room temperature, the reaction mixture was warmed to 60 C., after 30 min it was concentrated and the filtrated was used in the next step directly.

[1433] To a 600 mL solution of 4,4-dibromo-3,3-dimethyl-isoquinoline (51.6 g, 0.13 mol) in acetonitrile, triethylamine*3HF (0.99 mL, 0.4 mol) was added dropwise. After 3 h at room temperature, the reaction mixture was allowed to react overnight at 80 C. After quenching with 300 mL 20% NaOH solution (pH=12-14), the aq. phase was extracted 3 times with ethyl acetate. The combined org. phase were washed, dried with Na.sub.2SO.sub.4 and concentrated. 31.6 g (900%) of the tittle compound were isolated as a brown oil and used in the next step after distillation.

[1434] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.3 (s, 1H); 7.8 (d, 1H); 7.7 (m, 2H); 7.4 (d, 1H); 1.4 (s, 6H).

3.2 4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline

[1435] To a solution of 4,4-difluoro-3,3-dimethyl-isoquinoline (15 g, 70.7 mmol) in 300 mL MeOH at 0 C., sodium borohydride (4 g, 0.11 mol) was added slowly. The reaction mixture was stirred for 1 h, then concentrated. The rest was diluted in dichloromethane and water, the aq. Phase was extracted 3 times with dichloromethane. The organic phase was dried with Na.sub.2SO.sub.4 and concentrated. 13.9 g (100%) of the tittle compound were isolated as a brown oil and used a in the next step without any further purification.

[1436] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.7 (d, 1H); 7.5-7.3 (m, 2H); 7.1 (d, 1H); 4.0 (br s, 2H); 2.0 (br s, 1H); 1.2 (s, 6H).

3.3 4,4-difluoro-3,3-dimethyl-isoquinoline 2-oxide

[1437] To a solution of 4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (13.9 g, 70.5 mmol) in 300 mL MeOH at 0 C., sodium wolframat dehydrate (2.3 g, 7.0 mmol) was added. Then, a 30% hydrogen peroxide solution (28.8 mL, 281.9 mmol) was added over 5 min. The reaction mixture was allowed to warm to room temperature overnight. After cooling with a ice bath, 150 mL of sodium thiosulfate solution was added, 30 min later the aq. phase was extracted 3 times with dichloromethane. The combined organic phases were washed with a sodium thiosulfate solution, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (heptane/diisopropylether) to yield 11, 9 g (80%) of the title compound as a brown oil

[1438] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.7 (d+s, 2H); 7.6-7.4 (m, 2H), 7.2 (dd, 1H); 1.6 (s, 6H).

3.4 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-2-hydroxy-3,3-dimethyl-1H-isoquinoline (I-15)

[1439] To a flask with magnesium (0,387 g, 16 mmol) and LiCl (0.7 g, 16.0 mmol) under Ar atmosphere, 5 mL of 1M DIBALH solution were added. The reaction mixture was stirred for 10 min at 0 C., 5-bromo-2,3-dimethylpyridine (2.7 g, 14.5 mmol) was slowly added (exothermic reaction). The reaction mixture was allowed to warm to rt and stirred for 2 h. At rt, a 9 mL solution of 4,4-difluoro-3,3-dimethyl-isoquinoline 2-oxide (3.1 g, 14.5 mmol) in THF was added over the mixture, the reaction was controlled below 30 C. using an ice bath. After 1.5 h, a mixture of 150 mL cold water and 100 mL MTBE were added, the aq. phase was extracted 3 times with MTBE. The combined org. phase were filtrated throught celite, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (heptane/diisopropylether) to yield 2.2 g (48%) of the title compound as a brown oil

[1440] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.3 (br s, 1H); 8.1 (s, 1H); 7.7 (d, 1H); 7.3 (dd, 1H), 7.2 (dd, 1H); 7.1 (s, 1H), 6.6 (d, 1H); 4.8 (d, 1H); 2.2 (s, 3H); 2.1 (s, 3H); 1.6 (s, 3H); 1.2 (s, 3H).

[1441] HPLC/MS: 0.884 min; M++H=319.0

4. Synthesis of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-2-hydroxy-3,3-dimethyl-1H-isoquinoline (I-16)

[1442] To a solution of 5-bromo-2-(difluoromethyl)-3-methyl-pyridine (161 mg, 0.73 mmol) in 1 mL THF, turbo Grignard (0.8 mL, 1.04 mmol) was added at room temperature under Ar atmosphere. After 3 h at rt, a solution of 4,4-difluoro-3,3-dimethyl-2-oxido-isoquinolin-2-ium (168.5 mg, 1.04 mmol) in 1 mL THF was added dropwise. The reaction mixture was allowed to react overnight, then diluted with water. The aq. phase was extracted 3 times with MTBE, the combined organic phases were concentrated, and dried over Na2SO4. The crude was purified via MPLC (water/acetonitrile) to yield 50 mg (20%) of the title compound.

[1443] HPLC/MS: 1.179 min; M++H=355.1

5. Synthesis of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-14)

Route A

5.1 6-(dichloromethyl)-5-methyl-pyridine-3-carbonitrile

[1444] To a solution of 5,6-dimethylpyridine-3-carbonitrile (50 g, 0.34 mol) in 500 mL acetic acid, potassium acetate (186 g, 1.9 mol) was added followed by trichloroisocyanuric acid (66 g, 0.28 mol). The reaction mixture was warmed to 50 C. for 7 h, then it was quenched with a 10% NaOH solution followed by addition of ethyl acetate. The org. phase was washed 2 times with 10% NaOH sol. Finally, the org. phase was dried over Na2SO4 and concentrated. 65.5 g of the titled compound (86%) were isolated as a white powder after crystallization (iisopropylether) as a white solid (see ref. JP2009/67682).

[1445] .sup.1H-NMR (CDCl.sub.3, route in ppm): 8.7 (s, 1H), 7.9 (s, 1H); 6.9 (s, 1H); 2.6 (s, 3H).

5.2 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-4H-isoquinoline

[1446] To 500 mL a solution of 6-(dichloromethyl)-5-methyl-pyridine-3-carbonitrile (50 g, 0.25 mol) and 2-methyl-1-phenyl-propan-2-ol (46.7 g, 0.31 mol) in dichloroethane in an ice bath, triflruoacetic acid (117.7 mL, 1.33 mol) were added dropwise added. After 3 h at rt, the reaction mixture was diluted with dichloromethane, and quenched with a 10% NaOH solution. The org.phase was washed with water, dried over Na2SO4 and concentrated. 33 g of the tittle compound (64%) was obtain after recrystallization (isopropylether) and silica gel column chromatography (ethyl acetate/heptane) as white solid.

[1447] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.6 (s, 1H), 7.8 (s, 1H), 7.4 (t, 1H), 7.2 (m, 2H), 7.1 (d, 1H), 7.0 (s, 1H), 2.9 (s, 3H), 2.6 (s, 6H).

5.3 4,4-dibromo-1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-isoquinoline

[1448] To a solution of 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-4H-isoquinoline (5 g, 0.015 mol) in 250 mL EtOAc, AlBN (0.25 g, 0.002 mol) and NBS (11.2 g, 0.063 mol) were added. The reaction mixture was stirred at 80 C. for 2 h, then diluted with EtOAc and quenched with a 10% NaOH solution. The org.phase was washed with water, dried over Na2SO4 and concentrated. 5.1 g of the titled compound (45%) were isolated after crystallization (diisopropyl ether/pentane 1:1) as a white powder.

5.4 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline

[1449] To a solution of 4,4-dibromo-1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-isoquinoline (1 g, 0.001 mol) in 6 mL triethylamine, Et3N*3HF (6 mL, 0.037 mol) was added. The reaction was stirred for overnight at 100 C., then quenched with ice followed by a 10% NaOH sol. and diluted with EtOAc. The org.phase was washed with water, dried over Na.sub.2SO.sub.4 and concentrated. 0.41 g of the title compound (69%) were isolated after silica gel column chromatography (EtOAc/heptane) as a yellow oil.

[1450] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.7 (d, 1H), 7.8 (m, 2H), 7.7 (t, 1H), 7.5 (t, 1H), 7.0 (s, 1H), 6.8 (t, 1H), 2.7 (s, 3H), 1.4 (s, 6H).

5.5 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-14)

[1451] To a solution of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline (0.3 g, 0.001 mol) in 10 mL MeOH, 3 mL acetic acid and sodium cyanoborohydride (0.17 g, 0.003 mol) were added. The reaction mixture was allowed to react at rt overnight, then it was diluted with EtOAc, and washed with a Na.sub.2CO.sub.3 sol. The org. phase was washed again with water, dried over Na2SO4 and concentrated. The crude was purified via MPLC (water/acetonitrile) to give 247 mg of the titled compound (95%) as an oil.

[1452] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.4 (s, 1H); 7.8 (d, 1H), 7.5-7.3 (m, 3H), 6.8 (d, 1H), 6.7 (t, 1H), 5.2 (d, 1H), 2, 5 (s, 3H), 1.7 (br s, 1H), 1.3 (s, 3H), 1.2 (s, 3H).

[1453] HPLC-MS: 0.864 min, M++H=321.0

Route B

[1454] Alternatively synthesis to 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline

5.6 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline

[1455] To a solution of 1-(5,6-dimethyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline (1 g, 0.003 mol) in 5 mL acetic esther, potassium acetate (1.6 g, 0.017 mol) and tribromoisocyanuric acid (0.58 g, 0.002 mol) were added at rt. The reaction mixture was stirred at 50 C. for 6 h, then it was diluted with ethyl acetate and quenched with a Na.sub.2CO.sub.3 solution. The org. phase was washed with water, dried over Na.sub.2SO.sub.4 and concentrated. The crude was purified via silica gel column chromatography (EtOAc/heptane) giving 1.11 g of the tittle compound (95%) as an aoil.

[1456] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.7 (s, 1H); 7.9 (d, 1H); 7.8 (s, 1H); 7.6 (t, 1H); 7.5 (t, 1H); 7.3 (d, 1H); 7.0 (s, 1H); 2.5 (s, 3H); 1.4 (s, 6H).

5.7 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline

[1457] A solution of 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline (0,150 g, 0.4 mmol) in 9 mL Et3N*3HCl was allowed to react at 80 C. overnight. The reaction was diluted with EtOAc and extracted with 10% NaOH solution. The org.phase was washed with water, dried over Na.sub.2SO.sub.4 and concentrated. 75 mg of the title compound (55%) were obtained as a brown oil, which was used in the next step without purification.

Route C

[1458] In another hand, compound 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-4H-isoquinoline can also be obtained via 1-(5,6-dimethyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline using Intermediate B

5.8 1-(5,6-dimethyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline

Variant A using 3,3-dimethyl-1-methylsulfanyl-4H-isoquinoline

[1459] To a solution of magnesium (71.9 mg, 0.003 mol) and LiCl (125.3 mg, 0.003 mol) under Ar atmosphere in 0.5 mL THF, 0.7 mL of 1M DIBALH solution were added at 0 C. The reaction mixture was stirred for 10 min, 5-bromo-2,3-dimethylpyridine (500 mg, 2.7 mmol) was slowly added (exothermic reaction). After 2 h at rt, this mixture was added to a solution of 3,3-dimethyl-1-methylsulfanyl-4H-isoquinoline (97.6 mg, 0.47 mmol) and 3.1 mg from NiCl.sub.2(PPh.sub.3).sub.2 in 2.5 mL THF under Ar atmosphere at 0 C. The final mixture was allowed to react overnight at rt. Cold water and MTBE were added, the aq. phase was extracted 3 times with MTBE. The combined org. phase were dried over Na.sub.2SO.sub.4 and concentrated. 100 mg of the tittle compound were isolated (9%) as a brown oil

[1460] The synthesis of 3,3-dimethyl-1-methylsulfanyl-4H-isoquinoline is literature described (WO2015/117563)

Variant B using 3,3-dimethyl-1-phenylsulfanyl-4H-isoquinoline

[1461] To a solution of magnesium (71.9 mg, 0.003 mol) and LiCl (125.3 mg, 0.003 mol) under Ar atmosphere in 0.5 mL THF, 0.7 mL of 1M DIBALH solution were added at 0 C. The reaction mixture was stirred for 10 min, 5-bromo-2,3-dimethylpyridine (500 mg, 2.7 mmol) was slowly added (exothermic reaction). After 2 h at rt, this mixture was added to a solution of 3,3-dimethyl-1-phenylsulfanyl-4H-isoquinoline (97.6 mg, 0.37 mmol) and 2.4 mg from NiCl.sub.2(PPh.sub.3).sub.2 in 2.5 mL TH F under Ar atmosphere at 0 C. The final mixture was allowed to react overnight at rt. Cold water and MTBE were added, the aq. phase was extracted 3 times with MTBE. The combined org. phase were dried over Na.sub.2SO.sub.4 and concentrated. The residue was purified by silica gel column chromatography (EtOAc/Heptane) giving 40 mg of the titled compound (37%) as colorless oil.

[1462] For the synthesis of 3,3-dimethyl-1-phenylsulfanyl-4H-isoquinoline see reaction 5.9

Variant C using 1-benzylsulfanyl-3,3-dimethyl-4H-isoquinoline

[1463] To a solution of magnesium (53.9 mg, 0.002 mol) and LiCl (94, o mg, 0.002 mol) under Ar atmosphere in 0.5 mL THF, 0.5 mL of 1M DIBALH solution were added at 0 C. The reaction mixture was stirred for 10 min, 5-bromo-2,3-dimethylpyridine (375.1 mg, 2.0 mmol) was slowly added (exothermic reaction). After 2 h at rt, this mixture was added to a solution of 1-benzylsulfanyl-3,3-dimethyl-4H-isoquinoline (97.6 mg, 0.34 mmol) and 2.3 mg from NiCl.sub.2(PPh.sub.3).sub.2 in 2.5 mL THF under Ar atmosphere at 0 C. The final mixture was allowed to react overnight at rt. Cold water and MTBE were added, the aq. phase was extracted 3 times with MTBE. The combined org. phase were dried over Na.sub.2SO.sub.4 and concentrated. 200 mg of the title compound (15%) were isolated and used at the next step without further purification.

[1464] For the synthesis of 1-benzylsulfanyl-3,3-dimethyl-4H-isoquinoline check reaction 5.10

5.9 3,3-dimethyl-1-phenylsulfanyl-4H-isoquinoline

[1465] To a solution of 14 mL sulfuric acid and 7.5 mL cyclohexan at 0 C., a solution of 2-methyl-1-phenyl-propan-2-ol (5 g, 0.033 mol) and phenylthiocyanate (4.1 g, 0.031 mol) in 7.5 mL cyclohexan was added dropwise during 30 min. The reaction was allowed to react overnight at rt, then it was diluted by addition of 100 mL water and quenched with a 40% K.sub.2CO.sub.3 sol. After separation, the aq. phase was extracted 2 times with MTBE, the combined org. phases were dried over Na.sub.2SO.sub.4 and concentrated. 7.2 g of the titled compound (88%) were isolated and used at the next step without further purification.

[1466] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.7 (d, 1H), 7.5 (d, 1H), 7.4-7.2 (m, 6H), 7.1 (d, 1H), 2.7 (s, 2H), 1.1, (s, 6H).

5.10 1-benzylsulfanyl-3,3-dimethyl-4H-isoquinoline

[1467] To a solution of 15 mL sulfuric acid and 7.5 mL cyclohexan at 0 C., a solution of 2-methyl-1-phenyl-propan-2-ol (5 g, 0.033 mol) and benzylthiocyanate (4.1 g, 0.028 mol) in 7.5 mL cyclohexan was added dropwise during 30 min. The reaction was allowed to react overnight at rt, then it was diluted by addition of 100 mL water and quenched with a 40% K.sub.2CO.sub.3 sol. After separation, the aq. phase was extracted 2 times with MTBE, the combined org. phases were dried over Na.sub.2SO.sub.4 and concentrated. The residue was purified by silica gel column chromatograpy giving 4.3 g of the tittle compound (52%) as a light yellow oil.

[1468] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.6 (d, 1H), 7.4 (t, 1H), 7.3-7.1 (m, 6H), 7.1 (d, 1H), 4.3 (s, 2H), 2.7 (s, 2H), 1.2 (s, 6H)

5.11 1-[6-(dichloromethyl)-5-methyl-3-pyridyl]-3,3-dimethyl-4H-isoquinoline

Route D

[1469] Alternative synthesis of compound 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-isoquinoline

5.12 Ethyl 4,4-difluoro-3,3-dimethyl-isoquinoline-1-carboxylate

[1470] To a solution of ethyl 3,3-dimethyl-4H-isoquinoline-1-carboxylate (20 g, 0.086 mol) in 250 mL HCCl.sub.3, NBS (33, 9 g, 0.19 mol) and AlBN (2.84 g, 0.017 mol) were added at rt. After 1 h, 200 mL heptane was added and 15 min later, 40 g of Ethyl 4,4-dibromo-3,3-dimethyl-isoquinoline-1-carboxylate (95%) were isolated by filtration and used in the next step without further purification.

[1471] To a solution of ethyl 4,4-dibromo-3,3-dimethyl-isoquinoline-1-carboxylate (40 g, 0.082 mol) in 100 mL acetonitrile, Et3N*3HF (80 mL, 0.43 mol) was added at rt. After 2 h at 80 C., the reaction mixture was allowed to cold to rt and quenched with a 20% NaOH sol. The aq. phase was washed 2 times with EtOAc, the combined org. phases were washed with a sat. NaCl sol., dried over Na.sub.2SO.sub.4. 12 g of the tittle compound were isolated (55%) after filtration and concentration of the crude. The compound was used in the next step without further purification.

[1472] .sup.1H-NMR (CDCl.sub.3, in ppm): 7.8 (d, 1H); 7.7 (d, 1H); 7.6-7.5 (m, 2H); 4.5 (q, 2H); 1.5 (t, 3H); 1.2 (s, 6H).

[1473] Ethyl 3,3-dimethyl-4H-isoquinoline-1-carboxylate can be synthesized following the literature (see Org. Lett. 2009, 11, 729-732).

5.13 Potassium 4,4-difluoro-3,3-dimethyl-isoquinoline-1-carboxylate

[1474] A mixture of 12 g (0.045 mol), 100 ml isopropanol and 200 ml of 10% hydrochloric acid was heated to reflux for 1 hour. Afterwards the reaction mixture was concentrated under vacuum, 500 ml of toluene were added and the mixture was concentrated again. The residue was taken up in 500 ml of warm isopropanol and this solution was dried over molecular sieves. Subsequently 5,038 g (0.045 mol) potassium t-butanolate were added and the volatiles were evaporated yielding a solid residue. Methyl-t-butyl ether was added, the mixture was stirred and the crystalline title compound was filtered off (yield 5.5 g (44% of theorie)).

[1475] The compound was used in the next step without further purification.

5.14-1-(6-Difluoromethyl-5-methyl-3-pyridyl))-4,4-difluoro-3,3-dimethyl-isoquinoline

5.14.1 Lithium 4,4-difluoro-3,3-dimethyl-isoquinoline-1-carboxylate

[1476] A mixture of 7.3 g (0.026 mol) Ethyl 4,4-difluoro-3,3-dimethyl-isoquinoline-1-carboxylate and 1,143 g (0.027 mol) lithium hydroxideH.sub.2O in 100 ml methanol was stirred for 2.5 hours at room temperature. Afterwards the volatiles were evaporated at room temperature, diethylether was added to the residue and the unsoluble crystals were filtered off yielding 6.3 g (99% of theory) of the title compound.

5.14.2 1-(6-Difluoromethyl-5-methyl-3-pyridyl)-4,4-difluoro-3,3-dimethyl-isoquinoline

[1477] 2,429 g (9,909 mmol) lithium 4,4-difluoro-3,3-dimethyl-isoquinoline-1-carboxylate and 2 g (8,738 mmol) 5-bromo-2-(difluoromethyl)-3-methyl-pyridine in 20 ml N-methyl-pyrrolidone and 30 ml toluene were heated at 70 C. under a stream of argon. Subsequently 0,194 g (1,351 mmol) copper(I)bromide and 0,122 g Pd(dppf)Cl.sub.2CH.sub.2Cl.sub.2 have been added and the reaction mixture was heated at reflux over night. Afterwards the volatiles were evaporated under reduced pressure, the residue was taken up in MTBE and was filtered over a layer of silica. The silica layer was eluted with MTBE and the combined organic layers were extracted with ammonia- and lithium chloride-solution, dried over sodium sulfate and evaporated. The residue was purified via column chromatography over silica eluting with heptane/MTBE-mixtures yielding 2 g (5.9 mmol, 68% of theory) of the title compound as slightly brownish oil which slowly solidified.

[1478] .sup.1H-NMR (in CDCl.sub.3, in ppm): 8.6 (s, 1H); 7.88 (d, 1H); 7.84 (s, 1H); 7.67 (t, 1H); 7.56 (t, 1H); 7.26 (d, 1H); 6.77 (t, 1H); 2.58 (s, 3H); 1.4 (s, 6H).

Route E

[1479] Alternative synthesis of compound 1-(5,6-dimethyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline from ethyl 3,3-dimethyl-4H-isoquinoline-1-carboxylate

5.15 Potassium 3,3-dimethyl-4H-isoquinoline-1-carboxylate

[1480] A solution of ethyl 3,3-dimethyl-4H-isoquinoline-1-carboxylate (20 g, 0.086 mol) in 100 mL EtOH and 200 mL HCl was heated 2 h at reflux. Afterwards the volatiles were evaporated and 200 mL EtOH and 400 mL iPrOH were added to the residue. Again the volatiles were evaporated and after cooling 250 mL iPrOH were added. The volatiles were evaporated again MTBE and KOtBu (14, 5 g, 0.13 mol) were added, the mixture was stirred, the crystalline solid was filtered off and washed with more MTBE. 19 g of the titled compound (91%) were isolated. The compound was used in the next step without further purification.

[1481] .sup.1H-NMR (D.sub.2O in ppm): 7.6 (t, 1H); 7.5-7.4 (m, 2H); 7.3 (d, 1H); 2, 8 (s, 2H); 1.1 (s, 6H).

5.16 1-(5,6-dimethyl-3-pyridyl)-3,3-dimethyl-4H-isoquinoline

[1482] To a solution of potassium 3,3-dimethyl-4H-isoquinoline-1-carboxylate (3.1 g, 12.9 mmol), 5-bromo-2,3-methyl-pyridine (2 g, 10.8 mmol), CuBr (0.23 g, 1.6 mmol) and Pd(dppf) Cl.sub.2 (0,157 g, 0.1 mmol) in 50 mL NMP, molecular sieves was added. After 20 h at 130 C., a NaHCO.sub.3 sol. and CH.sub.2Cl.sub.2 were added. The aq. phase was extracted with CH.sub.2Cl.sub.2 and EtOAc. The combined org. phases were washed with a sat. LiCl and sat. NaCl sol., dried and concentrated. 1.27 g of the titled compound (45%) were isolated.

6. Synthesis of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-2,3,3-trimethyl-1H-isoquinoline (I-19)

[1483] To a solution of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-14) (0,375 g, 1.1 mmol) in 7.5 mL acetonitrile, formaldehyde (0.9 g, 11.1 mmol), NaBH.sub.3CN (0.21 g, 3.3 mmol) and 0.7 mL acetic acid were added. The reaction mixture was allowed to react overnight at rt, then it was diluted with EtOAc and quenched with a 1M NaOH sol. The org. phase was washed with Na.sub.2CO.sub.3 sol., water, dried and concentrated. 0.2 g of the tittle compound (49%) were isolated as a yellow oil.

[1484] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.5 (s, 1H); 7.7 (d, 1H); 7.5 (s, 1H); 7.4-7.3 (m, 2H); 6.7 (t, 1H); 4.6 (d, 1H); 2.4 (s, 3H); 2.2 (s, 3H); 1.4 (s, 3H); 1.0 (s, 3H).

[1485] HPLC/MS: 1.275 min; M++H=3537. Synthesis of 1-[1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-1H-isoquinolin-2-yl]ethanone (I-20)

[1486] To a solution of 1-[6-(difluoromethyl)-5-methyl-3-pyridyl]-4,4-difluoro-3,3-dimethyl-1,2-dihydroisoquinoline (I-14) (0,375 g, 0.001 mol) in 6 mL CH.sub.2Cl.sub.2, pyridine (5 mL, 0.006 mol) and acetyl chloride (3 mL, 0.003 moL) were added. The reaction was heated for 2 h at 90 C. in the microwave. The reaction mixture was diluted with EtOAc and quenched with NH4Cl sat. sol. The org. phase was washed with Na.sub.2CO.sub.3 sol., water, dried and concentrated. 0,184 g of the tittle compound (42%) were isolated as a yellow oil.

[1487] .sup.1H-NMR (CDCl.sub.3, in ppm): 8.4 (s, 1H); 7.8 (d, 1H); 7.7 (t, 1H); 7.6-7.5 (m, 2H); 7.3 (s, 1H), 6.7 (t, 1H); 6.1 (s, 1H); 2.5 (s, 3H); 2.2 (s, 3H); 2.0 (s, 3H); 1.5 (s, 3H); 1.2 (s, 3H).

[1488] HPLC/MS: 1.180 min; M++H=381.0

TABLE-US-00016 TABLE I The positions of the heteroaryls given as R.sup.7 + R.sup.8 marked with # represents the connection points (carbon atoms 5 and 6 in formula I) with the remaining skeleton of the compounds of formula [00707] Mp [ C.]; HPLC-MS (R.sub.t [min], M.sup.+ + H); R.sup.5, .sup.1H-NMR No. R.sup.1 R.sup.2 R.sup.3, R.sup.4 R.sup.6 R.sup.7 + R.sup.8 R.sup.9 R.sup.10 R.sup.12 ( in ppm) I-1 H H CH.sub.3 CH.sub.3 F, F [00708] CH.sub.3 CH.sub.3 H 0.773 min; M.sup.+ + H = 303.2 I-2 H H CH.sub.3, CH.sub.3 F, F [00709] CH.sub.3 OCH.sub.3 H 0.773 min; M.sup.+ + H = 303.2 I-3 H H CH.sub.3, CH.sub.3 F, F [00710] CH.sub.3 CH.sub.3 H 0.799 min; M.sup.+ + H = 319.1 I-4 H H CH.sub.3, CH.sub.3 F, F [00711] CHF.sub.2 OCH.sub.3 H 1.009 min; M.sup.+ + H = 355.0 I-5 H H CH.sub.3, CH.sub.3 F, F [00712] CH.sub.3 CH.sub.3 CH.sub.3 0.899 min; M.sup.+ + H = 317.1 I-6 H H CH.sub.3, CH.sub.3 F, F [00713] CH.sub.3 CH.sub.3 COCH.sub.3 0.808 min; M.sup.+ + H = 345.1 I-7 H H CH.sub.3, CH.sub.3 F, F [00714] CHF.sub.2 Br H 1.194 min; M.sup.+ + H = 404.9 I-9 H H CH.sub.3, CH.sub.3 F, F [00715] CH.sub.3 CCH H 0.928 min; M.sup.+ + H = 313.0 I-10 H H CH.sub.3, CH.sub.3 F, F [00716] Br CH.sub.3 H 1.061 min; M.sup.+ + H = 369.0 I-11 H H CH.sub.3, CH.sub.3 F, F [00717] CH.sub.2F CH.sub.3 H 1.033 min; M.sup.+ + H = 339.1 I-12 H H CH.sub.3, CH.sub.3 F, F [00718] CH.sub.3 Br H 1.044 min; M.sup.+ + H = 369.0 I-13 H H CH.sub.3, CH.sub.3 F, F [00719] CH.sub.3 CH.sub.2F H 0.819 min; M.sup.+ + H = 321.0 I-14 H H CH.sub.3, CH.sub.3 F, F [00720] CH.sub.2F CH.sub.3 H 0.864 min; M.sup.+ + H = 321.0 I-15 H H CH.sub.3, CH.sub.3 F, F [00721] CH.sub.3 CH.sub.3 OH 0.884 min; M.sup.+ + H = 319.0 I-16 H H CH.sub.3, CH.sub.3 F, F [00722] CH.sub.2F CH.sub.3 OH 1.179 min, M.sup.+ + H = 355.1 I-17 H H CH.sub.3, CH.sub.3 F, F [00723] CH.sub.2F CH.sub.3 H 1.101 min, M.sup.+ + H = 357.1 I-18 H H CH.sub.3, Et F, F [00724] CH.sub.3 CH.sub.3 H 0.886 min, M.sup.+ + H = 317 I-19 H H CH.sub.3, CH.sub.3 F, F [00725] CH.sub.2F CH.sub.3 CH.sub.3 1.275 min; M.sup.+ + H = 353 I-20 H H CH.sub.3, CH.sub.3 F, F [00726] CH.sub.2F CH.sub.3 COCH.sub.3 1.180 min; M.sup.+ + H = 381.0 I-21 CN H CH.sub.3, CH.sub.3 F, F [00727] CH.sub.3 N(CH.sub.3).sub.2 H 1.225 min; M.sup.+ + H = 357.1 I-22 H H CH.sub.3, Pr F, F [00728] CH.sub.3 CH.sub.3 H 0.979 min; M.sup.+ + H = 331.1 I-23 H H CH.sub.3, CH.sub.3 F, F [00729] CH.sub.3 CH.sub.3 H 0.811 min; M.sup.+ + H = 309.0 I-24 H H CH.sub.3, CH.sub.3 F, F [00730] CH.sub.3 CH.sub.3 H 0.809 min; M.sup.+ + H = 309.0 I-25 H H CH.sub.3, CH.sub.3 F, F [00731] H Br H 0.955 min; M.sup.+ + H = 352.8 I-26 H H CH.sub.3, CH.sub.3 F, F [00732] Cl H H 0.903 min; M.sup.+ + H = 308.9 I-27 H Cl CH.sub.3, CH.sub.3 F, F [00733] CI H H 1.2 min; M.sup.+ + H = 343.2 I-28 CF3 H CH.sub.3, CH.sub.3 F, F [00734] H H H 1.210 min; M.sup.+ + H = 342.9 I-29 H H CH.sub.3, CH.sub.3 F, F [00735] Cl H CH.sub.3 1.288 & 1.230 min; M.sup.+ + H = 323.0 I-30 H H CH.sub.3, CH.sub.3 F, F [00736] H Br CH.sub.3 1.277 & 1.306 min; M.sup.+ + H = 366.9 I-31 H H CH.sub.3, CH.sub.3 F, F [00737] [00738] H O, 817 min; M.sup.+ + H = 333.0 I-32 H H CH.sub.3, CH.sub.3 F, F [00739] [00740] H O, 789 min; M.sup.+ + H = 328.0 I-33 H H CH.sub.3, CH.sub.3 F, F [00741] [00742] H O, 986 min; M.sup.+ + H = 336.9 *HPLC-MS: HPLC-column Kinetex XB C18 1.7 (50 2.1 mm); eluent: acetonitrile/water 0.1% TFA (5 gradient from 5:95 to 100:0 in 1.5 min at 60 C., flow gradient from 0.8 to 1.0 ml/min in 1.5 min). MS: Quadrupol Electrospray Ionisation, 80 V (positive Mode).

TABLE-US-00017 TABLE II The positions of the heteroaryls given as R.sup.7 + R.sup.8 marked with # represents the connection points (carbon atoms 5 and 6 in formula B) with the remaining skeleton of the compounds of formula [00743] Data (Mp [ C.]; NMR ( in ppm); HPLC-MS (R.sub.t No. R.sup.3 R.sup.4 R.sup.5 R.sup.6 R.sup.7 R.sup.8 Y [min], M.sup.+ + H) B-1 CH.sub.3 CH.sub.3 F F Phenyl H HPLC-MS: 196.1 g/mol bei 0.805 min B-2 CH.sub.3 CH.sub.3 H H Phenyl S-Benzyl 282.0 g/mol bei 1.020 min B-4 CH.sub.3 CH.sub.3 H H Phenyl S-Phenyl 268.0 g/mol bei 0.866 min B-5 CH.sub.3 CH.sub.3 F F Phenyl S-Phenyl 303.9 g/mol bei 1.438 min B-8 CH.sub.3 CH.sub.3 H H Phenyl C(O)OLi M = 203.9 (0.569 min) B-9 CH.sub.3 CH.sub.3 H H Phenyl C(O)OK .sup.1H-NMR (in D.sub.2O, in ppm) 1.2 (s, 6H); 2.8 (s, 2H); 7.3 (d, 1H); 7.4 (t, 1H); 7.45 (d, 1H); 7.5 (t, 1H) B-10 CH.sub.3 CH.sub.3 F F Phenyl C(O)OC.sub.2H.sub.5 M = 268 (1.168 min) B-11 CH.sub.3 CH.sub.3 F F Phenyl C(O)OLi M = 239.9 (0.797 min) B-13 CH.sub.3 CH.sub.3 F F Phenyl C(O)OCH.sub.3 253.9 g/mol bei 1.096 min B-14 CH3 C.sub.2H.sub.5 F F Phenyl C(O)OC.sub.2H.sub.5 282.1 g/mol bei 1.261 min B-15 CH.sub.3 CH.sub.3 F F [00744] C(O)OC.sub.2H.sub.5 285.8 g/mol bei 1.193 min; 7.85 (m, 1H); 7.48 (d, 1H); 7.25 (m, 1H); 4.45 (q, 2H); 1.45 (t, 3H); 1.4 (s, 6H)

TABLE-US-00018 TABLE III The positions of the heteroaryls given as R.sup.7 + R.sup.8 marked with # represents the connection points (carbon atoms 5 and 6 in formula C) with the remaining skeleton of the compounds of formula [00745] Data (Mp [ C.]; NMR ( in ppm); HPLC-MS (R.sub.t No. R.sup.3 R.sup.4 R.sup.5 R.sup.6 R.sup.7 R.sup.8 [min], M.sup.+ + H) C-1 CH.sub.3 CH.sub.3 F F Phenyl Fp: 110 C./M = 211.9 (0.889 min)

TABLE-US-00019 TABLE IV The positions of the heteroaryls given as R.sup.7 + R.sup.8 marked with # represents the connection points (carbon atoms 5 and 6 in formula II) with the remaining skeleton of the compounds of formula [00746] Data (Mp [ C.]; NMR ( in ppm); HPLC-MS (R.sub.t [min], M.sup.+ + H); No. R.sup.3 R.sup.4 R.sup.7 R.sup.8 R.sup.9 R.sup.10 elemental analysis 1 CH.sub.3 CH.sub.3 Phenyl CHCl.sub.2 CH.sub.3 HPLC-MS: 332.9 g/mol bei 0.892 min 2 CH.sub.3 CH.sub.3 Phenyl CHF.sub.2 CH.sub.3 HPLC-MS: 301.1 g/mol bei 0.815 min

TABLE-US-00020 TABLE V The positions of the heteroaryls given as R.sup.7 + R.sup.8 marked with # represents the connection points (carbon atoms 5 and 6 in formula D) with the remaining skeleton of the compounds of formulae [00747] Data (Mp [ C.]; NMR ( in ppm); HPLC- MS R.sub.t ([min], No. R.sup.1 R.sup.2 R.sup.3 R.sup.4 R.sup.5 R.sup.6 R.sup.7 R.sup.8 R.sup.9 R.sup.10 M.sup.+ + H); D-1 H H CH.sub.3 CH.sub.3 F F Phen- CH.sub.3 CH.sub.3 Fp: yl 105 C./ M = 319 (0.871 min) [00748] Data (Mp [ C.]; NMR ( in ppm); HPLC- MS R.sub.t ([min], M.sup.+ + H); elemental No. R.sup.1 R.sup.2 R.sup.3 R.sup.4 R.sup.5 R.sup.6 R.sup.7 R.sup.8 R.sup.9 R.sup.10 analysis D-2 H H CH.sub.3 CH.sub.3 F F Phen- CH.sub.3 CH.sub.3 Fp: yl 91 C./ M = 335 (0.995 min)